| 1 |
LYLVCGERV |
Insulin |
9 |
39–47 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.98 |
-0.43 |
0.00 |
1,051.40 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
10.1155/2016/9083103 |
| 2 |
VYLKTNVFL |
IGRP |
9 |
206–214 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1155/2016/9083103 |
| 3 |
LYLACERLL |
ZnT8 |
9 |
158–166 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.01 |
1.13 |
-0.56 |
0.00 |
1,093.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1155/2016/9083103 |
| 4 |
SYNSVKEII |
ZnT8 |
9 |
282–290 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.10 |
-0.07 |
-0.07 |
0.00 |
1,052.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1155/2016/9083103 |
| 5 |
TYWCYITEL |
DβH |
9 |
233–241 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.08 |
0.27 |
-1.16 |
-1.00 |
1,191.49 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
10.1155/2016/9083103 |
| 6 |
NLAQDLATV |
GFAP |
9 |
143–151 |
-- |
-- |
Homo Sapiens |
HLA‐A2 |
-- |
-- |
-- |
-- |
-0.01 |
0.47 |
-0.34 |
-1.00 |
944.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 7 |
SLEEEIRFL |
GFAP |
9 |
192–200 |
-- |
-- |
Homo Sapiens |
HLA‐A2 |
-- |
-- |
-- |
-- |
-0.16 |
-0.10 |
0.49 |
-2.00 |
1,135.41 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 8 |
QLARQQVHV |
GFAP |
9 |
214–222 |
-- |
-- |
Homo Sapiens |
HLA‐A2 |
-- |
-- |
-- |
-- |
-0.26 |
-0.47 |
-0.24 |
1.50 |
1,078.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 9 |
KLQVFLIVL |
IAPP |
9 |
5–13 |
-- |
-- |
Homo Sapiens |
HLA‐A2 |
-- |
-- |
-- |
-- |
0.25 |
2.19 |
-1.06 |
1.00 |
1,072.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 10 |
FLIVLSVAL |
IAPP |
9 |
9–17 |
-- |
-- |
Homo Sapiens |
HLA‐A2 |
-- |
-- |
-- |
-- |
0.44 |
3.12 |
-1.43 |
0.00 |
974.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 11 |
FLWSVFWLI |
IGRP |
9 |
152–160 |
-- |
-- |
Homo Sapiens |
HLA‐A2 |
-- |
-- |
-- |
-- |
0.45 |
2.14 |
-2.04 |
0.00 |
1,210.62 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 12 |
FLFAVGFYL |
IGRP |
9 |
215–223 |
-- |
-- |
Homo Sapiens |
HLA‐A2 |
-- |
-- |
-- |
-- |
0.43 |
2.26 |
-1.71 |
0.00 |
1,076.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 13 |
RLLCALTSL |
IGRP |
9 |
293–301 |
-- |
-- |
Homo Sapiens |
HLA‐A2 |
-- |
-- |
-- |
-- |
0.02 |
1.50 |
-0.64 |
1.00 |
989.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 14 |
SLSPLQAEL |
IA‐2 |
9 |
172–180 |
-- |
-- |
-- |
HLA‐A*0201 |
-- |
HLA‐A*0201 |
-- |
-- |
-0.01 |
0.33 |
-0.23 |
-1.00 |
957.22 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 15 |
SLAAGVKLL |
IA‐2 |
9 |
482–490 |
-- |
-- |
-- |
HLA‐A*0201 |
-- |
HLA‐A*0201 |
-- |
-- |
0.16 |
1.57 |
-0.51 |
1.00 |
871.22 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 16 |
KLQVFLIVL |
IAPP |
9 |
5–13 |
-- |
-- |
-- |
HLA‐A*0201 |
-- |
HLA‐A*0201 |
-- |
-- |
0.25 |
2.19 |
-1.06 |
1.00 |
1,072.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 17 |
ALWMRLLPL |
Insulin L |
9 |
2–10 |
-- |
-- |
-- |
HLA‐A*0201 |
-- |
HLA‐A*0201 |
-- |
-- |
0.13 |
1.32 |
-1.04 |
1.00 |
1,112.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 18 |
HLVEALYLV |
Insulin B |
9 |
10–18 |
-- |
-- |
-- |
HLA‐A*0201 |
-- |
HLA‐A*0201 |
-- |
-- |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1111/j.1365-2249.2006.03244.x |
| 19 |
MNILLEYVVKSFD |
GAD65 |
14 |
115‐127 |
-- |
GAD115–127 transglutaminated at position 120 (GAD120E) |
-- |
DRB1*04:01 |
-- |
DRB1*04:01 |
0.2 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
10.2337/db13-1952 |
| 20 |
PENLEEILMHCETTLKYAIK |
GAD65 |
20 |
153‐172 |
-- |
GAD153–172 transglutaminated at positions 154 and 164 (GAD154E,164E) |
-- |
DRB1*04:01 |
-- |
DRB1*04:01 |
12.79 |
-- |
-0.13 |
-0.31 |
0.14 |
-1.50 |
2,376.09 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
10.2337/db13-1952 |
| 21 |
KGMAALPXLIAFTSEHSHFS |
GAD65 |
20 |
265‐284 |
-- |
GAD265–284 citrullinated at position 272 (GAD272cit) |
-- |
DRB1*04:01 |
-- |
DRB1*04:01 |
0.81 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
10.2337/db13-1952 |
| 22 |
HGDTTFEYQDIPALDSLTPANED |
IA-2 |
23 |
449-460 |
-- |
-- |
Diabetic mice |
-- |
-- |
-- |
-- |
-- |
-0.16 |
-0.89 |
0.25 |
-5.50 |
2,549.97 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
10.1177/1479164116664189 |
| 23 |
VLGGGVALLRVIPALDSLYPANED |
IA-2 |
24 |
-- |
-- |
-- |
Diabetic mice |
-- |
-- |
-- |
-- |
-- |
0.06 |
0.69 |
-0.28 |
-2.00 |
2,453.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
10.1177/1479164116664189 |
| 24 |
EVKEKGMAALPRLIA |
GAD65 |
15 |
261-275 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.12 |
0.15 |
0.35 |
1.00 |
1,626.21 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 25 |
AAALGIGTDSVILIK |
GAD65 |
15 |
289-303 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.17 |
1.40 |
-0.41 |
0.00 |
1,441.96 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 26 |
ERTYLVNDKAAKMHA |
ZnT8 |
15 |
5 - 19 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.29 |
-0.85 |
0.39 |
1.50 |
1,747.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 27 |
LQQKPVNKDQCPRER |
ZnT8 |
15 |
27-41 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.59 |
-2.03 |
0.97 |
2.00 |
1,839.32 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 28 |
YAYAKWKLCSASAI |
ZnT8 |
14 |
67-80 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.36 |
-0.57 |
2.00 |
1,575.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 29 |
SSKPPSKRLTFGWHR |
ZnT8 |
15 |
124-138 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.37 |
-1.40 |
0.29 |
4.50 |
1,784.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 30 |
YKIADPICTFIFSIL |
ZnT8 |
15 |
244-258 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.18 |
1.33 |
-0.79 |
0.00 |
1,744.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 31 |
IFSILVLASTITILK |
ZnT8 |
15 |
254-268 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.26 |
2.09 |
-0.95 |
1.00 |
1,632.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 32 |
DSQVVRREIAKALSK |
ZnT8 |
15 |
326-340 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.36 |
-0.57 |
0.75 |
2.00 |
1,700.18 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 33 |
ESPVDQDPDCLFCED |
ZnT8 |
15 |
352-366 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.23 |
-0.85 |
0.71 |
-6.00 |
1,711.98 |
Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 34 |
ALIDVFHQY |
GFAP or S100-b |
9 |
10–18 |
-- |
-- |
-- |
A*02:01 (A2.1) |
I |
A*02:01 (A2.1) |
-- |
-- |
0.10 |
0.62 |
-0.86 |
-0.50 |
1,105.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
doi: 10.1096/fj.201802270R |
| 35 |
GREGDKHKL |
GFAP or S100-b |
9 |
20–28 |
-- |
-- |
-- |
A*02:01 (A2.1) |
I |
A*02:01 (A2.1) |
-- |
-- |
-0.54 |
-2.17 |
1.41 |
1.50 |
1,039.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
doi: 10.1096/fj.201802270R |
| 36 |
CACDEKPCSCSKVDVNYAFL |
GAD65 |
20 |
GAD 73‐92 |
-- |
77E (E denotes a transglutamination) |
-- |
DR0401 |
-- |
-- |
5.02 |
-- |
-0.13 |
0.12 |
0.06 |
-1.00 |
2,195.78 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 37 |
MNILLEYVVKSFD |
GAD65 |
13 |
GAD115‐127 a [a indicates peptides that were shown to be immunogenic] |
-- |
120E (E denotes a transglutamination) |
-- |
DR0401 |
-- |
-- |
0.2 |
-- |
0.03 |
0.67 |
-0.38 |
-1.00 |
1,571.06 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 38 |
PENLEEILMHCETTLKYAIK |
GAD65 |
20 |
GAD 153‐172 a |
-- |
154E, 164E (E denotes a transglutamination) |
-- |
DR0401 |
-- |
-- |
12.79 |
-- |
-0.13 |
-0.31 |
0.14 |
-1.50 |
2,376.09 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 39 |
RYFNELSTGLDMVGLAADWL |
GAD65 |
20 |
GAD 177‐196 |
-- |
181E (E denotes a transglutamination) |
-- |
DR0401 |
-- |
-- |
2.7 |
-- |
-0.01 |
0.23 |
-0.35 |
-2.00 |
2,271.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 40 |
EAKEKGFVPFLVSATAGTTV |
GAD65 |
20 |
GAD 321‐340 |
-- |
324E (E denotes a transglutamination) |
-- |
DR0401 |
-- |
-- |
5.09 |
-- |
0.01 |
0.36 |
-0.08 |
0.00 |
2,052.64 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 41 |
YAFLHATDLLPACDGEXPTL |
GAD65 |
20 |
GAD 89‐108 a [a indicates peptides that were shown to be immunogenic] |
-- |
105X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
2.88 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 42 |
KGMAALPXLIAFTSEHSHFS |
GAD65 |
20 |
GAD 265‐284 a [a indicates peptides that were shown to be immunogenic] |
-- |
272X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
0.81 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 43 |
HKWKLSGVEXANSVTWNPHK |
GAD65 |
20 |
GAD 377‐396 |
-- |
386X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
7.94 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 44 |
DKALQCGXHVDVFKLWLMW |
GAD65 |
19 |
GAD 441‐456 |
-- |
448X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
20.55 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 45 |
KCLELAEYLYNIIKNXEGYE |
GAD65 |
20 |
GAD 473‐492 |
-- |
488X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
0.89 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 46 |
LYNIIKNXEGYEMVFDGKPQ |
GAD65 |
20 |
GAD 481‐500 |
-- |
488X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
3.81 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 47 |
CFWYIPPSLXTLEDNEEXMS |
GAD65 |
20 |
GAD 505‐524 |
-- |
514X, 522X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
3.3 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 48 |
VAPVIKAXMMEYGTTMVSYQ |
GAD65 |
20 |
GAD 529‐548 |
-- |
536X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
5.23 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 49 |
VSYQPLGDKVNFFXMVISNP |
GAD65 |
20 |
GAD 545‐564 |
-- |
558X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
8.07 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 50 |
KVNFFXMVISNPAATHQDID |
GAD65 |
20 |
GAD 553‐572 a [a indicates peptides that were shown to be immunogenic] |
-- |
558X (X denotes a citrullination) |
-- |
DR0401 |
-- |
-- |
0.04 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 51 |
SPSLWEIEFAKQLASV |
28S ribosomal protein S31, mitochondrial |
16 |
263 - 278 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
ELISPOT |
0.00 |
0.21 |
-0.23 |
-1.00 |
1,805.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 29976617 |
| 52 |
SPSLWEIEFAKQLASV |
28S ribosomal protein S31, mitochondrial |
16 |
263 - 278 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
0.00 |
0.21 |
-0.23 |
-1.00 |
1,805.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 29976617 |
| 53 |
SPSLWEIEFAKQLASV |
28S ribosomal protein S31, mitochondrial |
16 |
263 - 278 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.00 |
0.21 |
-0.23 |
-1.00 |
1,805.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 29976617 |
| 54 |
PSLWEIEFAKQLAS |
28S ribosomal protein S31, mitochondrial |
14 |
264 - 277 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
ELISPOT |
-0.02 |
0.00 |
-0.18 |
-1.00 |
1,619.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 29976617 |
| 55 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17065344 |
| 56 |
VLGGGVALLRVIPALDSLYPANED |
60 kDa heat shock protein, mitochondrial |
24 |
-- |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.06 |
0.69 |
-0.28 |
-2.00 |
2,453.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17065344 |
| 57 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17065344 |
| 58 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17065344 |
| 59 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17478003 |
| 60 |
VLGGGVALLRVIPALDSLYPANED |
60 kDa heat shock protein, mitochondrial |
24 |
-- |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.06 |
0.69 |
-0.28 |
-2.00 |
2,453.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17478003 |
| 61 |
VLGGGVALLRVIPALDSLYPANED |
60 kDa heat shock protein, mitochondrial |
24 |
-- |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DRB1*04:01;HLA-DRB1*04:04 |
-- |
Multimer/tetramer |
0.06 |
0.69 |
-0.28 |
-2.00 |
2,453.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16249070 |
| 62 |
VLGGGVALLRVIPALDSLYPANED |
60 kDa heat shock protein, mitochondrial |
24 |
-- |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DRB1*04:01;HLA-DRB1*04:04 |
-- |
CFSE |
0.06 |
0.69 |
-0.28 |
-2.00 |
2,453.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16249070 |
| 63 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7911924 |
| 64 |
VLGGGVALLRVIPALDSLYPANED |
60 kDa heat shock protein, mitochondrial |
24 |
-- |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
0.06 |
0.69 |
-0.28 |
-2.00 |
2,453.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 65 |
TVIIEQSWGSPKVTKDGVTV |
60 kDa heat shock protein, mitochondrial |
20 |
61 - 80 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.05 |
0.03 |
-0.07 |
0.00 |
2,144.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 66 |
DGVTVAKSIDLKDKYKNIGA |
60 kDa heat shock protein, mitochondrial |
20 |
76 - 95 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.19 |
-0.42 |
0.47 |
1.00 |
2,135.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 67 |
EEIAQVATISANGDKDIGNI |
60 kDa heat shock protein, mitochondrial |
20 |
166 - 185 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.08 |
-0.15 |
0.27 |
-3.00 |
2,058.53 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 68 |
RKGVITVKDGKTLNDELEII |
60 kDa heat shock protein, mitochondrial |
20 |
195 - 214 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.20 |
-0.32 |
0.57 |
0.00 |
2,241.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 69 |
KGDKAHIEKRIQEITEQLDI |
60 kDa heat shock protein, mitochondrial |
20 |
361 - 380 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.32 |
-1.07 |
0.85 |
-0.50 |
2,365.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 70 |
RTALLDAAGVASLLTTAEAV |
60 kDa heat shock protein, mitochondrial |
20 |
526 - 545 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
0.05 |
0.98 |
-0.26 |
-1.00 |
1,943.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 71 |
TAEAVVTEIPKEEKDPGMGA |
60 kDa heat shock protein, mitochondrial |
20 |
541 - 560 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.14 |
-0.52 |
0.63 |
-3.00 |
2,072.60 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 72 |
EEIAQVATISANGDKDIGNI |
60 kDa heat shock protein, mitochondrial |
20 |
166 - 185 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.08 |
-0.15 |
0.27 |
-3.00 |
2,058.53 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 73 |
LAKLSDGVAVLKVGG |
60 kDa heat shock protein, mitochondrial |
15 |
394 - 408 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
0.07 |
0.95 |
-0.11 |
1.00 |
1,426.95 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 74 |
LAKLSDGVAVLKVGG |
60 kDa heat shock protein, mitochondrial |
15 |
394 - 408 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR3;HLA-DR4;HLA-DQB1*02:01;HLA-DQB1*02:02;HLA-DQB1*03:02 |
-- |
3H-thymidine |
0.07 |
0.95 |
-0.11 |
1.00 |
1,426.95 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644 |
| 75 |
VLGGGCALLRCIPALDSLKPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR1;HLA-DR3;HLA-DQ2;HLA-DQ1 |
-- |
3H-thymidine |
-0.03 |
0.44 |
-0.01 |
-1.00 |
2,426.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816975 |
| 76 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816975 |
| 77 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR4;HLA-DQ8 |
-- |
3H-thymidine |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816975 |
| 78 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816975 |
| 79 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA class I |
I |
-- |
-- |
Biological activity |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9073547 |
| 80 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA class I |
I |
-- |
-- |
Biological activity |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9073547 |
| 81 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 82 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 83 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 84 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 85 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 86 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 87 |
VMRIINEPTAAAIAY + CITR(R3) |
78 kDa glucose-regulated protein |
26 |
195 - 209 |
-- |
VMRIINEPTAAAIAY + CITR(R3) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 88 |
VMRIINEPTAAAIAY + CITR(R3) |
78 kDa glucose-regulated protein |
26 |
195 - 209 |
-- |
VMRIINEPTAAAIAY + CITR(R3) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 89 |
EVTFEIDVNGILRVT + CITR(R13) |
78 kDa glucose-regulated protein |
27 |
498 - 512 |
-- |
EVTFEIDVNGILRVT + CITR(R13) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 90 |
TFEIDVNGILRVTAE + CITR(R11) |
78 kDa glucose-regulated protein |
27 |
500 - 514 |
-- |
TFEIDVNGILRVTAE + CITR(R11) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 91 |
VMRIINEPTAAAIAY |
78 kDa glucose-regulated protein |
15 |
195 - 209 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.05 |
0.78 |
-0.45 |
0.00 |
1,633.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 92 |
EVTFEIDVNGILRVT |
78 kDa glucose-regulated protein |
15 |
498 - 512 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.53 |
-0.07 |
-2.00 |
1,705.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 93 |
VEKAKRALSSQHQA + CITR(R6) |
78 kDa glucose-regulated protein |
25 |
292 - 305 |
-- |
VEKAKRALSSQHQA + CITR(R6) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18390725 |
| 94 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 95 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 96 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 97 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 98 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 99 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 100 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 101 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 102 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17327428 |
| 103 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16641112 |
| 104 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16641112 |
| 105 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16641112 |
| 106 |
MLYQHLLPL + OX(M1) |
alternatively spliced Insulin |
18 |
-- |
-- |
MLYQHLLPL + OX(M1) |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16641112 |
| 107 |
GIVEQCCTSICS |
Chain A, Insulin, Monoclinic Crystal Form |
12 |
1 - 12 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.02 |
0.92 |
-0.39 |
-1.00 |
1,242.61 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432 |
| 108 |
QCCTSICSLYQL |
Chain A, Insulin, Monoclinic Crystal Form |
12 |
5 - 16 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.01 |
0.75 |
-0.84 |
0.00 |
1,361.78 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432 |
| 109 |
SLYQLENYC |
Chain A, Insulin, Monoclinic Crystal Form |
9 |
12 - 20 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432 |
| 110 |
GIVEQCCTSICS |
Chain A, Insulin, Monoclinic Crystal Form |
12 |
1 - 12 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.02 |
0.92 |
-0.39 |
-1.00 |
1,242.61 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432 |
| 111 |
FVNQHLCGSHLVEAL |
Chain B, Structure Of Insulin |
15 |
1 - 15 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.05 |
0.59 |
-0.65 |
0.00 |
1,667.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432 |
| 112 |
QHLCGSHLVEALYLV |
Chain B, Structure Of Insulin |
15 |
4 - 18 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.09 |
0.80 |
-0.77 |
0.00 |
1,682.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432 |
| 113 |
QHLCGSHLVEALYLV |
Chain B, Structure Of Insulin |
15 |
4 - 18 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.09 |
0.80 |
-0.77 |
0.00 |
1,682.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432 |
| 114 |
HLCGSHLVEALYLVC |
Chain B, Structure Of Insulin |
15 |
5 - 19 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.14 |
1.20 |
-0.85 |
0.00 |
1,657.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432 |
| 115 |
GSHLVEALYLVCGER |
Chain B, Structure Of Insulin |
15 |
8 - 22 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7722468 |
| 116 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7722468 |
| 117 |
HLVEALYLVCGERGF |
Chain B, Structure Of Insulin |
15 |
10 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
0.03 |
0.67 |
-0.41 |
-0.50 |
1,706.22 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7722468 |
| 118 |
HLVEALYLVCGERGF |
Chain B, Structure Of Insulin |
15 |
10 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
0.03 |
0.67 |
-0.41 |
-0.50 |
1,706.22 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7722468 |
| 119 |
LVEALYLVCGERGFF |
Chain B, Structure Of Insulin |
15 |
11 - 25 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.10 |
1.07 |
-0.55 |
-1.00 |
1,716.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11978633 |
| 120 |
LVEALYLVCGERGFF |
Chain B, Structure Of Insulin |
15 |
11 - 25 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.10 |
1.07 |
-0.55 |
-1.00 |
1,716.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10330297 |
| 121 |
VEALYLVCGERGFFY |
Chain B, Structure Of Insulin |
15 |
12 - 26 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.07 |
0.73 |
-0.58 |
-1.00 |
1,766.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10330297 |
| 122 |
VEALYLVCGERGFFY |
Chain B, Structure Of Insulin |
15 |
12 - 26 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.07 |
0.73 |
-0.58 |
-1.00 |
1,766.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10330297 |
| 123 |
LYLVCGERGFFYTPK |
Chain B, Structure Of Insulin |
15 |
15 - 29 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.03 |
0.15 |
-0.47 |
1.00 |
1,793.33 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10330297 |
| 124 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 125 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 126 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 127 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 128 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 129 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 130 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 131 |
HLVEALYLV |
Chain B, Structure Of Insulin |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 132 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 133 |
HLVEALYLV |
Chain B, Structure Of Insulin |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 134 |
VCGERGFFYT |
Chain B, Structure Of Insulin |
10 |
18 - 27 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 135 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 136 |
LCGSHLVEALYLVCGER |
Chain B, Structure Of Insulin |
17 |
6 - 22 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.75 |
-0.36 |
-0.50 |
1,862.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 137 |
LCGSHLVEALYLVCGER |
Chain B, Structure Of Insulin |
17 |
6 - 22 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.75 |
-0.36 |
-0.50 |
1,862.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 138 |
LCGSHLVEALYLVCGER |
Chain B, Structure Of Insulin |
17 |
6 - 22 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.75 |
-0.36 |
-0.50 |
1,862.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 139 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 140 |
SHLVEALYLVCGERG |
Chain B, Structure Of Insulin |
15 |
9 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 141 |
LYLVCGERG |
Chain B, Structure Of Insulin |
9 |
15 - 23 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 142 |
HLVEALYLV |
Chain B, Structure Of Insulin |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 143 |
HLVEALYLV |
Chain B, Structure Of Insulin |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 144 |
HLVEALYLV |
Chain B, Structure Of Insulin |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 145 |
HLVEALYLV |
Chain B, Structure Of Insulin |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 146 |
MLRLPTVFRQMRPVSRVLAP |
60 kDa heat shock protein, mitochondrial |
20 |
1 - 20 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.19 |
0.23 |
-0.17 |
4.00 |
2,368.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 147 |
RVLAPHLTRAYAKDVKFGAD |
60 kDa heat shock protein, mitochondrial |
20 |
16 - 35 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.25 |
0.18 |
2.50 |
2,228.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317 |
| 148 |
LLADAVAVTMGPKGRTVIIE |
60 kDa heat shock protein, mitochondrial |
20 |
46 - 65 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
ELISA |
0.04 |
0.86 |
-0.16 |
0.00 |
2,054.78 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11414702 |
| 149 |
NEEAGDGTTTATVLARSIAK |
60 kDa heat shock protein, mitochondrial |
20 |
106 - 125 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.17 |
-0.35 |
0.34 |
-1.00 |
2,005.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11414702 |
| 150 |
RSIAKEGFEKISKGANPVEI |
60 kDa heat shock protein, mitochondrial |
20 |
121 - 140 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.20 |
-0.50 |
0.57 |
1.00 |
2,173.79 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11414702 |
| 151 |
EEIAQVATISANGDKEIGNI |
60 kDa heat shock protein, mitochondrial |
20 |
166 - 185 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
-0.15 |
0.27 |
-3.00 |
2,072.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816972 |
| 152 |
LVIIAEDVDGEALSTLVLNR |
60 kDa heat shock protein, mitochondrial |
20 |
271 - 290 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.02 |
0.82 |
-0.06 |
-3.00 |
2,140.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8565273 |
| 153 |
KAPGFGDNRKNQLKDMAIAT |
60 kDa heat shock protein, mitochondrial |
20 |
301 - 320 |
-- |
-- |
Homo sapiens |
H2-IEg7 |
II |
-- |
-- |
3H-thymidine |
-0.28 |
-0.92 |
0.46 |
2.00 |
2,175.78 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8565273 |
| 154 |
KFGADARALMLQGVDLLADA |
60 kDa heat shock protein, mitochondrial |
20 |
31 - 50 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.03 |
0.49 |
0.01 |
-1.00 |
2,075.70 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 155 |
VIAELKKQSKPVTTPEEIAQ |
60 kDa heat shock protein, mitochondrial |
20 |
151 - 170 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.49 |
0.42 |
0.00 |
2,209.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 156 |
RKGVITVKDGKTLNDELEII |
60 kDa heat shock protein, mitochondrial |
20 |
195 - 214 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.20 |
-0.32 |
0.57 |
0.00 |
2,241.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 157 |
QDAYVLLSEKKISSIQSIVP |
60 kDa heat shock protein, mitochondrial |
20 |
240 - 259 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.07 |
0.17 |
-0.06 |
0.00 |
2,218.88 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 158 |
VTDALNATRAAVEEGIVLGG |
60 kDa heat shock protein, mitochondrial |
20 |
421 - 440 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.54 |
-0.03 |
-2.00 |
1,956.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 159 |
NPVEIRRGVMLAVDAVIAEL |
60 kDa heat shock protein, mitochondrial |
20 |
136 - 155 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.79 |
-0.04 |
-1.00 |
2,165.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 160 |
LVLNRLKVGLQVVAVKAPGF |
60 kDa heat shock protein, mitochondrial |
20 |
286 - 305 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.04 |
1.05 |
-0.44 |
3.00 |
2,121.96 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 161 |
IVLGGGCALLRCIPALDSLT |
60 kDa heat shock protein, mitochondrial |
20 |
436 - 455 |
-- |
-- |
Homo sapiens |
HLA-DR1 |
II |
-- |
-- |
Biological activity |
0.14 |
1.43 |
-0.56 |
0.00 |
1,985.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8700877 |
| 162 |
QSIVPALEIANAHRKPLVIIA |
60 kDa heat shock protein, mitochondrial |
21 |
255 - 275 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.02 |
0.72 |
-0.31 |
1.50 |
2,254.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 163 |
GEVIVTKDDAMLLKGKGDKA |
60 kDa heat shock protein, mitochondrial |
20 |
346 - 365 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.16 |
-0.28 |
0.65 |
0.00 |
2,088.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 164 |
EIIKRTLKIPAMTIAKNAGV |
60 kDa heat shock protein, mitochondrial |
20 |
466 - 485 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.33 |
0.06 |
3.00 |
2,167.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11206414 |
| 165 |
VNMVEKGIIDPTKVVRTALL |
60 kDa heat shock protein, mitochondrial |
20 |
511 - 530 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
-0.05 |
0.55 |
-0.03 |
1.00 |
2,196.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 166 |
VLGGGCALLRCIPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795 |
| 167 |
VLGGGCALLRCIPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11465945 |
| 168 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
RNA/DNA detection |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11465945 |
| 169 |
IPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
13 |
448 - 460 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
RNA/DNA detection |
-0.08 |
-0.23 |
0.21 |
-3.00 |
1,355.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11465945 |
| 170 |
VLGGGCALLRCIPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISA |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11172025 |
| 171 |
VLGGGCALLRCIPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9148785 |
| 172 |
WSKMDQLAKELTAE |
Chromogranin-A |
14 |
342 - 355 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.22 |
-0.79 |
0.41 |
-1.00 |
1,650.08 |
Non-Toxin |
IEDB;SATPdb |
Type 1 Diabetes |
-- |
PMID: 9148785 |
| 173 |
VLEVISDSL |
Chromogranin-A |
9 |
36 - 44 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.11 |
1.32 |
-0.20 |
-2.00 |
974.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9148785 |
| 174 |
LQTLALWSRMD |
Chromogranin-A |
11 |
Insulin-1 (75-80) Chromogranin-A (358-362) |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.10 |
0.11 |
-0.41 |
0.00 |
1,333.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9148785 |
| 175 |
LQTLALWSRMD |
Chromogranin-A |
11 |
Insulin-1 (75-80) Chromogranin-A (358-362) |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Biological activity |
-0.10 |
0.11 |
-0.41 |
0.00 |
1,333.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19120311 |
| 176 |
LQTLALWSRMD |
Chromogranin-A |
11 |
Insulin-1 (75-80) Chromogranin-A (358-362) |
-- |
-- |
Mus musculus |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
-0.10 |
0.11 |
-0.41 |
0.00 |
1,333.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19292763 |
| 177 |
LQTLALWSRMD |
Chromogranin-A |
11 |
Insulin-1 (75-80) Chromogranin-A (358-362) |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.10 |
0.11 |
-0.41 |
0.00 |
1,333.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17376840 |
| 178 |
WSRMDQLAKELTAE |
Chromogranin-A |
14 |
358 - 371 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.27 |
-0.84 |
0.41 |
-1.00 |
1,678.09 |
Non-Toxin |
IEDB;SATPdb |
Type 1 Diabetes |
-- |
PMID: 17947651 |
| 179 |
WSRMDQLAKELTAE |
Chromogranin-A |
14 |
358 - 371 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
3H-thymidine |
-0.27 |
-0.84 |
0.41 |
-1.00 |
1,678.09 |
Non-Toxin |
IEDB;SATPdb |
Type 1 Diabetes |
-- |
PMID: 16979383 |
| 180 |
WSRMDQLAKELTAE |
Chromogranin-A |
14 |
358 - 371 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
3H-thymidine |
-0.27 |
-0.84 |
0.41 |
-1.00 |
1,678.09 |
Non-Toxin |
IEDB;SATPdb |
Type 1 Diabetes |
-- |
PMID: 16979383 |
| 181 |
WSRMDQLAKELTAE |
Chromogranin-A |
14 |
358 - 371 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.27 |
-0.84 |
0.41 |
-1.00 |
1,678.09 |
Non-Toxin |
IEDB;SATPdb |
Type 1 Diabetes |
-- |
PMID: 16283109 |
| 182 |
WSRMDQLAKELTAE |
Chromogranin-A |
14 |
358 - 371 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.27 |
-0.84 |
0.41 |
-1.00 |
1,678.09 |
Non-Toxin |
IEDB;SATPdb |
Type 1 Diabetes |
-- |
PMID: 16283109 |
| 183 |
WSRMDQLAKELTAE |
Chromogranin-A |
14 |
358 - 371 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
ELISPOT |
-0.27 |
-0.84 |
0.41 |
-1.00 |
1,678.09 |
Non-Toxin |
IEDB;SATPdb |
Type 1 Diabetes |
-- |
PMID: 16283109 |
| 184 |
DTKVMKCVLEVISD |
Chromogranin-A |
14 |
29 - 42 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
ELISPOT |
-0.11 |
0.39 |
0.32 |
-1.00 |
1,580.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16283109 |
| 185 |
LLCAGQVFAL |
Chromogranin-A |
10 |
10 - 19 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
bioassay |
0.28 |
2.06 |
-1.12 |
0.00 |
1,034.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 186 |
SLSKPSPMPV |
Chromogranin-A |
10 |
43 - 52 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.08 |
-0.12 |
-0.07 |
1.00 |
1,042.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 187 |
LLCAGQVFAL |
Chromogranin-A |
10 |
10 - 19 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.28 |
2.06 |
-1.12 |
0.00 |
1,034.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 188 |
SLSKPSPMPV |
Chromogranin-A |
10 |
43 - 52 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.08 |
-0.12 |
-0.07 |
1.00 |
1,042.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 189 |
LLCAGQVFAL |
Chromogranin-A |
10 |
10 - 19 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.28 |
2.06 |
-1.12 |
0.00 |
1,034.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 190 |
LLCAGQVFAL |
Chromogranin-A |
10 |
10 - 19 |
-- |
-- |
Mus musculus |
HLA-DRB1*16:01 |
II |
-- |
-- |
3H-thymidine |
0.28 |
2.06 |
-1.12 |
0.00 |
1,034.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9650096 |
| 191 |
LLCAGQVFAL |
Chromogranin-A |
10 |
10 - 19 |
-- |
-- |
Mus musculus |
HLA-DRB1*16:01 |
II |
-- |
-- |
3H-thymidine |
0.28 |
2.06 |
-1.12 |
0.00 |
1,034.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9650096 |
| 192 |
SLSKPSPMPV |
Chromogranin-A |
10 |
43 - 52 |
-- |
-- |
Mus musculus |
HLA-DRB1*16:01 |
II |
-- |
-- |
ELISA |
-0.08 |
-0.12 |
-0.07 |
1.00 |
1,042.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9650096 |
| 193 |
SLSKPSPMPV |
Chromogranin-A |
10 |
43 - 52 |
-- |
-- |
Mus musculus |
HLA-DRB1*16:01 |
II |
-- |
-- |
ELISA |
-0.08 |
-0.12 |
-0.07 |
1.00 |
1,042.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9650096 |
| 194 |
SLSKPSPMPV |
Chromogranin-A |
10 |
43 - 52 |
-- |
-- |
Mus musculus |
HLA-DRB1*16:01 |
II |
-- |
-- |
ELISA |
-0.08 |
-0.12 |
-0.07 |
1.00 |
1,042.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9650096 |
| 195 |
LLCAGQVTAL |
Chromogranin-A |
10 |
10 - 19 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.20 |
1.71 |
-0.91 |
0.00 |
988.36 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16263242 |
| 196 |
TLSKPSPMPV |
Chromogranin-A |
10 |
43 - 52 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.07 |
-0.11 |
-0.14 |
1.00 |
1,056.42 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16263242 |
| 197 |
DVMNILLQYVVKSFDRSTKV |
Glutamate decarboxylase 2 |
20 |
113 - 132 |
-- |
-- |
Homo sapiens |
HLA-DRB1*15:01 |
II |
-- |
-- |
3H-thymidine |
-0.13 |
0.18 |
-0.10 |
1.00 |
2,356.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283 |
| 198 |
TQYEAVATSNMQE |
Glial fibrillary acidic protein |
13 |
237 - 249 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.20 |
-0.87 |
0.00 |
-2.00 |
1,471.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283 |
| 199 |
TQYEAVATSNMQE |
Glial fibrillary acidic protein |
13 |
237 - 249 |
-- |
-- |
Mus musculus |
HLA-DRB1*16:01 |
II |
-- |
-- |
3H-thymidine |
-0.20 |
-0.87 |
0.00 |
-2.00 |
1,471.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283 |
| 200 |
WYRSKFADL |
Glial fibrillary acidic protein |
9 |
253 - 261 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.23 |
-0.72 |
-0.13 |
1.00 |
1,185.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283 |
| 201 |
AELNQLRAKEPTKLA |
Glial fibrillary acidic protein |
15 |
96 - 110 |
-- |
-- |
Mus musculus |
HLA-DRB4*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.30 |
-0.79 |
0.54 |
1.00 |
1,682.17 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11905849 |
| 202 |
ELRELRLRLDQLTAN |
Glial fibrillary acidic protein |
15 |
116 - 130 |
-- |
-- |
Mus musculus |
HLA-DRB4*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.39 |
-0.73 |
0.57 |
0.00 |
1,840.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11905849 |
| 203 |
QVHVEMDVAKPDLTA |
Glial fibrillary acidic protein |
15 |
216 - 230 |
-- |
-- |
Mus musculus |
HLA-DRB4*01:01 |
II |
-- |
-- |
ELISA |
-0.11 |
-0.10 |
0.18 |
-1.50 |
1,653.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11905849 |
| 204 |
NLAQDLATV |
Glial fibrillary acidic protein |
9 |
143 - 151 |
-- |
-- |
Homo sapiens |
HLA-DRB4*01:01 |
II |
-- |
-- |
ELISA |
-0.01 |
0.47 |
-0.34 |
-1.00 |
944.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11905849 |
| 205 |
QLARQQVHV |
Glial fibrillary acidic protein |
9 |
214 - 222 |
-- |
-- |
Homo sapiens |
HLA-DRB4*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.26 |
-0.47 |
-0.24 |
1.50 |
1,078.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11905849 |
| 206 |
EWVHIDTTPFASL |
Glucose-6-phosphatase |
13 |
249 - 261 |
-- |
-- |
Homo sapiens |
HLA-DRB4*01:01 |
II |
-- |
-- |
3H-thymidine |
0.05 |
0.17 |
-0.50 |
-1.50 |
1,515.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11905849 |
| 207 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DRB4*01:01 |
II |
-- |
-- |
ELISA |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11905849 |
| 208 |
PIAKKWCANPDWIHI |
Glucose-6-phosphatase 2 |
15 |
237 - 251 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
Multimer/tetramer |
-0.04 |
-0.23 |
-0.37 |
1.50 |
1,792.35 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 209 |
KWCANPDWIHIDSTP |
Glucose-6-phosphatase 2 |
15 |
241 - 255 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
3H-thymidine |
-0.11 |
-0.72 |
-0.22 |
-0.50 |
1,783.20 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 210 |
NPDWIHIDSTPFAGL |
Glucose-6-phosphatase 2 |
15 |
245 - 259 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
3H-thymidine |
0.02 |
-0.15 |
-0.41 |
-1.50 |
1,683.07 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 211 |
INSEMFLRSCQGENG |
Glucose-6-phosphatase 2 |
15 |
273 - 287 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.20 |
-0.59 |
0.12 |
-1.00 |
1,685.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 212 |
KWCANPDWI |
Glucose-6-phosphatase 2 |
9 |
241 - 249 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.09 |
-0.61 |
-0.43 |
0.00 |
1,132.42 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 213 |
LRLFGIDLL |
Glucose-6-phosphatase 2 |
9 |
225 - 233 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.13 |
1.57 |
-0.61 |
0.00 |
1,059.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 214 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 215 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 216 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15277377 |
| 217 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
51 chromium |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18157812 |
| 218 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18157812 |
| 219 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18157812 |
| 220 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-B15 |
I |
-- |
-- |
51 chromium |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10439311 |
| 221 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17376837 |
| 222 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17376837 |
| 223 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17376837 |
| 224 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283 |
| 225 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283 |
| 226 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DRB1*15:01 |
II |
-- |
-- |
ELISA |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283 |
| 227 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DRB1*15:01 |
II |
-- |
-- |
ELISA |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283 |
| 228 |
TAALSYTISRMEESSVTL |
Glucose-6-phosphatase 2 |
18 |
128 - 145 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.21 |
-0.14 |
-1.00 |
1,959.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7997851 |
| 229 |
LHRSGVLIIHHLQEDYRTY |
Glucose-6-phosphatase 2 |
19 |
4 - 22 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
51 chromium |
-0.18 |
-0.47 |
-0.24 |
1.50 |
2,350.97 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 230 |
WYVMVTAALSYTISRMEESSVTL |
Glucose-6-phosphatase 2 |
23 |
123 - 145 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
0.01 |
0.51 |
-0.54 |
-1.00 |
2,638.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 231 |
HTPGVHMASLSVYLKTNVFL |
Glucose-6-phosphatase 2 |
20 |
195 - 214 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
0.05 |
0.52 |
-0.73 |
2.00 |
2,214.92 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 232 |
TYYGFLNFM |
Glucose-6-phosphatase 2 |
9 |
21 - 29 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
0.15 |
0.46 |
-1.43 |
0.00 |
1,155.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 233 |
QLNQNVGTK |
Glucose-6-phosphatase 2 |
9 |
48 - 56 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
-0.30 |
-1.22 |
0.01 |
1.00 |
1,001.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 234 |
NQNVGTKMI |
Glucose-6-phosphatase 2 |
9 |
50 - 58 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
-0.17 |
-0.54 |
-0.16 |
1.00 |
1,004.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 235 |
GHAMGSSCV |
Glucose-6-phosphatase 2 |
9 |
114 - 122 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
0.05 |
0.53 |
-0.47 |
0.50 |
848.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 236 |
ALSYTISRM |
Glucose-6-phosphatase 2 |
9 |
130 - 138 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
-0.07 |
0.43 |
-0.50 |
1.00 |
1,041.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 237 |
RMEESSVTL |
Glucose-6-phosphatase 2 |
9 |
137 - 145 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.26 |
-0.43 |
0.51 |
-1.00 |
1,051.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 238 |
VFWLIQISV |
Glucose-6-phosphatase 2 |
9 |
156 - 164 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
0.34 |
2.09 |
-1.53 |
0.00 |
1,104.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 239 |
SRVFIATHF |
Glucose-6-phosphatase 2 |
9 |
167 - 175 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
0.02 |
0.77 |
-0.71 |
1.50 |
1,077.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 240 |
ATHFPHQVI |
Glucose-6-phosphatase 2 |
9 |
172 - 180 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
0.04 |
0.12 |
-0.83 |
1.00 |
1,049.33 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 241 |
FEHTPGVHM |
Glucose-6-phosphatase 2 |
9 |
193 - 201 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.01 |
-0.41 |
-0.41 |
0.00 |
1,054.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 242 |
LSVYLKTNV |
Glucose-6-phosphatase 2 |
9 |
204 - 212 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
0.00 |
0.64 |
-0.64 |
1.00 |
1,036.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 243 |
YLKTNVFLF |
Glucose-6-phosphatase 2 |
9 |
207 - 215 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
0.10 |
0.89 |
-1.07 |
1.00 |
1,144.51 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 244 |
LRLFGIDLL |
Glucose-6-phosphatase 2 |
9 |
225 - 233 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
51 chromium |
0.13 |
1.57 |
-0.61 |
0.00 |
1,059.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 245 |
KWCANPDWI |
Glucose-6-phosphatase 2 |
9 |
241 - 249 |
-- |
-- |
Mus musculus |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
-0.09 |
-0.61 |
-0.43 |
0.00 |
1,132.42 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19292763 |
| 246 |
CANPDWIHI |
Glucose-6-phosphatase 2 |
9 |
243 - 251 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
51 chromium |
0.03 |
0.07 |
-0.64 |
-0.50 |
1,068.34 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430939 |
| 247 |
GLVRNLGVL |
Glucose-6-phosphatase 2 |
9 |
258 - 266 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.07 |
1.22 |
-0.58 |
1.00 |
940.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7997851 |
| 248 |
GFAINSEMF |
Glucose-6-phosphatase 2 |
9 |
270 - 278 |
-- |
-- |
Mus musculus |
HLA-DQ |
II |
HLA-DQB1*02:01;HLA-DQB1*03:02;HLA-DQB1*05:01;HLA-DQ2 |
-- |
3H-thymidine |
0.12 |
0.62 |
-0.57 |
-1.00 |
1,015.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321 |
| 249 |
CQGENGTKP |
Glucose-6-phosphatase 2 |
9 |
282 - 290 |
-- |
-- |
Mus musculus |
HLA-DQ |
II |
HLA-DQB1*03:02;HLA-DQB1*05:01 |
-- |
3H-thymidine |
-0.33 |
-1.67 |
0.56 |
0.00 |
933.13 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10570321 |
| 250 |
GTKPSFRLL |
Glucose-6-phosphatase 2 |
9 |
287 - 295 |
-- |
-- |
Mus musculus |
HLA-DQ |
II |
HLA-DQB1*02:01;HLA-DQB1*03:02;HLA-DQB1*05:01 |
-- |
3H-thymidine |
-0.17 |
-0.17 |
-0.02 |
2.00 |
1,018.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321 |
| 251 |
CALTSLTTM |
Glucose-6-phosphatase 2 |
9 |
296 - 304 |
-- |
-- |
Mus musculus |
HLA-DQ |
II |
HLA-DQB1*02:01;HLA-DQB1*03:02;HLA-DQB1*05:01;HLA-DQ2 |
-- |
3H-thymidine |
0.09 |
1.21 |
-0.81 |
0.00 |
940.26 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10570321 |
| 252 |
LTSLTTMQL |
Glucose-6-phosphatase 2 |
9 |
298 - 306 |
-- |
-- |
Mus musculus |
HLA-DQ |
II |
HLA-DQB1*02:01;HLA-DQB1*03:02;HLA-DQB1*05:01;HLA-DQ2;HLA-DQB1*06:09 |
-- |
3H-thymidine |
0.04 |
0.77 |
-0.82 |
0.00 |
1,007.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321 |
| 253 |
THAEPLFYL |
Glucose-6-phosphatase 2 |
9 |
314 - 322 |
-- |
-- |
Mus musculus |
HLA-DQ |
II |
HLA-DQB1*02:01;HLA-DQB1*03:02;HLA-DQB1*05:01;HLA-DQ2;HLA-DQB1*06:09 |
-- |
3H-thymidine |
0.07 |
0.21 |
-0.76 |
-0.50 |
1,090.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321 |
| 254 |
HAEPLFYLL |
Glucose-6-phosphatase 2 |
9 |
315 - 323 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.15 |
0.71 |
-0.91 |
-0.50 |
1,102.43 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 255 |
SFCKSASIP |
Glucose-6-phosphatase 2 |
9 |
324 - 332 |
-- |
-- |
Mus musculus |
HLA-DRB5*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.04 |
0.41 |
-0.21 |
1.00 |
939.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 256 |
YLKTNVFLF |
Glucose-6-phosphatase 2 |
9 |
207 - 215 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.10 |
0.89 |
-1.07 |
1.00 |
1,144.51 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 17475829 |
| 257 |
DFLHRSGVL |
Glucose-6-phosphatase 2 |
9 |
2 - 10 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
3H-thymidine |
-0.09 |
0.24 |
-0.20 |
0.50 |
1,043.32 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 15549775 |
| 258 |
FLHRSGVLI |
Glucose-6-phosphatase 2 |
9 |
3 - 11 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
Cytometric bead array |
0.08 |
1.13 |
-0.73 |
1.50 |
1,041.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15549775 |
| 259 |
DYRTYYGFL |
Glucose-6-phosphatase 2 |
9 |
18 - 26 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
Cytometric bead array |
-0.14 |
-0.71 |
-0.62 |
0.00 |
1,197.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15549775 |
| 260 |
GDPRNIFSI |
Glucose-6-phosphatase 2 |
9 |
33 - 41 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
Cytometric bead array |
-0.14 |
-0.28 |
0.04 |
0.00 |
1,018.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15549775 |
| 261 |
IYFPLWFQL |
Glucose-6-phosphatase 2 |
9 |
41 - 49 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
Cytometric bead array |
0.29 |
1.16 |
-1.77 |
0.00 |
1,226.62 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15549775 |
| 262 |
QLNQNVGTK |
Glucose-6-phosphatase 2 |
9 |
48 - 56 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
Cytometric bead array |
-0.30 |
-1.22 |
0.01 |
1.00 |
1,001.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15549775 |
| 263 |
NQNVGTKMI |
Glucose-6-phosphatase 2 |
9 |
50 - 58 |
-- |
-- |
Mus musculus |
HLA-DRB4*01:03 |
II |
-- |
-- |
ELISA |
-0.17 |
-0.54 |
-0.16 |
1.00 |
1,004.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 264 |
IYPNHSSPC |
Glucose-6-phosphatase 2 |
9 |
89 - 97 |
-- |
-- |
Mus musculus |
HLA-DRB4*01:03 |
II |
-- |
-- |
3H-thymidine |
-0.10 |
-0.64 |
-0.53 |
0.50 |
1,017.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 265 |
YPNHSSPCL |
Glucose-6-phosphatase 2 |
9 |
90 - 98 |
-- |
-- |
Mus musculus |
HLA-DRB4*01:03 |
II |
-- |
-- |
3H-thymidine |
-0.12 |
-0.72 |
-0.53 |
0.50 |
1,017.24 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 266 |
ALSYTISRM |
Glucose-6-phosphatase 2 |
9 |
130 - 138 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
ELISA |
-0.07 |
0.43 |
-0.50 |
1.00 |
1,041.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 267 |
YTISRMEES |
Glucose-6-phosphatase 2 |
9 |
133 - 141 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.30 |
-0.97 |
0.42 |
-1.00 |
1,115.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 268 |
SRMEESSVT |
Glucose-6-phosphatase 2 |
9 |
136 - 144 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.35 |
-0.94 |
0.74 |
-1.00 |
1,025.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 269 |
ESSVTLHRL |
Glucose-6-phosphatase 2 |
9 |
140 - 148 |
-- |
-- |
Mus musculus |
HLA-DPw2 |
II |
-- |
-- |
ELISA |
-0.21 |
-0.19 |
0.07 |
0.50 |
1,041.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 270 |
SFLWSVFWL |
Glucose-6-phosphatase 2 |
9 |
151 - 159 |
-- |
-- |
Mus musculus |
HLA-DPw2 |
II |
-- |
-- |
3H-thymidine |
0.34 |
1.56 |
-1.81 |
0.00 |
1,184.53 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 271 |
THFPHQVIL |
Glucose-6-phosphatase 2 |
9 |
173 - 181 |
-- |
-- |
Mus musculus |
HLA-DPw2 |
II |
-- |
-- |
3H-thymidine |
0.07 |
0.34 |
-0.98 |
1.00 |
1,091.42 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 272 |
FEHTPGVHM |
Glucose-6-phosphatase 2 |
9 |
193 - 201 |
-- |
-- |
Mus musculus |
HLA-DR |
II |
-- |
-- |
ELISA |
-0.01 |
-0.41 |
-0.41 |
0.00 |
1,054.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 273 |
HMASLSVYL |
Glucose-6-phosphatase 2 |
9 |
200 - 208 |
-- |
-- |
Mus musculus |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
0.13 |
1.04 |
-1.01 |
0.50 |
1,020.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 274 |
LSVYLKTNV |
Glucose-6-phosphatase 2 |
9 |
204 - 212 |
-- |
-- |
Mus musculus |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.64 |
-0.64 |
1.00 |
1,036.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 275 |
KWCANPDWI |
Glucose-6-phosphatase 2 |
9 |
241 - 249 |
-- |
-- |
Mus musculus |
HLA-DRB4*01:03 |
II |
-- |
-- |
51 chromium |
-0.09 |
-0.61 |
-0.43 |
0.00 |
1,132.42 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 276 |
CANPDWIHI |
Glucose-6-phosphatase 2 |
9 |
243 - 251 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
51 chromium |
0.03 |
0.07 |
-0.64 |
-0.50 |
1,068.34 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911 |
| 277 |
GLVRNLGVL |
Glucose-6-phosphatase 2 |
9 |
258 - 266 |
-- |
-- |
Mus musculus |
H2-Kb |
I |
-- |
-- |
ICS |
0.07 |
1.22 |
-0.58 |
1.00 |
940.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17615584 |
| 278 |
LGFAINSEM |
Glucose-6-phosphatase 2 |
9 |
269 - 277 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.11 |
0.73 |
-0.49 |
-1.00 |
981.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9776713 |
| 279 |
GFAINSEMF |
Glucose-6-phosphatase 2 |
9 |
270 - 278 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
ELISA |
0.12 |
0.62 |
-0.57 |
-1.00 |
1,015.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9776713 |
| 280 |
FAINSEMFL |
Glucose-6-phosphatase 2 |
9 |
271 - 279 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
ELISA |
0.16 |
1.09 |
-0.77 |
-1.00 |
1,071.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9776713 |
| 281 |
CQGENGTKP |
Glucose-6-phosphatase 2 |
9 |
282 - 290 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
ELISA |
-0.33 |
-1.67 |
0.56 |
0.00 |
933.13 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9776713 |
| 282 |
LTSLTTMQL |
Glucose-6-phosphatase 2 |
9 |
298 - 306 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
ELISA |
0.04 |
0.77 |
-0.82 |
0.00 |
1,007.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9776713 |
| 283 |
TSLTTMQLY |
Glucose-6-phosphatase 2 |
9 |
299 - 307 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.02 |
0.20 |
-0.88 |
0.00 |
1,057.36 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 284 |
MQLYRFIKI |
Glucose-6-phosphatase 2 |
9 |
304 - 312 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.07 |
0.48 |
-0.59 |
2.00 |
1,211.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 285 |
RFIKIPTHA |
Glucose-6-phosphatase 2 |
9 |
308 - 316 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.13 |
-0.03 |
-0.17 |
2.50 |
1,082.44 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 286 |
KIPTHAEPL |
Glucose-6-phosphatase 2 |
9 |
311 - 319 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.10 |
-0.49 |
0.11 |
0.50 |
1,005.31 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 287 |
THAEPLFYL |
Glucose-6-phosphatase 2 |
9 |
314 - 322 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
0.07 |
0.21 |
-0.76 |
-0.50 |
1,090.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 288 |
HAEPLFYLL |
Glucose-6-phosphatase 2 |
9 |
315 - 323 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
0.15 |
0.71 |
-0.91 |
-0.50 |
1,102.43 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 289 |
LSFCKSASI |
Glucose-6-phosphatase 2 |
9 |
323 - 331 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
0.03 |
1.01 |
-0.41 |
1.00 |
955.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 290 |
CKSASIPLM |
Glucose-6-phosphatase 2 |
9 |
326 - 334 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
0.01 |
0.82 |
-0.31 |
1.00 |
949.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 291 |
DYRTYYGFL |
Glucose-6-phosphatase 2 |
9 |
18 - 26 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.14 |
-0.71 |
-0.62 |
0.00 |
1,197.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 292 |
QLNQNVGTK |
Glucose-6-phosphatase 2 |
9 |
48 - 56 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.30 |
-1.22 |
0.01 |
1.00 |
1,001.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 293 |
IYPNHSSPC |
Glucose-6-phosphatase 2 |
9 |
89 - 97 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.10 |
-0.64 |
-0.53 |
0.50 |
1,017.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 294 |
GHAMGSSCV |
Glucose-6-phosphatase 2 |
9 |
114 - 122 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
0.05 |
0.53 |
-0.47 |
0.50 |
848.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 295 |
YTISRMEES |
Glucose-6-phosphatase 2 |
9 |
133 - 141 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.30 |
-0.97 |
0.42 |
-1.00 |
1,115.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 296 |
SRMEESSVT |
Glucose-6-phosphatase 2 |
9 |
136 - 144 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.35 |
-0.94 |
0.74 |
-1.00 |
1,025.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16492987 |
| 297 |
RMEESSVTL |
Glucose-6-phosphatase 2 |
9 |
137 - 145 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.26 |
-0.43 |
0.51 |
-1.00 |
1,051.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16398702 |
| 298 |
ATHFPHQVI |
Glucose-6-phosphatase 2 |
9 |
172 - 180 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
ELISPOT |
0.04 |
0.12 |
-0.83 |
1.00 |
1,049.33 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16398702 |
| 299 |
YLKTNVFLF |
Glucose-6-phosphatase 2 |
9 |
207 - 215 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
0.10 |
0.89 |
-1.07 |
1.00 |
1,144.51 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16398702 |
| 300 |
LRLFGIDLL |
Glucose-6-phosphatase 2 |
9 |
225 - 233 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
ELISPOT |
0.13 |
1.57 |
-0.61 |
0.00 |
1,059.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16398702 |
| 301 |
KWCANPDWI |
Glucose-6-phosphatase 2 |
9 |
241 - 249 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.09 |
-0.61 |
-0.43 |
0.00 |
1,132.42 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16398702 |
| 302 |
GLVRNLGVL |
Glucose-6-phosphatase 2 |
9 |
258 - 266 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
ELISPOT |
0.07 |
1.22 |
-0.58 |
1.00 |
940.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16398702 |
| 303 |
LGFAINSEM |
Glucose-6-phosphatase 2 |
9 |
269 - 277 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
0.11 |
0.73 |
-0.49 |
-1.00 |
981.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16398702 |
| 304 |
GFAINSEMF |
Glucose-6-phosphatase 2 |
9 |
270 - 278 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
ELISPOT |
0.12 |
0.62 |
-0.57 |
-1.00 |
1,015.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16398702 |
| 305 |
FAINSEMFL |
Glucose-6-phosphatase 2 |
9 |
271 - 279 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.16 |
1.09 |
-0.77 |
-1.00 |
1,071.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11160133 |
| 306 |
CQGENGTKP |
Glucose-6-phosphatase 2 |
9 |
282 - 290 |
-- |
-- |
Mus musculus |
HLA-DQ8 |
II |
-- |
-- |
3H-thymidine |
-0.33 |
-1.67 |
0.56 |
0.00 |
933.13 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11160133 |
| 307 |
GTKPSFRLL |
Glucose-6-phosphatase 2 |
9 |
287 - 295 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
ELISPOT |
-0.17 |
-0.17 |
-0.02 |
2.00 |
1,018.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11160133 |
| 308 |
RLLCALTSL |
Glucose-6-phosphatase 2 |
9 |
293 - 301 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.02 |
1.50 |
-0.64 |
1.00 |
989.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9421467 |
| 309 |
KIPTHAEPL |
Glucose-6-phosphatase 2 |
9 |
311 - 319 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.10 |
-0.49 |
0.11 |
0.50 |
1,005.31 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16339897 |
| 310 |
HAEPLFYLL |
Glucose-6-phosphatase 2 |
9 |
315 - 323 |
-- |
-- |
Mus musculus |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.15 |
0.71 |
-0.91 |
-0.50 |
1,102.43 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 311 |
CKSASIPLM |
Glucose-6-phosphatase 2 |
9 |
326 - 334 |
-- |
-- |
Mus musculus |
HLA-DRB5*01:01 |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.82 |
-0.31 |
1.00 |
949.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 312 |
FGIDLLWSV |
Glucose-6-phosphatase 2 |
9 |
228 - 236 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.28 |
1.50 |
-1.06 |
-1.00 |
1,049.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10360970 |
| 313 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10360970 |
| 314 |
ALIPYCVHM |
Glucose-6-phosphatase 2 |
9 |
337 - 345 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.40 |
-1.19 |
0.50 |
1,046.44 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14599847 |
| 315 |
FGIDLLWSV |
Glucose-6-phosphatase 2 |
9 |
228 - 236 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISA |
0.28 |
1.50 |
-1.06 |
-1.00 |
1,049.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14599847 |
| 316 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISA |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14599847 |
| 317 |
AINSEMFLR |
Glucose-6-phosphatase 2 |
9 |
272 - 280 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISA |
-0.10 |
0.28 |
-0.16 |
0.00 |
1,080.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14599847 |
| 318 |
AINSEMFLR |
Glucose-6-phosphatase 2 |
9 |
272 - 280 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
In vivo assay |
-0.10 |
0.28 |
-0.16 |
0.00 |
1,080.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14599847 |
| 319 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14599847 |
| 320 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 321 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 322 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 323 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 324 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 325 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 326 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 327 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 328 |
TKMIWVAVIGDWFNLIFK |
Glucose-6-phosphatase 2 |
18 |
55 - 72 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.15 |
0.96 |
-0.83 |
1.00 |
2,181.95 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 329 |
FAINSEMFLRSCQGENGT |
Glucose-6-phosphatase 2 |
18 |
271 - 288 |
-- |
-- |
Mus musculus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.28 |
-0.09 |
-1.00 |
2,004.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713 |
| 330 |
LTTMQLYRFIKIPTHAEP |
Glucose-6-phosphatase 2 |
18 |
301 - 318 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:04 |
II |
-- |
-- |
Multimer/tetramer |
-0.09 |
-0.12 |
-0.35 |
1.50 |
2,159.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11978633 |
| 331 |
FIKIPTHAEPLFYLLSFC |
Glucose-6-phosphatase 2 |
18 |
309 - 326 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.14 |
0.92 |
-0.83 |
0.50 |
2,139.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11751995 |
| 332 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956 |
| 333 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11751995 |
| 334 |
FGIDLLWSV |
Glucose-6-phosphatase 2 |
9 |
228 - 236 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.28 |
1.50 |
-1.06 |
-1.00 |
1,049.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956 |
| 335 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DPB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956 |
| 336 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DPB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956 |
| 337 |
VYLKTNVFL |
Glucose-6-phosphatase 2 |
9 |
206 - 214 |
-- |
-- |
Mus musculus |
HLA-DPB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956 |
| 338 |
MASPGSGFWSFGSEDGSGDS |
Glutamate decarboxylase 2 |
20 |
1 - 20 |
-- |
-- |
Homo sapiens |
HLA-DPB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.04 |
-0.53 |
0.03 |
-3.00 |
1,965.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956 |
| 339 |
LLYGDAEKPAESGGSQPPRA |
Glutamate decarboxylase 2 |
20 |
47 - 66 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
51 chromium |
-0.20 |
-0.92 |
0.42 |
-1.00 |
2,043.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12815107 |
| 340 |
LAFLQDVMNILLQYVVKSFDRS |
Glutamate decarboxylase 2 |
22 |
108 - 129 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.03 |
0.58 |
-0.43 |
0.00 |
2,600.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12815107 |
| 341 |
EEILMHCQTTLKYAIKTGHP |
Glutamate decarboxylase 2 |
20 |
157 - 176 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
51 chromium |
-0.11 |
-0.37 |
-0.11 |
1.00 |
2,314.03 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12815107 |
| 342 |
KTGHPRYFNQLSTGLDMVGL |
Glutamate decarboxylase 2 |
20 |
172 - 191 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
51 chromium |
-0.12 |
-0.40 |
-0.23 |
1.50 |
2,234.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12815107 |
| 343 |
TNMFTYEIAPVFVLLEYVTL |
Glutamate decarboxylase 2 |
20 |
202 - 221 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
RNA/DNA detection |
0.16 |
1.05 |
-0.91 |
-2.00 |
2,364.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9840449 |
| 344 |
GGSGDGIFSPGGAISNMYAM |
Glutamate decarboxylase 2 |
20 |
232 - 251 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
RNA/DNA detection |
0.09 |
0.22 |
-0.39 |
-1.00 |
1,889.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9840449 |
| 345 |
NMYAMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
20 |
247 - 266 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
RNA/DNA detection |
-0.14 |
-0.23 |
0.07 |
2.00 |
2,422.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9840449 |
| 346 |
PEVKEKGMAALPRLIAFTSE |
Glutamate decarboxylase 2 |
20 |
260 - 279 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
ELISA |
-0.11 |
-0.07 |
0.28 |
0.00 |
2,187.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10415012 |
| 347 |
AALGIGTDSVILIKCDERGK |
Glutamate decarboxylase 2 |
20 |
290 - 309 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
ELISA |
-0.08 |
0.30 |
0.27 |
0.00 |
2,059.71 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10415012 |
| 348 |
LEAKQKGFVPFLVSATAGTT |
Glutamate decarboxylase 2 |
20 |
320 - 339 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.34 |
-0.24 |
1.00 |
2,065.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10415012 |
| 349 |
ERANSVTWNPHKMMGVPLQC |
Glutamate decarboxylase 2 |
20 |
385 - 404 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.17 |
-0.57 |
-0.17 |
1.50 |
2,298.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10415012 |
| 350 |
QNCNQMHASYLFQQDKHYDL |
Glutamate decarboxylase 2 |
20 |
416 - 435 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
-0.27 |
-1.25 |
-0.20 |
0.00 |
2,484.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18647597 |
| 351 |
CGRHVDVFKLWLMWRAKGTTG |
Glutamate decarboxylase 2 |
21 |
446 - 466 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
-0.13 |
-0.14 |
-0.24 |
3.50 |
2,462.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18647597 |
| 352 |
KGTTGFEAHVDKCLELAEYLYN |
Glutamate decarboxylase 2 |
22 |
462 - 483 |
-- |
-- |
Homo sapiens |
HLA class I |
I |
-- |
-- |
3H-thymidine |
-0.12 |
-0.40 |
0.04 |
-1.50 |
2,502.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 353 |
EYLYNIIKNREGYEMVFDGK |
Glutamate decarboxylase 2 |
20 |
479 - 498 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.20 |
-0.81 |
0.19 |
-1.00 |
2,482.11 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 354 |
VFDGKPQHTNVCFWYIPPSL |
Glutamate decarboxylase 2 |
20 |
494 - 513 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
RNA/DNA detection |
0.00 |
-0.09 |
-0.62 |
0.50 |
2,349.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 355 |
IPPSLRTLEDNEERMSRLSK |
Glutamate decarboxylase 2 |
20 |
509 - 528 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
HLA-DRB1*04:01;HLA-DRB1*04:03;HLA-DRB1*04:05 |
-- |
3H-thymidine |
-0.41 |
-1.17 |
0.81 |
0.00 |
2,371.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10562307 |
| 356 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19040615 |
| 357 |
EYGTTMVSYQPLGDKVNFFR |
Glutamate decarboxylase 2 |
20 |
539 - 558 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
-0.14 |
-0.49 |
-0.19 |
0.00 |
2,352.94 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19040615 |
| 358 |
VNFFRMVISNPAATHQDIDF |
Glutamate decarboxylase 2 |
20 |
554 - 573 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
HLA-DRB1*04:01;HLA-DRB1*04:03;HLA-DRB1*04:05 |
-- |
3H-thymidine |
-0.05 |
0.15 |
-0.37 |
-0.50 |
2,322.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10562307 |
| 359 |
ATHQDIDFLIEEIERLGQDL |
Glutamate decarboxylase 2 |
20 |
566 - 585 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
HLA-DRB1*04:01;HLA-DRB1*04:03;HLA-DRB1*04:05 |
-- |
3H-thymidine |
-0.15 |
-0.37 |
0.34 |
-4.50 |
2,355.90 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10562307 |
| 360 |
VNFFRMVISNPAAT |
Glutamate decarboxylase 2 |
14 |
554 - 567 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
HLA-DRB1*04:01;HLA-DRB1*04:03;HLA-DRB1*04:05 |
-- |
3H-thymidine |
0.02 |
0.67 |
-0.63 |
1.00 |
1,567.03 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10562307 |
| 361 |
VNFFRMVISNPAAT |
Glutamate decarboxylase 2 |
14 |
554 - 567 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
HLA-DRB1*04:01;HLA-DRB1*04:03;HLA-DRB1*04:05 |
-- |
3H-thymidine |
0.02 |
0.67 |
-0.63 |
1.00 |
1,567.03 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10562307 |
| 362 |
LPRLIAFTSEHSHFSLKK |
Glutamate decarboxylase 2 |
18 |
270 - 287 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
In vivo assay |
-0.15 |
-0.20 |
-0.07 |
3.00 |
2,111.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19040615 |
| 363 |
LPRLIAFTSEHSHFSLKK |
Glutamate decarboxylase 2 |
18 |
270 - 287 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.15 |
-0.20 |
-0.07 |
3.00 |
2,111.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527 |
| 364 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527 |
| 365 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527 |
| 366 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527 |
| 367 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527 |
| 368 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897 |
| 369 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897 |
| 370 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-DQB1*03:02 |
II |
HLA-DQB1*03:02 |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897 |
| 371 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-DQB1*03:02 |
II |
HLA-DQB1*03:02 |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897 |
| 372 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897 |
| 373 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10333048 |
| 374 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10333048 |
| 375 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9480726 |
| 376 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9480726 |
| 377 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9480726 |
| 378 |
ALPRLIAFT + CITR(R4) |
Glutamate decarboxylase 2 |
20 |
269 - 277 |
-- |
ALPRLIAFT + CITR(R4) |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12887099 |
| 379 |
YFNQLSTGL |
Glutamate decarboxylase 2 |
9 |
178 - 186 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.02 |
-0.90 |
0.00 |
1,042.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12887099 |
| 380 |
YFNQLSTGL |
Glutamate decarboxylase 2 |
9 |
178 - 186 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.02 |
-0.90 |
0.00 |
1,042.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12887099 |
| 381 |
IAPVFVLLEYVTLKKMREII |
Glutamate decarboxylase 2 |
20 |
224 - 243 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.05 |
1.06 |
-0.37 |
1.00 |
2,376.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12887099 |
| 382 |
ICKKYKIWMHVDAAWGGGLL |
Glutamate decarboxylase 2 |
20 |
368 - 387 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.03 |
0.30 |
-0.48 |
2.50 |
2,290.10 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12887099 |
| 383 |
VAPVIKARMMEYGTTMVSYQ |
Glutamate decarboxylase 2 |
20 |
544 - 563 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
-0.05 |
0.21 |
-0.35 |
1.00 |
2,276.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12887099 |
| 384 |
KVNFFRMVISNPAATHQDID |
Glutamate decarboxylase 2 |
20 |
568 - 587 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.18 |
-0.09 |
0.50 |
2,303.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8738959 |
| 385 |
ATHQDIDFLIEEIERLGQDL |
Glutamate decarboxylase 2 |
20 |
581 - 600 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.15 |
-0.37 |
0.34 |
-4.50 |
2,355.90 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17513797 |
| 386 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8738959 |
| 387 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-g7 class I |
I |
-- |
-- |
In vivo assay |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17675466 |
| 388 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10756085 |
| 389 |
VSYQPLGDKVNFFRMVISNPAATHQDIDFLIEEIERLGQDL |
Glutamate decarboxylase 2 |
41 |
545 - 585 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.11 |
-0.15 |
-0.01 |
-3.50 |
4,720.97 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10756085 |
| 390 |
CFWYIPPSLRTLEDN |
Glutamate decarboxylase 2 |
15 |
505 - 519 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.10 |
-0.30 |
-0.37 |
-1.00 |
1,854.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10756085 |
| 391 |
CFWYIPPSLRTLEDN |
Glutamate decarboxylase 2 |
15 |
505 - 519 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.10 |
-0.30 |
-0.37 |
-1.00 |
1,854.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10756085 |
| 392 |
ERMSRLSKVAPVIKA |
Glutamate decarboxylase 2 |
15 |
521 - 535 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.26 |
-0.09 |
0.45 |
3.00 |
1,685.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14530340 |
| 393 |
ERMSRLSKVAPVIKA |
Glutamate decarboxylase 2 |
15 |
521 - 535 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.26 |
-0.09 |
0.45 |
3.00 |
1,685.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10756085 |
| 394 |
FLQDVMNIL |
Glutamate decarboxylase 2 |
9 |
110 - 118 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.13 |
1.17 |
-0.81 |
-1.00 |
1,092.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10756085 |
| 395 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10756085 |
| 396 |
LLQEYNWEL |
Glutamate decarboxylase 2 |
9 |
141 - 149 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.07 |
-0.53 |
-0.52 |
-2.00 |
1,207.49 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10756085 |
| 397 |
RMMEYGTTMV |
Glutamate decarboxylase 2 |
10 |
536 - 545 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.12 |
-0.12 |
-0.25 |
0.00 |
1,218.61 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14530340 |
| 398 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
In vivo assay |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19208910 |
| 399 |
APVIKARMMEY |
Glutamate decarboxylase 2 |
11 |
530 - 540 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.11 |
0.12 |
-0.02 |
1.00 |
1,308.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9795769 |
| 400 |
APVIKARMMEY |
Glutamate decarboxylase 2 |
11 |
530 - 540 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.11 |
0.12 |
-0.02 |
1.00 |
1,308.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9795769 |
| 401 |
APVIKARMMEY |
Glutamate decarboxylase 2 |
11 |
530 - 540 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.11 |
0.12 |
-0.02 |
1.00 |
1,308.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9795769 |
| 402 |
APVIKARMMEY |
Glutamate decarboxylase 2 |
11 |
530 - 540 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.11 |
0.12 |
-0.02 |
1.00 |
1,308.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 403 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 404 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 405 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 406 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 407 |
NILLQYVVKSFDRS |
Glutamate decarboxylase 2 |
14 |
116 - 129 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.14 |
0.11 |
-0.23 |
1.00 |
1,682.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 408 |
NILLQYVVKSFDRS |
Glutamate decarboxylase 2 |
14 |
116 - 129 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.14 |
0.11 |
-0.23 |
1.00 |
1,682.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 409 |
LSKVAPVIKARMM |
Glutamate decarboxylase 2 |
13 |
526 - 538 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.07 |
0.72 |
-0.07 |
3.00 |
1,444.06 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 410 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 411 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 412 |
NPAATHQDIDFLI |
Glutamate decarboxylase 2 |
13 |
563 - 575 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
-0.02 |
-0.26 |
-1.50 |
1,454.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 413 |
KVNFFRMVISNPAATHQD |
Glutamate decarboxylase 2 |
18 |
553 - 570 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.15 |
-0.26 |
-0.17 |
1.50 |
2,075.63 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 414 |
TYEIAPVFVLLEYVT |
Glutamate decarboxylase 2 |
15 |
206 - 220 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.18 |
1.11 |
-0.82 |
-2.00 |
1,757.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 415 |
LKKMREIIGWPGGSG |
Glutamate decarboxylase 2 |
15 |
221 - 235 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.11 |
-0.40 |
0.15 |
2.00 |
1,629.19 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 416 |
KKGAAALGIGTDSVI |
Glutamate decarboxylase 2 |
15 |
286 - 300 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.03 |
0.56 |
0.03 |
1.00 |
1,400.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 417 |
IDFLIEEIERLGQDL |
Glutamate decarboxylase 2 |
15 |
571 - 585 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.08 |
0.12 |
0.33 |
-4.00 |
1,803.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 418 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 419 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 420 |
IAFTSEHSHFSLK |
Glutamate decarboxylase 2 |
13 |
274 - 286 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.06 |
-0.09 |
-0.28 |
1.00 |
1,503.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 421 |
MIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
15 |
252 - 266 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.20 |
-0.35 |
0.44 |
2.00 |
1,811.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 422 |
TSEHSHFSL |
Glutamate decarboxylase 2 |
9 |
277 - 285 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.71 |
-0.20 |
0.00 |
1,044.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 423 |
LPRLIAFTSEHSHF |
Glutamate decarboxylase 2 |
14 |
270 - 283 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.09 |
-0.41 |
1.00 |
1,655.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 424 |
LPRLIAFTSEHSHF |
Glutamate decarboxylase 2 |
14 |
270 - 283 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.09 |
-0.41 |
1.00 |
1,655.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 425 |
FFRMVISNPAATHQDIDFLI |
Glutamate decarboxylase 2 |
20 |
556 - 575 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.02 |
0.53 |
-0.48 |
-0.50 |
2,336.00 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 426 |
FFRMVISNPAATHQDIDFLI |
Glutamate decarboxylase 2 |
20 |
556 - 575 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.02 |
0.53 |
-0.48 |
-0.50 |
2,336.00 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 427 |
GHPRYFNQLSTG |
Glutamate decarboxylase 2 |
12 |
174 - 185 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.21 |
-1.11 |
-0.32 |
1.50 |
1,376.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 428 |
NWELADQPQNLEEILMHCQT |
Glutamate decarboxylase 2 |
20 |
146 - 165 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.17 |
-0.79 |
-0.07 |
-3.50 |
2,412.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 429 |
FFRMVISNPAATHQDIDFLI |
Glutamate decarboxylase 2 |
20 |
556 - 575 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.02 |
0.53 |
-0.48 |
-0.50 |
2,336.00 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 430 |
LPRLIAFTSEHSHFS |
Glutamate decarboxylase 2 |
15 |
270 - 284 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.03 |
-0.36 |
1.00 |
1,742.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 431 |
LPRLIAFTSEHSHFS |
Glutamate decarboxylase 2 |
15 |
270 - 284 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.03 |
-0.36 |
1.00 |
1,742.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 432 |
LPRLIAFTSEHSHFS |
Glutamate decarboxylase 2 |
15 |
270 - 284 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.03 |
-0.36 |
1.00 |
1,742.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 433 |
LPRLIAFTSEHSHFS |
Glutamate decarboxylase 2 |
15 |
270 - 284 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.03 |
-0.36 |
1.00 |
1,742.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 434 |
RLIAFTSEHSHF |
Glutamate decarboxylase 2 |
12 |
272 - 283 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.10 |
-0.08 |
-0.33 |
1.00 |
1,444.78 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 435 |
RLIAFTSEHSHF |
Glutamate decarboxylase 2 |
12 |
272 - 283 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.10 |
-0.08 |
-0.33 |
1.00 |
1,444.78 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 436 |
RLIAFTSEHSHF |
Glutamate decarboxylase 2 |
12 |
272 - 283 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.10 |
-0.08 |
-0.33 |
1.00 |
1,444.78 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 437 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 438 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 439 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 440 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 441 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 442 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 443 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 444 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 445 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 446 |
IAFTSEHSHFSLK |
Glutamate decarboxylase 2 |
13 |
274 - 286 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.06 |
-0.09 |
-0.28 |
1.00 |
1,503.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 447 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 448 |
LPRLIAFTSEHSHF |
Glutamate decarboxylase 2 |
14 |
270 - 283 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.09 |
-0.41 |
1.00 |
1,655.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 449 |
FFRMVISNPAATHQDIDFLI |
Glutamate decarboxylase 2 |
20 |
556 - 575 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.02 |
0.53 |
-0.48 |
-0.50 |
2,336.00 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 450 |
RMMEYGTTMVSYQPL |
Glutamate decarboxylase 2 |
15 |
536 - 550 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.11 |
-0.31 |
-0.41 |
0.00 |
1,807.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 451 |
CDGERPTLAFLQDVM |
Glutamate decarboxylase 2 |
15 |
101 - 115 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.12 |
-0.03 |
0.09 |
-2.00 |
1,695.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 452 |
FDRSTKVIDFHYPNE |
Glutamate decarboxylase 2 |
15 |
126 - 140 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.26 |
-1.05 |
0.27 |
-0.50 |
1,868.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 453 |
TYEIAPVFVLLEYVT |
Glutamate decarboxylase 2 |
15 |
206 - 220 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.18 |
1.11 |
-0.82 |
-2.00 |
1,757.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 454 |
KHYDLSYDTGDKALQ |
Glutamate decarboxylase 2 |
15 |
431 - 445 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.29 |
-1.34 |
0.39 |
-0.50 |
1,754.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 455 |
AKGTTGFEAHVDK |
Glutamate decarboxylase 2 |
13 |
461 - 473 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.18 |
-0.74 |
0.44 |
0.50 |
1,360.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 456 |
NYAFLHATDLLP |
Glutamate decarboxylase 2 |
12 |
88 - 99 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.06 |
0.33 |
-0.74 |
-0.50 |
1,374.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 457 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 458 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 459 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 460 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 461 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 462 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 463 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 464 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 465 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 466 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 467 |
GLMQNCNQMHASYLFQQDK |
Glutamate decarboxylase 2 |
19 |
413 - 431 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.20 |
-0.82 |
-0.29 |
0.50 |
2,256.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 468 |
GLMQNCNQMHASYLFQQDK |
Glutamate decarboxylase 2 |
19 |
413 - 431 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.20 |
-0.82 |
-0.29 |
0.50 |
2,256.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 469 |
GLMQNCNQMHASYLFQQDK |
Glutamate decarboxylase 2 |
19 |
413 - 431 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.20 |
-0.82 |
-0.29 |
0.50 |
2,256.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 470 |
GGGLLMSRKHKWKLSGVERAN |
Glutamate decarboxylase 2 |
21 |
368 - 388 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.25 |
-0.75 |
0.30 |
4.50 |
2,325.06 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 471 |
GGGLLMSRKHKWKLSGVERAN |
Glutamate decarboxylase 2 |
21 |
368 - 388 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.25 |
-0.75 |
0.30 |
4.50 |
2,325.06 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 472 |
GGGLLMSRKHKWKLSGVERAN |
Glutamate decarboxylase 2 |
21 |
368 - 388 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.25 |
-0.75 |
0.30 |
4.50 |
2,325.06 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 473 |
ANTNMFTYEIAPVFVLLE |
Glutamate decarboxylase 2 |
18 |
200 - 217 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.11 |
0.74 |
-0.69 |
-2.00 |
2,072.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 474 |
ANTNMFTYEIAPVFVLLE |
Glutamate decarboxylase 2 |
18 |
200 - 217 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.11 |
0.74 |
-0.69 |
-2.00 |
2,072.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 475 |
ANTNMFTYEIAPVFVLLE |
Glutamate decarboxylase 2 |
18 |
200 - 217 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.11 |
0.74 |
-0.69 |
-2.00 |
2,072.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 476 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 477 |
GLMQNCNQMHASYLFQQDK |
Glutamate decarboxylase 2 |
19 |
413 - 431 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.20 |
-0.82 |
-0.29 |
0.50 |
2,256.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 478 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Rattus norvegicus |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 479 |
NYAFLHATDLLP |
Glutamate decarboxylase 2 |
12 |
88 - 99 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
0.06 |
0.33 |
-0.74 |
-0.50 |
1,374.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 480 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 481 |
NMYAMMIARFKMFPEVKEKGMAALPRLIAFTSE |
Glutamate decarboxylase 2 |
33 |
247 - 279 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISPOT |
-0.07 |
0.20 |
-0.10 |
2.00 |
3,824.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957 |
| 482 |
NMYAMMIARFKMFPEVKEKGMAALPRLIAFTSE |
Glutamate decarboxylase 2 |
33 |
247 - 279 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR3;HLA-DR4 |
-- |
3H-thymidine |
-0.07 |
0.20 |
-0.10 |
2.00 |
3,824.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18565729 |
| 483 |
NMYAMMIARFKMFPEVKEKGMAALPRLIAFTSE |
Glutamate decarboxylase 2 |
33 |
247 - 279 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
-0.07 |
0.20 |
-0.10 |
2.00 |
3,824.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18565729 |
| 484 |
EYVTLKKMREIIGWPGGSGD |
Glutamate decarboxylase 2 |
20 |
217 - 236 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4 |
-- |
3H-thymidine |
-0.13 |
-0.54 |
0.20 |
0.00 |
2,236.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18565729 |
| 485 |
AALGIGTDSVILIKCDERGK |
Glutamate decarboxylase 2 |
20 |
290 - 309 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4 |
-- |
3H-thymidine |
-0.08 |
0.30 |
0.27 |
0.00 |
2,059.71 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18565729 |
| 486 |
EYVTLKKMREIIGWPGGSGD |
Glutamate decarboxylase 2 |
20 |
217 - 236 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4 |
-- |
3H-thymidine |
-0.13 |
-0.54 |
0.20 |
0.00 |
2,236.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18565729 |
| 487 |
AALGIGTDSVILIKCDERGK |
Glutamate decarboxylase 2 |
20 |
290 - 309 |
-- |
-- |
Mus musculus |
HLA class II |
II |
HLA-DR3;HLA-DR4 |
-- |
3H-thymidine |
-0.08 |
0.30 |
0.27 |
0.00 |
2,059.71 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18565729 |
| 488 |
TGHPRYFNQLSTGLD |
Glutamate decarboxylase 2 |
15 |
173 - 187 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR3;HLA-DR4 |
-- |
3H-thymidine |
-0.19 |
-0.91 |
-0.20 |
0.50 |
1,706.07 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18565729 |
| 489 |
MVFDGKPQHTNVCFW |
Glutamate decarboxylase 2 |
15 |
493 - 507 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.04 |
-0.19 |
-0.55 |
0.50 |
1,809.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14607967 |
| 490 |
CFWYIPPSLRTLEDN |
Glutamate decarboxylase 2 |
15 |
505 - 519 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.10 |
-0.30 |
-0.37 |
-1.00 |
1,854.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14607967 |
| 491 |
ERMSRLSKVAPVIKA |
Glutamate decarboxylase 2 |
15 |
521 - 535 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.26 |
-0.09 |
0.45 |
3.00 |
1,685.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14607967 |
| 492 |
IKARMMEYGTTMVSY |
Glutamate decarboxylase 2 |
15 |
533 - 547 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
-0.11 |
-0.06 |
-0.25 |
1.00 |
1,781.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11034420 |
| 493 |
VPPSLRTLEDNEERMS |
Glutamate decarboxylase 2 |
16 |
509 - 524 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
ELISA |
-0.36 |
-1.14 |
0.75 |
-2.00 |
1,873.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10843721 |
| 494 |
TNMFTYEIAPVFVLLEYVTL |
Glutamate decarboxylase 2 |
20 |
202 - 221 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
ELISA |
0.16 |
1.05 |
-0.91 |
-2.00 |
2,364.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10843721 |
| 495 |
EYVTLKKMREIIGWPGGSGD |
Glutamate decarboxylase 2 |
20 |
217 - 236 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
-0.13 |
-0.54 |
0.20 |
0.00 |
2,236.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10843721 |
| 496 |
FLQDVMNIL |
Glutamate decarboxylase 2 |
9 |
110 - 118 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
0.13 |
1.17 |
-0.81 |
-1.00 |
1,092.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11034420 |
| 497 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11034420 |
| 498 |
LLQEYNWEL |
Glutamate decarboxylase 2 |
9 |
141 - 149 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
-0.07 |
-0.53 |
-0.52 |
-2.00 |
1,207.49 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11034420 |
| 499 |
ILMHCQTTL |
Glutamate decarboxylase 2 |
9 |
159 - 167 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.07 |
0.93 |
-0.98 |
0.50 |
1,059.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 500 |
ELAEYLYNI |
Glutamate decarboxylase 2 |
9 |
476 - 484 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.02 |
0.09 |
-0.48 |
-2.00 |
1,127.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 501 |
RMMEYGTTMV |
Glutamate decarboxylase 2 |
10 |
536 - 545 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.12 |
-0.12 |
-0.25 |
0.00 |
1,218.61 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 502 |
TYEIAPVFVLLEYVT |
Glutamate decarboxylase 2 |
15 |
206 - 220 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.18 |
1.11 |
-0.82 |
-2.00 |
1,757.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 503 |
TNMFTYEIAPVFVLLEYVTL |
Glutamate decarboxylase 2 |
20 |
202 - 221 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.16 |
1.05 |
-0.91 |
-2.00 |
2,364.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 504 |
EYVTLKKMREIIGWPGGSGD |
Glutamate decarboxylase 2 |
20 |
217 - 236 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.13 |
-0.54 |
0.20 |
0.00 |
2,236.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 505 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 506 |
RMMEYGTTMV |
Glutamate decarboxylase 2 |
10 |
536 - 545 |
-- |
-- |
Rattus norvegicus |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.12 |
-0.12 |
-0.25 |
0.00 |
1,218.61 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 507 |
NYAFLHATDLLP |
Glutamate decarboxylase 2 |
12 |
88 - 99 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.06 |
0.33 |
-0.74 |
-0.50 |
1,374.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18305140 |
| 508 |
MYAMMIARFKMF |
Glutamate decarboxylase 2 |
12 |
248 - 259 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.05 |
0.97 |
-0.78 |
2.00 |
1,540.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15056379 |
| 509 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Rattus norvegicus |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15056379 |
| 510 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Rattus norvegicus |
HLA-DR1 |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9294207 |
| 511 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Rattus norvegicus |
HLA-DR1 |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9294207 |
| 512 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Rattus norvegicus |
HLA-DR1 |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9294207 |
| 513 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Homo sapiens |
HLA-DRA*01:01/DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11257303 |
| 514 |
GMAALPRLIAFTSEHSHFSL |
Glutamate decarboxylase 2 |
20 |
266 - 285 |
-- |
-- |
Homo sapiens |
HLA-DRB1*03:01 |
II |
-- |
-- |
Multimer/tetramer |
0.03 |
0.46 |
-0.47 |
1.00 |
2,185.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034 |
| 515 |
GMAALPRLIAFTSEHSHFSL |
Glutamate decarboxylase 2 |
20 |
266 - 285 |
-- |
-- |
Homo sapiens |
HLA-DRA*01:01/DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.03 |
0.46 |
-0.47 |
1.00 |
2,185.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11257303 |
| 516 |
GMAALPRLIAFTSEHSHFSL |
Glutamate decarboxylase 2 |
20 |
266 - 285 |
-- |
-- |
Homo sapiens |
HLA-DRB1*03:01 |
II |
-- |
-- |
Multimer/tetramer |
0.03 |
0.46 |
-0.47 |
1.00 |
2,185.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034 |
| 517 |
GMAALPRLIAFTSEHSHFSL |
Glutamate decarboxylase 2 |
20 |
266 - 285 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.03 |
0.46 |
-0.47 |
1.00 |
2,185.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034 |
| 518 |
YEMVFDGKPQHTNVCFWYIP |
Glutamate decarboxylase 2 |
20 |
491 - 510 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.03 |
-0.30 |
-0.58 |
-0.50 |
2,475.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034 |
| 519 |
YEMVFDGKPQHTNVCFWYIP |
Glutamate decarboxylase 2 |
20 |
491 - 510 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ICS |
-0.03 |
-0.30 |
-0.58 |
-0.50 |
2,475.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034 |
| 520 |
HTNVCFWYIPPSLRTLEDNE |
Glutamate decarboxylase 2 |
20 |
501 - 520 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ICS |
-0.14 |
-0.56 |
-0.24 |
-1.50 |
2,435.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034 |
| 521 |
HTNVCFWYIPPSLRTLEDNE |
Glutamate decarboxylase 2 |
20 |
501 - 520 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.14 |
-0.56 |
-0.24 |
-1.50 |
2,435.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034 |
| 522 |
PSLRTLEDNEERMSRLSKVA |
Glutamate decarboxylase 2 |
20 |
511 - 530 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.40 |
-1.02 |
0.80 |
0.00 |
2,331.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18198358 |
| 523 |
NMYAMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
20 |
247 - 266 |
-- |
-- |
Homo sapiens |
HLA-DQ |
II |
-- |
-- |
3H-thymidine |
-0.14 |
-0.23 |
0.07 |
2.00 |
2,422.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18565729 |
| 524 |
MMIARFKMFPEVKEKGMAAL |
Glutamate decarboxylase 2 |
20 |
251 - 270 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.07 |
0.30 |
0.06 |
2.00 |
2,329.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18198358 |
| 525 |
EVKEKGMAALPRLIAFTSEH |
Glutamate decarboxylase 2 |
20 |
261 - 280 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.16 |
0.26 |
0.50 |
2,227.90 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18198358 |
| 526 |
YEMVFDGKPQHTNVCFWYIP |
Glutamate decarboxylase 2 |
20 |
491 - 510 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
-0.03 |
-0.30 |
-0.58 |
-0.50 |
2,475.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12086942 |
| 527 |
YEMVFDGKPQHTNVCFWYIP |
Glutamate decarboxylase 2 |
20 |
491 - 510 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
3H-thymidine |
-0.03 |
-0.30 |
-0.58 |
-0.50 |
2,475.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047 |
| 528 |
YEMVFDGKPQHTNVCFWYIP |
Glutamate decarboxylase 2 |
20 |
491 - 510 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.03 |
-0.30 |
-0.58 |
-0.50 |
2,475.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18358785 |
| 529 |
YEMVFDGKPQHTNVCFWYIP |
Glutamate decarboxylase 2 |
20 |
491 - 510 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.03 |
-0.30 |
-0.58 |
-0.50 |
2,475.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18358785 |
| 530 |
HTNVCFWYIPPSLRTLEDNE |
Glutamate decarboxylase 2 |
20 |
501 - 520 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.56 |
-0.24 |
-1.50 |
2,435.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18358785 |
| 531 |
PSLRTLEDNEERMSRLSKVA |
Glutamate decarboxylase 2 |
20 |
511 - 530 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.40 |
-1.02 |
0.80 |
0.00 |
2,331.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18358785 |
| 532 |
PSLRTLEDNEERMSRLSKVA |
Glutamate decarboxylase 2 |
20 |
511 - 530 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.40 |
-1.02 |
0.80 |
0.00 |
2,331.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18358785 |
| 533 |
NMYAMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
20 |
247 - 266 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DRB1*04:01;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.14 |
-0.23 |
0.07 |
2.00 |
2,422.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047 |
| 534 |
NMYAMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
20 |
247 - 266 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
3H-thymidine |
-0.14 |
-0.23 |
0.07 |
2.00 |
2,422.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047 |
| 535 |
NMYAMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
20 |
247 - 266 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DRB1*04:01;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.14 |
-0.23 |
0.07 |
2.00 |
2,422.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047 |
| 536 |
MMIARFKMFPEVKEKGMAAL |
Glutamate decarboxylase 2 |
20 |
251 - 270 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
3H-thymidine |
-0.07 |
0.30 |
0.06 |
2.00 |
2,329.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047 |
| 537 |
MMIARFKMFPEVKEKGMAAL |
Glutamate decarboxylase 2 |
20 |
251 - 270 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DRB1*04:01;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.07 |
0.30 |
0.06 |
2.00 |
2,329.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047 |
| 538 |
EVKEKGMAALPRLIAFTSEH |
Glutamate decarboxylase 2 |
20 |
261 - 280 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DRB1*04:01;HLA-DQB1*03:02 |
-- |
3H-thymidine |
-0.13 |
-0.16 |
0.26 |
0.50 |
2,227.90 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047 |
| 539 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR4;HLA-DQB1*03:02 |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047 |
| 540 |
FWYIPPSLRTLED |
Glutamate decarboxylase 2 |
13 |
506 - 518 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.07 |
-0.27 |
-0.36 |
-1.00 |
1,637.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17459508 |
| 541 |
PEVKEKGMAALPRLIAFTSE |
Glutamate decarboxylase 2 |
20 |
260 - 279 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.11 |
-0.07 |
0.28 |
0.00 |
2,187.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17459508 |
| 542 |
ARFKMFPEVKEKGMAALPRLIAF |
Glutamate decarboxylase 2 |
23 |
254 - 276 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.10 |
0.19 |
0.09 |
3.00 |
2,651.60 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10963600 |
| 543 |
DKVNFFRMVISNPAATHQDID |
Glutamate decarboxylase 2 |
21 |
552 - 572 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.16 |
-0.34 |
0.05 |
-0.50 |
2,419.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10963600 |
| 544 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034 |
| 545 |
MIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
15 |
252 - 266 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
-0.20 |
-0.35 |
0.44 |
2.00 |
1,811.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9421467 |
| 546 |
IAFTSEHSHFSLK |
Glutamate decarboxylase 2 |
13 |
274 - 286 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.06 |
-0.09 |
-0.28 |
1.00 |
1,503.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9421467 |
| 547 |
NYAFLHATDLLP |
Glutamate decarboxylase 2 |
12 |
88 - 99 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
in vitro assay |
0.06 |
0.33 |
-0.74 |
-0.50 |
1,374.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9421467 |
| 548 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9421467 |
| 549 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10586096 |
| 550 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10586096 |
| 551 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10586096 |
| 552 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10586096 |
| 553 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 554 |
NYAFLHATDLLP |
Glutamate decarboxylase 2 |
12 |
88 - 99 |
-- |
-- |
Homo sapiens |
HLA-A3 |
I |
-- |
-- |
ELISPOT |
0.06 |
0.33 |
-0.74 |
-0.50 |
1,374.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 555 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 556 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 557 |
NYAFLHATDLLP |
Glutamate decarboxylase 2 |
12 |
88 - 99 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
0.06 |
0.33 |
-0.74 |
-0.50 |
1,374.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 558 |
MYAMMIARFK |
Glutamate decarboxylase 2 |
10 |
248 - 257 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 559 |
LSKVAPVIKARMM |
Glutamate decarboxylase 2 |
13 |
526 - 538 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.07 |
0.72 |
-0.07 |
3.00 |
1,444.06 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 560 |
LSKVAPVIKARMM |
Glutamate decarboxylase 2 |
13 |
526 - 538 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.07 |
0.72 |
-0.07 |
3.00 |
1,444.06 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 561 |
VDKCLELAEYLYNIIKNREG |
Glutamate decarboxylase 2 |
20 |
471 - 490 |
-- |
-- |
Homo sapiens |
HLA-A11 |
I |
-- |
-- |
ELISPOT |
-0.19 |
-0.37 |
0.24 |
-1.00 |
2,384.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 562 |
YEMVFDGKPQHTNVCFWYIP |
Glutamate decarboxylase 2 |
20 |
491 - 510 |
-- |
-- |
Homo sapiens |
HLA-A11 |
I |
-- |
-- |
ELISPOT |
-0.03 |
-0.30 |
-0.58 |
-0.50 |
2,475.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 563 |
HTNVCFWYIPPSLRTLEDNE |
Glutamate decarboxylase 2 |
20 |
501 - 520 |
-- |
-- |
Homo sapiens |
HLA-A3 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.56 |
-0.24 |
-1.50 |
2,435.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 564 |
ERMSRLSKVAPVIKARMMEY |
Glutamate decarboxylase 2 |
20 |
521 - 540 |
-- |
-- |
Homo sapiens |
HLA-A24 |
I |
-- |
-- |
ELISPOT |
-0.28 |
-0.34 |
0.39 |
3.00 |
2,396.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 565 |
PVIKARMMEYGTTMVSYQPL |
Glutamate decarboxylase 2 |
20 |
531 - 550 |
-- |
-- |
Homo sapiens |
HLA-A24 |
I |
-- |
-- |
ELISPOT |
-0.07 |
0.02 |
-0.34 |
1.00 |
2,316.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 566 |
GTTMVSYQPLGDKVNFFRMV |
Glutamate decarboxylase 2 |
20 |
541 - 560 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
-0.07 |
0.05 |
-0.36 |
1.00 |
2,290.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 567 |
GDKVNFFRMVISNPAATHQD |
Glutamate decarboxylase 2 |
20 |
551 - 570 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
-0.16 |
-0.43 |
0.00 |
0.50 |
2,247.80 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 568 |
ISNPAATHQDIDFLIEEIER |
Glutamate decarboxylase 2 |
20 |
561 - 580 |
-- |
-- |
Homo sapiens |
HLA-A3 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.35 |
0.27 |
-3.50 |
2,311.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 569 |
IDFLIEEIERLGQDL |
Glutamate decarboxylase 2 |
15 |
571 - 585 |
-- |
-- |
Homo sapiens |
HLA-A3 |
I |
-- |
-- |
ELISPOT |
-0.08 |
0.12 |
0.33 |
-4.00 |
1,803.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 570 |
PVIKARMMEYGTTMV |
Glutamate decarboxylase 2 |
15 |
531 - 545 |
-- |
-- |
Mus musculus |
HLA-A11 |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.25 |
-0.22 |
1.00 |
1,727.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 571 |
PVIKARMMEYGTTMV |
Glutamate decarboxylase 2 |
15 |
531 - 545 |
-- |
-- |
Mus musculus |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.25 |
-0.22 |
1.00 |
1,727.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 572 |
PVIKARMMEYGTTMV |
Glutamate decarboxylase 2 |
15 |
531 - 545 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.25 |
-0.22 |
1.00 |
1,727.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 573 |
PVIKARMMEYGTTMV |
Glutamate decarboxylase 2 |
15 |
531 - 545 |
-- |
-- |
Mus musculus |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.25 |
-0.22 |
1.00 |
1,727.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 574 |
PVIKARMMEYGTTMV |
Glutamate decarboxylase 2 |
15 |
531 - 545 |
-- |
-- |
Mus musculus |
HLA-B18 |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.25 |
-0.22 |
1.00 |
1,727.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 575 |
PVIKARMMEYGTTMV |
Glutamate decarboxylase 2 |
15 |
531 - 545 |
-- |
-- |
Mus musculus |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
-0.06 |
0.25 |
-0.22 |
1.00 |
1,727.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 576 |
EYVTLKKMREIIGW |
Glutamate decarboxylase 2 |
14 |
217 - 230 |
-- |
-- |
Mus musculus |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
-0.15 |
-0.26 |
0.05 |
1.00 |
1,766.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 577 |
EYVTLKKMREIIGW |
Glutamate decarboxylase 2 |
14 |
217 - 230 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.15 |
-0.26 |
0.05 |
1.00 |
1,766.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 578 |
EYVTLKKMREIIGW |
Glutamate decarboxylase 2 |
14 |
217 - 230 |
-- |
-- |
Mus musculus |
HLA-B18 |
I |
-- |
-- |
ELISPOT |
-0.15 |
-0.26 |
0.05 |
1.00 |
1,766.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 579 |
LIAFTSEHSHFSLKKGAAAL |
Glutamate decarboxylase 2 |
20 |
273 - 292 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
0.01 |
0.38 |
-0.29 |
2.00 |
2,128.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 580 |
KVNFFRMVISNPAATHQDID |
Glutamate decarboxylase 2 |
20 |
553 - 572 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
-0.13 |
-0.18 |
-0.09 |
0.50 |
2,303.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 581 |
LIAFTSEHSHFSLKKGAAAL |
Glutamate decarboxylase 2 |
20 |
273 - 292 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
0.01 |
0.38 |
-0.29 |
2.00 |
2,128.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 582 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 583 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
HLA-A3 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 584 |
LPRLIAFTSEHSHF |
Glutamate decarboxylase 2 |
14 |
270 - 283 |
-- |
-- |
Homo sapiens |
HLA-A3 |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.09 |
-0.41 |
1.00 |
1,655.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 585 |
FFRMVISNPAATHQDIDFLI |
Glutamate decarboxylase 2 |
20 |
556 - 575 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
0.02 |
0.53 |
-0.48 |
-0.50 |
2,336.00 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 586 |
LPRLIAFTSEHSHF |
Glutamate decarboxylase 2 |
14 |
270 - 283 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.09 |
-0.41 |
1.00 |
1,655.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147 |
| 587 |
RMMEYGTTMV |
Glutamate decarboxylase 2 |
10 |
536 - 545 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.12 |
-0.12 |
-0.25 |
0.00 |
1,218.61 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19180473 |
| 588 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 589 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18198358 |
| 590 |
RMMEYGTTMV |
Glutamate decarboxylase 2 |
10 |
536 - 545 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.12 |
-0.12 |
-0.25 |
0.00 |
1,218.61 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 591 |
SPGSGFWSF |
Glutamate decarboxylase 2 |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
0.12 |
-0.01 |
-0.83 |
0.00 |
971.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 592 |
ACDGERPTL |
Glutamate decarboxylase 2 |
9 |
100 - 108 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.26 |
-0.68 |
0.59 |
-1.00 |
961.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 593 |
HPRYFNQLST |
Glutamate decarboxylase 2 |
10 |
175 - 184 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.28 |
-1.25 |
-0.38 |
1.50 |
1,262.53 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 594 |
IPSDLERRIL |
Glutamate decarboxylase 2 |
10 |
311 - 320 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.27 |
-0.18 |
0.51 |
0.00 |
1,211.57 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 595 |
AHVDKCLEL |
Glutamate decarboxylase 2 |
9 |
469 - 477 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.11 |
0.22 |
0.21 |
-0.50 |
1,027.33 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 596 |
APVIKARMM |
Glutamate decarboxylase 2 |
9 |
530 - 538 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.07 |
0.68 |
-0.10 |
2.00 |
1,016.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 597 |
DVNYAFLHATDLLPACDG |
Glutamate decarboxylase 2 |
18 |
86 - 103 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
0.01 |
0.28 |
-0.33 |
-2.50 |
1,935.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 598 |
HPRYFNQLSTGLDMVG |
Glutamate decarboxylase 2 |
16 |
175 - 190 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.12 |
-0.43 |
-0.34 |
0.50 |
1,835.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 599 |
NMFTYEIAPVFVLLEYVTLKKMRE |
Glutamate decarboxylase 2 |
24 |
203 - 226 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.04 |
0.33 |
-0.29 |
0.00 |
2,935.90 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 600 |
GAISNMYAMMIARFKMFPEVKEKGM |
Glutamate decarboxylase 2 |
25 |
243 - 267 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.07 |
0.10 |
-0.08 |
2.00 |
2,881.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 601 |
EKGMAALPRLIAFTSEHSHFSLKK |
Glutamate decarboxylase 2 |
24 |
264 - 287 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.14 |
-0.25 |
0.10 |
3.00 |
2,699.52 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 602 |
TTVYGAFDPLLAVAD |
Glutamate decarboxylase 2 |
15 |
338 - 352 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
0.12 |
0.83 |
-0.51 |
-2.00 |
1,552.95 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 603 |
CKKYKIWMHVDAAWGGGLL |
Glutamate decarboxylase 2 |
19 |
354 - 372 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
0.00 |
0.08 |
-0.41 |
2.50 |
2,176.92 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 604 |
GGLLMSRKHKWKLSGVERANSVTW |
Glutamate decarboxylase 2 |
24 |
369 - 392 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.21 |
-0.56 |
0.05 |
4.50 |
2,741.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 605 |
SALLVREEGLMQNCNQMHAS |
Glutamate decarboxylase 2 |
20 |
405 - 424 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.16 |
-0.26 |
-0.08 |
-0.50 |
2,231.85 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 606 |
VDVFKLWLMWRAKGTTGFEAH |
Glutamate decarboxylase 2 |
21 |
450 - 470 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.04 |
0.03 |
-0.33 |
1.50 |
2,493.24 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 607 |
YLYNIIKNREGYEMVFD |
Glutamate decarboxylase 2 |
17 |
480 - 496 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.15 |
-0.50 |
-0.13 |
-1.00 |
2,167.72 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11441068 |
| 608 |
VCFWYIPPSLRTLED |
Glutamate decarboxylase 2 |
15 |
504 - 518 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.02 |
0.21 |
-0.48 |
-1.00 |
1,839.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 609 |
PSLRTLEDNEERMSR |
Glutamate decarboxylase 2 |
15 |
511 - 525 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.53 |
-1.69 |
1.10 |
-1.00 |
1,833.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 610 |
LGDKVNFFRMVISNPAATHQD |
Glutamate decarboxylase 2 |
21 |
550 - 570 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.23 |
-0.09 |
0.50 |
2,360.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 611 |
VNFFRMVISNPAATHQDIDFLI |
Glutamate decarboxylase 2 |
22 |
554 - 575 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.51 |
-0.50 |
-0.50 |
2,549.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 612 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 613 |
MNILLQYVVKSFD + DEAM(Q6) |
Glutamate decarboxylase 2 |
24 |
115 - 127 |
-- |
MNILLQYVVKSFD + DEAM(Q6) |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 614 |
MNILLQYVVKSFD + DEAM(Q6) |
Glutamate decarboxylase 2 |
24 |
115 - 127 |
-- |
MNILLQYVVKSFD + DEAM(Q6) |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811 |
| 615 |
MNILLQYVVKSFD + DEAM(Q6) |
Glutamate decarboxylase 2 |
24 |
115 - 127 |
-- |
MNILLQYVVKSFD + DEAM(Q6) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18422727 |
| 616 |
PQNLEEILMHCQTTLKYAIK + DEAM(Q2, Q12) |
Glutamate decarboxylase 2 |
36 |
153 - 172 |
-- |
PQNLEEILMHCQTTLKYAIK + DEAM(Q2, Q12) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 18422727 |
| 617 |
PQNLEEILMHCQTTLKYAIK + DEAM(Q2, Q12) |
Glutamate decarboxylase 2 |
36 |
153 - 172 |
-- |
PQNLEEILMHCQTTLKYAIK + DEAM(Q2, Q12) |
Homo sapiens |
HLA class II |
II |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 18422727 |
| 618 |
KGMAALPRLIAFTSEHSHFS + CITR(R8) |
Glutamate decarboxylase 2 |
31 |
265 - 284 |
-- |
KGMAALPRLIAFTSEHSHFS + CITR(R8) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18422727 |
| 619 |
KGMAALPRLIAFTSEHSHFS + CITR(R8) |
Glutamate decarboxylase 2 |
31 |
265 - 284 |
-- |
KGMAALPRLIAFTSEHSHFS + CITR(R8) |
Homo sapiens |
HLA class II |
II |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18422727 |
| 620 |
KGMAALPRLIAFTSEHSHFS + CITR(R8) |
Glutamate decarboxylase 2 |
31 |
265 - 284 |
-- |
KGMAALPRLIAFTSEHSHFS + CITR(R8) |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18422727 |
| 621 |
YAFLHATDLLPACDGERPTL + CITR(R17) |
Glutamate decarboxylase 2 |
32 |
89 - 108 |
-- |
YAFLHATDLLPACDGERPTL + CITR(R17) |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 18422727 |
| 622 |
KGMAALPRLIAFTSEHSHFS + CITR(R8) |
Glutamate decarboxylase 2 |
31 |
265 - 284 |
-- |
KGMAALPRLIAFTSEHSHFS + CITR(R8) |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11254737 |
| 623 |
KVNFFRMVISNPAATHQDID + CITR(R6) |
Glutamate decarboxylase 2 |
31 |
553 - 572 |
-- |
KVNFFRMVISNPAATHQDID + CITR(R6) |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11254737 |
| 624 |
YAFLHATDLLPACDGERPTL + CITR(R17) |
Glutamate decarboxylase 2 |
32 |
89 - 108 |
-- |
YAFLHATDLLPACDGERPTL + CITR(R17) |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8892082 |
| 625 |
KVNFFRMVISNPAATHQDID + CITR(R6) |
Glutamate decarboxylase 2 |
31 |
553 - 572 |
-- |
KVNFFRMVISNPAATHQDID + CITR(R6) |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 626 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 627 |
SRLSKVAPVIKARMMEYGTT |
Glutamate decarboxylase 2 |
20 |
524 - 543 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 628 |
RFKMFPEVK |
Glutamate decarboxylase 2 |
9 |
255 - 263 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.29 |
-0.63 |
0.47 |
2.00 |
1,181.58 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 629 |
MFPEVKEKG |
Glutamate decarboxylase 2 |
9 |
258 - 266 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.22 |
-0.88 |
0.74 |
0.00 |
1,064.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 630 |
FTSEHSHFS |
Glutamate decarboxylase 2 |
9 |
276 - 284 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.13 |
-0.82 |
-0.28 |
0.00 |
1,078.22 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 631 |
YVVKSFDRSTKVIDFHYPNE |
Glutamate decarboxylase 2 |
20 |
121 - 140 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
-0.21 |
-0.66 |
0.10 |
0.50 |
2,445.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 632 |
AMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
17 |
250 - 266 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.09 |
0.28 |
2.00 |
2,013.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 633 |
YVVKSFDRSTKVIDFHYPNE |
Glutamate decarboxylase 2 |
20 |
121 - 140 |
-- |
-- |
Homo sapiens |
HLA-A24 |
I |
-- |
-- |
ELISPOT |
-0.21 |
-0.66 |
0.10 |
0.50 |
2,445.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 634 |
YVVKSFDRSTKVIDFHYPNE |
Glutamate decarboxylase 2 |
20 |
121 - 140 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
-0.21 |
-0.66 |
0.10 |
0.50 |
2,445.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 635 |
YVVKSFDRSTKVIDFHYPNE |
Glutamate decarboxylase 2 |
20 |
121 - 140 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
ELISPOT |
-0.21 |
-0.66 |
0.10 |
0.50 |
2,445.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 636 |
AMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
17 |
250 - 266 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.09 |
0.28 |
2.00 |
2,013.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 637 |
AMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
17 |
250 - 266 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.09 |
0.28 |
2.00 |
2,013.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 638 |
AMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
17 |
250 - 266 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.09 |
0.28 |
2.00 |
2,013.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 639 |
AMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
17 |
250 - 266 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.09 |
0.28 |
2.00 |
2,013.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 640 |
YVVKSFDRSTKVIDFHYPNE |
Glutamate decarboxylase 2 |
20 |
121 - 140 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
ELISPOT |
-0.21 |
-0.66 |
0.10 |
0.50 |
2,445.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 641 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-A24 |
I |
-- |
-- |
ELISPOT |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 642 |
SYQPLGDKV |
Glutamate decarboxylase 2 |
9 |
546 - 554 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.18 |
-0.78 |
0.10 |
0.00 |
1,006.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 643 |
SYQPLGDKV |
Glutamate decarboxylase 2 |
9 |
546 - 554 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.18 |
-0.78 |
0.10 |
0.00 |
1,006.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19011169 |
| 644 |
SYQPLGDKV |
Glutamate decarboxylase 2 |
9 |
546 - 554 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.18 |
-0.78 |
0.10 |
0.00 |
1,006.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17065343 |
| 645 |
NMYAMMIARFKMFPEVKEKG |
Glutamate decarboxylase 2 |
20 |
247 - 266 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.23 |
0.07 |
2.00 |
2,422.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17065343 |
| 646 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17065343 |
| 647 |
IAFTSEHSHFSLK |
Glutamate decarboxylase 2 |
13 |
274 - 286 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.06 |
-0.09 |
-0.28 |
1.00 |
1,503.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17065343 |
| 648 |
MNILLQYVVKSFD |
Glutamate decarboxylase 2 |
13 |
115 - 127 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.03 |
0.67 |
-0.60 |
0.00 |
1,570.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19447008 |
| 649 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19447008 |
| 650 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19447008 |
| 651 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19447008 |
| 652 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19505724 |
| 653 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19505724 |
| 654 |
DVMNILLQYVVKSFDRSTKV |
Glutamate decarboxylase 2 |
20 |
113 - 132 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.13 |
0.18 |
-0.10 |
1.00 |
2,356.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19505724 |
| 655 |
ICKKYKIWMHVDAAWGGGLL |
Glutamate decarboxylase 2 |
20 |
353 - 372 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.03 |
0.30 |
-0.48 |
2.50 |
2,290.10 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 19505724 |
| 656 |
GGLLMSRKHKWKLSGVERAN |
Glutamate decarboxylase 2 |
20 |
369 - 388 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.28 |
-0.77 |
0.31 |
4.50 |
2,267.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15889096 |
| 657 |
HKWKLSGVERANSVTWNPHK |
Glutamate decarboxylase 2 |
20 |
377 - 396 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.29 |
-1.26 |
0.12 |
4.00 |
2,374.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15889096 |
| 658 |
YDLSYDTGDKALQCGRHVDV |
Glutamate decarboxylase 2 |
20 |
433 - 452 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
3H-thymidine |
-0.22 |
-0.69 |
0.25 |
-1.50 |
2,255.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 659 |
RYFNQLSTGLDMVGLAADWL |
Glutamate decarboxylase 2 |
20 |
177 - 196 |
-- |
-- |
Homo sapiens |
HLA-DQ5 |
II |
-- |
-- |
3H-thymidine |
-0.01 |
0.23 |
-0.49 |
-1.00 |
2,270.89 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 660 |
EYVTLKKMREIIGWPGGSGD |
Glutamate decarboxylase 2 |
20 |
217 - 236 |
-- |
-- |
Homo sapiens |
HLA-DR1 |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.54 |
0.20 |
0.00 |
2,236.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 661 |
REIIGWPGGSGDGIFSPGGA |
Glutamate decarboxylase 2 |
20 |
225 - 244 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
0.04 |
-0.10 |
-0.11 |
-1.00 |
1,930.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 662 |
YAMMIARFKMFPEVKEKGMA |
Glutamate decarboxylase 2 |
20 |
249 - 268 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
3H-thymidine |
-0.10 |
0.04 |
0.04 |
2.00 |
2,379.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 663 |
KGMAALPRLIAFTSEHSHFS |
Glutamate decarboxylase 2 |
20 |
265 - 284 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
3H-thymidine |
-0.06 |
0.08 |
-0.24 |
2.00 |
2,200.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 664 |
LIAFTSEHSHFSLKKGAAAL |
Glutamate decarboxylase 2 |
20 |
273 - 292 |
-- |
-- |
Homo sapiens |
HLA-DR12 |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.38 |
-0.29 |
2.00 |
2,128.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 665 |
KVNFFRMVISNPAATHQDID |
Glutamate decarboxylase 2 |
20 |
553 - 572 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.18 |
-0.09 |
0.50 |
2,303.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 666 |
CACDQKPCSCSKVDVNYAFL |
Glutamate decarboxylase 2 |
20 |
73 - 92 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
-0.13 |
0.12 |
-0.08 |
0.00 |
2,194.80 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 667 |
SCSKVDVNYAFLHATDLLPA |
Glutamate decarboxylase 2 |
20 |
81 - 100 |
-- |
-- |
Homo sapiens |
HLA-DPw4 |
II |
-- |
-- |
3H-thymidine |
-0.01 |
0.38 |
-0.34 |
-0.50 |
2,164.74 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 668 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 669 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISA |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 670 |
VMNILLQYV |
Glutamate decarboxylase 2 |
9 |
114 - 122 |
-- |
-- |
Homo sapiens |
HLA-DQ5 |
II |
-- |
-- |
ELISA |
0.20 |
1.57 |
-1.29 |
0.00 |
1,092.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 671 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISA |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 672 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISA |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 673 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISA |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 674 |
CDGERPTLAFLQDVM |
Glutamate decarboxylase 2 |
15 |
101 - 115 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISA |
-0.12 |
-0.03 |
0.09 |
-2.00 |
1,695.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 675 |
FDRSTKVIDFHYPNE |
Glutamate decarboxylase 2 |
15 |
126 - 140 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISA |
-0.26 |
-1.05 |
0.27 |
-0.50 |
1,868.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 676 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISA |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 677 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISA |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 678 |
NFFRMVISNPAAT |
Glutamate decarboxylase 2 |
13 |
555 - 567 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISA |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 679 |
DVMNILLQYVVKSFDRSTKV |
Glutamate decarboxylase 2 |
20 |
113 - 132 |
-- |
-- |
Homo sapiens |
HLA-DR12 |
II |
-- |
-- |
ELISA |
-0.13 |
0.18 |
-0.10 |
1.00 |
2,356.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 680 |
LIAFTSEHSHFSLKKGAAAL |
Glutamate decarboxylase 2 |
20 |
273 - 292 |
-- |
-- |
Homo sapiens |
HLA-DR12 |
II |
-- |
-- |
ELISA |
0.01 |
0.38 |
-0.29 |
2.00 |
2,128.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 681 |
TAGTTVYGAFDPLLAVAD |
Glutamate decarboxylase 2 |
18 |
335 - 352 |
-- |
-- |
Homo sapiens |
HLA-DPw4 |
II |
-- |
-- |
ELISA |
0.11 |
0.73 |
-0.48 |
-2.00 |
1,782.23 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 682 |
TAGTTVYGAFDPLLAVAD |
Glutamate decarboxylase 2 |
18 |
335 - 352 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
ELISA |
0.11 |
0.73 |
-0.48 |
-2.00 |
1,782.23 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462 |
| 683 |
RPTLAFLQDVMNILLQYVVK |
Glutamate decarboxylase 2 |
20 |
105 - 124 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.01 |
0.64 |
-0.54 |
1.00 |
2,362.19 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 20029631 |
| 684 |
DVMNILLQYVVKSFDRSTKV |
Glutamate decarboxylase 2 |
20 |
113 - 132 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
0.18 |
-0.10 |
1.00 |
2,356.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11409713 |
| 685 |
KGMAALPRLIAFTSEHSHFS |
Glutamate decarboxylase 2 |
20 |
265 - 284 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.06 |
0.08 |
-0.24 |
2.00 |
2,200.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11409713 |
| 686 |
LIAFTSEHSHFSLKKGAAAL |
Glutamate decarboxylase 2 |
20 |
273 - 292 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.38 |
-0.29 |
2.00 |
2,128.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11409713 |
| 687 |
DERGKMIPSDLERRILEAKQ |
Glutamate decarboxylase 2 |
20 |
305 - 324 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.43 |
-1.24 |
1.07 |
0.00 |
2,385.03 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11409713 |
| 688 |
EAKQKGFVPFLVSATAGTTV |
Glutamate decarboxylase 2 |
20 |
321 - 340 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.36 |
-0.23 |
1.00 |
2,051.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11409713 |
| 689 |
YDLSYDTGDKALQCGRHVDV |
Glutamate decarboxylase 2 |
20 |
433 - 452 |
-- |
-- |
Homo sapiens |
H2-Kb |
I |
-- |
-- |
ICS |
-0.22 |
-0.69 |
0.25 |
-1.50 |
2,255.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19890053 |
| 690 |
KCLELAEYLYNIIKNREGYE |
Glutamate decarboxylase 2 |
20 |
473 - 492 |
-- |
-- |
Homo sapiens |
H2-Kb |
I |
-- |
-- |
In vivo assay |
-0.21 |
-0.65 |
0.20 |
-1.00 |
2,462.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19890053 |
| 691 |
KVNFFRMVISNPAATHQDID |
Glutamate decarboxylase 2 |
20 |
553 - 572 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.18 |
-0.09 |
0.50 |
2,303.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 692 |
RPTLAFLQDVMNILLQYVVK |
Glutamate decarboxylase 2 |
20 |
105 - 124 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.01 |
0.64 |
-0.54 |
1.00 |
2,362.19 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 693 |
DVMNILLQYVVKSFDRSTKV |
Glutamate decarboxylase 2 |
20 |
113 - 132 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
0.18 |
-0.10 |
1.00 |
2,356.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 694 |
KGMAALPRLIAFTSEHSHFS |
Glutamate decarboxylase 2 |
20 |
265 - 284 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.06 |
0.08 |
-0.24 |
2.00 |
2,200.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 695 |
DERGKMIPSDLERRILEAKQ |
Glutamate decarboxylase 2 |
20 |
305 - 324 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.43 |
-1.24 |
1.07 |
0.00 |
2,385.03 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 696 |
KVNFFRMVISNPAATHQDID |
Glutamate decarboxylase 2 |
20 |
553 - 572 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.18 |
-0.09 |
0.50 |
2,303.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 697 |
DVMNILLQYVVKSFDRSTKV |
Glutamate decarboxylase 2 |
20 |
113 - 132 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
0.18 |
-0.10 |
1.00 |
2,356.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 698 |
DERGKMIPSDLERRILEAKQ |
Glutamate decarboxylase 2 |
20 |
305 - 324 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.43 |
-1.24 |
1.07 |
0.00 |
2,385.03 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 699 |
KVNFFRMVISNPAATHQDID |
Glutamate decarboxylase 2 |
20 |
553 - 572 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.18 |
-0.09 |
0.50 |
2,303.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 700 |
DERGKMIPSDLERRILEAKQ |
Glutamate decarboxylase 2 |
20 |
305 - 324 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.43 |
-1.24 |
1.07 |
0.00 |
2,385.03 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 701 |
HKWKLSGVERANSVTWNPHK |
Glutamate decarboxylase 2 |
20 |
377 - 396 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.29 |
-1.26 |
0.12 |
4.00 |
2,374.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 702 |
DSVILIKCDERGKMIPSDLE |
Glutamate decarboxylase 2 |
20 |
297 - 316 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.18 |
-0.19 |
0.59 |
-2.00 |
2,261.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 703 |
VMNILLQYVV |
Glutamate decarboxylase 2 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 704 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 705 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 706 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 707 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 708 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 709 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 710 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 711 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 712 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558 |
| 713 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12021103 |
| 714 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12021103 |
| 715 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10907121 |
| 716 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10907121 |
| 717 |
NILLQYVVKSFD |
Glutamate decarboxylase 2 |
12 |
116 - 127 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10907121 |
| 718 |
DVMNILLQYVVKSFDRSTKV |
Glutamate decarboxylase 2 |
20 |
113 - 132 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
-0.13 |
0.18 |
-0.10 |
1.00 |
2,356.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10907121 |
| 719 |
TAGTTVYGAFDPLLAVAD |
Glutamate decarboxylase 2 |
18 |
335 - 352 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.11 |
0.73 |
-0.48 |
-2.00 |
1,782.23 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10907121 |
| 720 |
YEIAPVFVLLEYVT |
Glutamate decarboxylase 2 |
14 |
41 - 54 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
3H-thymidine |
0.20 |
1.24 |
-0.85 |
-2.00 |
1,656.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10907121 |
| 721 |
RMMEYGTTMVSYQPL |
Glutamate decarboxylase 2 |
15 |
370 - 384 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.11 |
-0.31 |
-0.41 |
0.00 |
1,807.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9645372 |
| 722 |
QMRPVSRVL |
60 kDa heat shock protein, mitochondrial |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.30 |
-0.09 |
0.04 |
2.00 |
1,085.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9645372 |
| 723 |
QMRPVSRVL |
60 kDa heat shock protein, mitochondrial |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA-DRB5*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.30 |
-0.09 |
0.04 |
2.00 |
1,085.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9645372 |
| 724 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-DRB5*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9645372 |
| 725 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DRB5*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9645372 |
| 726 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17620420 |
| 727 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17620420 |
| 728 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17620420 |
| 729 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17620420 |
| 730 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17620420 |
| 731 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 17620420 |
| 732 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 733 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
ELISA |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 734 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 735 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 736 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 737 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 738 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 739 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 740 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 741 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 742 |
AYVLLSEKKISSIQS |
60 kDa heat shock protein, mitochondrial |
15 |
242 - 256 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
0.22 |
-0.07 |
1.00 |
1,666.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 743 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 744 |
GEALSTLVLNRLKVG |
60 kDa heat shock protein, mitochondrial |
15 |
280 - 294 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.05 |
0.51 |
-0.11 |
1.00 |
1,570.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 745 |
VLGGGCALLRCIPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 746 |
VLGGGCALLRCIPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 747 |
VLGGGCALLRCIPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 748 |
VLGGGCALLRCIPALDSLTPANED |
60 kDa heat shock protein, mitochondrial |
24 |
437 - 460 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 749 |
MAKAAAVGIDLGTTYSCVGV |
Heat shock 70 kDa protein 1B |
20 |
1 - 20 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
0.11 |
1.02 |
-0.46 |
0.00 |
1,927.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 750 |
SCVGVFQHGKVEIIANDQGN |
Heat shock 70 kDa protein 1B |
20 |
16 - 35 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.06 |
-0.07 |
-0.12 |
-0.50 |
2,115.66 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 751 |
DTERLIGDAAKNQVALNPQN |
Heat shock 70 kDa protein 1B |
20 |
46 - 65 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.26 |
-0.87 |
0.36 |
-1.00 |
2,167.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 752 |
KRTLSSSTQASLEIDSLFEG |
Heat shock 70 kDa protein 1B |
20 |
271 - 290 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.38 |
0.28 |
-1.00 |
2,169.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 753 |
RFEELCSDLFRSTLEPVEKA |
Heat shock 70 kDa protein 1B |
20 |
301 - 320 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.25 |
-0.44 |
0.54 |
-2.00 |
2,369.95 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 754 |
LESYAFNMKSAVEDEGLKGK |
Heat shock 70 kDa protein 1B |
20 |
541 - 560 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.19 |
-0.64 |
0.48 |
-1.00 |
2,216.78 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 755 |
AEKDEFEHKRKELEQVCNPI |
Heat shock 70 kDa protein 1B |
20 |
586 - 605 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.40 |
-1.47 |
1.04 |
-1.50 |
2,443.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 756 |
PGPGGFGAQGPKGGSGSGPT |
Heat shock 70 kDa protein 1B |
20 |
616 - 635 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.02 |
-0.76 |
0.02 |
1.00 |
1,670.07 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 757 |
NDQGNRTTPSYVAFTDTERL |
Heat shock 70 kDa protein 1B |
20 |
31 - 50 |
-- |
-- |
Homo sapiens |
HLA-DR53 |
II |
-- |
-- |
3H-thymidine |
-0.32 |
-1.21 |
0.29 |
-1.00 |
2,285.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12517961 |
| 758 |
PFQVINDGDKPKVQVSYKGE |
Heat shock 70 kDa protein 1B |
20 |
91 - 110 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.22 |
-0.95 |
0.39 |
0.00 |
2,248.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816972 |
| 759 |
GLNVLRIINEPTAAAIAYGL |
Heat shock 70 kDa protein 1B |
20 |
166 - 185 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
bioassay |
0.09 |
0.84 |
-0.53 |
0.00 |
2,069.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816972 |
| 760 |
IAYGLDRTGKGERNVLIFDL |
Heat shock 70 kDa protein 1B |
20 |
181 - 200 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
binding assay |
-0.13 |
-0.05 |
0.10 |
0.00 |
2,250.89 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20139986 |
| 761 |
VQKLLQDFFNGRDLNKSINP |
Heat shock 70 kDa protein 1B |
20 |
346 - 365 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
bioassay |
-0.24 |
-0.70 |
0.13 |
1.00 |
2,346.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20139986 |
| 762 |
AGGVMTALIKRNSTIPTKQT |
Heat shock 70 kDa protein 1B |
20 |
406 - 425 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.14 |
-0.14 |
-0.05 |
3.00 |
2,087.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20139986 |
| 763 |
PAPGVPQIEVTFDIDANGIL |
Heat shock 70 kDa protein 1B |
20 |
466 - 485 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.07 |
0.41 |
-0.24 |
-3.00 |
2,066.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20139986 |
| 764 |
AEDEVQRERVSAKNALESYA |
Heat shock 70 kDa protein 1B |
20 |
526 - 545 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
-0.35 |
-1.04 |
0.79 |
-2.00 |
2,265.69 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 765 |
VCNPIISGLYQGAGGPGPGG |
Heat shock 70 kDa protein 1B |
20 |
601 - 620 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
0.11 |
0.23 |
-0.50 |
0.00 |
1,814.36 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 766 |
GSGPTIEEVD |
Heat shock 70 kDa protein 1B |
10 |
631 - 640 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
-0.09 |
-0.57 |
0.56 |
-3.00 |
1,003.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 767 |
TIDDGIFEVKATAGDTHLGG |
Heat shock 70 kDa protein 1B |
20 |
211 - 230 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
-0.03 |
-0.07 |
0.14 |
-2.50 |
2,017.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 768 |
THLGGEDFDNRLVNHFVEEF |
Heat shock 70 kDa protein 1B |
20 |
226 - 245 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
-0.15 |
-0.62 |
0.15 |
-3.00 |
2,375.84 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 769 |
PTKQTQIFTTYSDNQPGVLI |
Heat shock 70 kDa protein 1B |
20 |
421 - 440 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
-0.12 |
-0.51 |
-0.31 |
0.00 |
2,251.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 770 |
KANKITITNDKGRLSKEEIE |
Heat shock 70 kDa protein 1B |
20 |
496 - 515 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
-0.38 |
-1.23 |
0.96 |
1.00 |
2,287.90 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 771 |
LLLLDVAPLSLGLETAGGVM |
Heat shock 70 kDa protein 1B |
20 |
391 - 410 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
0.21 |
1.46 |
-0.60 |
-2.00 |
1,982.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 772 |
KEEIERMVQEAEKYKAEDEV |
Heat shock 70 kDa protein 1B |
20 |
511 - 530 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
Biological activity |
-0.41 |
-1.53 |
1.34 |
-4.00 |
2,453.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19690518 |
| 773 |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Islet amyloid polypeptide |
37 |
65 - 84 |
-- |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 20369219 |
| 774 |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Islet amyloid polypeptide |
37 |
65 - 84 |
-- |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 20369219 |
| 775 |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Islet amyloid polypeptide |
37 |
65 - 84 |
-- |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 20369219 |
| 776 |
VGSNTYGKRNAVEVLKREPL + CITR(R73) |
Islet amyloid polypeptide |
32 |
65 - 84 |
-- |
VGSNTYGKRNAVEVLKREPL + CITR(R73) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20369219 |
| 777 |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Islet amyloid polypeptide |
37 |
65 - 84 |
-- |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 20369219 |
| 778 |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Islet amyloid polypeptide |
37 |
65 - 84 |
-- |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 20406664 |
| 779 |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Islet amyloid polypeptide |
37 |
65 - 84 |
-- |
VGSNTYGKRNAVEVLKREPL + CITR(R73, R81) |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 20406664 |
| 780 |
LYQKRICFL |
Islet cell autoantigen 1 |
9 |
78 - 86 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISPOT |
-0.12 |
0.47 |
-0.56 |
2.00 |
1,183.61 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20406664 |
| 781 |
GIVEQCCASVCS |
Insulin |
12 |
1 - 12 |
-- |
-- |
Bos taurus |
H2-IAg7 |
II |
-- |
-- |
bioassay |
0.04 |
1.10 |
-0.38 |
-1.00 |
1,198.55 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20534455 |
| 782 |
QCCASVCSLYQL |
Insulin |
12 |
5 - 16 |
-- |
-- |
Bos taurus |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.01 |
0.93 |
-0.83 |
0.00 |
1,317.72 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20407212 |
| 783 |
GIVEQCCASVCSLYQ |
Insulin |
15 |
1 - 15 |
-- |
-- |
Bos taurus |
-- |
-- |
-- |
-- |
ELISA |
0.02 |
0.81 |
-0.56 |
-1.00 |
1,603.07 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20540111 |
| 784 |
AAAFVNQHLCGSHLVEALYLVCGERGFFYT |
Insulin |
30 |
22 - 51 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.05 |
0.61 |
-0.65 |
0.00 |
3,317.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20540111 |
| 785 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20540111 |
| 786 |
RLLPLLALLAL |
Insulin |
11 |
6 - 16 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.22 |
2.19 |
-0.96 |
1.00 |
1,205.77 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 20540111 |
| 787 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20540111 |
| 788 |
ALWGPDPAAAF |
Insulin |
11 |
15 - 25 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.16 |
0.53 |
-0.61 |
-1.00 |
1,115.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 789 |
ALWMRLLPLL |
Insulin |
10 |
2 - 11 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.17 |
1.57 |
-1.12 |
1.00 |
1,225.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 790 |
ALWMRLLPLL |
Insulin |
10 |
2 - 11 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.17 |
1.57 |
-1.12 |
1.00 |
1,225.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 791 |
ALWMRLLPLL |
Insulin |
10 |
2 - 11 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.17 |
1.57 |
-1.12 |
1.00 |
1,225.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 792 |
ALWMRLLPLL |
Insulin |
10 |
2 - 11 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.17 |
1.57 |
-1.12 |
1.00 |
1,225.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 793 |
RLLPLLALLAL |
Insulin |
11 |
6 - 16 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.22 |
2.19 |
-0.96 |
1.00 |
1,205.77 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 794 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 795 |
LALWGPDPAA |
Insulin |
10 |
14 - 23 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.15 |
0.50 |
-0.55 |
-1.00 |
1,010.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 796 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20634998 |
| 797 |
ALWGPDPAAAF |
Insulin |
11 |
15 - 25 |
-- |
-- |
Homo sapiens |
HLA-E |
non classical |
-- |
-- |
3H-thymidine |
0.16 |
0.53 |
-0.61 |
-1.00 |
1,115.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20877010 |
| 798 |
ALWGPDPAAAF |
Insulin |
11 |
15 - 25 |
-- |
-- |
Homo sapiens |
HLA-E |
non classical |
-- |
-- |
3H-thymidine |
0.16 |
0.53 |
-0.61 |
-1.00 |
1,115.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20877010 |
| 799 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-E |
non classical |
-- |
-- |
3H-thymidine |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20877010 |
| 800 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-E |
non classical |
-- |
-- |
3H-thymidine |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20877010 |
| 801 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-E |
non classical |
-- |
-- |
3H-thymidine |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20877010 |
| 802 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-E |
non classical |
-- |
-- |
3H-thymidine |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20877010 |
| 803 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-E |
non classical |
-- |
-- |
3H-thymidine |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20877010 |
| 804 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-E |
non classical |
-- |
-- |
3H-thymidine |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20877010 |
| 805 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
H2-d class II |
II |
-- |
-- |
In vivo assay |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16005609 |
| 806 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21346176 |
| 807 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21346176 |
| 808 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20962260 |
| 809 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20962260 |
| 810 |
LPLLALLAL |
Insulin |
9 |
8 - 16 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.40 |
2.76 |
-1.31 |
0.00 |
936.39 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 20962260 |
| 811 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
H2-Db |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15557165 |
| 812 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15557165 |
| 813 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15557165 |
| 814 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21530685 |
| 815 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21530685 |
| 816 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21530685 |
| 817 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21530685 |
| 818 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ELISPOT |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21562577 |
| 819 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21562577 |
| 820 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21562577 |
| 821 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14678267 |
| 822 |
WMRLLPLLAL |
Insulin |
10 |
4 - 13 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.17 |
1.57 |
-1.12 |
1.00 |
1,225.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14678267 |
| 823 |
GIVEQCCTSI |
Insulin |
10 |
78 - 87 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.05 |
0.93 |
-0.40 |
-1.00 |
1,052.37 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14678267 |
| 824 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14678267 |
| 825 |
SLYQLENYC |
Insulin |
9 |
89 - 97 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
In vivo assay |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20381385 |
| 826 |
LVEALYLVCGERG |
Insulin |
13 |
19 - 31 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
In vivo assay |
0.02 |
0.81 |
-0.25 |
-1.00 |
1,421.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20381385 |
| 827 |
GSHLVEALY |
Insulin |
9 |
32 - 40 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.08 |
0.49 |
-0.57 |
-0.50 |
988.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21949373 |
| 828 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21949373 |
| 829 |
ALYLVCGER |
Insulin |
9 |
38 - 46 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.03 |
0.71 |
-0.32 |
0.00 |
1,023.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21949373 |
| 830 |
ALWMRLLPL |
Insulin |
9 |
2 - 10 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.13 |
1.32 |
-1.04 |
1.00 |
1,112.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21949373 |
| 831 |
LPLLALLAL |
Insulin |
9 |
8 - 16 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.40 |
2.76 |
-1.31 |
0.00 |
936.39 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 21949373 |
| 832 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069251 |
| 833 |
ALYLVCGER |
Insulin |
9 |
38 - 46 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.03 |
0.71 |
-0.32 |
0.00 |
1,023.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069251 |
| 834 |
LPLLALLAL |
Insulin |
9 |
8 - 16 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.40 |
2.76 |
-1.31 |
0.00 |
936.39 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 22069251 |
| 835 |
WGPDPAAA |
Insulin |
8 |
17 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.05 |
-0.33 |
-0.24 |
-1.00 |
783.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069251 |
| 836 |
WGPDPAAA |
Insulin |
8 |
17 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.05 |
-0.33 |
-0.24 |
-1.00 |
783.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069251 |
| 837 |
GAGSLQPLALEGSLQKR |
Insulin |
17 |
57 - 73 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.26 |
0.11 |
1.00 |
1,725.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069251 |
| 838 |
SHLVEALYLVCGERG |
Insulin |
15 |
17 - 31 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069251 |
| 839 |
SHLVEALYLVCGERG |
Insulin |
15 |
17 - 31 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069251 |
| 840 |
SHLVEALYLVCGERG |
Insulin |
15 |
17 - 31 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 841 |
SHLVEALYLVCGERG |
Insulin |
15 |
17 - 31 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 842 |
LVEALYLVCGERGFF |
Insulin |
15 |
19 - 33 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.10 |
1.07 |
-0.55 |
-1.00 |
1,716.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 843 |
SHLVEALYLVCGERG |
Insulin |
15 |
33 - 47 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 844 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 845 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 846 |
PLLALLALWGPDPAAAFVNQ |
Insulin |
20 |
9 - 28 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.17 |
0.92 |
-0.78 |
-1.00 |
2,077.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 847 |
ALWGPDPAAAFV |
Insulin |
12 |
15 - 26 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
ELISA |
0.20 |
0.83 |
-0.68 |
-1.00 |
1,214.54 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22043012 |
| 848 |
ALLALWGPDPAA |
Insulin |
12 |
12 - 23 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
ELISPOT |
0.19 |
0.88 |
-0.65 |
-1.00 |
1,194.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22043012 |
| 849 |
PLLALLALWGPD |
Insulin |
12 |
9 - 20 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
ELISPOT |
0.24 |
1.22 |
-0.87 |
-1.00 |
1,278.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22043012 |
| 850 |
GIVEQCCTSICSL |
Insulin |
13 |
74 - 86 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Biological activity |
0.06 |
1.14 |
-0.50 |
-1.00 |
1,355.79 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22043012 |
| 851 |
GIVEQCCTSICSL |
Insulin |
13 |
74 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.06 |
1.14 |
-0.50 |
-1.00 |
1,355.79 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 852 |
GIVEQCCTSICSL |
Insulin |
13 |
74 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.06 |
1.14 |
-0.50 |
-1.00 |
1,355.79 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22069252 |
| 853 |
GIVEQCCTSICSL |
Insulin |
13 |
74 - 86 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.06 |
1.14 |
-0.50 |
-1.00 |
1,355.79 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 854 |
GIVEQCCTSICSL |
Insulin |
13 |
74 - 86 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.06 |
1.14 |
-0.50 |
-1.00 |
1,355.79 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 855 |
GIVEQCCTSICSL |
Insulin |
13 |
74 - 86 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.06 |
1.14 |
-0.50 |
-1.00 |
1,355.79 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 856 |
GIVEQCCTSICSL |
Insulin |
13 |
74 - 86 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.06 |
1.14 |
-0.50 |
-1.00 |
1,355.79 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 857 |
LLWGPDPAAA |
insulin |
10 |
- |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.15 |
0.50 |
-0.55 |
-1.00 |
1,010.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 858 |
LYLVCGERG |
Insulin-1 |
9 |
36 - 44 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 859 |
LYLVCGERG |
Insulin-1 |
9 |
36 - 44 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 860 |
LYLVCGERG |
Insulin-1 |
9 |
36 - 44 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 861 |
PHLVEALYLVCGERG |
Insulin-1 |
15 |
30 - 44 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
RNA/DNA detection |
-0.01 |
0.38 |
-0.25 |
-0.50 |
1,656.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 862 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
30 - 44 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
RNA/DNA detection |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 863 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
30 - 44 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
RNA/DNA detection |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 864 |
LYLVCGERG |
Insulin-1 |
9 |
39 - 47 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
RNA/DNA detection |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21998398 |
| 865 |
LYLVCGERG |
Insulin-1 |
9 |
39 - 47 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 866 |
LYLVCGERG |
Insulin-1 |
9 |
39 - 47 |
-- |
-- |
Mus musculus |
HLA-A3 |
I |
-- |
-- |
Multimer/tetramer |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 867 |
QCCTSICSLYQLENYC |
Insulin-1 |
16 |
92 - 107 |
-- |
-- |
Mus musculus |
HLA-A3 |
I |
-- |
-- |
Multimer/tetramer |
-0.08 |
0.20 |
-0.64 |
-1.00 |
1,871.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 868 |
PHLVEALYLVCGERG |
Insulin-1 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A3 |
I |
-- |
-- |
Multimer/tetramer |
-0.01 |
0.38 |
-0.25 |
-0.50 |
1,656.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 869 |
LYLVCGERG |
Insulin-1 |
9 |
39 - 47 |
-- |
-- |
Mus musculus |
HLA-B7 |
I |
-- |
-- |
Multimer/tetramer |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 870 |
PHLVEALYLVCGERG |
Insulin-1 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A3 |
I |
-- |
-- |
Multimer/tetramer |
-0.01 |
0.38 |
-0.25 |
-0.50 |
1,656.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 871 |
LLVHFLPLL |
Insulin-1 |
9 |
3 - 11 |
-- |
-- |
Mus musculus |
HLA-A3 |
I |
-- |
-- |
Multimer/tetramer |
0.37 |
2.36 |
-1.50 |
0.50 |
1,064.53 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 872 |
HLCGPHLVEA |
Insulin-1 |
10 |
29 - 38 |
-- |
-- |
Mus musculus |
HLA-A3 |
I |
-- |
-- |
Multimer/tetramer |
0.06 |
0.42 |
-0.46 |
0.00 |
1,075.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 873 |
IVDQCCTSI |
Insulin-1 |
9 |
89 - 97 |
-- |
-- |
Mus musculus |
HLA-B7 |
I |
-- |
-- |
Multimer/tetramer |
0.03 |
1.08 |
-0.44 |
-1.00 |
981.27 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 874 |
FLPLLALLALWEPKPTQA |
Insulin-1 |
18 |
7 - 24 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.76 |
-0.69 |
0.00 |
2,021.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21636247 |
| 875 |
FLPLLALLALWEPKPTQA |
Insulin-1 |
18 |
7 - 24 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
x-ray crystallography |
0.12 |
0.76 |
-0.69 |
0.00 |
2,021.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22245737 |
| 876 |
TLALEVARQK |
Insulin-1 |
10 |
77 - 86 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Surface plasmon resonance (SPR) |
-0.23 |
-0.07 |
0.27 |
1.00 |
1,128.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22245737 |
| 877 |
LALEVARQKR |
Insulin-1 |
10 |
78 - 87 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.38 |
-0.45 |
0.61 |
2.00 |
1,183.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22245737 |
| 878 |
TLALEVARQK |
Insulin-1 |
10 |
77 - 86 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.23 |
-0.07 |
0.27 |
1.00 |
1,128.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22245737 |
| 879 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22245737 |
| 880 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 881 |
SLQPLALEGSLQKRG |
Insulin |
15 |
76 - 90 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.18 |
-0.39 |
0.15 |
1.00 |
1,597.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 882 |
ALWMRLLPL |
Insulin |
9 |
2 - 10 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.13 |
1.32 |
-1.04 |
1.00 |
1,112.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 883 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 884 |
SHLVEALYLVCGERG |
Insulin |
15 |
33 - 47 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 885 |
SHLVEALYLVCGERG |
Insulin |
15 |
33 - 47 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 886 |
MALWMRLLPLLALLAL |
Insulin |
16 |
1 - 16 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.25 |
2.04 |
-1.18 |
1.00 |
1,838.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 887 |
LLPLLALLALWGPDPAA |
Insulin |
17 |
7 - 23 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.25 |
1.42 |
-0.88 |
-1.00 |
1,744.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 888 |
LALWGPDPAAAFVNQHL |
Insulin |
17 |
14 - 30 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.10 |
0.44 |
-0.70 |
-0.50 |
1,820.33 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 889 |
PAAAFVNQHLCGSHLVE |
Insulin |
17 |
21 - 37 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.04 |
0.41 |
-0.52 |
0.00 |
1,793.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 890 |
QHLCGSHLVEALYLVCG |
Insulin |
17 |
28 - 44 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.09 |
0.83 |
-0.74 |
0.00 |
1,842.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 891 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
35 - 51 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 892 |
VCGERGFFYTPKTRREA |
Insulin |
17 |
42 - 58 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.33 |
-0.91 |
0.41 |
2.00 |
2,017.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 893 |
FYTPKTRREAEDLQVGQ |
Insulin |
17 |
49 - 65 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.37 |
-1.32 |
0.53 |
0.00 |
2,038.49 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 894 |
REAEDLQVGQVELGGGP |
Insulin |
17 |
56 - 72 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.16 |
-0.64 |
0.49 |
-3.00 |
1,754.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 895 |
VGQVELGGGPGAGSLQP |
Insulin |
17 |
63 - 79 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.06 |
0.05 |
-0.20 |
-1.00 |
1,522.95 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 896 |
GGPGAGSLQPLALEGSL |
Insulin |
17 |
70 - 86 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.09 |
0.29 |
-0.26 |
-1.00 |
1,523.97 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22586580 |
| 897 |
HLCGSHLVEA |
Insulin |
10 |
29 - 38 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.04 |
0.50 |
-0.43 |
0.00 |
1,065.36 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 898 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 899 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 900 |
GIVEQCCTSI |
Insulin |
10 |
90 - 99 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.05 |
0.93 |
-0.40 |
-1.00 |
1,052.37 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 901 |
SLYQLENYC |
Insulin |
9 |
101 - 109 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 902 |
LYLVCGERG |
Insulin |
9 |
39 - 47 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 903 |
ALWMRLLPL |
Insulin |
9 |
2 - 10 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.13 |
1.32 |
-1.04 |
1.00 |
1,112.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 904 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 905 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 906 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 907 |
SLQPLALEG |
Insulin |
9 |
76 - 84 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.04 |
0.38 |
-0.27 |
-1.00 |
927.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 908 |
SLQKRGIVEQ |
Insulin |
10 |
85 - 94 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.32 |
-0.76 |
0.46 |
1.00 |
1,157.49 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 909 |
SLYQLENYC |
Insulin |
9 |
101 - 109 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22526607 |
| 910 |
HLVEALYLVCGERGFF |
Insulin |
16 |
34 - 49 |
-- |
-- |
Homo sapiens |
HLA-A*24:02 |
I |
-- |
-- |
Multimer/tetramer |
0.07 |
0.81 |
-0.54 |
-0.50 |
1,853.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 911 |
EDLQVGQVELGGGPGA |
Insulin |
16 |
59 - 74 |
-- |
-- |
Homo sapiens |
HLA-A*24:02 |
I |
-- |
-- |
in vitro assay |
-0.01 |
-0.21 |
0.14 |
-3.00 |
1,525.89 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 912 |
VEQCCTSICSLYQ |
Insulin |
13 |
92 - 104 |
-- |
-- |
Homo sapiens |
HLA-A*24:02 |
I |
-- |
-- |
in vitro assay |
-0.06 |
0.45 |
-0.52 |
-1.00 |
1,476.88 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 913 |
FYTPKTRREAEDLQVG |
Insulin |
16 |
49 - 64 |
-- |
-- |
Homo sapiens |
HLA-A*24:02 |
I |
-- |
-- |
ELISA |
-0.35 |
-1.19 |
0.55 |
0.00 |
1,910.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 914 |
GAGSLQPLALEGSLQKRG |
Insulin |
18 |
73 - 90 |
-- |
-- |
Homo sapiens |
HLA-A*24:02 |
I |
-- |
-- |
ELISA |
-0.12 |
-0.27 |
0.10 |
1.00 |
1,782.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 915 |
KRGIVEQCCTSICSL |
Insulin |
15 |
88 - 102 |
-- |
-- |
Homo sapiens |
HLA-A*24:02 |
I |
-- |
-- |
ELISA |
-0.14 |
0.43 |
-0.03 |
1.00 |
1,640.18 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 916 |
LALEGSLQK |
Insulin |
9 |
80 - 88 |
-- |
-- |
Homo sapiens |
HLA-A*24:02 |
I |
-- |
-- |
ELISA |
-0.07 |
0.12 |
0.07 |
0.00 |
958.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 917 |
LALEGSLQK |
Insulin |
9 |
80 - 88 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
in vitro assay |
-0.07 |
0.12 |
0.07 |
0.00 |
958.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 918 |
LALEGSLQK |
Insulin |
9 |
80 - 88 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
in vitro assay |
-0.07 |
0.12 |
0.07 |
0.00 |
958.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22522618 |
| 919 |
LALEGSLQK |
Insulin |
9 |
80 - 88 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
-0.07 |
0.12 |
0.07 |
0.00 |
958.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 920 |
LALEGSLQK |
Insulin |
9 |
80 - 88 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
-0.07 |
0.12 |
0.07 |
0.00 |
958.26 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 921 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
35 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 922 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
35 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 923 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
35 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 924 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
35 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 925 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
35 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
3H-thymidine |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 926 |
FFYTPKTRREAED |
Insulin |
13 |
48 - 60 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
ELISA |
-0.42 |
-1.56 |
0.72 |
0.00 |
1,659.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 927 |
WGPDPAAA |
Insulin |
8 |
17 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.05 |
-0.33 |
-0.24 |
-1.00 |
783.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 928 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 929 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 930 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 931 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 932 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 933 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 934 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
ELISA |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 935 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 936 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 937 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 938 |
KRGIVEQCCTSICSL |
Insulin |
15 |
88 - 102 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.14 |
0.43 |
-0.03 |
1.00 |
1,640.18 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 939 |
YLVCGERGFFYTPKT |
Insulin |
15 |
40 - 54 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.08 |
-0.15 |
-0.38 |
1.00 |
1,781.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 940 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 941 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 942 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
ELISA |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 943 |
VCGERGFFYTPKTRREAEDLQVGQVELGGG |
Insulin |
30 |
42 - 71 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.21 |
-0.62 |
0.32 |
-1.00 |
3,300.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 944 |
FVNQHLCGSHLVEALYL |
Insulin |
17 |
25 - 41 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.07 |
0.66 |
-0.81 |
0.00 |
1,943.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 945 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
35 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 946 |
GERGFFYTPKTRREAED |
Insulin |
17 |
44 - 60 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.45 |
-1.71 |
0.91 |
0.00 |
2,059.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 947 |
TRREAEDLQVGQVELGG |
Insulin |
17 |
54 - 70 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.28 |
-0.83 |
0.64 |
-2.00 |
1,857.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 948 |
GQVELGGGPGAGSLQPL |
Insulin |
17 |
64 - 80 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.06 |
0.03 |
-0.22 |
-1.00 |
1,536.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 949 |
AGSLQPLALEGSLQKRG |
Insulin |
17 |
74 - 90 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.14 |
-0.26 |
0.11 |
1.00 |
1,725.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 950 |
GSLQKRGIVEQCCTSIC |
Insulin |
17 |
84 - 100 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
ELISA |
-0.15 |
0.15 |
-0.02 |
1.00 |
1,825.40 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 951 |
CCTSICSLYQLENYCN |
Insulin |
16 |
95 - 110 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.08 |
0.20 |
-0.64 |
-1.00 |
1,857.34 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 952 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 953 |
LVCGERGFFY |
Insulin |
10 |
41 - 50 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.03 |
0.60 |
-0.56 |
0.00 |
1,190.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 954 |
FYTPKTRRE |
Insulin |
9 |
49 - 57 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.56 |
-1.99 |
0.71 |
2.00 |
1,197.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 955 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 956 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 957 |
ALYLVCGER |
Insulin |
9 |
38 - 46 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Cytometric bead array |
-0.03 |
0.71 |
-0.32 |
0.00 |
1,023.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 958 |
ALYLVCGER |
Insulin |
9 |
38 - 46 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
ICS |
-0.03 |
0.71 |
-0.32 |
0.00 |
1,023.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 959 |
ALYLVCGER |
Insulin |
9 |
38 - 46 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
ICS |
-0.03 |
0.71 |
-0.32 |
0.00 |
1,023.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22492505 |
| 960 |
LYLVCGERGF |
Insulin |
10 |
39 - 48 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.02 |
0.70 |
-0.49 |
0.00 |
1,156.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 961 |
LYLVCGERGF |
Insulin |
10 |
39 - 48 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.02 |
0.70 |
-0.49 |
0.00 |
1,156.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 962 |
LVCGERGFFY |
Insulin |
10 |
41 - 50 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.03 |
0.60 |
-0.56 |
0.00 |
1,190.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 963 |
LVCGERGFFY |
Insulin |
10 |
41 - 50 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.03 |
0.60 |
-0.56 |
0.00 |
1,190.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 964 |
LVCGERGFFY |
Insulin |
10 |
41 - 50 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.03 |
0.60 |
-0.56 |
0.00 |
1,190.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 965 |
LVCGERGFFY |
Insulin |
10 |
41 - 50 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.03 |
0.60 |
-0.56 |
0.00 |
1,190.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 966 |
LVCGERGFFY |
Insulin |
10 |
41 - 50 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.03 |
0.60 |
-0.56 |
0.00 |
1,190.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 967 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 968 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 969 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 970 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 971 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 972 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 973 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 974 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 975 |
GERGFFYT |
Insulin |
8 |
44 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.12 |
-0.65 |
-0.21 |
0.00 |
976.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 976 |
GERGFFYT |
Insulin |
8 |
44 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.12 |
-0.65 |
-0.21 |
0.00 |
976.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 977 |
GERGFFYT |
Insulin |
8 |
44 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.12 |
-0.65 |
-0.21 |
0.00 |
976.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 978 |
GERGFFYT |
Insulin |
8 |
44 - 51 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.12 |
-0.65 |
-0.21 |
0.00 |
976.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 979 |
ERGFFYTPK |
Insulin |
9 |
45 - 53 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.26 |
-1.14 |
0.14 |
1.00 |
1,144.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 980 |
ERGFFYTPK |
Insulin |
9 |
45 - 53 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.26 |
-1.14 |
0.14 |
1.00 |
1,144.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 981 |
FYTPKTRRE |
Insulin |
9 |
49 - 57 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.56 |
-1.99 |
0.71 |
2.00 |
1,197.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 982 |
FYTPKTRRE |
Insulin |
9 |
49 - 57 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.56 |
-1.99 |
0.71 |
2.00 |
1,197.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 983 |
GIVEQCCTSICSLYQ |
Insulin |
15 |
90 - 104 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.01 |
0.67 |
-0.57 |
-1.00 |
1,647.13 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 984 |
GIVEQCCTSICSLYQ |
Insulin |
15 |
90 - 104 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.01 |
0.67 |
-0.57 |
-1.00 |
1,647.13 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 985 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 986 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 987 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 988 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 989 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 990 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 991 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 992 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 993 |
SLQPLALEGSLQKRG |
Insulin |
15 |
76 - 90 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.18 |
-0.39 |
0.15 |
1.00 |
1,597.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 994 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 995 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 996 |
SHLVEALYLVCGERG |
Insulin |
15 |
33 - 47 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 997 |
SHLVEALYLVCGERG |
Insulin |
15 |
33 - 47 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 998 |
SHLVEALYLVCGERG |
Insulin |
15 |
33 - 47 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 999 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 1,000 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 1,001 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 1,002 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 1,003 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
HLA-DR4 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 1,004 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
HLA-DR3 |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21471440 |
| 1,005 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-B*07:02 |
I |
-- |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22997432 |
| 1,006 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-B*07:02 |
I |
-- |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22997432 |
| 1,007 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-B*07:02 |
I |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22997432 |
| 1,008 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-B*07:02 |
I |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22997432 |
| 1,009 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-B*07:02 |
I |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22997432 |
| 1,010 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-B*07:02 |
I |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22997432 |
| 1,011 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-B*07:02 |
I |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22997432 |
| 1,012 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*11:01 |
I |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22539795 |
| 1,013 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*11:01 |
I |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22539795 |
| 1,014 |
EALYLVCGERG |
Insulin |
11 |
37 - 47 |
-- |
-- |
Homo sapiens |
HLA-A*11:01 |
I |
-- |
-- |
ELISPOT |
-0.07 |
0.23 |
0.01 |
-1.00 |
1,209.54 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 22539795 |
| 1,015 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*11:01 |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22539795 |
| 1,016 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*11:01 |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22539795 |
| 1,017 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*11:01 |
I |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22539795 |
| 1,018 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,019 |
MALWMRLLPLLALLA |
Insulin |
15 |
1 - 15 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.23 |
1.92 |
-1.14 |
1.00 |
1,725.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,020 |
LPLLALLALWGPDPAA |
Insulin |
16 |
8 - 23 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.24 |
1.28 |
-0.83 |
-1.00 |
1,631.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,021 |
WGPDPAAAFVNQHL |
Insulin |
14 |
17 - 30 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.03 |
-0.14 |
-0.56 |
-0.50 |
1,522.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,022 |
PDPAAAFVNQHL |
Insulin |
12 |
19 - 30 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.01 |
-0.06 |
-0.37 |
-0.50 |
1,279.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,023 |
DPAAAFVNQHLCGSHL |
Insulin |
16 |
20 - 35 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.17 |
-0.46 |
0.00 |
1,680.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,024 |
FVNQHLCGSHLVEALY |
Insulin |
16 |
25 - 40 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
0.05 |
0.47 |
-0.75 |
0.00 |
1,830.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,025 |
SHLVEALYLVCGERG |
Insulin |
15 |
33 - 47 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,026 |
YLVCGERGFFYTPKTR |
Insulin |
16 |
40 - 55 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
In vivo assay |
-0.19 |
-0.42 |
-0.17 |
2.00 |
1,937.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23155466 |
| 1,027 |
RGFFYTPKTRREAEDL |
Insulin |
16 |
46 - 61 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
In vivo skin test |
-0.41 |
-1.34 |
0.66 |
1.00 |
1,986.43 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 22647732 |
| 1,028 |
RREAEDLQVGQVELGG |
Insulin |
16 |
55 - 70 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
In vivo skin test |
-0.29 |
-0.84 |
0.71 |
-2.00 |
1,756.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22647732 |
| 1,029 |
LQVGQVELGGGPGAGS |
Insulin |
16 |
61 - 76 |
-- |
-- |
Homo sapiens |
H2-Db |
I |
-- |
-- |
Multimer/tetramer |
0.06 |
0.16 |
-0.21 |
-1.00 |
1,425.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23209415 |
| 1,030 |
GGPGAGSLQPLALEGSL |
Insulin |
17 |
70 - 86 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
in vitro assay |
0.09 |
0.29 |
-0.26 |
-1.00 |
1,523.97 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,031 |
LALEGSLQKRGIVEQCCT |
Insulin |
18 |
80 - 97 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
in vitro assay |
-0.13 |
0.12 |
0.06 |
0.00 |
1,948.56 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,032 |
VEQCCTSICSLYQLENYCN |
Insulin |
19 |
92 - 110 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Cytometric bead array |
-0.11 |
0.02 |
-0.45 |
-2.00 |
2,213.77 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,033 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Cytometric bead array |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,034 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Cytometric bead array |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,035 |
LCGSHLVEAL |
Insulin |
10 |
30 - 39 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Cytometric bead array |
0.13 |
1.20 |
-0.56 |
-0.50 |
1,041.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,036 |
SHLVEALYLV |
Insulin |
10 |
33 - 42 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ICS |
0.17 |
1.28 |
-0.84 |
-0.50 |
1,143.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,037 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-A24 |
I |
-- |
-- |
in vitro assay |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,038 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Surface plasmon resonance (SPR) |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,039 |
SLYQLENYC |
Insulin |
9 |
101 - 109 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Surface plasmon resonance (SPR) |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,040 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Surface plasmon resonance (SPR) |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,041 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Surface plasmon resonance (SPR) |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22936177 |
| 1,042 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22102287 |
| 1,043 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
ELISA |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22971988 |
| 1,044 |
LYLVCGERGF |
Insulin |
10 |
39 - 48 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
ELISA |
0.02 |
0.70 |
-0.49 |
0.00 |
1,156.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22971988 |
| 1,045 |
EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ |
Insulin |
31 |
57 - 87 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
ELISA |
-0.02 |
-0.08 |
0.04 |
-5.00 |
3,020.80 |
Non-Toxin |
IEDB;SATPdb |
Type 1 Diabetes |
-- |
PMID: 22971988 |
| 1,046 |
AGSLQPLALE |
Insulin |
10 |
74 - 83 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
ELISA |
0.06 |
0.52 |
-0.29 |
-1.00 |
998.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22971988 |
| 1,047 |
AGSLQPLAL |
Insulin |
9 |
74 - 82 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
ELISA |
0.14 |
0.97 |
-0.66 |
0.00 |
869.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22971988 |
| 1,048 |
VELGGGPG |
Insulin |
8 |
66 - 73 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
0.13 |
0.16 |
-0.04 |
-1.00 |
684.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23255554 |
| 1,049 |
SLQPLALEGSL |
Insulin |
11 |
76 - 86 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
0.06 |
0.58 |
-0.35 |
-1.00 |
1,127.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23255554 |
| 1,050 |
QVELGGGPGAG |
Insulin |
11 |
65 - 75 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.07 |
-0.07 |
-0.05 |
-1.00 |
941.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22983906 |
| 1,051 |
QVELGGGPG |
Insulin |
9 |
65 - 73 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.04 |
-0.24 |
-0.01 |
-1.00 |
813.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22983906 |
| 1,052 |
PGAGSLQPLALE |
Insulin |
12 |
72 - 83 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.06 |
0.27 |
-0.24 |
-1.00 |
1,152.49 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22983906 |
| 1,053 |
QPLALEGSL |
Insulin |
9 |
78 - 86 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
3H-thymidine |
0.04 |
0.38 |
-0.27 |
-1.00 |
927.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22983906 |
| 1,054 |
QPLALEGSLQ |
Insulin |
10 |
78 - 87 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.03 |
-0.01 |
-0.22 |
-1.00 |
1,055.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,055 |
AEDLQVGQVE |
Insulin |
10 |
58 - 67 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.13 |
-0.39 |
0.41 |
-3.00 |
1,087.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,056 |
LALEGSL |
Insulin |
7 |
80 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.16 |
1.21 |
-0.37 |
-1.00 |
701.92 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,057 |
SLQPLALEGS |
Insulin |
10 |
76 - 85 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.01 |
0.26 |
-0.21 |
-1.00 |
1,014.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,058 |
VELGGGPGA |
Insulin |
9 |
66 - 74 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.14 |
0.34 |
-0.09 |
-1.00 |
755.96 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,059 |
EAEDLQVGQVELGG |
Insulin |
14 |
57 - 70 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.08 |
-0.31 |
0.38 |
-4.00 |
1,443.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,060 |
SLQPLALEGSLQ |
Insulin |
12 |
76 - 87 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.00 |
0.24 |
-0.31 |
-1.00 |
1,255.62 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,061 |
GAGSLQPLAL |
Insulin |
10 |
73 - 82 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.14 |
0.83 |
-0.59 |
0.00 |
926.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,062 |
SLQPLALEGSL |
Insulin |
11 |
76 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.06 |
0.58 |
-0.35 |
-1.00 |
1,127.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,063 |
LALEGSL |
Insulin |
7 |
80 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.16 |
1.21 |
-0.37 |
-1.00 |
701.92 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,064 |
QPLALEGSL |
Insulin |
9 |
78 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.04 |
0.38 |
-0.27 |
-1.00 |
927.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,065 |
SLQPLALEGSL |
Insulin |
11 |
76 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.06 |
0.58 |
-0.35 |
-1.00 |
1,127.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,066 |
AEDLQVGQVE |
Insulin |
10 |
58 - 67 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.13 |
-0.39 |
0.41 |
-3.00 |
1,087.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,067 |
LALEGSL |
Insulin |
7 |
80 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.16 |
1.21 |
-0.37 |
-1.00 |
701.92 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,068 |
VELGGGPGA |
Insulin |
9 |
66 - 74 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Cytometric bead array |
0.14 |
0.34 |
-0.09 |
-1.00 |
755.96 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,069 |
GAGSLQPLAL |
Insulin |
10 |
73 - 82 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
ICS |
0.14 |
0.83 |
-0.59 |
0.00 |
926.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,070 |
AGSLQPLALE |
Insulin |
10 |
74 - 83 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Cytometric bead array |
0.06 |
0.52 |
-0.29 |
-1.00 |
998.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,071 |
VELGGGPG |
Insulin |
8 |
66 - 73 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
Cytometric bead array |
0.13 |
0.16 |
-0.04 |
-1.00 |
684.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,072 |
SLQPLALEGSL |
Insulin |
11 |
76 - 86 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Cytometric bead array |
0.06 |
0.58 |
-0.35 |
-1.00 |
1,127.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,073 |
QVELGGGPGAG |
Insulin |
11 |
65 - 75 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
Cytometric bead array |
0.07 |
-0.07 |
-0.05 |
-1.00 |
941.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,074 |
QVELGGGPG |
Insulin |
9 |
65 - 73 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
Cytometric bead array |
0.04 |
-0.24 |
-0.01 |
-1.00 |
813.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,075 |
PGAGSLQPLALE |
Insulin |
12 |
72 - 83 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Cytometric bead array |
0.06 |
0.27 |
-0.24 |
-1.00 |
1,152.49 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,076 |
QPLALEGSL |
Insulin |
9 |
78 - 86 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
ICS |
0.04 |
0.38 |
-0.27 |
-1.00 |
927.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,077 |
QPLALEGSLQ |
Insulin |
10 |
78 - 87 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
Cytometric bead array |
-0.03 |
-0.01 |
-0.22 |
-1.00 |
1,055.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,078 |
AEDLQVGQVE |
Insulin |
10 |
58 - 67 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
Cytometric bead array |
-0.13 |
-0.39 |
0.41 |
-3.00 |
1,087.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,079 |
LALEGSL |
Insulin |
7 |
80 - 86 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
ICS |
0.16 |
1.21 |
-0.37 |
-1.00 |
701.92 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,080 |
SLQPLALEGS |
Insulin |
10 |
76 - 85 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
ICS |
0.01 |
0.26 |
-0.21 |
-1.00 |
1,014.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23390544 |
| 1,081 |
VELGGGPGA |
Insulin |
9 |
66 - 74 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.14 |
0.34 |
-0.09 |
-1.00 |
755.96 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,082 |
EAEDLQVGQVELGG |
Insulin |
14 |
57 - 70 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.08 |
-0.31 |
0.38 |
-4.00 |
1,443.75 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,083 |
SLQPLALEGSLQ |
Insulin |
12 |
76 - 87 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.24 |
-0.31 |
-1.00 |
1,255.62 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,084 |
GAGSLQPLAL |
Insulin |
10 |
73 - 82 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.14 |
0.83 |
-0.59 |
0.00 |
926.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,085 |
SLQPLALEGSL |
Insulin |
11 |
76 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.06 |
0.58 |
-0.35 |
-1.00 |
1,127.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,086 |
LALEGSL |
Insulin |
7 |
80 - 86 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.16 |
1.21 |
-0.37 |
-1.00 |
701.92 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23228173 |
| 1,087 |
AGSLQPLAL |
Insulin |
9 |
74 - 82 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
In vivo assay |
0.14 |
0.97 |
-0.66 |
0.00 |
869.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23246542 |
| 1,088 |
SLQPLALEGSLQKRG |
Insulin |
15 |
76 - 90 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
In vivo assay |
-0.18 |
-0.39 |
0.15 |
1.00 |
1,597.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23246542 |
| 1,089 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
In vivo assay |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23246542 |
| 1,090 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21799852 |
| 1,091 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,092 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,093 |
VELGGGPGA |
Insulin |
9 |
66 - 74 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.14 |
0.34 |
-0.09 |
-1.00 |
755.96 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,094 |
QVELGGGPGAG |
Insulin |
11 |
65 - 75 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.07 |
-0.07 |
-0.05 |
-1.00 |
941.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,095 |
QVELGGGPG |
Insulin |
9 |
65 - 73 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.04 |
-0.24 |
-0.01 |
-1.00 |
813.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,096 |
AGSLQPLALE |
Insulin |
10 |
74 - 83 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.06 |
0.52 |
-0.29 |
-1.00 |
998.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,097 |
AGSLQPLAL |
Insulin |
9 |
74 - 82 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.14 |
0.97 |
-0.66 |
0.00 |
869.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,098 |
SLQPLALEGSL |
Insulin |
11 |
76 - 86 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.06 |
0.58 |
-0.35 |
-1.00 |
1,127.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,099 |
VELGGGPGA |
Insulin |
9 |
66 - 74 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.14 |
0.34 |
-0.09 |
-1.00 |
755.96 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,100 |
PGAGSLQPLALEGSL |
Insulin |
15 |
72 - 86 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.08 |
0.39 |
-0.29 |
-1.00 |
1,409.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,101 |
SHLVEALYLVCGERG |
Insulin |
15 |
33 - 47 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,102 |
HLCGSHLVEA |
Insulin |
10 |
29 - 38 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.04 |
0.50 |
-0.43 |
0.00 |
1,065.36 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,103 |
SHLVEALYLVAGERG |
Insulin-1 |
15 |
-- |
-- |
-- |
Mus musculus |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
-0.01 |
0.39 |
-0.19 |
-0.50 |
1,614.06 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,104 |
HLVERLYLVAGEEG |
Insulin-1 |
14 |
-- |
-- |
-- |
Mus musculus |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
-0.05 |
0.09 |
0.02 |
-1.50 |
1,585.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23710469 |
| 1,105 |
HLVERLYLVAGEEG |
Insulin-1 |
14 |
-- |
-- |
-- |
Mus musculus |
H2 class I |
I |
-- |
-- |
ELISA |
-0.05 |
0.09 |
0.02 |
-1.50 |
1,585.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23770292 |
| 1,106 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2 class I |
I |
-- |
-- |
ELISA |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23770292 |
| 1,107 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2 class I |
I |
-- |
-- |
ELISA |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23770292 |
| 1,108 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2 class I |
I |
-- |
-- |
ELISA |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23770292 |
| 1,109 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
In vivo assay |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23894591 |
| 1,110 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2 class II |
II |
-- |
-- |
In vivo assay |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23894591 |
| 1,111 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22972920 |
| 1,112 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24043895 |
| 1,113 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24043895 |
| 1,114 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24043895 |
| 1,115 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24043895 |
| 1,116 |
SHLVEALY |
Insulin-2 |
8 |
33 - 40 |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
Multimer/tetramer |
0.07 |
0.60 |
-0.64 |
-0.50 |
931.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22972920 |
| 1,117 |
SHLVEALY |
Insulin-2 |
8 |
33 - 40 |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
In vivo assay |
0.07 |
0.60 |
-0.64 |
-0.50 |
931.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22972920 |
| 1,118 |
SHLVEALY |
Insulin-2 |
8 |
33 - 40 |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
ICS |
0.07 |
0.60 |
-0.64 |
-0.50 |
931.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22972920 |
| 1,119 |
SHLVEALY |
Insulin-2 |
8 |
33 - 40 |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
intracellular staining |
0.07 |
0.60 |
-0.64 |
-0.50 |
931.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22972920 |
| 1,120 |
EALYLVCGERG |
Insulin-2 |
11 |
37 - 47 |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
in vitro assay |
-0.07 |
0.23 |
0.01 |
-1.00 |
1,209.54 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 22972920 |
| 1,121 |
EALYLVCGERG |
Insulin-2 |
11 |
37 - 47 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.07 |
0.23 |
0.01 |
-1.00 |
1,209.54 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23803704 |
| 1,122 |
EALYLVCGERG |
Insulin-2 |
11 |
37 - 47 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.07 |
0.23 |
0.01 |
-1.00 |
1,209.54 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23803704 |
| 1,123 |
EALYLVCGERG |
Insulin-2 |
11 |
37 - 47 |
-- |
-- |
Mus musculus |
HLA-B7 |
I |
-- |
-- |
Multimer/tetramer |
-0.07 |
0.23 |
0.01 |
-1.00 |
1,209.54 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 23803704 |
| 1,124 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23803704 |
| 1,125 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23803704 |
| 1,126 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23803704 |
| 1,127 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23803704 |
| 1,128 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-Kb |
I |
-- |
-- |
ICS |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23977133 |
| 1,129 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24550292 |
| 1,130 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24550292 |
| 1,131 |
TLALEVAQQK |
Insulin-2 |
10 |
79 - 88 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.12 |
0.03 |
-0.01 |
0.00 |
1,100.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24550292 |
| 1,132 |
LYLVCGERG |
Insulin-2 |
9 |
39 - 47 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24550292 |
| 1,133 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24550292 |
| 1,134 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21896930 |
| 1,135 |
EALYLVCGE |
Insulin-2 |
9 |
37 - 45 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.09 |
0.82 |
-0.32 |
-2.00 |
996.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21896930 |
| 1,136 |
EALYLVCGE |
Insulin-2 |
9 |
37 - 45 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.09 |
0.82 |
-0.32 |
-2.00 |
996.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21896930 |
| 1,137 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 21896930 |
| 1,138 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19837003 |
| 1,139 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19837003 |
| 1,140 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA class I |
I |
-- |
-- |
Biological activity |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24016298 |
| 1,141 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
H2-IAg7 |
II |
-- |
-- |
binding assay |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 23894487 |
| 1,142 |
SLYQLENYCN |
Insulin-2 |
10 |
101 - 110 |
-- |
-- |
Mus musculus |
H2 class I |
I |
-- |
-- |
ELISPOT |
-0.17 |
-0.73 |
-0.53 |
-1.00 |
1,246.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24387268 |
| 1,143 |
SLYQLENYCN |
Insulin-2 |
10 |
101 - 110 |
-- |
-- |
Mus musculus |
H2 class I |
I |
-- |
-- |
ELISPOT |
-0.17 |
-0.73 |
-0.53 |
-1.00 |
1,246.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24387268 |
| 1,144 |
SLYQLENYCN |
Insulin-2 |
10 |
101 - 110 |
-- |
-- |
Mus musculus |
H2 class I |
I |
-- |
-- |
ELISPOT |
-0.17 |
-0.73 |
-0.53 |
-1.00 |
1,246.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24387268 |
| 1,145 |
LQTLALNAARDP |
Islet amyloid polypeptide |
12 |
Insulin-1 (75-80) |
-- |
-- |
Mus musculus |
H2 class I |
I |
-- |
-- |
ELISPOT |
-0.14 |
-0.04 |
-0.07 |
0.00 |
1,282.63 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24387268 |
| 1,146 |
LQTLALNAARDP |
Islet amyloid polypeptide |
12 |
Insulin-1 (75-80) |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
In vivo assay |
-0.14 |
-0.04 |
-0.07 |
0.00 |
1,282.63 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24387268 |
| 1,147 |
LQTLALNAARDP |
Islet amyloid polypeptide |
12 |
Insulin-1 (75-80) |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
In vivo assay |
-0.14 |
-0.04 |
-0.07 |
0.00 |
1,282.63 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24387268 |
| 1,148 |
LQTLALNAARDP |
Islet amyloid polypeptide |
12 |
Insulin-1 (75-80) |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
In vivo assay |
-0.14 |
-0.04 |
-0.07 |
0.00 |
1,282.63 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24387268 |
| 1,149 |
LQTLALNAARDP |
Islet amyloid polypeptide |
12 |
Insulin-1 (75-80) |
-- |
-- |
Mus musculus |
H2-Db |
I |
-- |
-- |
In vivo assay |
-0.14 |
-0.04 |
-0.07 |
0.00 |
1,282.63 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24387268 |
| 1,150 |
KCNTATCATQRALNFLVRSS |
Islet amyloid polypeptide |
20 |
-- |
-- |
-- |
Mus musculus |
HLA-DQ8 |
II |
-- |
-- |
ELISPOT |
-0.23 |
-0.11 |
-0.11 |
3.00 |
2,184.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24239002 |
| 1,151 |
KCNTATCATQRALNFLVRSS |
Islet amyloid polypeptide |
20 |
-- |
-- |
-- |
Mus musculus |
HLA-DQ8 |
II |
-- |
-- |
ELISPOT |
-0.23 |
-0.11 |
-0.11 |
3.00 |
2,184.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24239002 |
| 1,152 |
KLQVFLIVL |
Islet amyloid polypeptide |
9 |
5 - 13 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.25 |
2.19 |
-1.06 |
1.00 |
1,072.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24239002 |
| 1,153 |
KLQVFLIVL |
Islet amyloid polypeptide |
9 |
5 - 13 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.25 |
2.19 |
-1.06 |
1.00 |
1,072.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24239002 |
| 1,154 |
FLIVLSVAL |
Islet amyloid polypeptide |
9 |
9 - 17 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
ELISPOT |
0.44 |
3.12 |
-1.43 |
0.00 |
974.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24239002 |
| 1,155 |
KLQVFLIVL |
Islet amyloid polypeptide |
9 |
5 - 13 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.25 |
2.19 |
-1.06 |
1.00 |
1,072.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24239002 |
| 1,156 |
FLIVLSVAL |
Islet amyloid polypeptide |
9 |
9 - 17 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.44 |
3.12 |
-1.43 |
0.00 |
974.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19837003 |
| 1,157 |
KCNTATCATQRLANFLVRSS |
Islet amyloid polypeptide |
20 |
38 - 57 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.23 |
-0.11 |
-0.11 |
3.00 |
2,184.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19837003 |
| 1,158 |
KCNTATCATQRLANFLVRSS |
Islet amyloid polypeptide |
20 |
38 - 57 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.23 |
-0.11 |
-0.11 |
3.00 |
2,184.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19837003 |
| 1,159 |
KCNTATCATQRLANFLVRSS |
Islet amyloid polypeptide |
20 |
38 - 57 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.23 |
-0.11 |
-0.11 |
3.00 |
2,184.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19837003 |
| 1,160 |
KCNTATCATQRLANFLVRSS |
Islet amyloid polypeptide |
20 |
38 - 57 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.23 |
-0.11 |
-0.11 |
3.00 |
2,184.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20299469 |
| 1,161 |
KLQVFLIVL |
Islet amyloid polypeptide |
9 |
5 - 13 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.25 |
2.19 |
-1.06 |
1.00 |
1,072.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24435807 |
| 1,162 |
KCNTATCATQRLANFLVRSS |
Islet amyloid polypeptide |
20 |
38 - 57 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.23 |
-0.11 |
-0.11 |
3.00 |
2,184.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,163 |
KCNTATCATQRLANFLVRSS |
Islet amyloid polypeptide |
20 |
38 - 57 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.23 |
-0.11 |
-0.11 |
3.00 |
2,184.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,164 |
VGSNTYGKRNAVEVLKREPL + CITR(R9, R17) |
Islet amyloid polypeptide |
36 |
65 - 84 |
-- |
VGSNTYGKRNAVEVLKREPL + CITR(R9, R17) |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,165 |
KLQVFLIVL |
Islet amyloid polypeptide |
9 |
5 - 13 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.25 |
2.19 |
-1.06 |
1.00 |
1,072.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,166 |
AFIEFKADEKKEDE |
Islet cell autoantigen 1 |
14 |
-- |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.34 |
-1.36 |
1.37 |
-3.00 |
1,699.03 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,167 |
AFIKATGKKEDE |
Islet cell autoantigen 1 |
12 |
35 - 46 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.29 |
-1.03 |
1.03 |
0.00 |
1,336.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,168 |
AFIKATGKKEDE |
Islet cell autoantigen 1 |
12 |
36 - 47 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.29 |
-1.03 |
1.03 |
0.00 |
1,336.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,169 |
AFIKATGKKEDE |
Islet cell autoantigen 1 |
12 |
36 - 47 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
-0.29 |
-1.03 |
1.03 |
0.00 |
1,336.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,170 |
FLWSVFMLI |
Glucose-6-phosphatase 2 |
9 |
-- |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.44 |
2.46 |
-1.81 |
0.00 |
1,155.60 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,171 |
FLFAVGFYL |
Glucose-6-phosphatase 2 |
9 |
215 - 223 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
3H-thymidine |
0.43 |
2.26 |
-1.71 |
0.00 |
1,076.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,172 |
LNIDLLWSV |
Glucose-6-phosphatase 2 |
9 |
228 - 236 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.18 |
1.27 |
-0.96 |
-1.00 |
1,072.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,173 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,174 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24705406 |
| 1,175 |
LNIDLLWSV |
Glucose-6-phosphatase 2 |
9 |
228 - 236 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
in vitro assay |
0.18 |
1.27 |
-0.96 |
-1.00 |
1,072.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20299469 |
| 1,176 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20299469 |
| 1,177 |
QHLQKDYRAYYTF |
Glucose-6-phosphatase 2 |
13 |
13 - 25 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.31 |
-1.41 |
-0.25 |
1.50 |
1,733.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24550292 |
| 1,178 |
RVLNIDLLWSVPI |
Glucose-6-phosphatase 2 |
13 |
226 - 238 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.08 |
1.08 |
-0.68 |
0.00 |
1,538.07 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22829452 |
| 1,179 |
YTFLNFMSNVGDP |
Glucose-6-phosphatase 2 |
13 |
23 - 35 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.02 |
0.02 |
-0.66 |
-1.00 |
1,504.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22829452 |
| 1,180 |
DWIHIDTTPFAGL |
Glucose-6-phosphatase 2 |
13 |
247 - 259 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Biological activity |
0.09 |
0.22 |
-0.55 |
-1.50 |
1,485.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 22829452 |
| 1,181 |
DWIHIDTTPFAGL |
Glucose-6-phosphatase 2 |
13 |
247 - 259 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.09 |
0.22 |
-0.55 |
-1.50 |
1,485.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24677716 |
| 1,182 |
DWIHIDTTPFAGL |
Glucose-6-phosphatase 2 |
13 |
247 - 259 |
-- |
-- |
Homo sapiens |
H2 class II |
II |
-- |
-- |
3H-thymidine |
0.09 |
0.22 |
-0.55 |
-1.50 |
1,485.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24677716 |
| 1,183 |
DWIHIDTTPFAGL |
Glucose-6-phosphatase 2 |
13 |
247 - 259 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.09 |
0.22 |
-0.55 |
-1.50 |
1,485.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24943217 |
| 1,184 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-A11 |
I |
-- |
-- |
51 chromium |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10439311 |
| 1,185 |
NLFLFLFAV |
Glucose-6-phosphatase 2 |
9 |
211 - 219 |
-- |
-- |
Homo sapiens |
HLA-A11 |
I |
-- |
-- |
51 chromium |
0.40 |
2.48 |
-1.63 |
0.00 |
1,083.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10439311 |
| 1,186 |
FLFAVGFYL |
Glucose-6-phosphatase 2 |
9 |
215 - 223 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:04 |
II |
-- |
-- |
3H-thymidine |
0.43 |
2.26 |
-1.71 |
0.00 |
1,076.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10439311 |
| 1,187 |
YLLLRVLNI |
Glucose-6-phosphatase 2 |
9 |
222 - 230 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
any method |
0.11 |
1.62 |
-1.07 |
1.00 |
1,116.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24943217 |
| 1,188 |
DWIHIDTTPFAGL |
Glucose-6-phosphatase 2 |
13 |
247 - 259 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
In vivo assay |
0.09 |
0.22 |
-0.55 |
-1.50 |
1,485.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24943217 |
| 1,189 |
FLWSVFWLI |
Glucose-6-phosphatase 2 |
9 |
152 - 160 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.45 |
2.14 |
-2.04 |
0.00 |
1,210.62 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,190 |
KDYRAYYTFLNFMSNVGDPR |
Glucose-6-phosphatase 2 |
20 |
17 - 36 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
-0.24 |
-0.85 |
-0.08 |
1.00 |
2,458.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,191 |
LNIDLLWSV |
Glucose-6-phosphatase 2 |
9 |
228 - 236 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.18 |
1.27 |
-0.96 |
-1.00 |
1,072.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,192 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,193 |
LNIDLLWSV |
Glucose-6-phosphatase 2 |
9 |
228 - 236 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.18 |
1.27 |
-0.96 |
-1.00 |
1,072.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,194 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,195 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,196 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,197 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,198 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,199 |
GLVRNLGVL + CITR(R4) |
Glucose-6-phosphatase 2 |
20 |
258 - 266 |
-- |
GLVRNLGVL + CITR(R4) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,200 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,201 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,202 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
ELISPOT |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25225671 |
| 1,203 |
QLYHFLQIPTHEEHLFYVLS |
Glucose-6-phosphatase 2 |
20 |
305 - 324 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
Multimer/tetramer |
0.02 |
0.01 |
-0.77 |
-0.50 |
2,515.19 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,204 |
KWCANPDWIHIDTTPFAGLV |
Glucose-6-phosphatase 2 |
20 |
241 - 260 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
Multimer/tetramer |
0.03 |
0.08 |
-0.51 |
-0.50 |
2,284.91 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,205 |
HQVILGVIGGMLVAEAFEHT |
Glucose-6-phosphatase 2 |
20 |
177 - 196 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ICS |
0.15 |
0.94 |
-0.59 |
-1.00 |
2,121.81 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,206 |
FLFAVGFYL |
Glucose-6-phosphatase 2 |
9 |
215 - 223 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ICS |
0.43 |
2.26 |
-1.71 |
0.00 |
1,076.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,207 |
RLLCALTSL |
Glucose-6-phosphatase 2 |
9 |
293 - 301 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ICS |
0.02 |
1.50 |
-0.64 |
1.00 |
989.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,208 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ICS |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,209 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ICS |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,210 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ICS |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,211 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25405480 |
| 1,212 |
KWCANPDWIHIDTTPFAGLV |
Glucose-6-phosphatase 2 |
20 |
241 - 260 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
Multimer/tetramer |
0.03 |
0.08 |
-0.51 |
-0.50 |
2,284.91 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,213 |
VLFGLGFAI |
Glucose-6-phosphatase 2 |
9 |
265 - 273 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,214 |
DWIHIDTTPFAGL |
Glucose-6-phosphatase 2 |
13 |
247 - 259 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
0.09 |
0.22 |
-0.55 |
-1.50 |
1,485.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,215 |
YTFLNFMSNVGDP |
Glucose-6-phosphatase 2 |
13 |
23 - 35 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ELISA |
0.02 |
0.02 |
-0.66 |
-1.00 |
1,504.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,216 |
DWIHIDTTPFAGL |
Glucose-6-phosphatase 2 |
13 |
247 - 259 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ELISA |
0.09 |
0.22 |
-0.55 |
-1.50 |
1,485.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,217 |
SLYQLENYCN |
Insulin-2 |
10 |
101 - 110 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Cytometric bead array |
-0.17 |
-0.73 |
-0.53 |
-1.00 |
1,246.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25112375 |
| 1,218 |
SHLVEALYLVCGERG |
Insulin-2 |
15 |
33 - 47 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25112375 |
| 1,219 |
SLYQLENYCN |
Insulin-2 |
10 |
101 - 110 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
in vitro assay |
-0.17 |
-0.73 |
-0.53 |
-1.00 |
1,246.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25112375 |
| 1,220 |
RGFFYTPM |
Insulin-2 |
8 |
46 - 53 |
-- |
-- |
Mus musculus |
HLA-A*02:01 |
I |
-- |
-- |
Cytometric bead array |
-0.04 |
-0.13 |
-0.75 |
1.00 |
1,018.30 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 25112375 |
| 1,221 |
RGFFYTPM |
Insulin-2 |
8 |
46 - 53 |
-- |
-- |
Mus musculus |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.04 |
-0.13 |
-0.75 |
1.00 |
1,018.30 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 24844227 |
| 1,222 |
ALWMRLLPL |
Insulin |
9 |
2 - 10 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
RNA/DNA detection |
0.13 |
1.32 |
-1.04 |
1.00 |
1,112.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24844227 |
| 1,223 |
FFYTPKTRREAED |
Insulin |
13 |
48 - 60 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
RNA/DNA detection |
-0.42 |
-1.56 |
0.72 |
0.00 |
1,659.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24844227 |
| 1,224 |
AGSLQPLALEGSLQKRG |
Insulin |
17 |
74 - 90 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
RNA/DNA detection |
-0.14 |
-0.26 |
0.11 |
1.00 |
1,725.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24844227 |
| 1,225 |
AGSLQPLALEGSLQKRG |
Insulin |
17 |
74 - 90 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
-0.14 |
-0.26 |
0.11 |
1.00 |
1,725.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24844227 |
| 1,226 |
AGSLQPLALEGSLQKRG |
Insulin |
17 |
74 - 90 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.14 |
-0.26 |
0.11 |
1.00 |
1,725.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25249579 |
| 1,227 |
AGSLQPLALEGSLQKRG |
Insulin |
17 |
74 - 90 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.14 |
-0.26 |
0.11 |
1.00 |
1,725.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25249579 |
| 1,228 |
AGSLQPLALEGSLQKRG |
Insulin |
17 |
74 - 90 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.14 |
-0.26 |
0.11 |
1.00 |
1,725.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25249579 |
| 1,229 |
GGGPGAGSLQPLALEGSLQK |
Insulin |
20 |
69 - 88 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.01 |
-0.14 |
-0.06 |
0.00 |
1,837.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25249579 |
| 1,230 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25249579 |
| 1,231 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25302633 |
| 1,232 |
GAGSLQPLALEGSLQKRGIV |
Insulin |
20 |
73 - 92 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.05 |
0.19 |
-0.07 |
1.00 |
1,994.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25302633 |
| 1,233 |
GAGSLQPLALEGSLQKRGIV |
Insulin |
20 |
73 - 92 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
in vitro assay |
-0.05 |
0.19 |
-0.07 |
1.00 |
1,994.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25302633 |
| 1,234 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-A1 |
I |
-- |
-- |
Multimer/tetramer |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25597827 |
| 1,235 |
SLYQLENYC |
Insulin |
9 |
101 - 109 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
Multimer/tetramer |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25597827 |
| 1,236 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-A3 |
I |
-- |
-- |
Multimer/tetramer |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25597827 |
| 1,237 |
SLYQLENYC |
Insulin |
9 |
101 - 109 |
-- |
-- |
Homo sapiens |
HLA-B8 |
I |
-- |
-- |
Multimer/tetramer |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25597827 |
| 1,238 |
SLQPLALEGSLQKRG |
Insulin |
15 |
76 - 90 |
-- |
-- |
Homo sapiens |
HLA-B35 |
I |
-- |
-- |
Multimer/tetramer |
-0.18 |
-0.39 |
0.15 |
1.00 |
1,597.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25597827 |
| 1,239 |
ALWMRLLPLL |
Insulin |
10 |
2 - 11 |
-- |
-- |
Homo sapiens |
HLA-A24 |
I |
-- |
-- |
Multimer/tetramer |
0.17 |
1.57 |
-1.12 |
1.00 |
1,225.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25597827 |
| 1,240 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-A11 |
I |
-- |
-- |
Multimer/tetramer |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25597827 |
| 1,241 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
HLA-B51 |
I |
-- |
-- |
Multimer/tetramer |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25597827 |
| 1,242 |
LCGSHLVEAL |
Insulin |
10 |
30 - 39 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
In vivo assay |
0.13 |
1.20 |
-0.56 |
-0.50 |
1,041.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24777314 |
| 1,243 |
SHLVEALYLV |
Insulin |
10 |
33 - 42 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.17 |
1.28 |
-0.84 |
-0.50 |
1,143.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 24777314 |
| 1,244 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25831495 |
| 1,245 |
VCGERGFFYT |
Insulin |
10 |
42 - 51 |
-- |
-- |
Homo sapiens |
HLA-DQB1*03:02 |
II |
-- |
-- |
ELISPOT |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25831495 |
| 1,246 |
SLYQLENYC |
Insulin |
9 |
101 - 109 |
-- |
-- |
Homo sapiens |
HLA-DQB1*03:02 |
II |
-- |
-- |
ELISPOT |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25831495 |
| 1,247 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
ELISPOT |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25831495 |
| 1,248 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-DQB1*03:02 |
II |
-- |
-- |
ELISPOT |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25831495 |
| 1,249 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-DQB1*03:02 |
II |
-- |
-- |
ELISPOT |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25831495 |
| 1,250 |
RLLPLLALL |
Insulin |
9 |
6 - 14 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
CFSE |
0.18 |
2.06 |
-0.92 |
1.00 |
1,021.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25831495 |
| 1,251 |
HLCGSHLVEA |
Insulin |
10 |
29 - 38 |
-- |
-- |
Homo sapiens |
HLA-DQB1*03:02 |
II |
-- |
-- |
CFSE |
0.04 |
0.50 |
-0.43 |
0.00 |
1,065.36 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25831495 |
| 1,252 |
PLLALLALWG |
Insulin |
10 |
9 - 18 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.36 |
1.97 |
-1.34 |
0.00 |
1,066.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25728493 |
| 1,253 |
SLQPLALEG |
Insulin |
9 |
76 - 84 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.04 |
0.38 |
-0.27 |
-1.00 |
927.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25516468 |
| 1,254 |
PLALEGSLQK |
Insulin |
10 |
79 - 88 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.07 |
-0.05 |
0.06 |
0.00 |
1,055.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25728493 |
| 1,255 |
WMRLLPLLAL |
Insulin |
10 |
4 - 13 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.17 |
1.57 |
-1.12 |
1.00 |
1,225.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25516468 |
| 1,256 |
PLLALLALWG |
Insulin |
10 |
9 - 18 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.36 |
1.97 |
-1.34 |
0.00 |
1,066.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25516468 |
| 1,257 |
SLQPLALEG |
Insulin |
9 |
76 - 84 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.04 |
0.38 |
-0.27 |
-1.00 |
927.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25516468 |
| 1,258 |
PLALEGSLQK |
Insulin |
10 |
79 - 88 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
-0.07 |
-0.05 |
0.06 |
0.00 |
1,055.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25516468 |
| 1,259 |
WMRLLPLLAL |
Insulin |
10 |
4 - 13 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.17 |
1.57 |
-1.12 |
1.00 |
1,225.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25516468 |
| 1,260 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25516468 |
| 1,261 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25516468 |
| 1,262 |
ALWMRLLPL |
Insulin |
9 |
2 - 10 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.13 |
1.32 |
-1.04 |
1.00 |
1,112.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25992863 |
| 1,263 |
ALWMRLLPL |
Insulin |
9 |
2 - 10 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
51 chromium |
0.13 |
1.32 |
-1.04 |
1.00 |
1,112.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26019217 |
| 1,264 |
SLQPLALEGSLQKRG |
Insulin |
15 |
76 - 90 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
-0.18 |
-0.39 |
0.15 |
1.00 |
1,597.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26019217 |
| 1,265 |
SLQPLALEGSLQKRG |
Insulin |
15 |
76 - 90 |
-- |
-- |
Homo sapiens |
Class II, allele undetermined |
-- |
-- |
-- |
ELISA |
-0.18 |
-0.39 |
0.15 |
1.00 |
1,597.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26209627 |
| 1,266 |
SLQPLALEGSLQKRG |
Insulin |
15 |
76 - 90 |
-- |
-- |
Homo sapiens |
Class II, allele undetermined |
-- |
-- |
-- |
ELISA |
-0.18 |
-0.39 |
0.15 |
1.00 |
1,597.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26209627 |
| 1,267 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
Class II, allele undetermined |
-- |
-- |
-- |
ELISA |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26209627 |
| 1,268 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
Class II, allele undetermined |
-- |
-- |
-- |
ELISA |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26209627 |
| 1,269 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
Class II, allele undetermined |
-- |
-- |
-- |
ELISA |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26209627 |
| 1,270 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
Class II, allele undetermined |
-- |
-- |
-- |
ELISA |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26209627 |
| 1,271 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
Class II, allele undetermined |
-- |
-- |
-- |
ELISA |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26209627 |
| 1,272 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
Biological activity |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26370701 |
| 1,273 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
Biological activity |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26370701 |
| 1,274 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
Biological activity |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26370701 |
| 1,275 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-A2 |
I |
-- |
-- |
Biological activity |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26370701 |
| 1,276 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
75 - 92 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,277 |
ALWGPDPAAA |
Insulin |
10 |
15 - 24 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
bioassay |
0.12 |
0.30 |
-0.42 |
-1.00 |
968.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26453556 |
| 1,278 |
LWMRLLPLL |
Insulin |
9 |
3 - 11 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.16 |
1.54 |
-1.19 |
1.00 |
1,154.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26453556 |
| 1,279 |
HLVEALYLV |
Insulin |
9 |
34 - 42 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26453556 |
| 1,280 |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Insulin |
32 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
bioassay |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 26453556 |
| 1,281 |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Insulin |
32 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
bioassay |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 26453556 |
| 1,282 |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Insulin |
32 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,283 |
TRREAEDLQVGQVELG |
Insulin |
16 |
54 - 69 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
-0.31 |
-0.86 |
0.68 |
-2.00 |
1,800.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,284 |
TRREAEDLQVGQVELG |
Insulin |
16 |
54 - 69 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
-0.31 |
-0.86 |
0.68 |
-2.00 |
1,800.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,285 |
TRREAEDLQVGQVELG |
Insulin |
16 |
54 - 69 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
3H-thymidine |
-0.31 |
-0.86 |
0.68 |
-2.00 |
1,800.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 25267644 |
| 1,286 |
TRREAEDLQVGQVELG + DEAM(Q12) |
Insulin |
28 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q12) |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,287 |
TRREAEDLQVGQVELG + DEAM(Q12) |
Insulin |
28 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q12) |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,288 |
TRREAEDLQVGQVELG + DEAM(Q12) |
Insulin |
28 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q12) |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,289 |
TRREAEDLQVGQVELG |
Insulin |
16 |
54 - 69 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.31 |
-0.86 |
0.68 |
-2.00 |
1,800.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,290 |
TRREAEDLQVGQVELG + DEAM(Q12) |
Insulin |
28 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q12) |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,291 |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Insulin |
32 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,292 |
TRREAEDLQVGQVELG |
Insulin |
16 |
54 - 69 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.31 |
-0.86 |
0.68 |
-2.00 |
1,800.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,293 |
TRREAEDLQVGQVELG + DEAM(Q12) |
Insulin |
28 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q12) |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,294 |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Insulin |
32 |
54 - 69 |
-- |
TRREAEDLQVGQVELG + DEAM(Q9, Q12) |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,295 |
PSLSYEPALLQPY |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
197 - 209 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.01 |
-0.22 |
-0.52 |
-1.00 |
1,477.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,296 |
LEILAEHVHMSSG |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
490 - 502 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.03 |
0.35 |
-0.24 |
-1.00 |
1,422.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,297 |
GSFINISVVGPAL |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
502 - 514 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.23 |
1.41 |
-0.82 |
0.00 |
1,273.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,298 |
RSVLLTLVALAGV |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
575 - 587 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.17 |
1.92 |
-0.75 |
1.00 |
1,311.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,299 |
CAYQAEPNTCATA |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
717 - 729 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.10 |
-0.20 |
-0.28 |
-1.00 |
1,342.62 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,300 |
PAYIATQGPLSHT |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
778 - 790 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.01 |
-0.15 |
-0.59 |
0.50 |
1,355.70 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,301 |
CTVIVMLTPLVED |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
803 - 815 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.15 |
1.47 |
-0.54 |
-2.00 |
1,432.95 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,302 |
SLYHVYEVNLVSE |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
830 - 842 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.01 |
0.18 |
-0.49 |
-1.50 |
1,551.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,303 |
TYILIDMVLNRMA |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
918 - 930 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.04 |
0.99 |
-0.64 |
0.00 |
1,553.11 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,304 |
DQFEFALTAVAEE |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
957 - 969 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.03 |
0.06 |
0.15 |
-4.00 |
1,469.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,305 |
IKLKVESSPSRSDYINASPI |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
751 - 770 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.19 |
-0.40 |
0.26 |
1.00 |
2,204.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,306 |
IKLKVESSPSRSDYINASPI |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
751 - 770 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.19 |
-0.40 |
0.26 |
1.00 |
2,204.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,307 |
LYHVYEVNLVSEHIWCEDFL |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
831 - 850 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.04 |
0.28 |
-0.58 |
-3.00 |
2,509.14 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,308 |
LYHVYEVNLVSEHIWCEDFL |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
831 - 850 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.04 |
0.28 |
-0.58 |
-3.00 |
2,509.14 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,309 |
SEHIWCEDFLVRSFYLKNVQ |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
841 - 860 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.13 |
-0.21 |
-0.23 |
-0.50 |
2,514.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,310 |
SEHIWCEDFLVRSFYLKNVQ |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
841 - 860 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.13 |
-0.21 |
-0.23 |
-0.50 |
2,514.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,311 |
MVWESGCTVIVMLTPLVEDGV |
Receptor-type tyrosine-protein phosphatase-like N |
21 |
797 - 817 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.15 |
1.11 |
-0.54 |
-3.00 |
2,279.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,312 |
FYLKNVQTQETRTLTQFHF |
Receptor-type tyrosine-protein phosphatase-like N |
19 |
854 - 872 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.20 |
-0.68 |
-0.38 |
1.50 |
2,402.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,313 |
SKDQFEFALTAVAEEVNAILK |
Receptor-type tyrosine-protein phosphatase-like N |
21 |
955 - 975 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.07 |
0.14 |
0.14 |
-2.00 |
2,323.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,314 |
TIADFWQMV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
790 - 798 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.13 |
0.73 |
-0.91 |
-1.00 |
1,110.42 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,315 |
VIVMLTPLV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
805 - 813 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.38 |
2.70 |
-1.29 |
0.00 |
984.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,316 |
SLYHVYEVNL |
Receptor-type tyrosine-protein phosphatase-like N |
10 |
830 - 839 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.03 |
0.24 |
-0.82 |
-0.50 |
1,236.54 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,317 |
ALTAVAEEV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
962 - 970 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.10 |
1.10 |
-0.08 |
-2.00 |
902.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,318 |
LPGPSPAQLFQDSGLLYLAQE |
Receptor-type tyrosine-protein phosphatase-like N |
21 |
264 - 284 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
-0.03 |
-0.36 |
-2.00 |
2,244.85 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 26541133 |
| 1,319 |
LPGPSPAQLFQDSGLLYLAQE |
Receptor-type tyrosine-protein phosphatase-like N |
21 |
264 - 284 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.00 |
-0.03 |
-0.36 |
-2.00 |
2,244.85 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 26826277 |
| 1,320 |
DRGEKPASPAVQPDAALQRLAAVL |
Receptor-type tyrosine-protein phosphatase-like N |
24 |
319 - 342 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
-0.17 |
-0.24 |
0.30 |
0.00 |
2,474.15 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 26826277 |
| 1,321 |
DRGEKPASPAVQPDAALQRLAAVL |
Receptor-type tyrosine-protein phosphatase-like N |
24 |
319 - 342 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.17 |
-0.24 |
0.30 |
0.00 |
2,474.15 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 26826277 |
| 1,322 |
SPLGQSQPTVAGQPSARPAAEEYGYIVTDQKPLSLAAGVK |
Receptor-type tyrosine-protein phosphatase-like N |
40 |
449 - 488 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.11 |
-0.36 |
0.00 |
0.00 |
4,084.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26826277 |
| 1,323 |
LAKEWQALCAYQAEPNTCATAQGEG |
Receptor-type tyrosine-protein phosphatase-like N |
25 |
709 - 733 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
-0.11 |
-0.44 |
-0.09 |
-2.00 |
2,654.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26826277 |
| 1,324 |
SLSPLQAEL |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
172 - 180 |
-- |
-- |
Homo sapiens |
HLA-DQ |
II |
HLA-DQA1*05:01/DQB1*03:02;HLA-DQA1*03:01/DQB1*03:02 |
-- |
ELISPOT |
-0.01 |
0.33 |
-0.23 |
-1.00 |
957.22 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26718497 |
| 1,325 |
LLPPLLEHL |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
180 - 188 |
-- |
-- |
Homo sapiens |
HLA-DQ |
II |
HLA-DQA1*05:01/DQB1*03:02;HLA-DQA1*03:01/DQB1*03:02 |
-- |
ELISPOT |
0.17 |
1.01 |
-0.72 |
-0.50 |
1,044.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26718497 |
| 1,326 |
SLAAGVKLL |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
482 - 490 |
-- |
-- |
Homo sapiens |
HLA-DQA1*05:01/DQB1*03:02 |
II |
-- |
-- |
ELISPOT |
0.16 |
1.57 |
-0.51 |
1.00 |
871.22 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26718497 |
| 1,327 |
TIADFWQMV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
790 - 798 |
-- |
-- |
Homo sapiens |
HLA-DQ |
II |
HLA-DQA1*05:01/DQB1*03:02;HLA-DQA1*03:01/DQB1*03:02 |
-- |
ELISPOT |
0.13 |
0.73 |
-0.91 |
-1.00 |
1,110.42 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26718497 |
| 1,328 |
VIVMLTPLV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
805 - 813 |
-- |
-- |
Homo sapiens |
HLA-DQ |
II |
HLA-DQA1*05:01/DQB1*03:02;HLA-DQA1*03:01/DQB1*03:02 |
-- |
ELISPOT |
0.38 |
2.70 |
-1.29 |
0.00 |
984.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26718497 |
| 1,329 |
SLYHVYEVNL |
Receptor-type tyrosine-protein phosphatase-like N |
10 |
830 - 839 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.03 |
0.24 |
-0.82 |
-0.50 |
1,236.54 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,330 |
ALTAVAEEV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
962 - 970 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.10 |
1.10 |
-0.08 |
-2.00 |
902.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,331 |
VSSQFSDAAQASPSSHSS |
Receptor-type tyrosine-protein phosphatase-like N |
18 |
657 - 674 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.15 |
-0.52 |
-0.01 |
-0.50 |
1,780.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,332 |
LAKEWQALCAYQAEPNTCATAQG |
Receptor-type tyrosine-protein phosphatase-like N |
23 |
709 - 731 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
-0.10 |
-0.31 |
-0.23 |
-1.00 |
2,468.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,333 |
VIVMLTPLV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
805 - 813 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
ELISA |
0.38 |
2.70 |
-1.29 |
0.00 |
984.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,334 |
LYHVYEVNLVSEHIWCEDFL |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
831 - 850 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.04 |
0.28 |
-0.58 |
-3.00 |
2,509.14 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,335 |
LYHVYEVNLVSEHIWCEDFL |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
831 - 850 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.04 |
0.28 |
-0.58 |
-3.00 |
2,509.14 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,336 |
SEHIWCEDFLVRSFYLKNVQ |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
841 - 860 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.13 |
-0.21 |
-0.23 |
-0.50 |
2,514.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,337 |
SEHIWCEDFLVRSFYLKNVQ |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
841 - 860 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.13 |
-0.21 |
-0.23 |
-0.50 |
2,514.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,338 |
SRVSSVSSQFSDAAQASPSSHSSTPSWCE |
Receptor-type tyrosine-protein phosphatase-like N |
29 |
652 - 680 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.19 |
-0.59 |
0.02 |
-0.50 |
3,000.49 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,339 |
LAKEWQALCAYQAEPNTCATAQGEGNIK |
Receptor-type tyrosine-protein phosphatase-like N |
28 |
709 - 736 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
-0.13 |
-0.50 |
-0.03 |
-1.00 |
3,009.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,340 |
LAKEWQALCAYQAEPNTCATAQGEGNIK |
Receptor-type tyrosine-protein phosphatase-like N |
28 |
709 - 736 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
HLA-DR4;HLA-DQ8 |
-- |
ELISA |
-0.13 |
-0.50 |
-0.03 |
-1.00 |
3,009.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,341 |
KLKVESSPSRSDYINASPIIEHDP |
Receptor-type tyrosine-protein phosphatase-like N |
24 |
752 - 775 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ELISA |
-0.24 |
-0.83 |
0.45 |
-0.50 |
2,683.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,342 |
SFYLKNVQTQETRTLTQFHF |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
853 - 872 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ELISA |
-0.21 |
-0.69 |
-0.34 |
1.50 |
2,489.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26912858 |
| 1,343 |
SKDQFEFALTAVAEEVNAILKA |
Receptor-type tyrosine-protein phosphatase-like N |
22 |
955 - 976 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
bioassay |
-0.06 |
0.22 |
0.11 |
-2.00 |
2,395.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26944932 |
| 1,344 |
SKDQFEFALTAVAEEVNAILKA |
Receptor-type tyrosine-protein phosphatase-like N |
22 |
955 - 976 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
bioassay |
-0.06 |
0.22 |
0.11 |
-2.00 |
2,395.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26944932 |
| 1,345 |
MVWESGCTV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
797 - 805 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
bioassay |
0.09 |
0.72 |
-0.64 |
-1.00 |
1,011.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26944932 |
| 1,346 |
SFYLKNVQTQETRTLTQFHF |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
853 - 872 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
bioassay |
-0.21 |
-0.69 |
-0.34 |
1.50 |
2,489.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26944932 |
| 1,347 |
LAKEWQALCAYQAEPNTCATAQGEGNIK |
Receptor-type tyrosine-protein phosphatase-like N |
28 |
709 - 736 |
-- |
-- |
Homo sapiens |
HLA-DR3 |
II |
-- |
-- |
bioassay |
-0.13 |
-0.50 |
-0.03 |
-1.00 |
3,009.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26944932 |
| 1,348 |
LAKEWQALCAYQAEPNTCATAQGEGNIK |
Receptor-type tyrosine-protein phosphatase-like N |
28 |
709 - 736 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.13 |
-0.50 |
-0.03 |
-1.00 |
3,009.77 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26994137 |
| 1,349 |
KLKVESSPSRSDYINASPIIEHDP |
Receptor-type tyrosine-protein phosphatase-like N |
24 |
752 - 775 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
in vitro assay |
-0.24 |
-0.83 |
0.45 |
-0.50 |
2,683.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 26994137 |
| 1,350 |
KLKVESSPSRSDYINASPIIEHDP |
Receptor-type tyrosine-protein phosphatase-like N |
24 |
752 - 775 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
-0.24 |
-0.83 |
0.45 |
-0.50 |
2,683.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,351 |
DFWQMVWESGCTVIVMLTPLVEDGV |
Receptor-type tyrosine-protein phosphatase-like N |
25 |
793 - 817 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
x-ray crystallography |
0.11 |
0.73 |
-0.56 |
-4.00 |
2,855.72 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,352 |
DFWQMVWESGCTVIVMLTPLVEDGV |
Receptor-type tyrosine-protein phosphatase-like N |
25 |
793 - 817 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
x-ray crystallography |
0.11 |
0.73 |
-0.56 |
-4.00 |
2,855.72 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,353 |
SFYLKNVQTQETRTLTQFHF |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
853 - 872 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
x-ray crystallography |
-0.21 |
-0.69 |
-0.34 |
1.50 |
2,489.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,354 |
SFYLKNVQTQETRTLTQFHF |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
853 - 872 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
x-ray crystallography |
-0.21 |
-0.69 |
-0.34 |
1.50 |
2,489.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,355 |
SKDQFEFALTAVAEEVNAILKA |
Receptor-type tyrosine-protein phosphatase-like N |
22 |
955 - 976 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
x-ray crystallography |
-0.06 |
0.22 |
0.11 |
-2.00 |
2,395.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,356 |
SKDQFEFALTAVAEEVNAILKA |
Receptor-type tyrosine-protein phosphatase-like N |
22 |
955 - 976 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
x-ray crystallography |
-0.06 |
0.22 |
0.11 |
-2.00 |
2,395.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,357 |
LYHVYEVNLVSEHIWCEDFL |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
831 - 850 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
x-ray crystallography |
0.04 |
0.28 |
-0.58 |
-3.00 |
2,509.14 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,358 |
LYHVYEVNLVSEHIWCEDFL |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
831 - 850 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
0.04 |
0.28 |
-0.58 |
-3.00 |
2,509.14 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,359 |
SEHIWCEDFLVRSFYLKNVQ |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
841 - 860 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.13 |
-0.21 |
-0.23 |
-0.50 |
2,514.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,360 |
SEHIWCEDFLVRSFYLKNVQ |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
841 - 860 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
-0.13 |
-0.21 |
-0.23 |
-0.50 |
2,514.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,361 |
MVWESGCTV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
797 - 805 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
0.09 |
0.72 |
-0.64 |
-1.00 |
1,011.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,362 |
VIVMLTPLV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
805 - 813 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.38 |
2.70 |
-1.29 |
0.00 |
984.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,363 |
KLKVESSPSRSDYINASPIIEHDP |
Receptor-type tyrosine-protein phosphatase-like N |
24 |
752 - 775 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
-0.24 |
-0.83 |
0.45 |
-0.50 |
2,683.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,364 |
KLKVESSPSRSDYINASPIIEHDP |
Receptor-type tyrosine-protein phosphatase-like N |
24 |
752 - 775 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.24 |
-0.83 |
0.45 |
-0.50 |
2,683.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,365 |
KAMVALIDVFHQYSGREGDK |
Protein S100-B |
20 |
6 - 25 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.17 |
-0.37 |
0.21 |
0.50 |
2,264.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,366 |
KAMVALIDVFHQYSGREGDK |
Protein S100-B |
20 |
6 - 25 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.17 |
-0.37 |
0.21 |
0.50 |
2,264.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,367 |
KHKLKKSELKELINNELSHFLE |
Protein S100-B |
22 |
25 - 46 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
-0.30 |
-1.01 |
0.62 |
2.00 |
2,678.48 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,368 |
KHKLKKSELKELINNELSHFLE |
Protein S100-B |
22 |
25 - 46 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.30 |
-1.01 |
0.62 |
2.00 |
2,678.48 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,369 |
REGDKHKLKKSELKEL |
Protein S100-B |
16 |
21 - 36 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.55 |
-1.94 |
1.52 |
2.50 |
1,938.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,370 |
REGDKHKLKKSELKEL |
Protein S100-B |
16 |
21 - 36 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
-0.55 |
-1.94 |
1.52 |
2.50 |
1,938.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,371 |
ECDFQEFMAFVAMVTTACHEFFEHE |
Protein S100-B |
25 |
68 - 92 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.01 |
0.17 |
-0.21 |
-5.00 |
2,999.70 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,372 |
ECDFQEFMAFVAMVTTACHEFFEHE |
Protein S100-B |
25 |
68 - 92 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.01 |
0.17 |
-0.21 |
-5.00 |
2,999.70 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,373 |
ALIDVFHQY |
Protein S100-B |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
0.10 |
0.62 |
-0.86 |
-0.50 |
1,105.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,374 |
GREGDKHKL |
Protein S100-B |
9 |
20 - 28 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.54 |
-2.17 |
1.41 |
1.50 |
1,039.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,375 |
ALIDVFHQY |
Protein S100-B |
9 |
10 - 18 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.10 |
0.62 |
-0.86 |
-0.50 |
1,105.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,376 |
GREGDKHKL |
Protein S100-B |
9 |
20 - 28 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISA |
-0.54 |
-2.17 |
1.41 |
1.50 |
1,039.29 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27183389 |
| 1,377 |
SYNSVKEII |
Zinc transporter 8 |
9 |
282 - 290 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
-0.10 |
-0.07 |
-0.07 |
0.00 |
1,052.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,378 |
SYNSVKEII |
Zinc transporter 8 |
9 |
282 - 290 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.10 |
-0.07 |
-0.07 |
0.00 |
1,052.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,379 |
SYNSVKEII |
Zinc transporter 8 |
9 |
282 - 290 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.10 |
-0.07 |
-0.07 |
0.00 |
1,052.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,380 |
LYLACERLL |
Zinc transporter 8 |
9 |
158 - 166 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
0.01 |
1.13 |
-0.56 |
0.00 |
1,093.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,381 |
LYLACERLL |
Zinc transporter 8 |
9 |
158 - 166 |
-- |
-- |
Mus musculus |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
0.01 |
1.13 |
-0.56 |
0.00 |
1,093.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,382 |
MEFLERTYLVNDKAAKMHAFTLESVEL |
Zinc transporter 8 |
27 |
1 - 27 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
-0.12 |
-0.06 |
0.06 |
-1.50 |
3,187.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,383 |
MEFLERTYLVNDKAAKMHAFTLESVEL |
Zinc transporter 8 |
27 |
1 - 27 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
ELISA |
-0.12 |
-0.06 |
0.06 |
-1.50 |
3,187.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,384 |
AKMHAFTLESVELQQKPVNKDQCPRER |
Zinc transporter 8 |
27 |
15 - 41 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.35 |
-1.10 |
0.55 |
1.50 |
3,184.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,385 |
AKMHAFTLESVELQQKPVNKDQCPRER |
Zinc transporter 8 |
27 |
15 - 41 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
3H-thymidine |
-0.35 |
-1.10 |
0.55 |
1.50 |
3,184.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27069933 |
| 1,386 |
QKPVNKDQCPRERPEELESGGMYHCHS |
Zinc transporter 8 |
27 |
29 - 55 |
-- |
-- |
Homo sapiens |
H2-Kb |
I |
-- |
-- |
In vivo assay |
-0.40 |
-1.66 |
0.68 |
0.00 |
3,155.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27406624 |
| 1,387 |
QKPVNKDQCPRERPEELESGGMYHCHS |
Zinc transporter 8 |
27 |
29 - 55 |
-- |
-- |
Homo sapiens |
H2-Kb |
I |
-- |
-- |
ICS |
-0.40 |
-1.66 |
0.68 |
0.00 |
3,155.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27406624 |
| 1,388 |
EELESGGMYHCHSGSKPTEKGANEYAY |
Zinc transporter 8 |
27 |
43 - 69 |
-- |
-- |
Homo sapiens |
H2-Kb |
I |
-- |
-- |
ICS |
-0.21 |
-1.24 |
0.32 |
-2.00 |
2,975.56 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 27406624 |
| 1,389 |
EELESGGMYHCHSGSKPTEKGANEYAY |
Zinc transporter 8 |
27 |
43 - 69 |
-- |
-- |
Homo sapiens |
H2-Kd |
I |
-- |
-- |
Multimer/tetramer |
-0.21 |
-1.24 |
0.32 |
-2.00 |
2,975.56 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 27185276 |
| 1,390 |
ANEYAYAKWKLCSASAICFIFMIAEVV |
Zinc transporter 8 |
27 |
64 - 90 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.10 |
0.95 |
-0.62 |
0.00 |
3,043.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27185276 |
| 1,391 |
ANEYAYAKWKLCSASAICFIFMIAEVV |
Zinc transporter 8 |
27 |
64 - 90 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.10 |
0.95 |
-0.62 |
0.00 |
3,043.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,392 |
SAICFIFMIAEVVGGHIAGSLAVVTDA |
Zinc transporter 8 |
27 |
78 - 104 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.63 |
-0.71 |
-1.50 |
2,692.59 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,393 |
SAICFIFMIAEVVGGHIAGSLAVVTDA |
Zinc transporter 8 |
27 |
78 - 104 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.24 |
1.63 |
-0.71 |
-1.50 |
2,692.59 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,394 |
GHIAGSLAVVTDAAHLLIDLTSFLLSL |
Zinc transporter 8 |
27 |
92 - 118 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.18 |
1.33 |
-0.69 |
-1.00 |
2,748.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,395 |
GHIAGSLAVVTDAAHLLIDLTSFLLSL |
Zinc transporter 8 |
27 |
92 - 118 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.18 |
1.33 |
-0.69 |
-1.00 |
2,748.64 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,396 |
HLLIDLTSFLLSLFSLWLSSKPPSKRL |
Zinc transporter 8 |
27 |
106 - 132 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.58 |
-0.50 |
2.50 |
3,113.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,397 |
HLLIDLTSFLLSLFSLWLSSKPPSKRL |
Zinc transporter 8 |
27 |
106 - 132 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.00 |
0.58 |
-0.50 |
2.50 |
3,113.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,398 |
SLWLSSKPPSKRLTFGWHRAEILGALL |
Zinc transporter 8 |
27 |
120 - 146 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.07 |
0.02 |
-0.28 |
3.50 |
3,065.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,399 |
SLWLSSKPPSKRLTFGWHRAEILGALL |
Zinc transporter 8 |
27 |
120 - 146 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
-0.07 |
0.02 |
-0.28 |
3.50 |
3,065.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,400 |
FGWHRAEILGALLSILCIWVVTGVLVYLACERLLYPDYQIQ |
Zinc transporter 8 |
41 |
134 - 174 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.10 |
0.94 |
-0.79 |
-0.50 |
4,737.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,401 |
FGWHRAEILGALLSILCIWVVTGVLVYLACERLLYPDYQIQ |
Zinc transporter 8 |
41 |
134 - 174 |
-- |
-- |
Homo sapiens |
HLA-DRB1*01:01 |
II |
-- |
-- |
3H-thymidine |
0.10 |
0.94 |
-0.79 |
-0.50 |
4,737.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801 |
| 1,402 |
ACERLLYPDYQIQATVMIIVSSCAVAA |
Zinc transporter 8 |
27 |
162 - 188 |
-- |
-- |
Homo sapiens |
HLA-DR4 |
II |
-- |
-- |
3H-thymidine |
0.05 |
0.91 |
-0.53 |
-1.00 |
2,929.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 19292763 |
| 1,403 |
ACERLLYPDYQIQATVMIIVSSCAVAA |
Zinc transporter 8 |
27 |
162 - 188 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
CFSE |
0.05 |
0.91 |
-0.53 |
-1.00 |
2,929.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27604323 |
| 1,404 |
SCAVAANIVLTVVLHQRCLGHNHKEVQ |
Zinc transporter 8 |
27 |
183 - 209 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
CFSE |
-0.07 |
0.37 |
-0.37 |
2.50 |
2,940.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27604323 |
| 1,405 |
SCAVAANIVLTVVLHQRCLGHNHKEVQ |
Zinc transporter 8 |
27 |
183 - 209 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.07 |
0.37 |
-0.37 |
2.50 |
2,940.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27832962 |
| 1,406 |
HQRCLGHNHKEVQANASVRAAFVHALG |
Zinc transporter 8 |
27 |
197 - 223 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
3H-thymidine |
-0.18 |
-0.38 |
-0.11 |
4.00 |
2,951.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27832962 |
| 1,407 |
HQRCLGHNHKEVQANASVRAAFVHALG |
Zinc transporter 8 |
27 |
197 - 223 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
-0.18 |
-0.38 |
-0.11 |
4.00 |
2,951.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27832962 |
| 1,408 |
NASVRAAFVHALGDLFQSISVLISALI |
Zinc transporter 8 |
27 |
211 - 237 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.12 |
1.26 |
-0.65 |
0.50 |
2,813.70 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27832962 |
| 1,409 |
NASVRAAFVHALGDLFQSISVLISALI |
Zinc transporter 8 |
27 |
211 - 237 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
In vivo assay |
0.12 |
1.26 |
-0.65 |
0.50 |
2,813.70 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27832962 |
| 1,410 |
LFQSISVLISALIIYFKPEYKIADPIC |
Zinc transporter 8 |
27 |
225 - 251 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
bioassay |
0.12 |
1.03 |
-0.60 |
0.00 |
3,086.15 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,411 |
LFQSISVLISALIIYFKPEYKIADPIC |
Zinc transporter 8 |
27 |
225 - 251 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.12 |
1.03 |
-0.60 |
0.00 |
3,086.15 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,412 |
YFKPEYKIADPICTFIFSILVLASTIT |
Zinc transporter 8 |
27 |
239 - 265 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.11 |
0.91 |
-0.62 |
0.00 |
3,095.10 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,413 |
YFKPEYKIADPICTFIFSILVLASTIT |
Zinc transporter 8 |
27 |
239 - 265 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.11 |
0.91 |
-0.62 |
0.00 |
3,095.10 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,414 |
LKDFSILLMEGVPKSLNYSGVKELILA |
Zinc transporter 8 |
27 |
267 - 293 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.02 |
0.55 |
-0.18 |
0.00 |
2,979.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,415 |
LKDFSILLMEGVPKSLNYSGVKELILA |
Zinc transporter 8 |
27 |
267 - 293 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.02 |
0.55 |
-0.18 |
0.00 |
2,979.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,416 |
SLNYSGVKELILAVDGVLSVHSLHIWS |
Zinc transporter 8 |
27 |
281 - 307 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
bioassay |
0.08 |
0.70 |
-0.56 |
0.00 |
2,937.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,417 |
SLNYSGVKELILAVDGVLSVHSLHIWS |
Zinc transporter 8 |
27 |
281 - 307 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.08 |
0.70 |
-0.56 |
0.00 |
2,937.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,418 |
DGVLSVHSLHIWSLTMNQVILSAHVAT |
Zinc transporter 8 |
27 |
295 - 321 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.09 |
0.76 |
-0.75 |
0.50 |
2,929.82 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,419 |
TMNQVILSAHVATAASRDSQVVRREIA |
Zinc transporter 8 |
27 |
309 - 335 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
bioassay |
-0.17 |
0.09 |
0.00 |
1.50 |
2,924.72 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,420 |
TMNQVILSAHVATAASRDSQVVRREIA |
Zinc transporter 8 |
27 |
309 - 335 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.17 |
0.09 |
0.00 |
1.50 |
2,924.72 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,421 |
ASRDSQVVRREIAKALSKSFTMHSLTIQMESPVD |
Zinc transporter 8 |
34 |
323 - 356 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.23 |
-0.36 |
0.28 |
1.50 |
3,819.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,422 |
ASRDSQVVRREIAKALSKSFTMHSLTIQMESPVD |
Zinc transporter 8 |
34 |
323 - 356 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
bioassay |
-0.23 |
-0.36 |
0.28 |
1.50 |
3,819.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,423 |
MHSLTIQMESPVDQDPDCLFCEDPCD |
Zinc transporter 8 |
26 |
344 - 369 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.15 |
-0.44 |
0.23 |
-6.50 |
2,969.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,424 |
MHSLTIQMESPVDQDPDCLFCEDPCD |
Zinc transporter 8 |
26 |
344 - 369 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.15 |
-0.44 |
0.23 |
-6.50 |
2,969.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,425 |
FIFSILVLASTITILKDFSILLMEGVP |
Zinc transporter 8 |
27 |
253 - 279 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.23 |
1.68 |
-0.79 |
-1.00 |
2,982.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,426 |
FIFSILVLASTITILKDFSILLMEGVP |
Zinc transporter 8 |
27 |
253 - 279 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.23 |
1.68 |
-0.79 |
-1.00 |
2,982.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,427 |
ERTYLVNDKAAKMHA |
Zinc transporter 8 |
15 |
5 - 19 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
bioassay |
-0.29 |
-0.85 |
0.39 |
1.50 |
1,747.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,428 |
ERTYLVNDKAAKMHA |
Zinc transporter 8 |
15 |
5 - 19 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
bioassay |
-0.29 |
-0.85 |
0.39 |
1.50 |
1,747.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,429 |
ERTYLVNDKAAKMHA |
Zinc transporter 8 |
15 |
5 - 19 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.29 |
-0.85 |
0.39 |
1.50 |
1,747.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,430 |
ERTYLVNDKAAKMHA |
Zinc transporter 8 |
15 |
5 - 19 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.29 |
-0.85 |
0.39 |
1.50 |
1,747.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,431 |
YAYAKWKLCSASAI |
Zinc transporter 8 |
14 |
67 - 80 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.00 |
0.36 |
-0.57 |
2.00 |
1,575.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,432 |
YAYAKWKLCSASAI |
Zinc transporter 8 |
14 |
67 - 80 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
bioassay |
0.00 |
0.36 |
-0.57 |
2.00 |
1,575.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,433 |
YAYAKWKLCSASAI |
Zinc transporter 8 |
14 |
67 - 80 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.00 |
0.36 |
-0.57 |
2.00 |
1,575.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,434 |
YKIADPICTFIFSIL |
Zinc transporter 8 |
15 |
244 - 258 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.18 |
1.33 |
-0.79 |
0.00 |
1,744.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,435 |
YKIADPICTFIFSIL |
Zinc transporter 8 |
15 |
244 - 258 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.18 |
1.33 |
-0.79 |
0.00 |
1,744.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,436 |
YKIADPICTFIFSIL |
Zinc transporter 8 |
15 |
244 - 258 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.18 |
1.33 |
-0.79 |
0.00 |
1,744.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,437 |
IFSILVLASTITILK |
Zinc transporter 8 |
15 |
254 - 268 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.26 |
2.09 |
-0.95 |
1.00 |
1,632.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,438 |
ERTYLVNDKAAKMHA |
Zinc transporter 8 |
15 |
5 - 19 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.29 |
-0.85 |
0.39 |
1.50 |
1,747.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,439 |
YKIADPICTFIFSIL |
Zinc transporter 8 |
15 |
244 - 258 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
0.18 |
1.33 |
-0.79 |
0.00 |
1,744.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16868084 |
| 1,440 |
VLNRMAKGV + CITR(R4) |
Receptor-type tyrosine-protein phosphatase-like N |
20 |
925 - 933 |
-- |
VLNRMAKGV + CITR(R4) |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,441 |
VPRLPEQGSSSRAEDSPEG |
Receptor-type tyrosine-protein phosphatase-like N |
19 |
293 - 311 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
-0.34 |
-1.34 |
0.82 |
-2.00 |
1,998.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,442 |
GDRGEKPASPAVQPDA |
Receptor-type tyrosine-protein phosphatase-like N |
16 |
318 - 333 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
-0.28 |
-1.20 |
0.78 |
-1.00 |
1,594.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,443 |
VPRLPEQGSSSRAEDSPEG |
Receptor-type tyrosine-protein phosphatase-like N |
19 |
293 - 311 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.34 |
-1.34 |
0.82 |
-2.00 |
1,998.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,444 |
GDRGEKPASPAVQPDA |
Receptor-type tyrosine-protein phosphatase-like N |
16 |
318 - 333 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISA |
-0.28 |
-1.20 |
0.78 |
-1.00 |
1,594.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,445 |
TGLQILQTGVGQREEAAA + DEAM(Q4, Q7, Q12) |
Receptor-type tyrosine-protein phosphatase-like N |
38 |
545 - 562 |
-- |
TGLQILQTGVGQREEAAA + DEAM(Q4, Q7, Q12) |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
ELISA |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,446 |
MVWESGCTV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
797 - 805 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
Cytometric bead array |
0.09 |
0.72 |
-0.64 |
-1.00 |
1,011.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,447 |
MVWESGCTV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
797 - 805 |
-- |
-- |
Homo sapiens |
HLA-DQ8 |
II |
-- |
-- |
Cytometric bead array |
0.09 |
0.72 |
-0.64 |
-1.00 |
1,011.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,448 |
MVWESGCTV |
Receptor-type tyrosine-protein phosphatase-like N |
9 |
797 - 805 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.09 |
0.72 |
-0.64 |
-1.00 |
1,011.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,449 |
MVWESGCTVIVML |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
797 - 809 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.22 |
1.61 |
-0.94 |
-1.00 |
1,468.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,450 |
FYLKNVQTQETRT |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
854 - 866 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
-0.33 |
-1.15 |
0.02 |
1.00 |
1,628.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,451 |
DKERLAALGPEGA |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
608 - 620 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
-0.21 |
-0.64 |
0.76 |
-1.00 |
1,326.65 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,452 |
TVIVMLTPLVEDG |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
804 - 816 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.16 |
1.25 |
-0.46 |
-2.00 |
1,386.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,453 |
VKEIDIAATLEHV |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
933 - 945 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
-0.01 |
0.50 |
0.13 |
-1.50 |
1,437.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,454 |
MVWESGCTVIVML |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
797 - 809 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.22 |
1.61 |
-0.94 |
-1.00 |
1,468.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,455 |
VKEIDIAATLEHV |
Receptor-type tyrosine-protein phosphatase-like N |
13 |
933 - 945 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
-0.01 |
0.50 |
0.13 |
-1.50 |
1,437.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,456 |
VMIIVSSLAV |
Zinc transporter 8 |
10 |
-- |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.36 |
2.75 |
-1.11 |
0.00 |
1,031.47 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,457 |
VMIIVSSLAV |
Zinc transporter 8 |
10 |
-- |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Cytometric bead array |
0.36 |
2.75 |
-1.11 |
0.00 |
1,031.47 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 27798614 |
| 1,458 |
LLIDLTSFL |
Zinc transporter 8 |
9 |
107 - 115 |
-- |
-- |
Homo sapiens |
HLA-DQA1*03:01/DQB1*03:02 |
II |
-- |
-- |
ELISA |
0.26 |
1.94 |
-0.96 |
-1.00 |
1,034.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27920090 |
| 1,459 |
LLIDLTSFL |
Zinc transporter 8 |
9 |
107 - 115 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.26 |
1.94 |
-0.96 |
-1.00 |
1,034.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28300170 |
| 1,460 |
LLIDLTSFL |
Zinc transporter 8 |
9 |
107 - 115 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.26 |
1.94 |
-0.96 |
-1.00 |
1,034.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28300170 |
| 1,461 |
LLIDLTSFL |
Zinc transporter 8 |
9 |
107 - 115 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
0.26 |
1.94 |
-0.96 |
-1.00 |
1,034.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28300170 |
| 1,462 |
LLIDLTSFL |
Zinc transporter 8 |
9 |
107 - 115 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.26 |
1.94 |
-0.96 |
-1.00 |
1,034.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,463 |
LLIDLTSFLL |
Zinc transporter 8 |
10 |
107 - 116 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.28 |
2.13 |
-1.04 |
-1.00 |
1,147.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,464 |
LLSLFSLWL |
Zinc transporter 8 |
9 |
115 - 123 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
0.35 |
2.14 |
-1.59 |
0.00 |
1,091.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,465 |
VVTGVLVYL |
Zinc transporter 8 |
9 |
153 - 161 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.36 |
2.44 |
-1.37 |
0.00 |
962.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,466 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,467 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,468 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
51 chromium |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,469 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,470 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
ELISPOT |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28263308 |
| 1,471 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27802879 |
| 1,472 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27802879 |
| 1,473 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,474 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,475 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
in vitro assay |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,476 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,477 |
LYPDYQIQAGIMIT |
Zinc transporter 8 |
14 |
166 - 179 |
-- |
-- |
Mus musculus |
-- |
-- |
-- |
-- |
ELISA |
0.08 |
0.37 |
-0.76 |
-1.00 |
1,626.12 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,478 |
ILAVDGVLSV |
Zinc transporter 8 |
10 |
291 - 300 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
in vitro assay |
0.28 |
2.18 |
-0.71 |
-1.00 |
985.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,479 |
HIAGSLAVV |
Zinc transporter 8 |
9 |
93 - 101 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.26 |
1.77 |
-0.87 |
0.50 |
866.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,480 |
SISVLISAL |
Zinc transporter 8 |
9 |
228 - 236 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.28 |
2.24 |
-0.92 |
0.00 |
902.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,481 |
AVAANIVLTV |
Zinc transporter 8 |
10 |
185 - 194 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.28 |
2.21 |
-0.98 |
0.00 |
970.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,482 |
FLLSLFSLWL |
Zinc transporter 8 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
in vitro assay |
0.37 |
2.21 |
-1.68 |
0.00 |
1,238.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,483 |
ALGDLFQSI |
Zinc transporter 8 |
9 |
221 - 229 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.13 |
0.94 |
-0.54 |
-1.00 |
963.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,484 |
ILKDFSILL |
Zinc transporter 8 |
9 |
266 - 274 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.18 |
1.67 |
-0.58 |
0.00 |
1,061.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,485 |
ILVLASTITI |
Zinc transporter 8 |
10 |
257 - 266 |
-- |
-- |
Homo sapiens |
H2-b class II |
II |
-- |
-- |
ELISA |
0.34 |
2.49 |
-1.15 |
0.00 |
1,043.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,486 |
VVTGVLVYL |
Zinc transporter 8 |
9 |
153 - 161 |
-- |
-- |
Homo sapiens |
H2-b class II |
II |
-- |
-- |
ELISA |
0.36 |
2.44 |
-1.37 |
0.00 |
962.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,487 |
ILAVDGVLSV |
Zinc transporter 8 |
10 |
291 - 300 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
in vitro assay |
0.28 |
2.18 |
-0.71 |
-1.00 |
985.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,488 |
HIAGSLAVV |
Zinc transporter 8 |
9 |
93 - 101 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.26 |
1.77 |
-0.87 |
0.50 |
866.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,489 |
SISVLISAL |
Zinc transporter 8 |
9 |
228 - 236 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
ELISA |
0.28 |
2.24 |
-0.92 |
0.00 |
902.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,490 |
AVAANIVLTV |
Zinc transporter 8 |
10 |
185 - 194 |
-- |
-- |
Homo sapiens |
H2-b class II |
II |
-- |
-- |
ELISA |
0.28 |
2.21 |
-0.98 |
0.00 |
970.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,491 |
FLLSLFSLWL |
Zinc transporter 8 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
H2-b class II |
II |
-- |
-- |
ELISA |
0.37 |
2.21 |
-1.68 |
0.00 |
1,238.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28376584 |
| 1,492 |
ALGDLFQSI |
Zinc transporter 8 |
9 |
221 - 229 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.13 |
0.94 |
-0.54 |
-1.00 |
963.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,493 |
ILKDFSILL |
Zinc transporter 8 |
9 |
266 - 274 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.18 |
1.67 |
-0.58 |
0.00 |
1,061.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28467202 |
| 1,494 |
VVTGVLVYL |
Zinc transporter 8 |
9 |
153 - 161 |
-- |
-- |
Homo sapiens |
H2-IAg7 |
II |
-- |
-- |
Multimer/tetramer |
0.36 |
2.44 |
-1.37 |
0.00 |
962.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27802879 |
| 1,495 |
KMYAFTLES |
Zinc transporter 8 |
9 |
16 - 24 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
-0.05 |
0.01 |
-0.28 |
0.00 |
1,089.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,496 |
VVTGVLVYL |
Zinc transporter 8 |
9 |
153 - 161 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.36 |
2.44 |
-1.37 |
0.00 |
962.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,497 |
IQATVMIIV |
Zinc transporter 8 |
9 |
173 - 181 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Biological activity |
0.32 |
2.38 |
-1.16 |
0.00 |
987.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,498 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,499 |
FIFSILVLA |
Zinc transporter 8 |
9 |
253 - 261 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.47 |
3.04 |
-1.54 |
0.00 |
1,022.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,500 |
ILKDFSILL |
Zinc transporter 8 |
9 |
266 - 274 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Biological activity |
0.18 |
1.67 |
-0.58 |
0.00 |
1,061.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,501 |
KSLNYSGVK |
Zinc transporter 8 |
9 |
280 - 288 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
-0.23 |
-0.73 |
0.13 |
2.00 |
995.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,502 |
VVTGVLVYL |
Zinc transporter 8 |
9 |
153 - 161 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.36 |
2.44 |
-1.37 |
0.00 |
962.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,503 |
RLLYPDYQI |
Zinc transporter 8 |
9 |
165 - 173 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
-0.16 |
-0.40 |
-0.42 |
0.00 |
1,180.50 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,504 |
VAANIVLTV |
Zinc transporter 8 |
9 |
186 - 194 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.28 |
2.26 |
-1.03 |
0.00 |
899.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,505 |
FIFSILVLA |
Zinc transporter 8 |
9 |
253 - 261 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Biological activity |
0.47 |
3.04 |
-1.54 |
0.00 |
1,022.43 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,506 |
ILKDFSILL |
Zinc transporter 8 |
9 |
266 - 274 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.18 |
1.67 |
-0.58 |
0.00 |
1,061.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,507 |
TMHSLTIQM |
Zinc transporter 8 |
9 |
343 - 351 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.01 |
0.36 |
-0.78 |
0.50 |
1,061.42 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,508 |
LLIDLTSFL |
Zinc transporter 8 |
9 |
107 - 115 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.26 |
1.94 |
-0.96 |
-1.00 |
1,034.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,509 |
LLSLFSLWL |
Zinc transporter 8 |
9 |
115 - 123 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.35 |
2.14 |
-1.59 |
0.00 |
1,091.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,510 |
LLSILCIWV |
Zinc transporter 8 |
9 |
145 - 153 |
-- |
-- |
Homo sapiens |
HLA-DR |
II |
-- |
-- |
Biological activity |
0.42 |
2.82 |
-1.62 |
0.00 |
1,059.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,511 |
FIFSILVLA + PHOS(S4) |
Zinc transporter 8 |
20 |
253 - 261 |
-- |
FIFSILVLA + PHOS(S4) |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Biological activity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,512 |
KMYAFTLESV |
Zinc transporter 8 |
10 |
16 - 25 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Biological activity |
0.00 |
0.43 |
-0.40 |
0.00 |
1,188.54 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,513 |
LLIDLTSFL |
Zinc transporter 8 |
9 |
107 - 115 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Biological activity |
0.26 |
1.94 |
-0.96 |
-1.00 |
1,034.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,514 |
LLIDLTSFLL |
Zinc transporter 8 |
10 |
107 - 116 |
-- |
-- |
Homo sapiens |
HLA class II |
II |
-- |
-- |
Biological activity |
0.28 |
2.13 |
-1.04 |
-1.00 |
1,147.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28550202 |
| 1,515 |
DLTSFLLSL |
Zinc transporter 8 |
9 |
110 - 118 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.15 |
1.36 |
-0.72 |
-1.00 |
1,008.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7589082 |
| 1,516 |
FLLSLFSLWL |
Zinc transporter 8 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.37 |
2.21 |
-1.68 |
0.00 |
1,238.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7589082 |
| 1,517 |
LLSLFSLWL |
Zinc transporter 8 |
9 |
115 - 123 |
-- |
-- |
Homo sapiens |
-- |
-- |
-- |
-- |
In vivo assay |
0.35 |
2.14 |
-1.59 |
0.00 |
1,091.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7589082 |
| 1,518 |
EILGALLSI |
Zinc transporter 8 |
9 |
140 - 148 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
In vivo assay |
0.29 |
1.94 |
-0.69 |
-1.00 |
928.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,519 |
ILGALLSIL |
Zinc transporter 8 |
9 |
141 - 149 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.41 |
2.76 |
-1.22 |
0.00 |
912.33 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,520 |
VVTGVLVYL |
Zinc transporter 8 |
9 |
153 - 161 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.36 |
2.44 |
-1.37 |
0.00 |
962.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,521 |
RLLYPDYQI |
Zinc transporter 8 |
9 |
165 - 173 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.16 |
-0.40 |
-0.42 |
0.00 |
1,180.50 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,522 |
CLGHNHKEV |
Zinc transporter 8 |
9 |
200 - 208 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.21 |
-0.80 |
0.10 |
1.00 |
1,036.31 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,523 |
ALGDLFQSI |
Zinc transporter 8 |
9 |
221 - 229 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.13 |
0.94 |
-0.54 |
-1.00 |
963.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,524 |
KIADPICTFI |
Zinc transporter 8 |
10 |
245 - 254 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.10 |
1.09 |
-0.38 |
0.00 |
1,120.51 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,525 |
LLMEGVPKSL |
Zinc transporter 8 |
10 |
273 - 282 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.05 |
0.73 |
-0.19 |
0.00 |
1,086.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,526 |
SLNYSGVKEL |
Zinc transporter 8 |
10 |
281 - 290 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
-0.11 |
-0.24 |
-0.06 |
0.00 |
1,109.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,527 |
ILAVDGVLSV |
Zinc transporter 8 |
10 |
291 - 300 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.28 |
2.18 |
-0.71 |
-1.00 |
985.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,528 |
LAVDGVLSV |
Zinc transporter 8 |
9 |
292 - 300 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.23 |
1.92 |
-0.59 |
-1.00 |
872.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,529 |
SVHSLHIWSL |
Zinc transporter 8 |
10 |
299 - 308 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
-- |
-- |
Multimer/tetramer |
0.11 |
0.66 |
-1.04 |
1.00 |
1,178.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,530 |
ILSAHVATA |
Zinc transporter 8 |
9 |
314 - 322 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.19 |
1.47 |
-0.80 |
0.50 |
882.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,531 |
LLIDLTSFL |
Zinc transporter 8 |
9 |
107 - 115 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
ELISPOT |
0.26 |
1.94 |
-0.96 |
-1.00 |
1,034.40 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 28794283 |
| 1,532 |
LLIDLTSFLL |
Zinc transporter 8 |
10 |
107 - 116 |
-- |
-- |
Homo sapiens |
HLA-DRB1*04:01 |
II |
-- |
-- |
Multimer/tetramer |
0.28 |
2.13 |
-1.04 |
-1.00 |
1,147.58 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 27942583 |
| 1,533 |
FLLSLFSLWL |
Zinc transporter 8 |
10 |
114 - 123 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Cytometric bead array |
0.37 |
2.21 |
-1.68 |
0.00 |
1,238.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,534 |
LLSLFSLWL |
Zinc transporter 8 |
9 |
115 - 123 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Cytometric bead array |
0.35 |
2.14 |
-1.59 |
0.00 |
1,091.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,535 |
EILGALLSI |
Zinc transporter 8 |
9 |
140 - 148 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Cytometric bead array |
0.29 |
1.94 |
-0.69 |
-1.00 |
928.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,536 |
ILGALLSIL |
Zinc transporter 8 |
9 |
141 - 149 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Cytometric bead array |
0.41 |
2.76 |
-1.22 |
0.00 |
912.33 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,537 |
VVTGVLVYL |
Zinc transporter 8 |
9 |
153 - 161 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Cytometric bead array |
0.36 |
2.44 |
-1.37 |
0.00 |
962.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,538 |
RLLYPDYQI |
Zinc transporter 8 |
9 |
165 - 173 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Cytometric bead array |
-0.16 |
-0.40 |
-0.42 |
0.00 |
1,180.50 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,539 |
ILAVDGVLSV |
Zinc transporter 8 |
10 |
291 - 300 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Cytometric bead array |
0.28 |
2.18 |
-0.71 |
-1.00 |
985.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,540 |
LAVDGVLSV |
Zinc transporter 8 |
9 |
292 - 300 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Cytometric bead array |
0.23 |
1.92 |
-0.59 |
-1.00 |
872.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,541 |
SVHSLHIWSL |
Zinc transporter 8 |
10 |
299 - 308 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Surface plasmon resonance (SPR) |
0.11 |
0.66 |
-1.04 |
1.00 |
1,178.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,542 |
ILSAHVATA |
Zinc transporter 8 |
9 |
314 - 322 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Multimer/tetramer |
0.19 |
1.47 |
-0.80 |
0.50 |
882.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,543 |
ILKDFSILLMEGVPKSLNYS |
Zinc transporter 8 |
20 |
266 - 285 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Surface plasmon resonance (SPR) |
0.01 |
0.45 |
-0.27 |
0.00 |
2,268.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,544 |
VRREIAKALSKSFTMHSLTI |
Zinc transporter 8 |
20 |
330 - 349 |
-- |
-- |
Homo sapiens |
HLA-A*02:01 |
I |
HLA-A*02:01 |
-- |
Multimer/tetramer |
-0.17 |
0.09 |
0.05 |
3.50 |
2,289.03 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 20639478 |
| 1,545 |
NYAFLHATDLLP |
GAD65 |
12 |
88–99 |
-- |
-- |
Homo sapiens |
DR1 |
I |
-- |
-- |
-- |
0.06 |
0.33 |
-0.74 |
-0.50 |
1,374.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801; PMID: 17349009 |
| 1,546 |
CDGERPTLAFLQDVM |
GAD65 |
15 |
101–115 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.12 |
-0.03 |
0.09 |
-2.00 |
1,695.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321; PMID: 17349009 |
| 1,547 |
MNILLQYVVKSFD |
GAD65 |
13 |
115–127 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.03 |
0.67 |
-0.60 |
0.00 |
1,570.08 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8958223; PMID: 17349009 |
| 1,548 |
MNILLQYVVKSFDRST |
GAD65 |
16 |
115–130 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.12 |
0.17 |
-0.31 |
1.00 |
1,914.49 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,549 |
NILLQYVVKSFD |
GAD65 |
12 |
116–127 |
-- |
-- |
Homo sapiens |
DR53 |
I |
-- |
-- |
-- |
0.01 |
0.57 |
-0.54 |
0.00 |
1,438.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9757911; PMID: 17349009 |
| 1,550 |
YVVKSFDRSTKVIDFHYPNE |
GAD65 |
20 |
121–140 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.21 |
-0.66 |
0.10 |
0.50 |
2,445.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10078545; PMID: 17349009 |
| 1,551 |
FDRSTKVIDFHYPNE |
GAD65 |
15 |
126–140 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.26 |
-1.05 |
0.27 |
-0.50 |
1,868.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321; PMID: 17349009 |
| 1,552 |
NWELADQPQNLEEILMHCQT |
GAD65 |
20 |
146–165 |
-- |
-- |
Homo sapiens |
DR2 |
I |
-- |
-- |
-- |
-0.17 |
-0.79 |
-0.07 |
-3.50 |
2,412.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283; PMID: 17349009 |
| 1,553 |
TGHPRYFNQLSTGLD |
GAD65 |
15 |
173–187 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.19 |
-0.91 |
-0.20 |
0.50 |
1,706.07 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897; PMID: 17349009 |
| 1,554 |
GHPRYFNQLSTG |
GAD65 |
12 |
174–185 |
-- |
-- |
Homo sapiens |
DR2 |
I |
-- |
-- |
-- |
-0.21 |
-1.11 |
-0.32 |
1.50 |
1,376.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283; PMID: 17349009 |
| 1,555 |
NTNMFTYEIAPVFVLLEYVT |
GAD65 |
20 |
201–220 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
0.10 |
0.68 |
-0.81 |
-2.00 |
2,365.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10078545; PMID: 17349009 |
| 1,556 |
TNMFTYEIAPVFVLL |
GAD65 |
15 |
202–216 |
-- |
-- |
Homo sapiens |
DR8 or DR9 |
I |
-- |
-- |
-- |
0.20 |
1.23 |
-1.01 |
-1.00 |
1,758.33 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9757911; PMID: 17349009 |
| 1,557 |
TYEIAPVFVLLEYVT |
GAD65 |
15 |
206–220 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
0.18 |
1.11 |
-0.82 |
-2.00 |
1,757.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321; PMID: 17349009 |
| 1,558 |
TYEIAPVFVLLFYVTLKKMR |
GAD65 |
20 |
206–225 |
-- |
-- |
Homo sapiens |
DR2 |
I |
-- |
-- |
-- |
0.03 |
0.82 |
-0.60 |
2.00 |
2,432.31 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9153283; PMID: 17349009 |
| 1,559 |
PGGSGDGIFSPGGAISNMYA |
GAD65 |
20 |
231–250 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
0.08 |
0.05 |
-0.33 |
-1.00 |
1,855.30 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10078545; PMID: 17349009 |
| 1,560 |
NMYAMMIARFKMFPEVKEKG |
GAD65 |
20 |
247–266 |
-- |
-- |
Homo sapiens |
DQ and/or DR |
I |
-- |
-- |
-- |
-0.14 |
-0.23 |
0.07 |
2.00 |
2,422.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558; PMID: 9084973; PMID: 17349009 |
| 1,561 |
NMYAMMIARFKMFPEVKEKG |
GAD65 |
20 |
247–266 |
-- |
-- |
Homo sapiens |
DR3 |
I |
-- |
-- |
-- |
-0.14 |
-0.23 |
0.07 |
2.00 |
2,422.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462; PMID: 17349009 |
| 1,562 |
MYAMMIARFK |
GAD65 |
10 |
248–257 |
-- |
-- |
Homo sapiens |
DR51 |
I |
-- |
-- |
-- |
-0.02 |
0.69 |
-0.55 |
2.00 |
1,261.76 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237801; PMID: 17349009 |
| 1,563 |
MMIARFKMFPEVKEKGMAAL |
GAD65 |
20 |
251–270 |
-- |
-- |
Homo sapiens |
DR12 |
I |
-- |
-- |
-- |
-0.07 |
0.30 |
0.06 |
2.00 |
2,329.23 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462; PMID: 17349009 |
| 1,564 |
PEVKEKGMAALPRLIAFTSE |
GAD65 |
20 |
260–279 |
-- |
-- |
Homo sapiens |
DQ and/or DR |
I |
-- |
-- |
-- |
-0.11 |
-0.07 |
0.28 |
0.00 |
2,187.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7962558; PMID: 9084973; PMID: 17349009 |
| 1,565 |
EVKEKGMAALPRLIAFTSEH |
GAD65 |
20 |
261–280 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.13 |
-0.16 |
0.26 |
0.50 |
2,227.90 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462; PMID: 17349009 |
| 1,566 |
LPRLIAFTSEHSHF |
GAD65 |
14 |
270–283 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.05 |
0.09 |
-0.41 |
1.00 |
1,655.09 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9153283; PMID: 17349009 |
| 1,567 |
PRLIAFTSEHSHFSL |
GAD65 |
15 |
271–285 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.06 |
0.03 |
-0.36 |
1.00 |
1,742.18 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,568 |
IAFTSEHSHFSLK |
GAD65 |
13 |
274–286 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.06 |
-0.09 |
-0.28 |
1.00 |
1,503.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8958223; PMID: 17349009 |
| 1,569 |
TVYGAFDPLLAVAD |
GAD65 |
14 |
339–352 |
-- |
-- |
Homo sapiens |
DR3 |
I |
-- |
-- |
-- |
0.14 |
0.94 |
-0.52 |
-2.00 |
1,451.83 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10330300; PMID: 17349009 |
| 1,570 |
KYKIWMHVDAAWGGG |
GAD65 |
15 |
356–370 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.00 |
-0.31 |
-0.41 |
1.50 |
1,719.22 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,571 |
GLLMSRKHKWKLSGVER |
GAD65 |
17 |
370–386 |
-- |
-- |
Homo sapiens |
DP2 |
I |
-- |
-- |
-- |
-0.31 |
-0.78 |
0.38 |
4.50 |
2,025.71 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9757911; PMID: 17349009 |
| 1,572 |
KHKWKLSGVERANSV |
GAD65 |
15 |
376–390 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.32 |
-1.02 |
0.44 |
3.50 |
1,739.23 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,573 |
NCNQMHASYLFQQ |
GAD65 |
13 |
417–429 |
-- |
-- |
Homo sapiens |
DR1 |
I |
-- |
-- |
-- |
-0.18 |
-0.77 |
-0.66 |
0.50 |
1,583.95 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9757911; PMID: 17349009 |
| 1,574 |
KHYDLSYDTGDKALQ |
GAD65 |
15 |
431–445 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.29 |
-1.34 |
0.39 |
-0.50 |
1,754.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321; PMID: 17349009 |
| 1,575 |
AKGTTGFEAHVDKCL |
GAD65 |
15 |
461–475 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.12 |
-0.22 |
0.19 |
0.50 |
1,577.00 |
Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10570321; PMID: 17349009 |
| 1,576 |
VDKCLELAEYLYNIIKNREG |
GAD65 |
20 |
471–490 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.19 |
-0.37 |
0.24 |
-1.00 |
2,384.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10078545; PMID: 17349009 |
| 1,577 |
LYNIIKNREGYEMVF |
GAD65 |
15 |
481–495 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.12 |
-0.25 |
-0.19 |
0.00 |
1,889.43 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,578 |
YEMVFDGKPQHTNVCFWYIP |
GAD65 |
20 |
491–510 |
-- |
-- |
Homo sapiens |
DR3 and DQ5 |
I |
-- |
-- |
-- |
-0.03 |
-0.30 |
-0.58 |
-0.50 |
2,475.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462; PMID: 17349009 |
| 1,579 |
MVFDGKPQHTNVCFW |
GAD65 |
15 |
493–507 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.04 |
-0.19 |
-0.55 |
0.50 |
1,809.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897; PMID: 17349009 |
| 1,580 |
HTNVCFWYIPPSLRTLEDNE |
GAD65 |
20 |
501–520 |
-- |
-- |
Homo sapiens |
DR1 and DR4 |
I |
-- |
-- |
-- |
-0.14 |
-0.56 |
-0.24 |
-1.50 |
2,435.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462; PMID: 17349009 |
| 1,581 |
CFWYIPPSLRTLEDN |
GAD65 |
15 |
505–519 |
-- |
-- |
Homo sapiens |
DQ1 or DR1 |
I |
-- |
-- |
-- |
-0.10 |
-0.30 |
-0.37 |
-1.00 |
1,854.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816975; PMID: 17349009 |
| 1,582 |
CFWYIPPSLRTLEDN |
GAD65 |
15 |
505–519 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.10 |
-0.30 |
-0.37 |
-1.00 |
1,854.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897; PMID: 17349009 |
| 1,583 |
FWYIPPSLRTLED |
GAD65 |
13 |
506–518 |
-- |
-- |
Homo sapiens |
DQ and/or DR |
I |
-- |
-- |
-- |
-0.07 |
-0.27 |
-0.36 |
-1.00 |
1,637.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8529129; PMID: 17349009 |
| 1,584 |
PSLRTLEDNEERMSR |
GAD65 |
15 |
511–525 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.53 |
-1.69 |
1.10 |
-1.00 |
1,833.21 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,585 |
PSLRTLEDNEERMSRLSKVA |
GAD65 |
20 |
511–530 |
-- |
-- |
Homo sapiens |
DR3 |
I |
-- |
-- |
-- |
-0.40 |
-1.02 |
0.80 |
0.00 |
2,331.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462; PMID: 17349009 |
| 1,586 |
ERMSRLSKVAPVIKA |
GAD65 |
15 |
521–535 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.26 |
-0.09 |
0.45 |
3.00 |
1,685.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897; PMID: 17349009 |
| 1,587 |
ERMSRLSKVAPVIKA |
GAD65 |
15 |
521–535 |
-- |
-- |
Homo sapiens |
DQ8 or DR4 |
I |
-- |
-- |
-- |
-0.26 |
-0.09 |
0.45 |
3.00 |
1,685.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8816975; PMID: 17349009 |
| 1,588 |
IKARMMEYGTTMVSY |
GAD65 |
15 |
533–547 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.11 |
-0.06 |
-0.25 |
1.00 |
1,781.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9885897; PMID: 17349009 |
| 1,589 |
RMMEYGTTMVSYQPL |
GAD65 |
15 |
536–550 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.11 |
-0.31 |
-0.41 |
0.00 |
1,807.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10570321; PMID: 17349009 |
| 1,590 |
SYQPLGDKVNFFRMV |
GAD65 |
15 |
546–560 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.13 |
-0.22 |
-0.25 |
1.00 |
1,801.31 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,591 |
GDKVNFFRMVISNPA |
GAD65 |
15 |
551–565 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.10 |
0.03 |
-0.13 |
1.00 |
1,695.18 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,592 |
NFFRMVISNPAAT |
GAD65 |
13 |
555–567 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.02 |
0.40 |
-0.56 |
1.00 |
1,467.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11172025; PMID: 11978633; PMID: 17349009 |
| 1,593 |
FFRMVISNPAATHQD |
GAD65 |
15 |
556–570 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.10 |
-0.10 |
-0.32 |
0.50 |
1,734.17 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,594 |
NPAATHQDIDFLI |
GAD65 |
13 |
563–575 |
-- |
-- |
Homo sapiens |
DR53 |
I |
-- |
-- |
-- |
-0.02 |
-0.02 |
-0.26 |
-1.50 |
1,454.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11206414; PMID: 17349009 |
| 1,595 |
ATHQDIDFLIEEIER |
GAD65 |
15 |
566–580 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.18 |
-0.50 |
0.47 |
-3.50 |
1,829.22 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9223318; PMID: 17349009 |
| 1,596 |
KFGADARALMLQGVDLLADA |
HSP60 |
20 |
31–50 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.03 |
0.49 |
0.01 |
-1.00 |
2,075.70 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432; PMID: 17349009 |
| 1,597 |
NPVEIRRGVMLAVDAVIAEL |
HSP60 |
20 |
136–155 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.02 |
0.79 |
-0.04 |
-1.00 |
2,165.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432; PMID: 17349009 |
| 1,598 |
QSIVPALEIANAHRKPLVIIA |
HSP60 |
21 |
255–275 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.02 |
0.72 |
-0.31 |
1.50 |
2,254.04 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432; PMID: 17349009 |
| 1,599 |
LVLNRLKVGLQVVAVKAPGF |
HSP60 |
20 |
286–305 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.04 |
1.05 |
-0.44 |
3.00 |
2,121.96 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432; PMID: 17349009 |
| 1,600 |
IVLGGGCALLRCIPALDSLT |
HSP60 |
20 |
436–455 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.14 |
1.43 |
-0.56 |
0.00 |
1,985.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432; PMID: 17349009 |
| 1,601 |
VLGGGCALLRCIPALDSLTPANED |
HSP60 |
24 |
437–460 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.01 |
0.57 |
-0.15 |
-2.00 |
2,399.13 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432; PMID: 17349009 |
| 1,602 |
EIIKRTLKIPAMTIAKNAGV |
HSP60 |
20 |
466–485 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.08 |
0.33 |
0.06 |
3.00 |
2,167.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432; PMID: 17349009 |
| 1,603 |
VNMVEKGIIDPTKVVRTALL |
HSP60 |
20 |
511–530 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.05 |
0.55 |
-0.03 |
1.00 |
2,196.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10047432; PMID: 17349009 |
| 1,604 |
MAKAAAVGIDLGTTYSCVGV |
HSP70 |
20 |
1–20 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.11 |
1.02 |
-0.46 |
0.00 |
1,927.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,605 |
GLNVLRIINEPTAAAIAYGL |
HSP70 |
20 |
166–185 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.09 |
0.84 |
-0.53 |
0.00 |
2,069.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,606 |
TIDDGIFEVKATAGDTHLGG |
HSP70 |
20 |
210–229 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.03 |
-0.07 |
0.14 |
-2.50 |
2,017.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,607 |
THLGGEDFDNRLVNHFVEEF |
HSP70 |
20 |
225–244 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.15 |
-0.62 |
0.15 |
-3.00 |
2,375.84 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,608 |
KRTLSSSTQASLEIDSLFEG |
HSP70 |
20 |
271–290 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.19 |
-0.38 |
0.28 |
-1.00 |
2,169.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,609 |
LLLLDVAPLSLGLETAGGVM |
HSP70 |
20 |
391–410 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.21 |
1.46 |
-0.60 |
-2.00 |
1,982.73 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,610 |
PTKQTQIFTTYSDNQPGVLI |
HSP70 |
20 |
421–440 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.12 |
-0.51 |
-0.31 |
0.00 |
2,251.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,611 |
KANKITITNDKGRLSKEEIE |
HSP70 |
20 |
496–515 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.38 |
-1.23 |
0.96 |
1.00 |
2,287.90 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,612 |
KEEIERMVQEAEKYKAEDEV |
HSP70 |
20 |
511–530 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.41 |
-1.53 |
1.34 |
-4.00 |
2,453.99 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12791317; PMID: 17349009 |
| 1,613 |
GSFINISVVGPAL |
IA-2 |
13 |
502–514 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.23 |
1.41 |
-0.82 |
0.00 |
1,273.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713; PMID: 17349009 |
| 1,614 |
RSVLLTLVALAGV |
IA-2 |
13 |
575–587 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.17 |
1.92 |
-0.75 |
1.00 |
1,311.83 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713; PMID: 17349009 |
| 1,615 |
RQHARQQDKERLAALGPE |
IA-2 |
18 |
601–618 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.49 |
-1.70 |
0.89 |
1.50 |
2,103.59 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,616 |
DKERLAALGPEGA |
IA-2 |
13 |
608–620 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.21 |
-0.64 |
0.76 |
-1.00 |
1,326.65 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10376440; PMID: 17349009 |
| 1,617 |
GPEGAHGDTTFEYQDLCR |
IA-2 |
18 |
616–633 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.22 |
-1.10 |
0.32 |
-2.50 |
1,996.35 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,618 |
EGPPEPSRVSSVSSQFSD |
IA-2 |
18 |
646–663 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.24 |
-0.96 |
0.47 |
-2.00 |
1,892.20 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,619 |
VSSVSSQFSDAAQASPSSHSS |
IA-2 |
21 |
654–674 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.13 |
-0.32 |
-0.05 |
-0.50 |
2,053.35 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10562307; PMID: 17349009 |
| 1,620 |
FSDAAQASPSSHSSTPSW |
IA-2 |
18 |
661–678 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.12 |
-0.69 |
-0.17 |
-0.50 |
1,850.11 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,621 |
ANMDISTGHMILAYME |
IA-2 |
16 |
685–700 |
-- |
-- |
Homo sapiens |
DR4–DQ8 |
I |
-- |
-- |
-- |
0.04 |
0.32 |
-0.44 |
-1.50 |
1,797.33 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,622 |
LAKEWQALCAYQAEPNTCATAQGE |
IA-2 |
24 |
709–732 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.12 |
-0.44 |
-0.10 |
-2.00 |
2,597.21 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10562307; PMID: 17349009 |
| 1,623 |
WQALCAYQAEPNTCAT |
IA-2 |
16 |
713–728 |
-- |
-- |
Homo sapiens |
DR4–DQ8 |
I |
-- |
-- |
-- |
-0.07 |
-0.20 |
-0.54 |
-1.00 |
1,770.18 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,624 |
AEPNTCATAQGEGNIKKN |
IA-2 |
18 |
721–738 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.26 |
-1.12 |
0.43 |
0.00 |
1,846.26 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,625 |
PYDHARIKLKVESSPS |
IA-2 |
16 |
745–760 |
-- |
-- |
Homo sapiens |
DR4–DQ8 |
I |
-- |
-- |
-- |
-0.28 |
-0.94 |
0.47 |
1.50 |
1,827.29 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,626 |
IKLKVESSPSRSDYINASPI |
IA-2 |
20 |
751–770 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.19 |
-0.40 |
0.26 |
1.00 |
2,204.79 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956; PMID: 17349009 |
| 1,627 |
KLKVESSPSRSDYINASPIIEHDP |
IA-2 |
24 |
752–775 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.24 |
-0.83 |
0.45 |
-0.50 |
2,683.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14755342; PMID: 17349009 |
| 1,628 |
NASPIIEHDPRMPAYIAT |
IA-2 |
18 |
766–783 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.09 |
-0.28 |
-0.11 |
-0.50 |
1,996.52 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,629 |
LSHTIADFWQMVWESG |
IA-2 |
16 |
787–802 |
-- |
-- |
Homo sapiens |
DR4–DQ8 |
I |
-- |
-- |
-- |
0.04 |
0.05 |
-0.64 |
-1.50 |
1,907.37 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,630 |
DFWQMVWESGCTVIVM |
IA-2 |
16 |
793–808 |
-- |
-- |
Homo sapiens |
DR4–DQ8 |
I |
-- |
-- |
-- |
0.12 |
0.75 |
-0.82 |
-2.00 |
1,931.51 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,631 |
MVWESGCTVIVML |
IA-2 |
13 |
797–809 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.22 |
1.61 |
-0.94 |
-1.00 |
1,468.02 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10376440; PMID: 17349009 |
| 1,632 |
MVWESGCTVIVMLTPLVEDGV |
IA-2 |
21 |
797–817 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.15 |
1.11 |
-0.54 |
-3.00 |
2,279.05 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10562307; PMID: 17349009 |
| 1,633 |
WESGCTVIVMLTPLVE |
IA-2 |
16 |
799–814 |
-- |
-- |
Homo sapiens |
DR3–DQ2; DR4–DQ8 |
I |
-- |
-- |
-- |
0.14 |
1.06 |
-0.63 |
-2.00 |
1,777.37 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,634 |
TVIVMLTPLVEDG |
IA-2 |
13 |
804–816 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.16 |
1.25 |
-0.46 |
-2.00 |
1,386.87 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10376440; PMID: 17349009 |
| 1,635 |
VIVMLTPLVEDGVKQC |
IA-2 |
16 |
805–820 |
-- |
-- |
Homo sapiens |
DR3–DQ2; DR4–DQ8 |
I |
-- |
-- |
-- |
0.06 |
1.01 |
-0.31 |
-1.00 |
1,744.39 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,636 |
DEGASLYHVYEVNLVSEH |
IA-2 |
18 |
826–843 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.08 |
-0.36 |
-0.08 |
-3.00 |
2,061.46 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,637 |
SLYHVYEVNLVSE |
IA-2 |
13 |
830–842 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.01 |
0.18 |
-0.49 |
-1.50 |
1,551.91 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10867713; PMID: 17349009 |
| 1,638 |
LYHVYEVNLVSEHIWCEDFL |
IA-2 |
20 |
831–850 |
-- |
-- |
Homo sapiens |
DPB4·1 |
I |
-- |
-- |
-- |
0.04 |
0.28 |
-0.58 |
-3.00 |
2,509.14 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956; PMID: 17349009 |
| 1,639 |
SEHIWCEDFLVRSFYL |
IA-2 |
16 |
841–856 |
-- |
-- |
Homo sapiens |
DR3–DQ2; DR4–DQ8 |
I |
-- |
-- |
-- |
-0.04 |
0.15 |
-0.41 |
-1.50 |
2,044.54 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,640 |
SEHIWCEDFLVRSFYLKNVQ |
IA-2 |
20 |
841–860 |
-- |
-- |
Homo sapiens |
DPB4·1 |
I |
-- |
-- |
-- |
-0.13 |
-0.21 |
-0.23 |
-0.50 |
2,514.15 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10868956; PMID: 17349009 |
| 1,641 |
WCEDFLVRSFYLKNVQ |
IA-2 |
16 |
845–860 |
-- |
-- |
Homo sapiens |
DR4–DQ8 |
I |
-- |
-- |
-- |
-0.12 |
-0.08 |
-0.35 |
0.00 |
2,047.59 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,642 |
EDFLVRSFYLKNVQTQ |
IA-2 |
16 |
847–862 |
-- |
-- |
Homo sapiens |
DR3–DQ2; DR4–DQ8 |
I |
-- |
-- |
-- |
-0.20 |
-0.44 |
-0.09 |
0.00 |
1,987.48 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,643 |
FYLKNVQTQETRT |
IA-2 |
13 |
854–866 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.33 |
-1.15 |
0.02 |
1.00 |
1,628.01 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10376440; PMID: 17349009 |
| 1,644 |
FYLKNVQTQETRTLTQFHF |
IA-2 |
19 |
854–872 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.20 |
-0.68 |
-0.38 |
1.50 |
2,402.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10562307; PMID: 17349009 |
| 1,645 |
DFRRKVNKCYRGRSCP |
IA-2 |
16 |
889–904 |
-- |
-- |
Homo sapiens |
DR4–DQ8 |
I |
-- |
-- |
-- |
-0.60 |
-1.56 |
0.82 |
5.00 |
1,985.52 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,646 |
TYILIDMVLNRMA |
IA-2 |
13 |
918–930 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.04 |
0.99 |
-0.64 |
0.00 |
1,553.11 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,647 |
YILIDMVLNRMAKGVK |
IA-2 |
16 |
919–934 |
-- |
-- |
Homo sapiens |
DR3–DQ2; DR4–DQ8 |
I |
-- |
-- |
-- |
-0.05 |
0.60 |
-0.21 |
2.00 |
1,864.59 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,648 |
KGVKEIDIAATLEHVRDQ |
IA-2 |
18 |
931–948 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.23 |
-0.52 |
0.61 |
-0.50 |
2,022.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,649 |
VKEIDIAATLEHV |
IA-2 |
13 |
933–945 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.01 |
0.50 |
0.13 |
-1.50 |
1,437.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10376440; PMID: 17349009 |
| 1,650 |
SKDQFEFALTAVAEEVNAILK |
IA-2 |
21 |
955–975 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.07 |
0.14 |
0.14 |
-2.00 |
2,323.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10562307; PMID: 17349009 |
| 1,651 |
FEFALTAVAEEVNAIL |
IA-2 |
16 |
959–974 |
-- |
-- |
Homo sapiens |
DR4–DQ8 |
I |
-- |
-- |
-- |
0.15 |
1.16 |
-0.41 |
-3.00 |
1,737.21 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9606176; PMID: 17349009 |
| 1,652 |
FALTAVAEEVNAILKALPQ |
IA-2 |
19 |
961–979 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
0.07 |
0.84 |
-0.33 |
-1.00 |
1,998.63 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,653 |
AFIKATGKKEDE |
ICA69 |
12 |
36–47 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.29 |
-1.03 |
1.03 |
0.00 |
1,336.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7822811; PMID: 17349009 |
| 1,654 |
QHLQKDYRAYYTF |
IGRP |
13 |
13–25 |
-- |
-- |
Homo sapiens |
DR3 |
I |
-- |
-- |
-- |
-0.31 |
-1.41 |
-0.25 |
1.50 |
1,733.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034; PMID: 17349009 |
| 1,655 |
YTFLNFMSNVGDP |
IGRP |
13 |
23–35 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.02 |
0.02 |
-0.66 |
-1.00 |
1,504.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034; PMID: 17349009 |
| 1,656 |
RVLNIDLLWSVPI |
IGRP |
13 |
226–238 |
-- |
-- |
Homo sapiens |
DR3 |
I |
-- |
-- |
-- |
0.08 |
1.08 |
-0.68 |
0.00 |
1,538.07 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034; PMID: 17349009 |
| 1,657 |
DWIHIDTTPFAGL |
IGRP |
13 |
247–259 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.09 |
0.22 |
-0.55 |
-1.50 |
1,485.85 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493034; PMID: 17349009 |
| 1,658 |
MALWMRLLPLLALLAL |
Insulin |
16 |
L1–16 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.25 |
2.04 |
-1.18 |
1.00 |
1,838.69 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,659 |
MALWMRLLPLLALLALWGPDPAAA |
Insulin |
24 |
L1–24 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
0.19 |
1.25 |
-0.87 |
0.00 |
2,604.62 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9438206; PMID: 17349009 |
| 1,660 |
MRLLPLLALLALWGPD |
Insulin |
16 |
L5–20 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.15 |
1.23 |
-0.77 |
0.00 |
1,792.51 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,661 |
PLLALLALWGPDPAAA |
Insulin |
16 |
L9–24 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.22 |
1.15 |
-0.74 |
-1.00 |
1,589.14 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,662 |
LALLALWGPDPAAAFV |
Insulin |
16 |
L11–B2 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.26 |
1.45 |
-0.88 |
-1.00 |
1,625.17 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9520453; PMID: 17349009 |
| 1,663 |
LLALWGPDPAAAFVNQ |
Insulin |
16 |
L13–B4 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.13 |
0.66 |
-0.71 |
-1.00 |
1,683.17 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,664 |
WGPDPAAAFVNQHLCG |
Insulin |
16 |
L17–B8 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.04 |
0.01 |
-0.55 |
-0.50 |
1,683.10 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,665 |
PAAAFVNQHLCGSHLV |
Insulin |
16 |
L21–B12 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.08 |
0.66 |
-0.74 |
1.00 |
1,664.15 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9520453; PMID: 17349009 |
| 1,666 |
PAAAFVNQHLCGSHLV |
Insulin |
16 |
L21–B12 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.08 |
0.66 |
-0.74 |
1.00 |
1,664.15 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,667 |
FVNQHLCGSHLVEALYL |
Insulin |
17 |
B1–17 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.07 |
0.66 |
-0.81 |
0.00 |
1,943.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047; PMID: 17349009 |
| 1,668 |
LCGSHLVEALYLVCGER |
Insulin |
17 |
B6–22 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.01 |
0.75 |
-0.36 |
-0.50 |
1,862.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,669 |
SHLVEALYLVCGERG |
Insulin |
15 |
B9–23 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11160133; PMID: 17349009 |
| 1,670 |
HLVEALYLVCGERGFF |
Insulin |
16 |
B10–25 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.07 |
0.81 |
-0.54 |
-0.50 |
1,853.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10330297; PMID: 17349009 |
| 1,671 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
B11–27 |
-- |
-- |
Homo sapiens |
DR16 |
I |
-- |
-- |
-- |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9650096; PMID: 17349009 |
| 1,672 |
LVEALYLVCGERGFFYT |
Insulin |
17 |
B11–27 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.08 |
0.83 |
-0.64 |
-1.00 |
1,980.56 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047; PMID: 17349009 |
| 1,673 |
ALYLVCGERGFFYTPKT |
Insulin |
17 |
B14–30 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.03 |
0.20 |
-0.47 |
1.00 |
1,965.54 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12592644; PMID: 17349009 |
| 1,674 |
YLVCGERGFFYTPKTRR |
Insulin |
17 |
B16–32 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.28 |
-0.66 |
0.02 |
3.00 |
2,093.67 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,675 |
GERGFFYTPKTRREAED |
Insulin |
17 |
B20–C4 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.45 |
-1.71 |
0.91 |
0.00 |
2,059.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11295462; PMID: 11869047; PMID: 17349009 |
| 1,676 |
GERGFFYTPKTRREAEDLQV |
Insulin |
20 |
B20–C7 |
-- |
-- |
Homo sapiens |
DQ8 |
I |
-- |
-- |
-- |
-0.36 |
-1.23 |
0.61 |
0.00 |
2,399.93 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9438206; PMID: 17349009 |
| 1,677 |
ERGFFYTPKTRREAEDL |
Insulin |
17 |
B21–C5 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.42 |
-1.46 |
0.80 |
0.00 |
2,115.56 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12592644; PMID: 17349009 |
| 1,678 |
FFYTPKTRREAED |
Insulin |
13 |
B24–C4 |
-- |
-- |
Homo sapiens |
DQ and/or DR |
I |
-- |
-- |
-- |
-0.42 |
-1.56 |
0.72 |
0.00 |
1,659.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8529129; PMID: 17349009 |
| 1,679 |
FYTPKTRREAEDLQVG |
Insulin |
16 |
B25–C8 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.35 |
-1.19 |
0.55 |
0.00 |
1,910.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10330297; PMID: 17349009 |
| 1,680 |
FYTPKTRREAEDLQVGQ |
Insulin |
17 |
B25–C9 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.37 |
-1.32 |
0.53 |
0.00 |
2,038.49 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,681 |
TRREAEDLQVGQVELGG |
Insulin |
17 |
B30–C14 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.28 |
-0.83 |
0.64 |
-2.00 |
1,857.27 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047; PMID: 17349009 |
| 1,682 |
EDLQVGQVELGGGPGA |
Insulin |
16 |
C3–18 |
-- |
-- |
Homo sapiens |
DR |
I |
-- |
-- |
-- |
-0.01 |
-0.21 |
0.14 |
-3.00 |
1,525.89 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10330297; PMID: 17349009 |
| 1,683 |
EDLQVGQVELGGGPGAG |
Insulin |
17 |
C3–19 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.00 |
-0.22 |
0.14 |
-3.00 |
1,582.96 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,684 |
GQVELGGGPGAGSLQPL |
Insulin |
17 |
C8–24 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.06 |
0.03 |
-0.22 |
-1.00 |
1,536.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047; PMID: 17349009 |
| 1,685 |
GGGPGAGSLQPLALEGS |
Insulin |
17 |
C13–29 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.06 |
0.05 |
-0.15 |
-1.00 |
1,467.86 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,686 |
GGGPGAGSLQPLALEGSLQK |
Insulin |
20 |
C13–32 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.01 |
-0.14 |
-0.06 |
0.00 |
1,837.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14755342; PMID: 17349009 |
| 1,687 |
GAGSLQPLALEGSLQKRG |
Insulin |
18 |
C17–A1 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.12 |
-0.27 |
0.10 |
1.00 |
1,782.31 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9520453; PMID: 17349009 |
| 1,688 |
AGSLQPLALEGSLQKRG |
Insulin |
17 |
C18–A1 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.14 |
-0.26 |
0.11 |
1.00 |
1,725.24 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047; PMID: 17349009 |
| 1,689 |
GSLQPLALEGSLQKRGIV |
Insulin |
18 |
C19–A3 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.07 |
0.13 |
-0.06 |
1.00 |
1,866.48 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14755342; PMID: 17349009 |
| 1,690 |
QPLALEGSLQKRGIVEQ |
Insulin |
17 |
C22–A5 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.18 |
-0.42 |
0.22 |
0.00 |
1,866.42 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14755342; PMID: 17349009 |
| 1,691 |
PLALEGSLQKRGIVEQC |
Insulin |
17 |
C23–A6 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.14 |
-0.07 |
0.15 |
0.00 |
1,841.42 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,692 |
LALEGSLQKRGIVEQCC |
Insulin |
17 |
C24–A7 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.13 |
0.17 |
0.09 |
0.00 |
1,847.44 |
Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12592644; PMID: 17349009 |
| 1,693 |
GSLQKRGIVEQCCTSIC |
Insulin |
17 |
C28–A11 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.15 |
0.15 |
-0.02 |
1.00 |
1,825.40 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047; PMID: 17349009 |
| 1,694 |
SLQKRGIVEQCCTSICS |
Insulin |
17 |
C29–A12 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
-0.18 |
0.12 |
0.00 |
1.00 |
1,855.42 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9520453; PMID: 17349009 |
| 1,695 |
GIVEQCCTSICSL |
Insulin |
13 |
A1–13 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.06 |
1.14 |
-0.50 |
-1.00 |
1,355.79 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16260488; PMID: 17349009 |
| 1,696 |
GIVEQCCTSICSLYQ |
Insulin |
15 |
A1–15 |
-- |
-- |
Homo sapiens |
DR4 |
I |
-- |
-- |
-- |
0.01 |
0.67 |
-0.57 |
-1.00 |
1,647.13 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15889096; PMID: 17349009 |
| 1,697 |
GIVEQCCTSICSLYQ |
Insulin |
15 |
A1–15 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.01 |
0.67 |
-0.57 |
-1.00 |
1,647.13 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10330297; PMID: 17349009 |
| 1,698 |
GIVEQCCTSICSLYQL |
Insulin |
16 |
A1–16 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
0.04 |
0.86 |
-0.65 |
-1.00 |
1,760.31 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14745491; PMID: 17349009 |
| 1,699 |
CCTSICSLYQLENYCN |
Insulin |
16 |
A6–21 |
-- |
-- |
Homo sapiens |
? |
I |
-- |
-- |
-- |
-0.08 |
0.20 |
-0.64 |
-1.00 |
1,857.34 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11869047; PMID: 17349009 |
| 1,700 |
TNMFTYEIAPVFVLLEYVTL |
GAD65 |
20 |
202–221 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.16 |
1.05 |
-0.91 |
-2.00 |
2,364.10 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9480726; PMID: 17349009 |
| 1,701 |
TYEIAPVFVLLEYVT |
GAD65 |
15 |
206–220 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.18 |
1.11 |
-0.82 |
-2.00 |
1,757.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11106373; PMID: 10430937; PMID: 17349009 |
| 1,702 |
EYVTLKKMREIIGWPGGSGD |
GAD65 |
20 |
217–236 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.13 |
-0.54 |
0.20 |
0.00 |
2,236.88 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9480726; PMID: 17349009 |
| 1,703 |
LKKMREIIGWPGGSG |
GAD65 |
15 |
221–235 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.11 |
-0.40 |
0.15 |
2.00 |
1,629.19 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430937; PMID: 17349009 |
| 1,704 |
NMYAMLIARYKMSPEVKEKG |
GAD65 |
20 |
247–266 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.20 |
-0.51 |
0.19 |
2.00 |
2,360.14 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 7694152; PMID: 17349009 |
| 1,705 |
KKGAAALGIGTDSVI |
GAD65 |
15 |
286–300 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.03 |
0.56 |
0.03 |
1.00 |
1,400.86 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10430937; PMID: 17349009 |
| 1,706 |
PLQCSALLVREEGLM |
GAD65 |
15 |
401–415 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.04 |
0.52 |
-0.13 |
-1.00 |
1,659.22 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10430937; PMID: 17349009 |
| 1,707 |
VPPSLRTLEDNEERMSRLSK |
GAD65 |
20 |
509–528 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.42 |
-1.19 |
0.82 |
0.00 |
2,357.95 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 7694152; PMID: 17349009 |
| 1,708 |
SRLSKVAPVIKARMMEYGTT |
GAD65 |
20 |
524–543 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9421467; PMID: 11106373; PMID: 7694152; PMID: 17349009 |
| 1,709 |
ISNPAATHQDIDFLI |
GAD65 |
15 |
561–575 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.01 |
0.23 |
-0.33 |
-1.50 |
1,655.06 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10430937; PMID: 17349009 |
| 1,710 |
IDFLIEEIERLGQDL |
GAD65 |
15 |
571–585 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.08 |
0.12 |
0.33 |
-4.00 |
1,803.28 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9148785; PMID: 17349009 |
| 1,711 |
DTWCGVAHGCTRKLGLKICG |
GAD67 |
20 |
29–48 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.09 |
0.14 |
-0.16 |
2.50 |
2,118.82 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9480726; PMID: 17349009 |
| 1,712 |
LKICGFLQRTNSLEEKSRL |
GAD67 |
19 |
44–62 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.28 |
-0.45 |
0.32 |
2.00 |
2,235.92 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 9480726; PMID: 17349009 |
| 1,713 |
DGVTVAKSIDLKDKYKNIGA |
HSP60 |
20 |
76–95 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.19 |
-0.42 |
0.47 |
1.00 |
2,135.74 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795; PMID: 17349009 |
| 1,714 |
EEIAQVATISANGDKDIGNI |
HSP60 |
20 |
166–185 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.08 |
-0.15 |
0.27 |
-3.00 |
2,058.53 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795; PMID: 17349009 |
| 1,715 |
RKGVITVKDGKTLNDELEII |
HSP60 |
20 |
195–214 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.20 |
-0.32 |
0.57 |
0.00 |
2,241.93 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795; PMID: 17349009 |
| 1,716 |
KGDKAHIEKRIQEITEQLDI |
HSP60 |
20 |
361–380 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.32 |
-1.07 |
0.85 |
-0.50 |
2,365.00 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795; PMID: 17349009 |
| 1,717 |
VLGGGCALLRCIPALDSLKPANED |
HSP60 |
24 |
437–460 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.03 |
0.44 |
-0.01 |
-1.00 |
2,426.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795; PMID: 17349009 |
| 1,718 |
RTALLDAAGVASLLTTAEAV |
HSP60 |
20 |
526–545 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.05 |
0.98 |
-0.26 |
-1.00 |
1,943.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795; PMID: 17349009 |
| 1,719 |
TAEAVVTEIPKEEKDPGMGA |
HSP60 |
20 |
541–560 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.14 |
-0.52 |
0.63 |
-3.00 |
2,072.60 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9237795; PMID: 17349009 |
| 1,720 |
PSWCEEPAQANMDISTGH |
IA-2 |
18 |
676–693 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.14 |
-0.83 |
0.03 |
-2.50 |
1,973.37 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,721 |
TGHMILAYMEDHLRNRDR |
IA-2 |
18 |
691–708 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.35 |
-1.03 |
0.33 |
1.00 |
2,228.80 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,722 |
RDRLAKEWQALCAYQAEP |
IA-2 |
18 |
706–723 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.31 |
-0.94 |
0.34 |
0.00 |
2,148.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,723 |
IKLKVESSPSRSDYINAS |
IA-2 |
18 |
751–768 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.25 |
-0.61 |
0.39 |
1.00 |
1,994.48 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,724 |
NASPIIEHDPRMPAYIAT |
IA-2 |
18 |
766–783 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.09 |
-0.28 |
-0.11 |
-0.50 |
1,996.52 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,725 |
IATQGPLSHTIADFWQMV |
IA-2 |
18 |
781–798 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.07 |
0.36 |
-0.71 |
-0.50 |
2,015.59 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,726 |
FALTAVAEEVNAILKALPQ |
IA-2 |
19 |
961–979 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.07 |
0.84 |
-0.33 |
-1.00 |
1,998.63 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11600216; PMID: 17349009 |
| 1,727 |
KLSGLGADPSADATEAYQEL |
IA-2β |
20 |
640–659 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.12 |
-0.44 |
0.29 |
-3.00 |
2,036.46 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11473031; PMID: 17349009 |
| 1,728 |
QREENAPKNRSLAVLTYDHASRI |
IA-2β |
23 |
755–777 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.36 |
-1.09 |
0.46 |
1.50 |
2,669.28 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11473031; PMID: 17349009 |
| 1,729 |
AFIKATGKKEDE |
ICA69 |
12 |
36–47 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.29 |
-1.03 |
1.03 |
0.00 |
1,336.67 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 9313748; PMID: 17349009 |
| 1,730 |
LHRSGVLIIHHLQEDYRTY |
IGRP |
19 |
4–22 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.18 |
-0.47 |
-0.24 |
1.50 |
2,350.97 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527; PMID: 17349009 |
| 1,731 |
WYVMVTAALSYTISRMEESSVTL |
IGRP |
23 |
123–145 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.01 |
0.51 |
-0.54 |
-1.00 |
2,638.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527; PMID: 17349009 |
| 1,732 |
TAALSYTISRMEESSVTL |
IGRP |
18 |
128–145 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.08 |
0.21 |
-0.14 |
-1.00 |
1,959.45 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527; PMID: 17349009 |
| 1,733 |
HTPGVHMASLSVYLKTNVFL |
IGRP |
20 |
195–214 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.05 |
0.52 |
-0.73 |
2.00 |
2,214.92 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15843527; PMID: 17349009 |
| 1,734 |
CTSICSLYQLENYCN |
Insulin 1/2 |
15 |
A7–21 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.09 |
0.05 |
-0.61 |
-1.00 |
1,754.19 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 8570667; PMID: 17349009 |
| 1,735 |
FLPLLALLALWEPKPTQ |
Insulin 1 |
17 |
L7–23 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.11 |
0.70 |
-0.70 |
0.00 |
1,950.66 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 17349009 |
| 1,736 |
KPTQAFVKQHLCGPHL |
Insulin 1 |
16 |
L20–B11 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.13 |
-0.41 |
-0.26 |
3.00 |
1,804.39 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 17349009 |
| 1,737 |
PHLVEALYLVCGERG |
Insulin 1 |
15 |
B9–23 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.01 |
0.38 |
-0.25 |
-0.50 |
1,656.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 7537670; PMID: 17349009 |
| 1,738 |
SPGDLQTLALEVARQK |
Insulin 1 |
16 |
C15–30 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.21 |
-0.42 |
0.27 |
0.00 |
1,726.20 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 17349009 |
| 1,739 |
TLALEVARQKRGIVDQ |
Insulin 1 |
16 |
C21–A5 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.25 |
-0.24 |
0.35 |
1.00 |
1,797.33 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 17349009 |
| 1,740 |
LFLWESHPTQAFVKQHL |
Insulin 2 |
17 |
L14–B6 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.03 |
-0.11 |
-0.62 |
1.00 |
2,081.67 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 17349009 |
| 1,741 |
HPTQAFVKQHLCGSHL |
Insulin 2 |
16 |
L20–B11 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.10 |
-0.32 |
-0.46 |
2.50 |
1,803.32 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12639991; PMID: 17349009 |
| 1,742 |
VKQHLCGSHLVEALYL |
Insulin 2 |
16 |
B2–17 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
0.01 |
0.51 |
-0.53 |
1.00 |
1,810.40 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 17349009 |
| 1,743 |
SHLVEALYLVCGERG |
Insulin 2 |
15 |
B9–23 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 7537670; PMID: 17349009 |
| 1,744 |
FFYTPMSRRE |
Insulin 2 |
10 |
B24–C1 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.32 |
-0.94 |
0.03 |
1.00 |
1,333.65 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11673498; PMID: 17349009 |
| 1,745 |
GPGAGDLQTLALEVAQQK |
Insulin 2 |
18 |
C15–32 |
-- |
-- |
Mus musculus |
Ag7 |
I |
-- |
-- |
-- |
-0.08 |
-0.22 |
0.04 |
-1.00 |
1,796.29 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12193712; PMID: 17349009 |
| 1,746 |
VMNILLQYVV |
GAD65 |
10 |
114–123 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.24 |
1.83 |
-1.31 |
0.00 |
1,191.66 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7722468; PMID: 17349009 |
| 1,747 |
MVWESGCTV |
IA-2 |
9 |
797–805 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.09 |
0.72 |
-0.64 |
-1.00 |
1,011.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11358432; PMID: 17349009 |
| 1,748 |
KLQVFLIVL |
IAPP (prepro) |
9 |
5–13 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.25 |
2.19 |
-1.06 |
1.00 |
1,072.55 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 14578281; PMID: 17349009 |
| 1,749 |
VLFGLGFAI |
IGRP |
9 |
265–273 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.46 |
2.54 |
-1.38 |
0.00 |
936.30 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16493087; PMID: 17349009 |
| 1,750 |
SHLVEALYLV |
Insulin |
10 |
B9–18 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.17 |
1.28 |
-0.84 |
-0.50 |
1,143.50 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15983206; PMID: 17349009 |
| 1,751 |
HLVEALYLV |
Insulin |
9 |
B10–18 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15983206; PMID: 17349009 |
| 1,752 |
HLVEALYLV |
Insulin |
9 |
B10–18 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,753 |
HLVEALYLV |
Insulin |
9 |
B10–18 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.21 |
1.51 |
-0.97 |
-0.50 |
1,056.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16339897; PMID: 17349009 |
| 1,754 |
ALYLVCGER |
Insulin |
9 |
B14–22 |
-- |
-- |
Homo sapiens |
A3, A11 |
II |
-- |
-- |
-- |
-0.03 |
0.71 |
-0.32 |
0.00 |
1,023.34 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,755 |
LYLVCGERG |
Insulin |
9 |
B15–23 |
-- |
-- |
Homo sapiens |
A24 |
II |
-- |
-- |
-- |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11269889; PMID: 17349009 |
| 1,756 |
LYLVCGERGF |
Insulin |
10 |
B15–24 |
-- |
-- |
Homo sapiens |
A24 |
II |
-- |
-- |
-- |
0.02 |
0.70 |
-0.49 |
0.00 |
1,156.51 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,757 |
LVCGERGFFY |
Insulin |
10 |
B17–26 |
-- |
-- |
Homo sapiens |
A1, A3, A11 |
II |
-- |
-- |
-- |
0.03 |
0.60 |
-0.56 |
0.00 |
1,190.52 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,758 |
VCGERGFFYT |
Insulin |
10 |
B18–27 |
-- |
-- |
Homo sapiens |
A1, A2, B8, B18 |
II |
-- |
-- |
-- |
-0.04 |
0.15 |
-0.42 |
0.00 |
1,178.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,759 |
GERGFFYT |
Insulin |
8 |
B20–27 |
-- |
-- |
Homo sapiens |
A1, B8 |
II |
-- |
-- |
-- |
-0.12 |
-0.65 |
-0.21 |
0.00 |
976.16 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,760 |
ERGFFYTPK |
Insulin |
9 |
B21–29 |
-- |
-- |
Homo sapiens |
A3 |
II |
-- |
-- |
-- |
-0.26 |
-1.14 |
0.14 |
1.00 |
1,144.41 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,761 |
FYTPKTRRE |
Insulin |
9 |
B25–C1 |
-- |
-- |
Homo sapiens |
B8 |
II |
-- |
-- |
-- |
-0.56 |
-1.99 |
0.71 |
2.00 |
1,197.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,762 |
TPKTRREAEDL |
Insulin |
11 |
B27–C5 |
-- |
-- |
Homo sapiens |
B8 |
II |
-- |
-- |
-- |
-0.57 |
-1.89 |
1.35 |
0.00 |
1,315.59 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 16030147; PMID: 17349009 |
| 1,763 |
SLQPLALEG |
Insulin |
9 |
C20–28 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.04 |
0.38 |
-0.27 |
-1.00 |
927.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15983206; PMID: 17349009 |
| 1,764 |
ALEGSLQKR |
Insulin |
9 |
C25–33 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
-0.33 |
-0.80 |
0.60 |
1.00 |
1,001.28 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 15983206; PMID: 17349009 |
| 1,765 |
SLQKRGIVEQ |
Insulin |
10 |
C29–A5 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
-0.32 |
-0.76 |
0.46 |
1.00 |
1,157.49 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15983206; PMID: 17349009 |
| 1,766 |
GIVEQCCTSI |
Insulin |
10 |
A1–10 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
0.05 |
0.93 |
-0.40 |
-1.00 |
1,052.37 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15983206; PMID: 17349009 |
| 1,767 |
SLYQLENYC |
Insulin |
9 |
A12–20 |
-- |
-- |
Homo sapiens |
A2 |
II |
-- |
-- |
-- |
-0.12 |
-0.42 |
-0.61 |
-1.00 |
1,132.38 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15983206; PMID: 17349009 |
| 1,768 |
FQDENYLYL |
DMK |
9 |
138–146 |
-- |
-- |
Mus musculus |
Db |
II |
-- |
-- |
-- |
-0.11 |
-0.69 |
-0.48 |
-2.00 |
1,204.43 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 15557165; PMID: 17349009 |
| 1,769 |
TYEIAPVFV |
GAD65 |
9 |
206–214 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
0.20 |
1.16 |
-0.83 |
-1.00 |
1,038.33 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 11466400; PMID: 17349009 |
| 1,770 |
WFVPPSLRTL |
GAD65 |
10 |
507–516 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
0.02 |
0.45 |
-0.81 |
1.00 |
1,215.60 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 12657523; PMID: 17349009 |
| 1,771 |
SYQPLGDKV |
GAD65 |
9 |
546–554 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
-0.18 |
-0.78 |
0.10 |
0.00 |
1,006.25 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 11466400; PMID: 17349009 |
| 1,772 |
WYIPQSLRGV |
GAD67 |
10 |
515–524 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
-0.04 |
-0.05 |
-0.73 |
1.00 |
1,218.57 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10556546; PMID: 17349009 |
| 1,773 |
TYYGFLNFM |
IGRP |
9 |
21–29 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
0.15 |
0.46 |
-1.43 |
0.00 |
1,155.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957; PMID: 17349009 |
| 1,774 |
VYLKTNVFL |
IGRP |
9 |
206–214 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
0.09 |
1.04 |
-0.96 |
1.00 |
1,096.47 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12815107; PMID: 17349009 |
| 1,775 |
LRLFGIDLL |
IGRP |
9 |
225–233 |
-- |
-- |
Mus musculus |
Db |
II |
-- |
-- |
-- |
0.13 |
1.57 |
-0.61 |
0.00 |
1,059.46 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957; PMID: 17349009 |
| 1,776 |
KWCANPDWI |
IGRP |
9 |
241–249 |
-- |
-- |
Mus musculus |
Db |
II |
-- |
-- |
-- |
-0.09 |
-0.61 |
-0.43 |
0.00 |
1,132.42 |
Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957; PMID: 17349009 |
| 1,777 |
SFCKSASIP |
IGRP |
9 |
324–332 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
-0.04 |
0.41 |
-0.21 |
1.00 |
939.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 15908957; PMID: 17349009 |
| 1,778 |
LYLVCGERG |
Insulin 1/2 |
9 |
B15–23 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
-0.04 |
0.47 |
-0.27 |
0.00 |
1,009.32 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 10470079; PMID: 17349009 |
| 1,779 |
FYTPMSRREV |
Insulin 2 |
10 |
B25–C2 |
-- |
-- |
Mus musculus |
Kd |
II |
-- |
-- |
-- |
-0.32 |
-0.80 |
0.13 |
1.00 |
1,285.61 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 12727928; PMID: 17349009 |
| 1,780 |
NMYAMLIARYKMSPEVKEKG |
GAD65 |
20 |
247–266 |
-- |
-- |
NOD mice |
Ag7 |
I |
-- |
-- |
-- |
-0.20 |
-0.51 |
0.19 |
2.00 |
2,360.14 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 8666914; PMID: 17349009 |
| 1,781 |
VPPSLRTLEDNEERMSRLSK |
GAD65 |
20 |
509–528 |
-- |
-- |
NOD mice |
Ag7 |
I |
-- |
-- |
-- |
-0.42 |
-1.19 |
0.82 |
0.00 |
2,357.95 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 8666914; PMID: 17349009 |
| 1,782 |
SRLSKVAPVIKARMMEYGTT |
GAD65 |
20 |
524–543 |
-- |
-- |
NOD mice |
Ag7 |
I |
-- |
-- |
-- |
-0.19 |
-0.12 |
0.12 |
3.00 |
2,238.98 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8666914; PMID: 17349009 |
| 1,783 |
EYGTTMVSYQPLGDKVNFFR |
GAD65 |
20 |
539–558 |
-- |
-- |
NOD mice |
Ag7 |
I |
-- |
-- |
-- |
-0.14 |
-0.49 |
-0.19 |
0.00 |
2,352.94 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8666914; PMID: 17349009 |
| 1,784 |
VLGGGCALLRCIPALDSLKPANED |
HSP60 |
24 |
437–460 |
-- |
-- |
NOD mice |
Ag7 |
I |
-- |
-- |
-- |
-0.03 |
0.44 |
-0.01 |
-1.00 |
2,426.20 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 7907681; PMID: 17349009 |
| 1,785 |
KYNKANAFL |
IGRP |
9 |
206–214 |
-- |
-- |
NOD mice |
Kd |
II |
-- |
-- |
-- |
-0.20 |
-0.66 |
-0.13 |
2.00 |
1,068.36 |
Non-Toxin |
-- |
Type 1 Diabetes |
-- |
PMID: 10963600; PMID: 17349009 |
| 1,786 |
SHLVEALYLVCGERG |
Insulin 2 |
15 |
B9–23 |
-- |
-- |
NOD mice |
Ag7 |
I |
-- |
-- |
-- |
-0.02 |
0.43 |
-0.23 |
-0.50 |
1,646.12 |
Non-Toxin |
IEDB |
Type 1 Diabetes |
-- |
PMID: 8570667; PMID: 17349009 |
| 1,787 |
VA |
Lactotransferrin |
2 |
Lactotransferrin (96-97, 114-115, 168-169, 225-226, 275-276, 357-358, 457-458, 561-562, 687-688) |
DPP‐IV inhibitory |
-- |
Homo sapiens |
-- |
-- |
-- |
(1) 168,24 µM, (2) 168,2 µM, (3) 168,2 µM |
-- |
0.40 |
3.00 |
-1.00 |
0.00 |
188.24 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
Natural Peptide |
10.1016/j.peptides.2012.11.018, 10.1016/j.foodres.2015.09.012, 10.1016/j.foodres.2015.09.013 |
| 1,788 |
FL |
Lactotransferrin |
2 |
Lactotransferrin (5-6, 10-11, 154-155, 707-708) |
DPP‐IV inhibitory |
-- |
Homo sapiens |
-- |
-- |
-- |
(1) 399,58 µM |
-- |
0.57 |
3.30 |
-2.15 |
0.00 |
278.37 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2012.11.018 |
| 1,789 |
AL |
Lactotransferrin |
2 |
Lactotransferrin (13-14, 401-402, 524-525, 591-592) |
DPP‐IV inhibitory |
-- |
Homo sapiens |
-- |
-- |
-- |
(1) 882,13 µM |
-- |
0.39 |
2.80 |
-1.15 |
0.00 |
202.27 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2012.11.018 |
| 1,790 |
WV |
Alpha-lactalbumin |
2 |
Alpha-lactalbumin (45-46) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 65,69 µM |
-- |
0.46 |
1.65 |
-2.45 |
0.00 |
303.38 |
Non-Toxin |
IEDB,SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2012.11.018 |
| 1,791 |
HL |
Lactotransferrin |
2 |
Lactotransferrin (265-266, 609-610) |
DPP‐IV inhibitory |
-- |
Homo sapiens |
-- |
-- |
-- |
(1) 143,19 µM, (2) 143,19 µM, (3) 143,19 µM, (4) 143,19 µM |
-- |
0.07 |
0.30 |
-1.15 |
0.50 |
268.34 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2012.11.023, 10.1016/j.peptides.2012.11.022, 10.1016/j.peptides.2012.11.021, 10.1016/j.peptides.2012.11.020 |
| 1,792 |
VR |
Serum albumin |
2 |
Serum albumin (432-433) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 826,1 µM |
-- |
-0.61 |
-0.15 |
0.75 |
1.00 |
273.35 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2013.09.012 |
| 1,793 |
LP |
Serum albumin |
2 |
Serum albumin (136-137, 202-203, 325-326, 539-540) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 712,5 µM |
-- |
0.23 |
1.10 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.jff.2013.09.012 |
| 1,794 |
IP |
Serum albumin |
2 |
Serum albumin (321-322) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 149,6 µM |
-- |
0.33 |
1.45 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2013.09.012 |
| 1,795 |
YP |
Lactotransferrin |
2 |
Lactotransferrin (185-186) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 658,1 µM, (2) 658,1 µM |
-- |
-0.03 |
-1.45 |
-1.15 |
0.00 |
278.32 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2013.09.012, 10.1016/j.foodchem.2013.08.097 |
| 1,796 |
WI |
Lactotransferrin |
2 |
Lactotransferrin (144-145) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 138,7 µM |
-- |
0.55 |
1.80 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodres.2015.09.012 |
| 1,797 |
VL |
Lactotransferrin |
2 |
Lactotransferrin (7-8, 403-404, 429-430, 569-570, 631-632) |
DPP‐IV inhibitory |
-- |
Homo sapiens |
-- |
-- |
-- |
(1) 74 µM |
-- |
0.54 |
4.00 |
-1.65 |
0.00 |
230.33 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.foodres.2015.09.012 |
| 1,798 |
IPM |
Lactotransferrin |
3 |
Lactotransferrin (490-492) |
DPP‐IV inhibitory |
-- |
Homo sapiens |
-- |
-- |
-- |
(1) 69,5 µM |
-- |
0.31 |
1.60 |
-1.03 |
0.00 |
359.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2016.03.005 |
| 1,799 |
YPYY |
Kappa-casein |
4 |
Kappa-casein (55-58) |
DPP‐IV inhibitory |
-- |
Homo sapiens |
-- |
-- |
-- |
(1) 194,4 µM |
-- |
0.00 |
-1.38 |
-1.72 |
0.00 |
604.70 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Opioid |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.08.097 |
| 1,800 |
YPY |
Kappa-casein |
3 |
Kappa-casein (79-81) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 243,7 µM |
-- |
-0.01 |
-1.40 |
-1.53 |
0.00 |
441.51 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.08.097 |
| 1,801 |
LPYPY |
Kappa-casein |
5 |
Kappa-casein (77-81) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 108,3 µM |
-- |
0.09 |
-0.40 |
-1.28 |
0.00 |
651.82 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.08.097 |
| 1,802 |
IPIQY |
Kappa-casein |
5 |
Kappa-casein (47-51) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 35,2 µM |
-- |
0.14 |
0.52 |
-1.14 |
0.00 |
632.83 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.08.097 |
| 1,803 |
IPI |
Kappa-casein |
3 |
Kappa-casein (47-49) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 3,5 µM, (2) 4,9 µM |
-- |
0.46 |
2.47 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.jff.2013.09.012, 10.1016/j.jff.2014.04.002 |
| 1,804 |
INNQFLPYPY |
Kappa-casein |
10 |
Kappa-casein (72-81) |
DPP‐IV inhibitory |
-- |
Capra hircus |
-- |
-- |
-- |
(1) 40,08 µM |
-- |
-0.02 |
-0.52 |
-1.01 |
0.00 |
1,268.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1021/acs.jafc.5b03062 |
| 1,805 |
VLVLDTDYK |
Beta-lactoglobulin |
9 |
Beta-lactoglobulin (108-116) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 424,4 µM |
-- |
-0.06 |
0.34 |
-0.03 |
-1.00 |
1,065.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.03.056 |
| 1,806 |
VLDTDY |
Beta-lactoglobulin |
6 |
Beta-lactoglobulin (110-115) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 471 µM |
-- |
-0.09 |
-0.17 |
0.00 |
-2.00 |
724.84 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2015.11.038 |
| 1,807 |
VAGTWY |
Beta-lactoglobulin |
6 |
Beta-lactoglobulin (31-36) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 74,9 µM |
-- |
0.19 |
0.45 |
-1.35 |
0.00 |
695.85 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Antioxidant,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.jff.2014.04.002 |
| 1,808 |
TPEVDDEALEK |
Beta-lactoglobulin |
11 |
Beta-lactoglobulin (141-151) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 319,5 µM , (2) 578,7 µM |
-- |
-0.30 |
-1.26 |
1.25 |
-4.00 |
1,245.45 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.03.056, 10.1016/j.jff.2014.04.002 |
| 1,809 |
LKPTPEGDLEIL |
Beta-lactoglobulin |
12 |
Beta-lactoglobulin (62-73) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 57 µM |
-- |
-0.08 |
-0.23 |
0.37 |
-2.00 |
1,324.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,810 |
LKPTPEGDLE |
Beta-lactoglobulin |
10 |
Beta-lactoglobulin (62-71) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 45 µM |
-- |
-0.22 |
-1.11 |
0.80 |
-2.00 |
1,098.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,811 |
LKPTPEGDL |
Beta-lactoglobulin |
9 |
Beta-lactoglobulin (62-70) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 45 µM |
-- |
-0.17 |
-0.84 |
0.56 |
-1.00 |
969.23 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,812 |
LKALPMH |
Beta-lactoglobulin |
7 |
Beta-lactoglobulin (156-162) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 193 µM |
-- |
0.00 |
0.37 |
-0.41 |
1.50 |
809.14 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2015.11.038 |
| 1,813 |
IQKVAGTW |
Beta-lactoglobulin |
8 |
Beta-lactoglobulin (28-35) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 329 µM |
-- |
0.01 |
0.14 |
-0.55 |
1.00 |
902.18 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2015.11.038 |
| 1,814 |
IPAVFKIDA |
Beta-lactoglobulin |
9 |
Beta-lactoglobulin (94-102) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 191 µM |
-- |
0.14 |
1.18 |
-0.29 |
0.00 |
973.30 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,815 |
IPAVFK |
Beta-lactoglobulin |
6 |
Beta-lactoglobulin (94-99) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 143 µM, (2) 149,1 µM |
-- |
0.16 |
1.30 |
-0.55 |
1.00 |
673.93 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.03.056, 10.1016/j.jff.2014.04.002 |
| 1,816 |
IPAVF |
Beta-lactoglobulin |
5 |
Beta-lactoglobulin (94-98) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 44,7 µM |
-- |
0.41 |
2.34 |
-1.26 |
0.00 |
545.74 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.03.056 |
| 1,817 |
IPA |
Beta-lactoglobulin |
3 |
Beta-lactoglobulin (94-96) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 49 µM |
-- |
0.30 |
1.57 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2011.01.002 |
| 1,818 |
YPVEPF |
Beta-casein |
6 |
Beta-casein (129-134) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 124,7 µM, (2) 138.0 ± 15.3 µM |
-- |
0.07 |
-0.17 |
-0.55 |
-1.00 |
750.92 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: Opioid |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2016.03.005, 10.1016/j.foodchem.2017.10.033 |
| 1,819 |
YPFPGPIPN |
Beta-casein |
9 |
Beta-casein (75-83) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 670. |
-- |
0.07 |
-0.48 |
-0.71 |
0.00 |
1,001.27 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2011.08.002 |
| 1,820 |
YPFPGP |
Beta-casein |
6 |
Beta-casein (75-80) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 749,2 µM |
-- |
0.10 |
-0.62 |
-0.80 |
0.00 |
676.84 |
Non-Toxin |
MBPDB: Opioid |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2016.03.005 |
| 1,821 |
VPGEIVE |
Beta-casein |
7 |
Beta-casein (23-29) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 224,5 µM |
-- |
0.09 |
0.56 |
0.17 |
-2.00 |
741.94 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2016.03.005 |
| 1,822 |
VLGP |
Beta-casein |
4 |
Beta-casein (212-215) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 580,4 µM |
-- |
0.29 |
1.50 |
-0.82 |
0.00 |
384.53 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.jff.2013.09.012 |
| 1,823 |
SPTVMFPPQSVL |
Beta-casein |
12 |
Beta-casein (167-178) |
DPP‐IV inhibitory |
-- |
Capra hircus |
-- |
-- |
-- |
(1) 676 µM |
-- |
0.07 |
0.52 |
-0.68 |
0.00 |
1,302.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1021/acs.jafc.5b03062 |
| 1,824 |
PQNIPPL |
Beta-casein |
7 |
Beta-casein (86-92) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 1500. |
-- |
-0.04 |
-0.50 |
-0.46 |
0.00 |
778.02 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2011.08.002 |
| 1,825 |
PGPIPNS |
Beta-casein |
7 |
Beta-casein (78-84) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 1000. |
-- |
-0.03 |
-0.71 |
-0.19 |
0.00 |
680.85 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2011.08.002 |
| 1,826 |
MHQPPQPL |
Beta-casein |
8 |
Beta-casein (159-166) |
DPP‐IV inhibitory |
-- |
Capra hircus |
-- |
-- |
-- |
(1) 350 µM |
-- |
-0.15 |
-1.16 |
-0.40 |
0.50 |
947.24 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1021/acs.jafc.5b03062 |
| 1,827 |
LPVPQ |
Beta-casein |
5 |
Beta-casein (186-190) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 43,8 µM |
-- |
0.05 |
0.26 |
-0.62 |
0.00 |
552.74 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2016.03.005 |
| 1,828 |
LPQNIPPLT |
Beta-casein |
9 |
Beta-casein (85-93) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 205,2 µM |
-- |
0.01 |
-0.04 |
-0.60 |
0.00 |
992.32 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2016.03.005 |
| 1,829 |
LPQNIPP |
Beta-casein |
7 |
Beta-casein (85-91) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 160. |
-- |
-0.04 |
-0.50 |
-0.46 |
0.00 |
778.02 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2011.08.002 |
| 1,830 |
LPQ |
Beta-casein |
3 |
Beta-casein (85-87) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 82. |
-- |
-0.08 |
-0.43 |
-0.53 |
0.00 |
356.46 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2011.08.002 |
| 1,831 |
LPLPLL |
Beta-casein |
6 |
Beta-casein (150-155) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 371,5 µM |
-- |
0.33 |
2.00 |
-1.20 |
0.00 |
664.98 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2016.03.005 |
| 1,832 |
LPLPL |
Beta-casein |
5 |
Beta-casein (150-154) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 325 µM, (2) 325 µM |
-- |
0.29 |
1.64 |
-1.08 |
0.00 |
551.80 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.08.097, 10.1016/j.peptides.2016.03.005 |
| 1,833 |
LPL |
Beta-casein |
3 |
Beta-casein (150-152) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 241,4 µM |
-- |
0.33 |
2.00 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2013.08.097 |
| 1,834 |
IPPLTQT |
Beta-casein |
7 |
Beta-casein (89-95) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 465,1 µM |
-- |
0.01 |
0.03 |
-0.60 |
0.00 |
769.01 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2016.03.005 |
| 1,835 |
GPFPILV |
Beta-casein |
7 |
Beta-casein (216-222) |
DPP‐IV inhibitory |
-- |
Capra hircus |
-- |
-- |
-- |
(1) 163. |
-- |
0.35 |
1.67 |
-1.09 |
0.00 |
742.03 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2015.10.001 |
| 1,836 |
FPGPIPN |
Beta-casein |
7 |
Beta-casein (77-83) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 260. |
-- |
0.09 |
-0.20 |
-0.59 |
0.00 |
740.95 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2011.08.002 |
| 1,837 |
FLQP |
Beta-casein |
4 |
Beta-casein (102-105) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 65,3 µM |
-- |
0.10 |
0.37 |
-1.02 |
0.00 |
503.65 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2013.09.012 |
| 1,838 |
WLAHKALCSEKLDQ |
Alpha-lactalbumin |
14 |
Alpha-lactalbumin (123-136) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 141 µM |
-- |
-0.17 |
-0.41 |
0.09 |
0.50 |
1,642.11 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,839 |
WLAHKAL |
Alpha-lactalbumin |
7 |
Alpha-lactalbumin (123-129) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 286 µM |
-- |
0.06 |
0.46 |
-0.79 |
1.50 |
838.12 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2015.11.038 |
| 1,840 |
WL |
Alpha-lactalbumin |
2 |
Alpha-lactalbumin (123-124, 137-138) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 43,6 µM |
-- |
0.45 |
1.45 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
IEDB,SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.foodres.2015.09.012 |
| 1,841 |
TKCEVFRE |
Alpha-lactalbumin |
8 |
Alpha-lactalbumin (23-30) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 166 µM |
-- |
-0.39 |
-0.82 |
0.82 |
0.00 |
1,011.26 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,842 |
LKGYGGVSLPE |
Alpha-lactalbumin |
11 |
Alpha-lactalbumin (34-44) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 486 µM |
-- |
0.00 |
-0.05 |
-0.10 |
0.00 |
1,119.45 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.jff.2015.11.038 |
| 1,843 |
LCSEKLDQ |
Alpha-lactalbumin |
8 |
Alpha-lactalbumin (129-136) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 186 µM |
-- |
-0.29 |
-0.64 |
0.61 |
-1.00 |
935.17 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,844 |
LAHKALCSEKL |
Alpha-lactalbumin |
11 |
Alpha-lactalbumin (124-134) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 165 µM |
-- |
-0.12 |
0.20 |
0.13 |
1.50 |
1,212.63 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,845 |
IVQNNDSTEYGLF |
Alpha-lactalbumin |
13 |
Alpha-lactalbumin (60-72) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 337 µM |
-- |
-0.09 |
-0.42 |
-0.26 |
-2.00 |
1,499.79 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002 |
| 1,846 |
ILDKVGINY |
Alpha-lactalbumin |
9 |
Alpha-lactalbumin (114-122) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 263 µM, (2) 321.5 ± 29.5 µM |
-- |
0.03 |
0.49 |
-0.33 |
0.00 |
1,034.36 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2014.01.002, 10.1016/j.foodchem.2017.10.033 |
| 1,847 |
WIQP |
Alpha-S2-casein |
4 |
Alpha-S2-casein (208-211) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 237,3 µM |
-- |
0.09 |
-0.38 |
-1.25 |
0.00 |
542.69 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.jff.2013.09.012 |
| 1,848 |
VPITPTL |
Alpha-S2-casein |
7 |
Alpha-S2-casein (132-138) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 110. |
-- |
0.19 |
1.13 |
-0.84 |
0.00 |
740.01 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2011.08.002 |
| 1,849 |
VPITPT |
Alpha-S2-casein |
6 |
Alpha-S2-casein (132-137) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 130. |
-- |
0.13 |
0.68 |
-0.68 |
0.00 |
626.83 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2011.08.002 |
| 1,850 |
HPINHR |
Alpha-S1-casein |
6 |
Alpha-S1-casein (19-24) |
DPP‐IV inhibitory |
-- |
Capra hircus |
-- |
-- |
-- |
(1) 452,2. |
-- |
-0.42 |
-1.92 |
0.07 |
2.00 |
772.95 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.idairyj.2015.10.001 |
| 1,851 |
SPVVPF |
Beta-casein |
6 |
Beta-casein (130-135) |
DPP‐IV inhibitory |
-- |
Camelus dromedarius |
-- |
-- |
-- |
(1) 214.1 ± 16.7 µM |
-- |
0.21 |
1.20 |
-0.87 |
0.00 |
644.84 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2017.10.033 |
| 1,852 |
MPVQA |
Beta-casein |
5 |
Beta-casein (201-205) |
DPP‐IV inhibitory |
-- |
Camelus dromedarius |
-- |
-- |
-- |
(1) 93.3 ± 8.0 µM |
-- |
0.06 |
0.56 |
-0.62 |
0.00 |
544.73 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2017.10.033 |
| 1,853 |
LPVP |
Beta-casein |
4 |
Beta-casein (186-189) |
DPP‐IV inhibitory |
-- |
Bos taurus |
-- |
-- |
-- |
(1) 87.0 ± 3.2 µM |
-- |
0.23 |
1.20 |
-0.82 |
0.00 |
424.59 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2017.10.033 |
| 1,854 |
LLQLEAIR |
Alpha-S1-casein |
8 |
Alpha-S1-casein (123-130) |
DPP‐IV inhibitory |
-- |
Camelus dromedarius OX=9838 |
-- |
-- |
-- |
(1) 177.8 ± 22.2 µM |
-- |
-0.06 |
0.77 |
-0.19 |
0.00 |
955.29 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2017.10.033 |
| 1,855 |
ILELA |
Alpha-S1-casein |
5 |
Alpha-S1-casein (43-47) |
DPP‐IV inhibitory |
-- |
Camelus dromedarius OX=9838 |
-- |
-- |
-- |
(1) 721.1 ± 46.3 µM |
-- |
0.28 |
2.08 |
-0.58 |
-1.00 |
557.76 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2017.10.033 |
| 1,856 |
ILDKEGIDY |
Alpha-lactalbumin |
9 |
Alpha-lactalbumin (95-103) |
DPP‐IV inhibitory |
-- |
Camelus dromedarius OX=9838 |
-- |
-- |
-- |
(1) 347.8 ± 42.8 µM |
-- |
-0.11 |
-0.37 |
0.48 |
-2.00 |
1,065.32 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.foodchem.2017.10.033 |
| 1,857 |
PPL |
-- |
3 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.13 |
0.20 |
-0.60 |
0.00 |
325.44 |
Non-Toxin |
IEDB,SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 25020248; PMID: 28445415 |
| 1,858 |
YP |
-- |
2 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.03 |
-1.45 |
-1.15 |
0.00 |
278.32 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
PMID: 24128555; PMID: 28445415 |
| 1,859 |
LP |
-- |
2 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.23 |
1.10 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 24128555; PMID: 28445415 |
| 1,860 |
IPI |
-- |
3 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.46 |
2.47 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
PMID: 24128555; PMID: 28445415 |
| 1,861 |
VPL |
-- |
3 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.33 |
2.13 |
-1.10 |
0.00 |
327.46 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 24128555; PMID: 28445415 |
| 1,862 |
IPA |
-- |
3 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.30 |
1.57 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
PMID: 24128555; PMID: 28445415 |
| 1,863 |
IPAVF |
-- |
5 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.41 |
2.34 |
-1.26 |
0.00 |
545.74 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 24128555; PMID: 28445415 |
| 1,864 |
PGVGGPLGPIGPCTE |
-- |
15 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.10 |
0.16 |
-0.23 |
-1.00 |
1,350.78 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22450467; PMID: 28445415 |
| 1,865 |
CAYNTERPVDRIR |
-- |
13 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.46 |
-1.12 |
0.59 |
1.00 |
1,592.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22450467; PMID: 28445415 |
| 1,866 |
PACCGPTISRPG |
-- |
12 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.09 |
-0.02 |
-0.12 |
1.00 |
1,158.51 |
Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22450467; PMID: 28445415 |
| 1,867 |
GPAE |
-- |
4 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.07 |
-0.93 |
0.62 |
-1.00 |
372.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22225496; PMID: 28445415 |
| 1,868 |
GPGA |
-- |
4 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.12 |
-0.15 |
-0.12 |
0.00 |
300.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22225496; PMID: 28445415 |
| 1,869 |
MHQPPQPL |
-- |
8 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.15 |
-1.16 |
-0.40 |
0.50 |
947.24 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26323964; PMID: 28445415 |
| 1,870 |
AWPQYL |
-- |
6 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.07 |
-0.28 |
-1.30 |
0.00 |
776.97 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26323964; PMID: 28445415 |
| 1,871 |
SPTVMFPPQSVL |
-- |
12 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.07 |
0.52 |
-0.68 |
0.00 |
1,302.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26323964; PMID: 28445415 |
| 1,872 |
VMFPPQSVL |
-- |
9 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.15 |
1.04 |
-0.90 |
0.00 |
1,017.38 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26323964; PMID: 28445415 |
| 1,873 |
AWPQYL |
-- |
6 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.07 |
-0.28 |
-1.30 |
0.00 |
776.97 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26323964; PMID: 28445415 |
| 1,874 |
INNQFLPYPY |
-- |
10 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.02 |
-0.52 |
-1.01 |
0.00 |
1,268.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26323964; PMID: 28445415 |
| 1,875 |
ILAP |
-- |
4 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.36 |
2.13 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 25442570; PMID: 28445415 |
| 1,876 |
LLAP |
-- |
4 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.31 |
1.95 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 25442570; PMID: 28445415 |
| 1,877 |
MAGVAHI |
-- |
7 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.26 |
1.51 |
-0.87 |
0.50 |
697.95 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 25442570; PMID: 28445415 |
| 1,878 |
IP |
-- |
2 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.33 |
1.45 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
doi: 10.1007/s10989-015-9478-4; PMID: 28445415 |
| 1,879 |
MP |
-- |
2 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.10 |
0.15 |
-0.65 |
0.00 |
246.34 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
doi: 10.1007/s10989-015-9478-4; PMID: 28445415 |
| 1,880 |
VP |
-- |
2 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.24 |
1.30 |
-0.75 |
0.00 |
214.28 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
doi: 10.1007/s10989-015-9478-4; PMID: 28445415 |
| 1,881 |
LP |
-- |
2 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.23 |
1.10 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
doi: 10.1007/s10989-015-9478-4; PMID: 28445415 |
| 1,882 |
LKPTPEGDL |
-- |
9 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.17 |
-0.84 |
0.56 |
-1.00 |
969.23 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 28098291; PMID: 28445415 |
| 1,883 |
LPYPY |
-- |
5 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.09 |
-0.40 |
-1.28 |
0.00 |
651.82 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
PMID: 28098291; PMID: 28445415 |
| 1,884 |
IPIQY |
-- |
5 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.14 |
0.52 |
-1.14 |
0.00 |
632.83 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28098291; PMID: 28445415 |
| 1,885 |
WR |
-- |
2 |
Food-derived |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.70 |
-2.70 |
-0.20 |
1.00 |
360.43 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28098291; PMID: 28445415 |
| 1,886 |
IQAEGGLT |
-- |
8 |
Quinoa (Chenopodium quinoa Willd.) |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.04 |
0.20 |
-0.16 |
-1.00 |
787.99 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Vilcacundo et al. (2017) |
| 1,887 |
ILAP |
-- |
4 |
Macroalga Palmaria palmate protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
43.4 |
-- |
0.36 |
2.13 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Harnedy et al. (2015) |
| 1,888 |
LLAP |
-- |
4 |
Macroalga Palmaria palmate protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
53.67 |
-- |
0.31 |
1.95 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Harnedy et al. (2015) |
| 1,889 |
MAGVDHI |
-- |
7 |
Macroalga Palmaria palmate protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
159.37 |
-- |
0.12 |
0.76 |
-0.37 |
-0.50 |
741.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Harnedy et al. (2015) |
| 1,890 |
WN |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
148.5 |
-- |
-0.14 |
-2.20 |
-1.60 |
0.00 |
318.35 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,891 |
IP |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
149.6 |
-- |
0.33 |
1.45 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,892 |
IPI |
-- |
3 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
3.5 |
-- |
0.46 |
2.47 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,893 |
IPIQY |
-- |
5 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
35.2 |
-- |
0.14 |
0.52 |
-1.14 |
0.00 |
632.83 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,894 |
FLQP |
-- |
4 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.3 |
-- |
0.10 |
0.37 |
-1.02 |
0.00 |
503.65 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,895 |
WV |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.7 |
-- |
0.46 |
1.65 |
-2.45 |
0.00 |
303.38 |
Non-Toxin |
IEDB,SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,896 |
LPVPQ |
-- |
5 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
48.2 |
-- |
0.05 |
0.26 |
-0.62 |
0.00 |
552.74 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,897 |
IPM |
-- |
3 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
73.9 |
-- |
0.31 |
1.60 |
-1.03 |
0.00 |
359.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,898 |
HL |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
143.2 |
-- |
0.07 |
0.30 |
-1.15 |
0.50 |
268.34 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,899 |
VA |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
168.2 |
-- |
0.40 |
3.00 |
-1.00 |
0.00 |
188.24 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,900 |
WL |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
43.6 |
-- |
0.45 |
1.45 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
IEDB,SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,901 |
WP |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
44.5 |
-- |
0.15 |
-1.25 |
-1.70 |
0.00 |
301.36 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,902 |
Wk |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
40.6 |
-- |
-0.37 |
-2.40 |
-0.20 |
1.00 |
332.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,903 |
WA |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
92.6 |
-- |
0.31 |
0.45 |
-1.95 |
0.00 |
275.32 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,904 |
LPYPY |
-- |
5 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
108.3 |
-- |
0.09 |
-0.40 |
-1.28 |
0.00 |
651.82 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,905 |
WQ |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
120.3 |
-- |
-0.16 |
-2.20 |
-1.60 |
0.00 |
332.38 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,906 |
WI |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
138.7 |
-- |
0.55 |
1.80 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,907 |
IP |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
149.6 |
-- |
0.33 |
1.45 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,908 |
YPYY |
-- |
4 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
194.4 |
-- |
0.00 |
-1.38 |
-1.72 |
0.00 |
604.70 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Opioid |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Nongonierma et al. (2013a,b,c, 2014a,b, and 2016) |
| 1,909 |
QQTG |
-- |
4 |
Phaseolus vulgaris L. |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.35 |
-2.02 |
0.00 |
0.00 |
432.49 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Oseguera‐Toledo et al. (2015) |
| 1,910 |
LSLL |
-- |
4 |
Phaseolus vulgaris L. |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.33 |
2.65 |
-1.27 |
0.00 |
444.63 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Oseguera‐Toledo et al. (2015) |
| 1,911 |
WVVL |
-- |
4 |
Phaseolus vulgaris L. |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.50 |
2.83 |
-2.05 |
0.00 |
515.71 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Oseguera‐Toledo et al. (2015) |
| 1,912 |
LLSL |
-- |
4 |
Phaseolus vulgaris L. |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.33 |
2.65 |
-1.28 |
0.00 |
444.63 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Oseguera‐Toledo et al. (2015) |
| 1,913 |
FFAAAFT |
-- |
7 |
Phaseolus vulgaris L. |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.34 |
1.87 |
-1.34 |
0.00 |
773.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Oseguera‐Toledo et al. (2015) |
| 1,914 |
FFL |
-- |
3 |
Phaseolus vulgaris L. |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.58 |
3.13 |
-2.27 |
0.00 |
425.56 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Oseguera‐Toledo et al. (2015) |
| 1,915 |
ALVLL |
-- |
5 |
Phaseolus vulgaris L. |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.48 |
3.48 |
-1.48 |
0.00 |
527.78 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Oseguera‐Toledo et al. (2015) |
| 1,916 |
IADHFL |
-- |
6 |
Bighead carp (Hypophthalmichthys nobilis) |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.17 |
1.03 |
-0.68 |
-0.50 |
714.90 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Zhang et al. (2018) |
| 1,917 |
LTFPGSAED |
-- |
9 |
Lupin proteins |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
207.5 |
-- |
-0.03 |
-0.23 |
0.12 |
-2.00 |
936.10 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Lammi et al. (2018) |
| 1,918 |
IAVPTGVA |
-- |
8 |
Soybean |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
223.2 |
-- |
0.28 |
1.73 |
-0.78 |
0.00 |
726.98 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Lammi et al. (2018) |
| 1,919 |
FFRSKLLSDGAAAAKGALLPQYW |
-- |
23 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.2 μm |
-- |
-0.03 |
0.19 |
-0.33 |
2.00 |
2,511.25 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Siow & Gan (2016) |
| 1,920 |
RCMAFLLSDGAAAAQQLLPQYQYW |
-- |
24 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.4 μm |
-- |
-0.03 |
0.13 |
-0.64 |
0.00 |
2,745.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Siow & Gan (2016) |
| 1,921 |
DPAQPNYPWTAVLVFRH |
-- |
17 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.3 μm |
-- |
-0.09 |
-0.43 |
-0.50 |
0.50 |
2,011.51 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Siow & Gan (2016) |
| 1,922 |
RCMAFLLSDGAAAAQQLLPQYW |
-- |
22 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.04 μm |
-- |
0.00 |
0.36 |
-0.60 |
0.00 |
2,454.18 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Siow et al. (2017) |
| 1,923 |
DPAQPNYPW TAVLVFRH |
-- |
18 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.15 μm |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Siow et al. (2017) |
| 1,924 |
PPHMLP |
-- |
6 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
6.08 mm |
-- |
0.03 |
-0.38 |
-0.60 |
0.50 |
690.94 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Ngoh et al. (2017, 2016) |
| 1,925 |
PLPWGAGF |
-- |
8 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
6.64 mm |
-- |
0.24 |
0.44 |
-1.02 |
0.00 |
844.09 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Ngoh et al. (2017, 2016) |
| 1,926 |
PPHMGGP |
-- |
7 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
6.14 mm |
-- |
0.00 |
-0.99 |
-0.26 |
0.50 |
691.90 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Ngoh et al. (2017, 2016) |
| 1,927 |
PLPLHMLP |
-- |
8 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
5.92 mm |
-- |
0.15 |
0.66 |
-0.90 |
0.50 |
917.30 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Ngoh et al. (2017, 2016) |
| 1,928 |
LSSLEMGSLGALFVCM |
-- |
16 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.31 mm |
-- |
0.19 |
1.47 |
-0.71 |
-1.00 |
1,658.26 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Ngoh et al. (2017, 2016) |
| 1,929 |
KLPGF |
-- |
5 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
120 μm |
-- |
0.03 |
0.14 |
-0.26 |
1.00 |
560.76 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Yu et al. (2012) |
| 1,930 |
EAGVD |
-- |
5 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
110 μm |
-- |
-0.08 |
-0.28 |
0.80 |
-2.00 |
489.54 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Yu et al. (2012) |
| 1,931 |
Contains: serine, threonine, tyrosine and valine amino acid |
-- |
59 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
3.75 μg/mL |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Singh & Kaur (2016) |
| 1,932 |
GEHGSDGNV |
-- |
9 |
-- |
α‐amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.18 |
-1.28 |
0.50 |
-1.50 |
870.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Vilcacundo et al. (2017) |
| 1,933 |
KLPGF |
-- |
5 |
-- |
α‐glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
59.5 μm |
-- |
0.03 |
0.14 |
-0.26 |
1.00 |
560.76 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Yu et al.(2012) |
| 1,934 |
NVLQPS |
-- |
6 |
-- |
α‐glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
100.0 μm |
-- |
-0.10 |
-0.23 |
-0.43 |
0.00 |
656.82 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Yu et al.(2012) |
| 1,935 |
IQAEGGLT |
-- |
8 |
-- |
α‐glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
109.48 μm |
-- |
0.04 |
0.20 |
-0.16 |
-1.00 |
787.99 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Vilcacundo et al. (2017) |
| 1,936 |
DKDYPK |
-- |
6 |
-- |
α‐glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.61 |
-2.95 |
1.62 |
0.00 |
764.90 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Vilcacundo et al. (2017) |
| 1,937 |
GEHGSDGNV |
-- |
9 |
-- |
α‐glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.18 |
-1.28 |
0.50 |
-1.50 |
870.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1111/ijfs.14090, Vilcacundo et al. (2017) |
| 1,938 |
APA |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
43.3 |
-- |
0.14 |
0.67 |
-0.33 |
0.00 |
257.31 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,939 |
APF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.8 |
-- |
0.26 |
1.00 |
-1.00 |
0.00 |
333.41 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,940 |
APR |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
119.7 |
-- |
-0.53 |
-1.43 |
0.83 |
1.00 |
342.42 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,941 |
IPA |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
28.3 |
-- |
0.30 |
1.57 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,942 |
KPA |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
74.5 |
-- |
-0.31 |
-1.23 |
0.83 |
1.00 |
314.41 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,943 |
FPF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
247 |
-- |
0.38 |
1.33 |
-1.67 |
0.00 |
409.51 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,944 |
FPI |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
45.2 |
-- |
0.42 |
1.90 |
-1.43 |
0.00 |
375.50 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,945 |
FPW |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
54.9 |
-- |
0.30 |
0.10 |
-1.97 |
0.00 |
448.55 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,946 |
IPF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
47.3 |
-- |
0.42 |
1.90 |
-1.43 |
0.00 |
375.50 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,947 |
IPW |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
175.3 |
-- |
0.34 |
0.67 |
-1.73 |
0.00 |
414.54 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,948 |
WPF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
159.8 |
-- |
0.30 |
0.10 |
-1.97 |
0.00 |
448.55 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,949 |
WPT |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
133 |
-- |
0.04 |
-1.07 |
-1.27 |
0.00 |
402.48 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,950 |
WPW |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
120.1 |
-- |
0.22 |
-1.13 |
-2.27 |
0.00 |
487.59 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 1,951 |
IAVPTGA |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
106 |
-- |
0.24 |
1.37 |
-0.67 |
0.00 |
627.83 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 27983830 |
| 1,952 |
LTFPGSAED |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
228 |
-- |
-0.03 |
-0.23 |
0.12 |
-2.00 |
936.10 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 27983830 |
| 1,953 |
RRDY |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
930 |
-- |
-1.06 |
-3.45 |
1.68 |
1.00 |
608.69 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 27499387 |
| 1,954 |
IHF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
3770 |
-- |
0.31 |
1.37 |
-1.60 |
0.50 |
415.53 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 27499387 |
| 1,955 |
KRIHF |
-- |
5 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
4110 |
-- |
-0.38 |
-0.86 |
0.24 |
2.50 |
699.92 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 27499387 |
| 1,956 |
RL |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1200 |
-- |
-0.61 |
-0.35 |
0.60 |
1.00 |
287.38 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 27499387 |
| 1,957 |
GPA |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2870 |
-- |
0.11 |
-0.07 |
-0.17 |
0.00 |
243.29 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 27499387 |
| 1,958 |
MGSF |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2120 |
-- |
0.19 |
0.88 |
-0.88 |
0.00 |
440.56 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 27499387 |
| 1,959 |
DPF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1540 |
-- |
-0.06 |
-0.77 |
0.17 |
-1.00 |
377.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 27499387 |
| 1,960 |
LPVPQ |
-- |
5 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
43.8 |
-- |
0.05 |
0.26 |
-0.62 |
0.00 |
552.74 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,961 |
VPGEIVE |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
224.5 |
-- |
0.09 |
0.56 |
0.17 |
-2.00 |
741.94 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,962 |
YPFPGP |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
749.2 |
-- |
0.10 |
-0.62 |
-0.80 |
0.00 |
676.84 |
Non-Toxin |
MBPDB: Opioid |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,963 |
LPQNIPPLT |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
205.2 |
-- |
0.01 |
-0.04 |
-0.60 |
0.00 |
992.32 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,964 |
IPPLTQT |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
465.1 |
-- |
0.01 |
0.03 |
-0.60 |
0.00 |
769.01 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,965 |
TPVVVPP |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1408.9 |
-- |
0.18 |
1.01 |
-0.70 |
0.00 |
707.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,966 |
YPVEPF |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
124.7 |
-- |
0.07 |
-0.17 |
-0.55 |
-1.00 |
750.92 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: Opioid |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,967 |
LPLPLL |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
371.5 |
-- |
0.33 |
2.00 |
-1.20 |
0.00 |
664.98 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,968 |
QPHQPLPPT |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1754.8 |
-- |
-0.19 |
-1.50 |
-0.26 |
0.50 |
1,014.28 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,969 |
QPLPPT |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1013.8 |
-- |
-0.09 |
-0.87 |
-0.33 |
0.00 |
651.84 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,970 |
IPPL |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
428.9 |
-- |
0.28 |
1.27 |
-0.90 |
0.00 |
438.62 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,971 |
LPP |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
563.3 |
-- |
0.13 |
0.20 |
-0.60 |
0.00 |
325.44 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,972 |
VP |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
380.3 |
-- |
0.24 |
1.30 |
-0.75 |
0.00 |
214.28 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,973 |
RP |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
657.2 |
-- |
-0.92 |
-3.05 |
1.50 |
1.00 |
271.33 |
Non-Toxin |
SATPdb;AHTPDB;AVPdb: Encephalomyocarditisvirus |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,974 |
FP |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
682.5 |
-- |
0.27 |
0.60 |
-1.25 |
0.00 |
262.32 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,975 |
HP |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
902.8 |
-- |
-0.24 |
-2.40 |
-0.25 |
0.50 |
252.29 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,976 |
IPM |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
69.5 |
-- |
0.31 |
1.60 |
-1.03 |
0.00 |
359.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,977 |
IPSK |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
406.8 |
-- |
-0.18 |
-0.45 |
0.38 |
1.00 |
443.59 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26988873 |
| 1,978 |
WSG |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
209.9 |
-- |
0.09 |
-0.70 |
-1.03 |
0.00 |
348.39 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 26687732 |
| 1,979 |
FSD |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
275.1 |
-- |
-0.12 |
-0.50 |
0.27 |
-1.00 |
367.38 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26687732 |
| 1,980 |
LPIIDI |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
105.4 |
-- |
0.32 |
2.03 |
-0.70 |
-1.00 |
682.95 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26758401 |
| 1,981 |
APGPAGP |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
229.1 |
-- |
0.09 |
-0.29 |
-0.14 |
0.00 |
565.71 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26758401 |
| 1,982 |
KVEPLP |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1071.9* |
-- |
-0.13 |
-0.43 |
0.45 |
0.00 |
681.91 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28556182 |
| 1,983 |
PAL |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2943.1* |
-- |
0.24 |
1.33 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28556182 |
| 1,984 |
FAGDDAPR |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
168.7 |
-- |
-0.25 |
-0.89 |
0.69 |
-1.00 |
847.97 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29027968 |
| 1,985 |
LAPSTM |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
140.8 |
-- |
0.09 |
0.73 |
-0.62 |
0.00 |
618.82 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29027968 |
| 1,986 |
FAGDDAPRA |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
393.3 |
-- |
-0.19 |
-0.59 |
0.56 |
-1.00 |
919.06 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29027968 |
| 1,987 |
FLMESH |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
> 500 |
-- |
0.02 |
0.17 |
-0.47 |
-0.50 |
762.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29027968 |
| 1,988 |
GGPAGPAV |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
8139.1 |
-- |
0.17 |
0.42 |
-0.31 |
0.00 |
624.80 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28873669 |
| 1,989 |
GPVA |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
264.7 |
-- |
0.22 |
1.00 |
-0.50 |
0.00 |
342.44 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28873669 |
| 1,990 |
PP |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
4343.5 |
-- |
-0.07 |
-1.60 |
0.00 |
0.00 |
212.26 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 28873669 |
| 1,991 |
GF |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1547.1 |
-- |
0.39 |
1.20 |
-1.25 |
0.00 |
222.26 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 28873669 |
| 1,992 |
NLGIILR |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
86.3 |
-- |
0.04 |
1.17 |
-0.57 |
1.00 |
798.11 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28711271 |
| 1,993 |
TQMVDEEIMEKFR |
-- |
13 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
68.8 |
-- |
-0.30 |
-0.87 |
0.72 |
-2.00 |
1,656.09 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28711271 |
| 1,994 |
QPQ |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
79.8 |
-- |
-0.48 |
-2.87 |
0.13 |
0.00 |
371.43 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 28675098 |
| 1,995 |
QPG |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
70.9 |
-- |
-0.20 |
-1.83 |
0.07 |
0.00 |
300.35 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28675098 |
| 1,996 |
QPF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
71.7 |
-- |
-0.05 |
-0.77 |
-0.77 |
0.00 |
390.47 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28675098 |
| 1,997 |
LPQ |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
56.7 |
-- |
-0.08 |
-0.43 |
-0.53 |
0.00 |
356.46 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 28675098 |
| 1,998 |
SPQ |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
78.9 |
-- |
-0.34 |
-1.97 |
0.17 |
0.00 |
330.37 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28675098 |
| 1,999 |
ILDKEGIDY |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
347.8 |
-- |
-0.11 |
-0.37 |
0.48 |
-2.00 |
1,065.32 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29120791 |
| 2,000 |
ILDKVGIQY |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
321.5 |
-- |
0.02 |
0.49 |
-0.33 |
0.00 |
1,048.39 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29120791 |
| 2,001 |
ILELA |
-- |
5 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
721.1 |
-- |
0.28 |
2.08 |
-0.58 |
-1.00 |
557.76 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29120791 |
| 2,002 |
LLQLEAIR |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
177.8 |
-- |
-0.06 |
0.77 |
-0.19 |
0.00 |
955.29 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29120791 |
| 2,003 |
LPVP |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
87 |
-- |
0.23 |
1.20 |
-0.82 |
0.00 |
424.59 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29120791 |
| 2,004 |
MPVQA |
-- |
5 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
93.3 |
-- |
0.06 |
0.56 |
-0.62 |
0.00 |
544.73 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29120791 |
| 2,005 |
SPVVPF |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
214.1 |
-- |
0.21 |
1.20 |
-0.87 |
0.00 |
644.84 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29120791 |
| 2,006 |
YPVEPF |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
138 |
-- |
0.07 |
-0.17 |
-0.55 |
-1.00 |
750.92 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: Opioid |
Type 2 Diabetes |
-- |
PMID: 29120791 |
| 2,007 |
KL |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
159.8* |
-- |
-0.29 |
-0.05 |
0.60 |
1.00 |
259.37 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 29739605 |
| 2,008 |
LR |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2083.6* |
-- |
-0.61 |
-0.35 |
0.60 |
1.00 |
287.38 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29739605 |
| 2,009 |
YPL |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
364.6 |
-- |
0.16 |
0.30 |
-1.37 |
0.00 |
391.50 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 30365987 |
| 2,010 |
YPG |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
174 |
-- |
0.04 |
-1.10 |
-0.77 |
0.00 |
335.39 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 30365987 |
| 2,011 |
GPAV |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
245.6 |
-- |
0.22 |
1.00 |
-0.50 |
0.00 |
342.44 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 27719926 |
| 2,012 |
FF |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
546.8 |
-- |
0.61 |
2.80 |
-2.50 |
0.00 |
312.38 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 27719926 |
| 2,013 |
VC |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
5413.4 |
-- |
0.29 |
3.35 |
-1.25 |
0.00 |
220.30 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 27719926 |
| 2,014 |
LQAFEPLR |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
103.5 |
-- |
-0.15 |
-0.11 |
-0.05 |
0.00 |
973.25 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26468909 |
| 2,015 |
WSG |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.09 |
-0.70 |
-1.03 |
0.00 |
348.39 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 26687732 |
| 2,016 |
FSD |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.12 |
-0.50 |
0.27 |
-1.00 |
367.38 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26687732 |
| 2,017 |
IAVPTGVA |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.28 |
1.73 |
-0.78 |
0.00 |
726.98 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 27983830 |
| 2,018 |
LTFPGSAED |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.03 |
-0.23 |
0.12 |
-2.00 |
936.10 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 27983830 |
| 2,019 |
AP |
-- |
2 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.09 |
0.10 |
-0.25 |
0.00 |
186.22 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
PMID: 28915418 |
| 2,020 |
IPA |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.30 |
1.57 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
PMID: 28915418 |
| 2,021 |
FAGDDAPR |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.25 |
-0.89 |
0.69 |
-1.00 |
847.97 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29027968 |
| 2,022 |
LAPSTM |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.09 |
0.73 |
-0.62 |
0.00 |
618.82 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29027968 |
| 2,023 |
FAGDDAPRA |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.19 |
-0.59 |
0.56 |
-1.00 |
919.06 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29027968 |
| 2,024 |
FLMESH |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.02 |
0.17 |
-0.47 |
-0.50 |
762.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29027968 |
| 2,025 |
AEWLHDWKL |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.09 |
-0.72 |
-0.27 |
-0.50 |
1,197.49 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,026 |
AVVSPLKPCC |
-- |
10 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.04 |
1.11 |
-0.40 |
1.00 |
1,016.41 |
Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,027 |
CFLPLPLLK |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.17 |
1.49 |
-0.86 |
1.00 |
1,043.51 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,028 |
DNLMPQFM |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.06 |
-0.21 |
-0.44 |
-1.00 |
995.29 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,029 |
FCLPLPLLK |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.17 |
1.49 |
-0.86 |
1.00 |
1,043.51 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,030 |
FMFFGPQ |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.21 |
0.69 |
-1.23 |
0.00 |
873.13 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,031 |
GMAGGPPLL |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.21 |
0.77 |
-0.60 |
0.00 |
812.13 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,032 |
HCPVPDPVRGL |
-- |
11 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.12 |
-0.15 |
-0.03 |
0.50 |
1,189.55 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,033 |
KFQWGY |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.11 |
-1.20 |
-0.83 |
1.00 |
828.02 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,034 |
LLPAPPLL |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.27 |
1.52 |
-0.96 |
0.00 |
833.20 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,035 |
LTMPQWW |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.08 |
-0.27 |
-1.44 |
0.00 |
961.25 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,036 |
MMHDFLTLCM |
-- |
10 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.12 |
1.12 |
-0.89 |
-0.50 |
1,241.71 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,037 |
MSKFLPLPLMFY |
-- |
12 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.15 |
0.97 |
-1.00 |
1.00 |
1,487.07 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,038 |
SQDWSFY |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.13 |
-1.14 |
-0.63 |
-1.00 |
932.04 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,039 |
WGLWDDMQGL |
-- |
10 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.03 |
-0.36 |
-0.55 |
-2.00 |
1,220.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,040 |
WNWGWLLWQL |
-- |
10 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.19 |
0.04 |
-1.86 |
0.00 |
1,401.80 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,041 |
YWYPPK |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.14 |
-1.77 |
-0.83 |
1.00 |
853.06 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,042 |
YWYPPQ |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.07 |
-1.70 |
-1.30 |
0.00 |
853.02 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,043 |
TLMPQWW |
-- |
7 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.08 |
-0.27 |
-1.44 |
0.00 |
961.25 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,044 |
MPSKPPLL |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.03 |
0.00 |
-0.20 |
1.00 |
882.24 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,045 |
AVVSPLKPCC |
-- |
10 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.04 |
1.11 |
-0.40 |
1.00 |
1,016.41 |
Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29680061 |
| 2,046 |
APA |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.14 |
0.67 |
-0.33 |
0.00 |
257.31 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,047 |
APF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.26 |
1.00 |
-1.00 |
0.00 |
333.41 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,048 |
APR |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.53 |
-1.43 |
0.83 |
1.00 |
342.42 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,049 |
IPA |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.30 |
1.57 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,050 |
KPA |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.31 |
-1.23 |
0.83 |
1.00 |
314.41 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,051 |
FPF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.38 |
1.33 |
-1.67 |
0.00 |
409.51 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,052 |
FPI |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.42 |
1.90 |
-1.43 |
0.00 |
375.50 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,053 |
FPW |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.30 |
0.10 |
-1.97 |
0.00 |
448.55 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,054 |
IPF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.42 |
1.90 |
-1.43 |
0.00 |
375.50 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,055 |
IPW |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.34 |
0.67 |
-1.73 |
0.00 |
414.54 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,056 |
WPF |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.30 |
0.10 |
-1.97 |
0.00 |
448.55 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,057 |
WPI |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.34 |
0.67 |
-1.73 |
0.00 |
414.54 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,058 |
WPW |
-- |
3 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.22 |
-1.13 |
-2.27 |
0.00 |
487.59 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 29963014 |
| 2,059 |
YPDANH2 |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
PMID: 30179653 |
| 2,060 |
AKSPLF |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.01 |
0.35 |
-0.25 |
1.00 |
661.87 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26824775 |
| 2,061 |
QTPF |
-- |
4 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.08 |
-0.75 |
-0.68 |
0.00 |
491.59 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26824775 |
| 2,062 |
FEELN |
-- |
5 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.15 |
-0.78 |
0.38 |
-2.00 |
650.75 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26824775 |
| 2,063 |
LSKSVL |
-- |
6 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
1.05 |
-0.25 |
1.00 |
645.88 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26824775 |
| 2,064 |
LQAFEPLR |
-- |
8 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.15 |
-0.11 |
-0.05 |
0.00 |
973.25 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26468909 |
| 2,065 |
EFLLAGNNK |
-- |
9 |
-- |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.10 |
-0.29 |
-0.02 |
0.00 |
1,005.27 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 26468909 |
| 2,066 |
ILAP |
-- |
4 |
Macroalga Palmaria palmateprotein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
43.4 |
-- |
0.36 |
2.13 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 25442570 |
| 2,067 |
LLAP |
-- |
4 |
Macroalga Palmaria palmateprotein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
53.67 |
-- |
0.31 |
1.95 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 25442570 |
| 2,068 |
MAGVDHI |
-- |
7 |
Macroalga Palmaria palmateprotein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
159.37 |
-- |
0.12 |
0.76 |
-0.37 |
-0.50 |
741.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 25442570 |
| 2,069 |
SPGSSGPQGFTG |
-- |
12 |
Halibut skin gelatin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
101.6 |
-- |
-0.05 |
-0.72 |
-0.15 |
0.00 |
1,078.27 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2015.09.037 |
| 2,070 |
GPVGPAGNPGANGLN |
-- |
15 |
Halibut skin gelatin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
81.3 |
-- |
0.02 |
-0.38 |
-0.25 |
0.00 |
1,291.61 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2015.09.037 |
| 2,071 |
PPGPTGPRGQPGNIGF |
-- |
16 |
Halibut skin gelatin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
146.7 |
-- |
-0.09 |
-0.93 |
-0.08 |
1.00 |
1,548.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2015.09.037 |
| 2,072 |
IPGDPGPPGPPGP |
-- |
13 |
Tilapia skin gelatin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.4 |
-- |
0.01 |
-0.91 |
0.09 |
-1.00 |
1,154.47 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2015.09.037 |
| 2,073 |
LPGERGRPGAPGP |
-- |
13 |
Tilapia skin gelatin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
76.8 |
-- |
-0.23 |
-1.15 |
0.52 |
1.00 |
1,260.60 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2015.09.037 |
| 2,074 |
GPKGDRGLPGPPGRDG |
-- |
16 |
Tilapia skin gelatin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
89.6 |
-- |
-0.30 |
-1.56 |
0.82 |
1.00 |
1,532.91 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2015.09.037 |
| 2,075 |
PACGGFWISGRPG |
-- |
13 |
Tuna cooking juice hydrolysates |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
96.4 |
-- |
0.04 |
0.05 |
-0.45 |
1.00 |
1,304.67 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 22450467 |
| 2,076 |
CAYQWQRPVDRIR |
-- |
13 |
Tuna cooking juice hydrolysates |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
78 |
-- |
-0.42 |
-1.14 |
0.15 |
2.00 |
1,691.12 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 22450467 |
| 2,077 |
PGVGGPLGPIGPCYE |
-- |
15 |
Tuna cooking juice hydrolysates |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
116.1 |
-- |
0.12 |
0.12 |
-0.36 |
-1.00 |
1,412.85 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22450467 |
| 2,078 |
GPVGXAGPPGK |
-- |
11 |
Deer skin protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
83.3 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2015.07.015 |
| 2,079 |
GPVGPSGPXGK |
-- |
11 |
Deer skin protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
93.7 |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2015.07.015 |
| 2,080 |
LKPTPEGDL |
α-Lactalbumin |
9 |
α-Lactalbumin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
45 |
-- |
-0.17 |
-0.84 |
0.56 |
-1.00 |
969.23 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 23943383 |
| 2,081 |
LAHKALCSEKL |
α-Lactalbumin |
11 |
α-Lactalbumin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
165 |
-- |
-0.12 |
0.20 |
0.13 |
1.50 |
1,212.63 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 23943383 |
| 2,082 |
LCSEKLDQ |
α-Lactalbumin |
8 |
α-Lactalbumin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
186 |
-- |
-0.29 |
-0.64 |
0.61 |
-1.00 |
935.17 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 23943383 |
| 2,083 |
TKCEVFRE |
α-Lactalbumin |
8 |
α-Lactalbumin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
166 |
-- |
-0.39 |
-0.82 |
0.82 |
0.00 |
1,011.26 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 23943383 |
| 2,084 |
VAGTWY |
β-Lactalbumin |
6 |
β-Lactalbumin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
174 |
-- |
0.19 |
0.45 |
-1.35 |
0.00 |
695.85 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Antioxidant,IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 21836374 |
| 2,085 |
IPAVF |
β-Lactalbumin |
5 |
β-Lactalbumin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
44.7 |
-- |
0.41 |
2.34 |
-1.26 |
0.00 |
545.74 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 23790888 |
| 2,086 |
GPAE |
-- |
4 |
Atlantic salmon collagen/gelatin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
49.6 |
-- |
-0.07 |
-0.93 |
0.62 |
-1.00 |
372.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22450467 |
| 2,087 |
GPGA |
-- |
4 |
Atlantic salmon collagen/gelatin |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
41.9 |
-- |
0.12 |
-0.15 |
-0.12 |
0.00 |
300.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22450467 |
| 2,088 |
VPITPTL |
-- |
7 |
Gouda-type cheese |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
110 |
-- |
0.19 |
1.13 |
-0.84 |
0.00 |
740.01 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22932295 |
| 2,089 |
VPITPT |
-- |
6 |
Gouda-type cheese |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
130 |
-- |
0.13 |
0.68 |
-0.68 |
0.00 |
626.83 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 22932295 |
| 2,090 |
LPQNIPPL |
-- |
8 |
Gouda-type cheese |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
46 |
-- |
0.03 |
0.04 |
-0.62 |
0.00 |
891.20 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 22932295 |
| 2,091 |
VAGTWY |
-- |
6 |
Gouda-type cheese |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
174 |
-- |
0.19 |
0.45 |
-1.35 |
0.00 |
695.85 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Antioxidant,IEDB |
Type 2 Diabetes |
-- |
PMID: 22932295 |
| 2,092 |
LPQ |
-- |
3 |
Gouda-type cheese |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
82 |
-- |
-0.08 |
-0.43 |
-0.53 |
0.00 |
356.46 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 22932295 |
| 2,093 |
LAHKALCSEKL |
-- |
11 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
165 |
-- |
-0.12 |
0.20 |
0.13 |
1.50 |
1,212.63 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,094 |
WLAHKALCSEKLDQ |
-- |
14 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
141 |
-- |
-0.17 |
-0.41 |
0.09 |
0.50 |
1,642.11 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,095 |
LKPTPEGDL |
-- |
9 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
45 9 |
-- |
-0.17 |
-0.84 |
0.56 |
-1.00 |
969.23 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,096 |
LKPTPEGDLEIL |
-- |
12 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
57 |
-- |
-0.08 |
-0.23 |
0.37 |
-2.00 |
1,324.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,097 |
WLAHKALCSEKLDQ |
-- |
14 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
141 |
-- |
-0.17 |
-0.41 |
0.09 |
0.50 |
1,642.11 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,098 |
WR |
-- |
2 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
31.4 |
-- |
-0.70 |
-2.70 |
-0.20 |
1.00 |
360.43 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,099 |
IPIQY |
-- |
5 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
28.2 |
-- |
0.14 |
0.52 |
-1.14 |
0.00 |
632.83 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,100 |
WCKDDQNPHS |
-- |
10 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
75 |
-- |
-0.42 |
-2.19 |
0.48 |
-0.50 |
1,229.42 |
Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,101 |
TKCEVFRE |
-- |
8 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
166 |
-- |
-0.39 |
-0.82 |
0.82 |
0.00 |
1,011.26 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,102 |
IPA |
-- |
3 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
49 |
-- |
0.30 |
1.57 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,103 |
VA |
-- |
2 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
<170 |
-- |
0.40 |
3.00 |
-1.00 |
0.00 |
188.24 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,104 |
VL |
-- |
2 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
<170 |
-- |
0.54 |
4.00 |
-1.65 |
0.00 |
230.33 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,105 |
WL |
-- |
2 |
Whey protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
<170 |
-- |
0.45 |
1.45 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
IEDB,SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,106 |
WI |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
<170 |
-- |
0.55 |
1.80 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,107 |
LKPTPEGDLE |
-- |
10 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
42 |
-- |
-0.22 |
-1.11 |
0.80 |
-2.00 |
1,098.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,108 |
LKALPMH |
-- |
7 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
193 |
-- |
0.00 |
0.37 |
-0.41 |
1.50 |
809.14 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
PMID: 23837435, PMID: 24440459, PMID: 25828735, doi: 10.1016/j.jff.2015.11.038, PMID: 21256171, PMID: 25466098 |
| 2,109 |
WA |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
92.6 |
-- |
0.31 |
0.45 |
-1.95 |
0.00 |
275.32 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,110 |
WR |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
37.8 |
-- |
-0.70 |
-2.70 |
-0.20 |
1.00 |
360.43 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,111 |
WK |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
40.6 |
-- |
-0.37 |
-2.40 |
-0.20 |
1.00 |
332.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,112 |
LPYPY |
-- |
5 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
108.3 |
-- |
0.09 |
-0.40 |
-1.28 |
0.00 |
651.82 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,113 |
WQ |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
120.3 |
-- |
-0.16 |
-2.20 |
-1.60 |
0.00 |
332.38 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,114 |
WI |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
138.7 |
-- |
0.55 |
1.80 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,115 |
WN |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
148.5 |
-- |
-0.14 |
-2.20 |
-1.60 |
0.00 |
318.35 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,116 |
YPYY |
-- |
4 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
194.4 |
-- |
0.00 |
-1.38 |
-1.72 |
0.00 |
604.70 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Opioid |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,117 |
WN |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
148.5 |
-- |
-0.14 |
-2.20 |
-1.60 |
0.00 |
318.35 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,118 |
IP |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
149.6 |
-- |
0.33 |
1.45 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,119 |
IPI |
-- |
3 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
3.5 |
-- |
0.46 |
2.47 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,120 |
IPIQY |
-- |
5 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
35.2 |
-- |
0.14 |
0.52 |
-1.14 |
0.00 |
632.83 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,121 |
FLQP |
-- |
4 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.3 |
-- |
0.10 |
0.37 |
-1.02 |
0.00 |
503.65 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,122 |
WV |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.7 |
-- |
0.46 |
1.65 |
-2.45 |
0.00 |
303.38 |
Non-Toxin |
IEDB,SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,123 |
LPVPQ |
-- |
5 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
48.2 |
-- |
0.05 |
0.26 |
-0.62 |
0.00 |
552.74 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,124 |
IPM |
-- |
3 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
73.9 |
-- |
0.31 |
1.60 |
-1.03 |
0.00 |
359.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,125 |
HL |
-- |
2 |
Milk protein |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
143.2 |
-- |
0.07 |
0.30 |
-1.15 |
0.50 |
268.34 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,126 |
VA |
-- |
2 |
Pinto bean |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
168.2 |
-- |
0.40 |
3.00 |
-1.00 |
0.00 |
188.24 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,127 |
WL |
-- |
2 |
Pinto bean |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
43.6 |
-- |
0.45 |
1.45 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
IEDB,SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,128 |
WP |
-- |
2 |
Pinto bean |
DPP‐IV inhibitory |
-- |
-- |
-- |
-- |
-- |
44.5 |
-- |
0.15 |
-1.25 |
-1.70 |
0.00 |
301.36 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2013.09.012, PMID: 23219487, PMID: 24793774, doi: 10.1016/j.tifs.2016.01.022 |
| 2,129 |
PPHMLP |
-- |
6 |
Pinto bean |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
1.97 (mg mL−1) |
-- |
0.03 |
-0.38 |
-0.60 |
0.50 |
690.94 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26212978 |
| 2,130 |
PLPWGAGF |
-- |
8 |
Pinto bean |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
8.96 (mg mL−1) |
-- |
0.24 |
0.44 |
-1.02 |
0.00 |
844.09 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26212978 |
| 2,131 |
PPHMGGP |
-- |
7 |
Cumin seed protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
14.63 (mg mL−1) |
-- |
0.00 |
-0.99 |
-0.26 |
0.50 |
691.90 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26212978 |
| 2,132 |
PLPLHMLP |
-- |
8 |
Cumin seed protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
18.45 (mg mL−1) |
-- |
0.15 |
0.66 |
-0.90 |
0.50 |
917.30 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26212978 |
| 2,133 |
LSSLEMGSLGALFVCM |
-- |
16 |
Cumin seed protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
20.56 (mg mL−1) |
-- |
0.19 |
1.47 |
-0.71 |
-1.00 |
1,658.26 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26212978 |
| 2,134 |
FFRSKLLSDGAAAAKGALLPQYW |
-- |
23 |
Cumin seed protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.02 (μM) |
-- |
-0.03 |
0.19 |
-0.33 |
2.00 |
2,511.25 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2016.01.011 |
| 2,135 |
RCMAFLLSDGAAAAQQLLPQYW |
-- |
22 |
Cumin seed protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.04 (μM) |
-- |
0.00 |
0.36 |
-0.60 |
0.00 |
2,454.18 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2016.01.011 |
| 2,136 |
DPAQPNYPWTAVLVFRH |
-- |
17 |
Black bean protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.03 (μM) |
-- |
-0.09 |
-0.43 |
-0.50 |
0.50 |
2,011.51 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi: 10.1016/j.jff.2016.01.011 |
| 2,137 |
RCMAFLLSDGAAAAQQLLPQYW |
-- |
22 |
Black bean protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.04 (μM) |
-- |
0.00 |
0.36 |
-0.60 |
0.00 |
2,454.18 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 27507449 |
| 2,138 |
DPAQPNYPW TAVLVFRH |
-- |
18 |
Rice bran protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.15 (μM) |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
PMID: 27507449 |
| 2,139 |
WEVM |
Albumin |
4 |
Albumin |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.14 |
0.42 |
-0.80 |
-1.00 |
563.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26824775 |
| 2,140 |
AKSPLF |
Albumin |
6 |
Albumin |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.01 |
0.35 |
-0.25 |
1.00 |
661.87 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 26824775 |
| 2,141 |
KLPGF |
-- |
5 |
Black bean protein |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
120.0 ± 4.0 (μM) |
-- |
0.03 |
0.14 |
-0.26 |
1.00 |
560.76 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22953959 |
| 2,142 |
NVLQPS |
Albumin |
6 |
Albumin |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
110.0 ± 6.2 (μM) |
-- |
-0.10 |
-0.23 |
-0.43 |
0.00 |
656.82 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22953959 |
| 2,143 |
TTGGKGGK |
a-Lactalbumin |
8 |
a-Lactalbumin |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.24 |
-1.35 |
0.65 |
2.00 |
704.90 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 25801199 |
| 2,144 |
KLPGF |
a-Lactalbumin |
5 |
a-Lactalbumin |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
59.5 ± 5.7 (μM) |
-- |
0.03 |
0.14 |
-0.26 |
1.00 |
560.76 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22953959 |
| 2,145 |
NVLQPS |
a-Lactalbumin |
6 |
a-Lactalbumin |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
100.0 ± 5.7 (μM) |
-- |
-0.10 |
-0.23 |
-0.43 |
0.00 |
656.82 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 22953959 |
| 2,146 |
WLAHKALCSEKLDQ |
a-Lactalbumin |
14 |
a-Lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
141 |
In vitro activity |
-0.17 |
-0.41 |
0.09 |
0.50 |
1,642.11 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2013*; Lacroix & Li-Chan, 2014b |
| 2,147 |
LAHKALCSEKL |
a-Lactalbumin |
11 |
a-Lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
165 |
In vitro activity |
-0.12 |
0.20 |
0.13 |
1.50 |
1,212.63 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2013*; Lacroix & Li-Chan, 2014b |
| 2,148 |
LCSEKLDQ |
a-Lactalbumin |
8 |
a-Lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
186 |
In vitro activity |
-0.29 |
-0.64 |
0.61 |
-1.00 |
935.17 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2013*; Lacroix & Li-Chan, 2014b |
| 2,149 |
TKCEVFRE |
a-Lactalbumin |
8 |
a-Lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
166 |
In vitro activity |
-0.39 |
-0.82 |
0.82 |
0.00 |
1,011.26 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2013*; Lacroix & Li-Chan, 2014b |
| 2,150 |
IVQNNDSTEYGLF |
b-Lactoglobulin |
13 |
b-Lactoglobulin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
337 |
In vitro activity |
-0.09 |
-0.42 |
-0.26 |
-2.00 |
1,499.79 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2013*; Lacroix & Li-Chan, 2014b |
| 2,151 |
ILDKVGINY |
-- |
9 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
263 |
In vitro activity |
0.03 |
0.49 |
-0.33 |
0.00 |
1,034.36 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2013*; Lacroix & Li-Chan, 2014b |
| 2,152 |
LKPTPEGDL |
-- |
9 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
45 |
In vitro activity |
-0.17 |
-0.84 |
0.56 |
-1.00 |
969.23 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2013*; Lacroix & Li-Chan, 2014b |
| 2,153 |
VAGTWY |
-- |
6 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
174 |
In vitro activity |
0.19 |
0.45 |
-1.35 |
0.00 |
695.85 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Antioxidant,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uchida et al., 2011 |
| 2,154 |
APFPEVF |
-- |
7 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
120 (6%) b |
In vitro activity |
0.18 |
0.70 |
-0.57 |
-1.00 |
806.01 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,155 |
APFPE |
-- |
5 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
120 (6%) b |
In vitro activity |
0.02 |
-0.42 |
0.00 |
-1.00 |
559.67 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,156 |
HPIK |
-- |
4 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(9%) b |
In vitro activity |
-0.21 |
-1.05 |
0.18 |
1.50 |
493.66 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,157 |
GPFPIIV |
-- |
7 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(9%) b |
In vitro activity |
0.38 |
1.77 |
-1.09 |
0.00 |
742.03 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,158 |
LPLP |
-- |
4 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(11%) b |
In vitro activity |
0.23 |
1.10 |
-0.90 |
0.00 |
438.62 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,159 |
EMPFPK |
-- |
6 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(12%) b |
In vitro activity |
-0.17 |
-0.98 |
0.37 |
0.00 |
747.98 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,160 |
LPVP |
-- |
4 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(15%) b |
In vitro activity |
0.23 |
1.20 |
-0.82 |
0.00 |
424.59 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,161 |
PFP |
-- |
3 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(20%) b |
In vitro activity |
0.16 |
-0.13 |
-0.83 |
0.00 |
359.45 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory; |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,162 |
PQSVLS |
-- |
6 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(20%) b |
In vitro activity |
-0.03 |
0.22 |
-0.42 |
0.00 |
629.79 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,163 |
YVPEPF |
-- |
6 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(20%) b |
In vitro activity |
0.07 |
-0.17 |
-0.55 |
-1.00 |
750.92 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,164 |
MPLW |
-- |
4 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(23%) b |
In vitro activity |
0.27 |
0.80 |
-1.62 |
0.00 |
545.75 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,165 |
LPQYL |
-- |
5 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(26%) b |
In vitro activity |
0.06 |
0.24 |
-1.14 |
0.00 |
632.83 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,166 |
LPVPQ |
-- |
5 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(28%) b |
In vitro activity |
0.05 |
0.26 |
-0.62 |
0.00 |
552.74 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,167 |
GPFP |
-- |
4 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(34%) b |
In vitro activity |
0.16 |
-0.20 |
-0.62 |
0.00 |
416.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,168 |
PLLQ |
-- |
4 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(37%) b |
In vitro activity |
0.08 |
0.62 |
-0.85 |
0.00 |
469.64 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,169 |
VPYPQ |
-- |
5 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(51%) b |
In vitro activity |
-0.05 |
-0.76 |
-0.72 |
0.00 |
602.75 |
Non-Toxin |
MBPDB: Antioxidant;MBPDB: Antioxidant |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,170 |
VPLGTQ |
-- |
6 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(55%) b |
In vitro activity |
0.05 |
0.30 |
-0.58 |
0.00 |
613.80 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,171 |
LPVPQK |
-- |
6 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(63%) b |
In vitro activity |
-0.14 |
-0.43 |
-0.02 |
1.00 |
680.93 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,172 |
KVLP |
-- |
4 |
Whey protein concentrate or isolate |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
(98%) b |
In vitro activity |
-0.03 |
0.62 |
-0.08 |
1.00 |
455.65 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,173 |
LPL |
-- |
3 |
Whey protein concentrate or isolate |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
5 (100%) b |
In vitro activity |
0.33 |
2.00 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,174 |
IPI |
-- |
3 |
Whey protein concentrate or isolate |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
5 (100%) b |
In vitro activity |
0.46 |
2.47 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Boots, 2009 |
| 2,175 |
VAGTWY |
-- |
6 |
Whey protein concentrate or isolate |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
174 |
In vitro activity |
0.19 |
0.45 |
-1.35 |
0.00 |
695.85 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Antioxidant,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Silveira, Martínez-Maqueda, Recio, & Hernández-Ledesma, 2013* |
| 2,176 |
TPEVDDEALEK |
-- |
11 |
Whey protein concentrate or isolate |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
319.5 |
In vitro activity |
-0.30 |
-1.26 |
1.25 |
-4.00 |
1,245.45 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Silveira, Martínez-Maqueda, Recio, & Hernández-Ledesma, 2013* |
| 2,177 |
IPAVF |
-- |
5 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
44.7 |
In vitro activity |
0.41 |
2.34 |
-1.26 |
0.00 |
545.74 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Silveira, Martínez-Maqueda, Recio, & Hernández-Ledesma, 2013* |
| 2,178 |
IPAVFK |
-- |
6 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
143 |
In vitro activity |
0.16 |
1.30 |
-0.55 |
1.00 |
673.93 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Silveira, Martínez-Maqueda, Recio, & Hernández-Ledesma, 2013* |
| 2,179 |
VLVLDTDYK |
-- |
9 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
424.4 |
In vitro activity |
-0.06 |
0.34 |
-0.03 |
-1.00 |
1,065.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Silveira, Martínez-Maqueda, Recio, & Hernández-Ledesma, 2013* |
| 2,180 |
WLAHKAL |
-- |
7 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
286 |
In vitro activity |
0.06 |
0.46 |
-0.79 |
1.50 |
838.12 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2012b; Lacroix & Li-Chan, 2014b |
| 2,181 |
WLAHKALCSEKLDQ |
-- |
14 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
141 |
In vitro activity |
-0.17 |
-0.41 |
0.09 |
0.50 |
1,642.11 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2012b; Lacroix & Li-Chan, 2014b |
| 2,182 |
LAHKALCSEKL |
-- |
11 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
165 |
In vitro activity |
-0.12 |
0.20 |
0.13 |
1.50 |
1,212.63 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2012b; Lacroix & Li-Chan, 2014b |
| 2,183 |
TKCEVFRE |
-- |
8 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
166 |
In vitro activity |
-0.39 |
-0.82 |
0.82 |
0.00 |
1,011.26 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2012b; Lacroix & Li-Chan, 2014b |
| 2,184 |
LKPTPEGDL |
-- |
9 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
45 |
In vitro activity |
-0.17 |
-0.84 |
0.56 |
-1.00 |
969.23 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2012b; Lacroix & Li-Chan, 2014b |
| 2,185 |
LKPTPEGDLEIL |
-- |
12 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
57 |
In vitro activity |
-0.08 |
-0.23 |
0.37 |
-2.00 |
1,324.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2012b; Lacroix & Li-Chan, 2014b |
| 2,186 |
IPAVFKIDA |
-- |
9 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
191 |
In vitro activity |
0.14 |
1.18 |
-0.29 |
0.00 |
973.30 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2012b; Lacroix & Li-Chan, 2014b |
| 2,187 |
IQKVAGTW |
-- |
8 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
329 |
In vitro activity |
0.01 |
0.14 |
-0.55 |
1.00 |
902.18 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix, Meng, Cheung, & Li-Chan, 2016* |
| 2,188 |
LKPTPEGDLE |
-- |
10 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
42 |
In vitro activity |
-0.22 |
-1.11 |
0.80 |
-2.00 |
1,098.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix, Meng, Cheung, & Li-Chan, 2016* |
| 2,189 |
LKPTPEGDLEIL |
-- |
12 |
Cow’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
57 |
In vitro activity |
-0.08 |
-0.23 |
0.37 |
-2.00 |
1,324.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix, Meng, Cheung, & Li-Chan, 2016* |
| 2,190 |
LKALPMH |
-- |
7 |
Goat’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
193 |
In vitro activity |
0.00 |
0.37 |
-0.41 |
1.50 |
809.14 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix, Meng, Cheung, & Li-Chan, 2016* |
| 2,191 |
LKGYGGVSLPE |
-- |
11 |
Goat’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
486 |
In vitro activity |
0.00 |
-0.05 |
-0.10 |
0.00 |
1,119.45 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix, Meng, Cheung, & Li-Chan, 2016* |
| 2,192 |
WLAHKAL |
-- |
7 |
Goat’s milk |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
286 |
In vitro activity |
0.06 |
0.46 |
-0.79 |
1.50 |
838.12 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix, Meng, Cheung, & Li-Chan, 2016* |
| 2,193 |
MHQPPQPL |
-- |
8 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
350.41 |
In vitro activity |
-0.15 |
-1.16 |
-0.40 |
0.50 |
947.24 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Zhang, Chen, Ma, & Chen, 2015 |
| 2,194 |
SPTVMFPPQSVL |
-- |
12 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
676.31 |
In vitro activity |
0.07 |
0.52 |
-0.68 |
0.00 |
1,302.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Zhang, Chen, Ma, & Chen, 2015 |
| 2,195 |
INNQFLPYPY |
-- |
10 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
40.08 |
In vitro activity |
-0.02 |
-0.52 |
-1.01 |
0.00 |
1,268.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Zhang, Chen, Ma, & Chen, 2015 |
| 2,196 |
VPITPT |
-- |
6 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
130 |
In vitro activity |
0.13 |
0.68 |
-0.68 |
0.00 |
626.83 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,197 |
LPQNIPP |
-- |
7 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
160 |
In vitro activity |
-0.04 |
-0.50 |
-0.46 |
0.00 |
778.02 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,198 |
PQNIPPL |
-- |
7 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1500 |
In vitro activity |
-0.04 |
-0.50 |
-0.46 |
0.00 |
778.02 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,199 |
VPITPTL |
-- |
7 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
110 |
In vitro activity |
0.19 |
1.13 |
-0.84 |
0.00 |
740.01 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,200 |
FPGPIPN |
-- |
7 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
260 |
In vitro activity |
0.09 |
-0.20 |
-0.59 |
0.00 |
740.95 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,201 |
PGPIHNS |
-- |
7 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1000 |
In vitro activity |
-0.08 |
-0.94 |
-0.26 |
0.50 |
720.88 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,202 |
IPPLTQTPV |
-- |
9 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1300 |
In vitro activity |
0.06 |
0.31 |
-0.63 |
0.00 |
965.29 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,203 |
VPPFIQPE |
-- |
8 |
Gouda-type cheese |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2500 |
In vitro activity |
0.04 |
-0.04 |
-0.32 |
-1.00 |
926.19 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,204 |
YPFPGPIPN |
-- |
9 |
Macroalgae (Palmaria palmata) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
670 |
In vitro activity |
0.07 |
-0.48 |
-0.71 |
0.00 |
1,001.27 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,205 |
LPQNIPPL |
-- |
8 |
Macroalgae (Palmaria palmata) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
46 |
In vitro activity |
0.03 |
0.04 |
-0.62 |
0.00 |
891.20 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,206 |
LPQ |
-- |
3 |
Macroalgae (Palmaria palmata) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
82 |
In vitro activity |
-0.08 |
-0.43 |
-0.53 |
0.00 |
356.46 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Uenishi, Kabuki, Seto, Serizawa, & Nakajima, 2012 |
| 2,207 |
ILAP |
-- |
4 |
Rice Bran |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
43.4 |
In vitro activity |
0.36 |
2.13 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Harnedy & FitzGerald, 2013*; Harnedy, O’Keeffe, & FitzGerald, 2015 |
| 2,208 |
LLAP |
-- |
4 |
Rice Bran |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
53.67 |
In vitro activity |
0.31 |
1.95 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Harnedy & FitzGerald, 2013*; Harnedy, O’Keeffe, & FitzGerald, 2015 |
| 2,209 |
MAGVDHI |
-- |
7 |
Atlantic salmon |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
159.37 |
In vitro activity |
0.12 |
0.76 |
-0.37 |
-0.50 |
741.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Harnedy & FitzGerald, 2013*; Harnedy, O’Keeffe, & FitzGerald, 2015 |
| 2,210 |
IP |
-- |
2 |
Atlantic salmon |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
410 |
In vitro activity |
0.33 |
1.45 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012* |
| 2,211 |
LP |
-- |
2 |
Deer |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2370 |
In vitro activity |
0.23 |
1.10 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012* |
| 2,212 |
GPAE |
-- |
4 |
Deer |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
49.6 |
In vitro activity |
-0.07 |
-0.93 |
0.62 |
-1.00 |
372.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Li-Chan, Hunag, Jao, Ho, & Hsu, 2012 |
| 2,213 |
GPGA |
-- |
4 |
Deer |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
41.9 |
In vitro activity |
0.12 |
-0.15 |
-0.12 |
0.00 |
300.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Li-Chan, Hunag, Jao, Ho, & Hsu, 2012 |
| 2,214 |
GPGSPGGPL |
-- |
9 |
Deer |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1638.3 |
In vitro activity |
0.08 |
-0.38 |
-0.17 |
0.00 |
737.94 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Jin, Yan, Yu, & Qi, 2015 |
| 2,215 |
GPVGXAGPPGK |
-- |
11 |
Deer |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
83.3 |
In vitro activity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Jin, Yan, Yu, & Qi, 2015 |
| 2,216 |
GPM(O)GPXGVK |
-- |
12 |
Halibut, hake, tilapia, milkfish |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
226.9 |
In vitro activity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Jin, Yan, Yu, & Qi, 2015 |
| 2,217 |
GPVGPSGPXGK |
-- |
11 |
Halibut, hake, tilapia, milkfish |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
93.7 |
In vitro activity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Jin, Yan, Yu, & Qi, 2015 |
| 2,218 |
GPAGPXGVXGL |
-- |
11 |
Halibut, hake, tilapia, milkfish |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
318.1 |
In vitro activity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Jin, Yan, Yu, & Qi, 2015 |
| 2,219 |
SPGSSGPQGFTG |
-- |
12 |
Halibut, hake, tilapia, milkfish |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
101.6 |
In vitro activity |
-0.05 |
-0.72 |
-0.15 |
0.00 |
1,078.27 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Wang et al., 2015* |
| 2,220 |
GPVGPAGNPGANGLN |
-- |
15 |
Halibut, hake, tilapia, milkfish |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
81.3 |
In vitro activity |
0.02 |
-0.38 |
-0.25 |
0.00 |
1,291.61 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Wang et al., 2015* |
| 2,221 |
PPGPTGPRGQPGNIGF |
-- |
16 |
Halibut, hake, tilapia, milkfish |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
146.7 |
In vitro activity |
-0.09 |
-0.93 |
-0.08 |
1.00 |
1,548.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Wang et al., 2015* |
| 2,222 |
IPGDPGPPGPPGP |
-- |
13 |
Halibut, hake, tilapia, milkfish |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.4 |
In vitro activity |
0.01 |
-0.91 |
0.09 |
-1.00 |
1,154.47 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Wang et al., 2015* |
| 2,223 |
LPGERGRPGAPGP |
-- |
13 |
Pork, cattle, fish, chicken feet |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
76.8 |
In vitro activity |
-0.23 |
-1.15 |
0.52 |
1.00 |
1,260.60 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Wang et al., 2015* |
| 2,224 |
GPKGDRGLPGPPGRDG |
-- |
16 |
Pork, cattle, fish, chicken feet |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
89.6 |
In vitro activity |
-0.30 |
-1.56 |
0.82 |
1.00 |
1,532.91 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Wang et al., 2015* |
| 2,225 |
M |
-- |
1 |
Pork, cattle, fish, chicken feet |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro activity |
0.26 |
1.90 |
-1.30 |
0.00 |
149.21 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Wang et al., 2015* |
| 2,226 |
GAX |
-- |
3 |
Pork |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
> 20000 |
In vitro activity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka, Kawakami, & Uraji, 2014* |
| 2,227 |
GPA |
-- |
3 |
Pork |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
5030 |
In vitro activity |
0.11 |
-0.07 |
-0.17 |
0.00 |
243.29 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka, Kawakami, & Uraji, 2014* |
| 2,228 |
GPX |
-- |
3 |
Spanish dry-cured ham |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2510 |
In vitro activity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka, Kawakami, & Uraji, 2014* |
| 2,229 |
GPX |
-- |
3 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
45.3 |
In vitro activity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hsu, Tung, Huang, & Jao, 2013* |
| 2,230 |
GPAG |
-- |
4 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
41.1 |
In vitro activity |
0.12 |
-0.15 |
-0.12 |
0.00 |
300.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hsu, Tung, Huang, & Jao, 2013* |
| 2,231 |
AAAAG |
-- |
5 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
8130 |
In vitro activity |
0.23 |
1.36 |
-0.40 |
0.00 |
359.43 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Gallego, Aristoy, & Toldrá, 2014* |
| 2,232 |
AAATP |
-- |
5 |
Tuna cooking juice |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
6470 |
In vitro activity |
0.10 |
0.62 |
-0.38 |
0.00 |
429.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Gallego, Aristoy, & Toldrá, 2014* |
| 2,233 |
ALGGA |
-- |
5 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>10000 |
In vitro activity |
0.27 |
1.32 |
-0.56 |
0.00 |
387.50 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Gallego, Aristoy, & Toldrá, 2014* |
| 2,234 |
LVSGM |
-- |
5 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>10000 |
In vitro activity |
0.25 |
1.74 |
-0.86 |
0.00 |
505.70 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Gallego, Aristoy, & Toldrá, 2014* |
| 2,235 |
PGVGGPLGPIGPCYE |
α1-Casein, Bovine serum albumin |
15 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
116.1 |
In vitro activity |
0.12 |
0.12 |
-0.36 |
-1.00 |
1,412.85 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Huang, Jao, Ho, & Hsu, 2012 |
| 2,236 |
CAYQWQRPVDRIR |
α1-Casein, Bovine serum albumin |
13 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
78 |
In vitro activity |
-0.42 |
-1.14 |
0.15 |
2.00 |
1,691.12 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Huang, Jao, Ho, & Hsu, 2012 |
| 2,237 |
PACGGFWISGRPG |
α1-Casein, Bovine serum albumin |
13 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
96.4 |
In vitro activity |
0.04 |
0.05 |
-0.45 |
1.00 |
1,304.67 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Huang, Jao, Ho, & Hsu, 2012 |
| 2,238 |
AA |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
9400 |
Discovered through chemical synthesis |
0.25 |
1.80 |
-0.50 |
0.00 |
160.18 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Gallego, Aristoy, & Toldrá, 2014 |
| 2,239 |
AL |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
882.13 |
Discovered through chemical synthesis |
0.39 |
2.80 |
-1.15 |
0.00 |
202.27 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,240 |
AP |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
7950 |
Discovered through chemical synthesis |
0.09 |
0.10 |
-0.25 |
0.00 |
186.22 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,241 |
AW |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>6000 |
Discovered through chemical synthesis |
0.31 |
0.45 |
-1.95 |
0.00 |
275.32 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,242 |
DP |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
-0.40 |
-2.55 |
1.50 |
-1.00 |
230.23 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Brandt et al., 1995 |
| 2,243 |
EK |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
3216.73 |
Discovered through chemical synthesis |
-0.86 |
-3.70 |
3.00 |
0.00 |
275.32 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,244 |
FA |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
94 |
Discovered through chemical synthesis |
0.43 |
2.30 |
-1.50 |
0.00 |
236.28 |
Non-Toxin |
SATPdb;MBPDB: ACE-inhibitory; |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,245 |
FL |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
399.58 |
Discovered through chemical synthesis |
0.57 |
3.30 |
-2.15 |
0.00 |
278.37 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,246 |
FP |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
3630 |
Discovered through chemical synthesis |
0.27 |
0.60 |
-1.25 |
0.00 |
262.32 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,247 |
FP |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.27 |
0.60 |
-1.25 |
0.00 |
262.32 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,248 |
GA |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.21 |
0.70 |
-0.25 |
0.00 |
146.16 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Yan, Ho, & Hou, 1992 |
| 2,249 |
GF |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.39 |
1.20 |
-1.25 |
0.00 |
222.26 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Brandt et al., 1995 |
| 2,250 |
GL |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2615.03 |
Discovered through chemical synthesis |
0.35 |
1.70 |
-0.90 |
0.00 |
188.25 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,251 |
GP |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
9690 |
Discovered through chemical synthesis |
0.04 |
-1.00 |
0.00 |
0.00 |
172.20 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Gallego et al., 2014 |
| 2,252 |
HA |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
-0.08 |
-0.70 |
-0.50 |
0.50 |
226.25 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Bella, Erickson, & Kim, 1982 |
| 2,253 |
HL |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
143.19 |
Discovered through chemical synthesis |
0.07 |
0.30 |
-1.15 |
0.50 |
268.34 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,254 |
HP |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2820 |
Discovered through chemical synthesis |
-0.24 |
-2.40 |
-0.25 |
0.50 |
252.29 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,255 |
IA |
α1-Casein, Bovine serum albumin |
2 |
α1-Casein, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
88 |
Discovered through chemical synthesis |
0.49 |
3.15 |
-1.15 |
0.00 |
202.27 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,256 |
IV |
β-lactoglobulin |
2 |
β-lactoglobulin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.64 |
4.35 |
-1.65 |
0.00 |
230.33 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Brandt et al., 1995 |
| 2,257 |
KA |
β-lactoglobulin |
2 |
β-lactoglobulin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
6270 |
Discovered through chemical synthesis |
-0.43 |
-1.05 |
1.25 |
1.00 |
217.28 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Gallego et al., 2014 |
| 2,258 |
KP |
β-lactoglobulin |
2 |
β-lactoglobulin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2540 |
Discovered through chemical synthesis |
-0.59 |
-2.75 |
1.50 |
1.00 |
243.32 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,259 |
LA |
β-lactoglobulin |
2 |
β-lactoglobulin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
454 |
Discovered through chemical synthesis |
0.39 |
2.80 |
-1.15 |
0.00 |
202.27 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Tulipano, Cocchi, & Caroli, 2012 |
| 2,260 |
LA |
αs1-casein |
2 |
αs1-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
91 |
Discovered through chemical synthesis |
0.39 |
2.80 |
-1.15 |
0.00 |
202.27 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,261 |
LF |
αs1-casein |
2 |
αs1-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.57 |
3.30 |
-2.15 |
0.00 |
278.37 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Anti-inflammatory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Brandt et al., 1995 |
| 2,262 |
LL |
αs1-casein |
2 |
αs1-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.53 |
3.80 |
-1.80 |
0.00 |
244.36 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Bella et al., 1982 |
| 2,263 |
LW |
αs1-casein |
2 |
αs1-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
993.4 |
Discovered through chemical synthesis |
0.45 |
1.45 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,264 |
LW |
αs1-casein |
2 |
αs1-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
98 |
Discovered through chemical synthesis |
0.45 |
1.45 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,265 |
MA |
αs1-casein |
2 |
αs1-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.26 |
1.85 |
-0.90 |
0.00 |
220.30 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Bella et al., 1982 |
| 2,266 |
ML |
αs1-casein |
2 |
αs1-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
91 |
Discovered through chemical synthesis |
0.40 |
2.85 |
-1.55 |
0.00 |
262.39 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,267 |
MM |
αs1-casein |
2 |
αs1-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
93 |
Discovered through chemical synthesis |
0.26 |
1.90 |
-1.30 |
0.00 |
280.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,268 |
MP |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
870 |
Discovered through chemical synthesis |
0.10 |
0.15 |
-0.65 |
0.00 |
246.34 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,269 |
MW |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1691.4 |
Discovered through chemical synthesis |
0.32 |
0.50 |
-2.35 |
0.00 |
335.44 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,270 |
NH |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
69 |
Discovered through chemical synthesis |
-0.52 |
-3.35 |
-0.15 |
0.50 |
269.28 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,271 |
NP |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>20000 |
Discovered through chemical synthesis |
-0.35 |
-2.55 |
0.10 |
0.00 |
229.25 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013d |
| 2,272 |
PA |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.09 |
0.10 |
-0.25 |
0.00 |
186.22 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Bella et al., 1982 |
| 2,273 |
PA |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.09 |
0.10 |
-0.25 |
0.00 |
186.22 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Yan et al., 1992 |
| 2,274 |
PF |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.27 |
0.60 |
-1.25 |
0.00 |
262.32 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Yan et al., 1992 |
| 2,275 |
PG |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.04 |
-1.00 |
0.00 |
0.00 |
172.20 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Brandt et al., 1995 |
| 2,276 |
PG |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.04 |
-1.00 |
0.00 |
0.00 |
172.20 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Yan et al., 1992 |
| 2,277 |
PI |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
2 |
αs1-casein, αs2-casein, β-lactoglobulin, α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.33 |
1.45 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Yan et al., 1992 |
| 2,278 |
PL |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>10000 |
Discovered through chemical synthesis |
0.23 |
1.10 |
-0.90 |
0.00 |
228.31 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Gallego et al., 2014 |
| 2,279 |
PM |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.10 |
0.15 |
-0.65 |
0.00 |
246.34 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Yan et al., 1992 |
| 2,280 |
PP |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
5860 |
Discovered through chemical synthesis |
-0.07 |
-1.60 |
0.00 |
0.00 |
212.26 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,281 |
QP |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>4000 |
Discovered through chemical synthesis |
-0.38 |
-2.55 |
0.10 |
0.00 |
243.28 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013d |
| 2,282 |
RP |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2240 |
Discovered through chemical synthesis |
-0.92 |
-3.05 |
1.50 |
1.00 |
271.33 |
Non-Toxin |
SATPdb;AHTPDB;AVPdb: Encephalomyocarditisvirus |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,283 |
SL |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2517.08 |
Discovered through chemical synthesis |
0.14 |
1.50 |
-0.75 |
0.00 |
218.27 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,284 |
SP |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
5980 |
Discovered through chemical synthesis |
-0.17 |
-1.20 |
0.15 |
0.00 |
202.22 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,285 |
TH |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
49 |
Discovered through chemical synthesis |
-0.29 |
-1.95 |
-0.45 |
0.50 |
256.28 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,286 |
TP |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2370 |
Discovered through chemical synthesis |
-0.12 |
-1.15 |
-0.20 |
0.00 |
216.25 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,287 |
TW |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
84 |
Discovered through chemical synthesis |
0.10 |
-0.80 |
-1.90 |
0.00 |
305.35 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,288 |
VA |
β-casein, αs2-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs2-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
168.24 |
Discovered through chemical synthesis |
0.40 |
3.00 |
-1.00 |
0.00 |
188.24 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,289 |
VL |
β-casein, κ-casein, β-lactoglobulin, Lactoferrin, Bovine serum albumin |
2 |
β-casein, κ-casein, β-lactoglobulin, Lactoferrin, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
74 |
Discovered through chemical synthesis |
0.54 |
4.00 |
-1.65 |
0.00 |
230.33 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,290 |
VP |
β-casein, κ-casein, β-lactoglobulin, Lactoferrin, Bovine serum albumin |
2 |
β-casein, κ-casein, β-lactoglobulin, Lactoferrin, Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
880 |
Discovered through chemical synthesis |
0.24 |
1.30 |
-0.75 |
0.00 |
214.28 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,291 |
VP |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
93 |
Discovered through chemical synthesis |
0.24 |
1.30 |
-0.75 |
0.00 |
214.28 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hikida, Ito, Motoyama, Kato, & |
| 2,292 |
VR |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
826.1 |
Discovered through chemical synthesis |
-0.61 |
-0.15 |
0.75 |
1.00 |
273.35 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013d Kawarasaki, 2013; Lan et al., 2015 |
| 2,293 |
VV |
α-lactalbumin, Lactoferrin |
2 |
α-lactalbumin, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.54 |
4.20 |
-1.50 |
0.00 |
216.30 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Bella et al., 1982 |
| 2,294 |
WA |
β-lactoglobulin, Lactoferrin |
2 |
β-lactoglobulin, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
92.6 |
Discovered through chemical synthesis |
0.31 |
0.45 |
-1.95 |
0.00 |
275.32 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,295 |
WA |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
48 |
Discovered through chemical synthesis |
0.31 |
0.45 |
-1.95 |
0.00 |
275.32 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hikida et al., 2013; Lan et al., 2015 |
| 2,296 |
WC |
Bovine serum albumin |
2 |
Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
420 |
Discovered through chemical synthesis |
0.20 |
0.80 |
-2.20 |
0.00 |
307.38 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,297 |
WE |
αs2-casein, Lactoferrin |
2 |
αs2-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>2000 |
Discovered through chemical synthesis |
-0.12 |
-2.20 |
-0.20 |
-1.00 |
333.36 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,298 |
WF |
αs2-casein, Lactoferrin |
2 |
αs2-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>3000 |
Discovered through chemical synthesis |
0.49 |
0.95 |
-2.95 |
0.00 |
351.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,299 |
WG |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>8000 |
Discovered through chemical synthesis |
0.27 |
-0.65 |
-1.70 |
0.00 |
261.30 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,300 |
WI |
α-lactalbumin |
2 |
α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
138.7 |
Discovered through chemical synthesis |
0.55 |
1.80 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,301 |
WI |
α-lactalbumin |
2 |
α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
89 |
Discovered through chemical synthesis |
0.55 |
1.80 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,302 |
WK |
β-casein |
2 |
β-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
40.6 |
Discovered through chemical synthesis |
-0.37 |
-2.40 |
-0.20 |
1.00 |
332.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,303 |
WL |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
43.6 |
Discovered through chemical synthesis |
0.45 |
1.45 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
IEDB,SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,304 |
WL |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.45 |
1.45 |
-2.60 |
0.00 |
317.41 |
Non-Toxin |
IEDB,SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,305 |
WM |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
243.1 |
Discovered through chemical synthesis |
0.32 |
0.50 |
-2.35 |
0.00 |
335.44 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,306 |
WN |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
148.5 |
Discovered through chemical synthesis |
-0.14 |
-2.20 |
-1.60 |
0.00 |
318.35 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,307 |
WP |
κ-casein, Lactoferrin |
2 |
κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
4530 |
Discovered through chemical synthesis |
0.15 |
-1.25 |
-1.70 |
0.00 |
301.36 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,308 |
WP |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
44.5 |
Discovered through chemical synthesis |
0.15 |
-1.25 |
-1.70 |
0.00 |
301.36 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,309 |
WP |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
44 |
Discovered through chemical synthesis |
0.15 |
-1.25 |
-1.70 |
0.00 |
301.36 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hikida et al., 2013; Lan et al., 2015 |
| 2,310 |
WQ |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
120.3 |
Discovered through chemical synthesis |
-0.16 |
-2.20 |
-1.60 |
0.00 |
332.38 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,311 |
WR |
Bovine serum albumin, Lactoferrin |
2 |
Bovine serum albumin, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
37.8 |
Discovered through chemical synthesis |
-0.70 |
-2.70 |
-0.20 |
1.00 |
360.43 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,312 |
WR |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
-0.70 |
-2.70 |
-0.20 |
1.00 |
360.43 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,313 |
WR |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
20 |
Discovered through chemical synthesis |
-0.70 |
-2.70 |
-0.20 |
1.00 |
360.43 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014; Lan et al., 2015 |
| 2,314 |
WS |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
643.5 |
Discovered through chemical synthesis |
0.05 |
-0.85 |
-1.55 |
0.00 |
291.32 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,315 |
WT |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
482.1 |
Discovered through chemical synthesis |
0.10 |
-0.80 |
-1.90 |
0.00 |
305.35 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,316 |
WV |
Lactoferrin |
2 |
Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.69 |
Discovered through chemical synthesis |
0.46 |
1.65 |
-2.45 |
0.00 |
303.38 |
Non-Toxin |
IEDB,SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,317 |
WV |
β-lactoglobulin, αs1 -CN |
2 |
β-lactoglobulin, αs1 -CN |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.46 |
1.65 |
-2.45 |
0.00 |
303.38 |
Non-Toxin |
IEDB,SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,318 |
WV |
β-casein, αs1-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs1-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
37 |
Discovered through chemical synthesis |
0.46 |
1.65 |
-2.45 |
0.00 |
303.38 |
Non-Toxin |
IEDB,SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2015 |
| 2,319 |
WW |
β-casein, αs1-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs1-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
554.8 |
Discovered through chemical synthesis |
0.37 |
-0.90 |
-3.40 |
0.00 |
390.46 |
Non-Toxin |
SATPdb;AHTPDB;Hemolytik |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,320 |
WY |
β-casein, αs1-casein, κ-casein, Lactoferrin |
2 |
β-casein, αs1-casein, κ-casein, Lactoferrin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
281 |
Discovered through chemical synthesis |
0.20 |
-1.10 |
-2.85 |
0.00 |
367.42 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,321 |
YP |
β-lactoglobulin |
2 |
β-lactoglobulin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
658.1 |
Discovered through chemical synthesis |
-0.03 |
-1.45 |
-1.15 |
0.00 |
278.32 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013d |
| 2,322 |
YP |
β-lactoglobulin |
2 |
β-lactoglobulin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
3170 |
Discovered through chemical synthesis |
-0.03 |
-1.45 |
-1.15 |
0.00 |
278.32 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Hatanaka et al., 2012 |
| 2,323 |
YT |
κ-casein |
2 |
κ-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>6000 |
Discovered through chemical synthesis |
-0.08 |
-1.00 |
-1.35 |
0.00 |
282.31 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma, Mooney, Shields, & FitzGerald, 2014 |
| 2,324 |
IPA |
αs2-casein |
3 |
αs2-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
49 |
Discovered through chemical synthesis |
0.30 |
1.57 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Tulipano, Sibilia, Caroli, & Cocchi, 2011 |
| 2,325 |
IPI |
αs2-casein |
3 |
αs2-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
4.7 |
Discovered through chemical synthesis |
0.46 |
2.47 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2014b; Lacroix & Li-Chan, 2015 b |
| 2,326 |
IPI |
Bovine collagen |
3 |
Bovine collagen |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
4.23 |
Discovered through chemical synthesis |
0.46 |
2.47 |
-1.20 |
0.00 |
341.49 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013a |
| 2,327 |
IQP |
Bovine serum albumin |
3 |
Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>4000 |
Discovered through chemical synthesis |
-0.01 |
-0.20 |
-0.53 |
0.00 |
356.46 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013c |
| 2,328 |
LQP |
Bovine serum albumin |
3 |
Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1181.1 |
Discovered through chemical synthesis |
-0.08 |
-0.43 |
-0.53 |
0.00 |
356.46 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma et al., 2014 |
| 2,329 |
PPG |
Bovine serum albumin |
3 |
Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
2252.68 |
Discovered through chemical synthesis |
0.01 |
-1.20 |
0.00 |
0.00 |
269.33 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lafarga, O’Connor, & Hayes, 2014 |
| 2,330 |
PPL |
Bovine serum albumin |
3 |
Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
390.14 |
Discovered through chemical synthesis |
0.13 |
0.20 |
-0.60 |
0.00 |
325.44 |
Non-Toxin |
IEDB,SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lafarga et al., 2014 |
| 2,331 |
VGL |
Bovine serum albumin |
3 |
Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>5000 |
Discovered through chemical synthesis |
0.41 |
2.53 |
-1.10 |
0.00 |
287.40 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2014b |
| 2,332 |
VPL |
Bovine serum albumin |
3 |
Bovine serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
47 |
Discovered through chemical synthesis |
0.33 |
2.13 |
-1.10 |
0.00 |
327.46 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Maruyama, Ohmori, & Nakagami, 1996 |
| 2,333 |
VPL |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.33 |
2.13 |
-1.10 |
0.00 |
327.46 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Umezawa et al., 1984 |
| 2,334 |
WRA |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
690 |
Discovered through chemical synthesis |
-0.38 |
-1.20 |
-0.30 |
1.00 |
431.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,335 |
WRD |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
376 |
Discovered through chemical synthesis |
-0.70 |
-2.97 |
0.87 |
0.00 |
475.53 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,336 |
WRE |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
350 |
Discovered through chemical synthesis |
-0.67 |
-2.97 |
0.87 |
0.00 |
489.56 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,337 |
WRF |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
413 |
Discovered through chemical synthesis |
-0.26 |
-0.87 |
-0.97 |
1.00 |
507.62 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,338 |
WRG |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
473 |
Discovered through chemical synthesis |
-0.41 |
-1.93 |
-0.13 |
1.00 |
417.50 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,339 |
WRH |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
670 |
Discovered through chemical synthesis |
-0.60 |
-2.87 |
-0.30 |
1.50 |
497.59 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,340 |
WRI |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
730 |
Discovered through chemical synthesis |
-0.22 |
-0.30 |
-0.73 |
1.00 |
473.61 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,341 |
WRK |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
406 |
Discovered through chemical synthesis |
-0.83 |
-3.10 |
0.87 |
2.00 |
488.62 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,342 |
WRL |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
903 |
Discovered through chemical synthesis |
-0.29 |
-0.53 |
-0.73 |
1.00 |
473.61 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,343 |
WRM |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
673 |
Discovered through chemical synthesis |
-0.38 |
-1.17 |
-0.57 |
1.00 |
491.64 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,344 |
WRN |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
403 |
Discovered through chemical synthesis |
-0.68 |
-2.97 |
-0.07 |
1.00 |
474.55 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,345 |
WRP |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
780 |
Discovered through chemical synthesis |
-0.49 |
-2.33 |
-0.13 |
1.00 |
457.56 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,346 |
WRQ |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
720 |
Discovered through chemical synthesis |
-0.69 |
-2.97 |
-0.07 |
1.00 |
488.58 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,347 |
WRR |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
570 |
Discovered through chemical synthesis |
-1.05 |
-3.30 |
0.87 |
2.00 |
516.63 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,348 |
WRS |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
483 |
Discovered through chemical synthesis |
-0.55 |
-2.07 |
-0.03 |
1.00 |
447.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,349 |
WRT |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
526 |
Discovered through chemical synthesis |
-0.52 |
-2.03 |
-0.27 |
1.00 |
461.55 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,350 |
WRW |
Soybean β-amylase |
3 |
Soybean β-amylase |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
487 |
Discovered through chemical synthesis |
-0.34 |
-2.10 |
-1.27 |
1.00 |
546.66 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,351 |
WRY |
β-casein |
3 |
β-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
640 |
Discovered through chemical synthesis |
-0.46 |
-2.23 |
-0.90 |
1.00 |
523.62 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lan et al., 2014 |
| 2,352 |
WWW |
β-casein |
3 |
β-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
216 |
Discovered through chemical synthesis |
0.37 |
-0.90 |
-3.40 |
0.00 |
576.69 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma et al., 2014 |
| 2,353 |
YPY |
β-casein |
3 |
β-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
243.7 |
Discovered through chemical synthesis |
-0.01 |
-1.40 |
-1.53 |
0.00 |
441.51 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2014b |
| 2,354 |
FLQP |
β-casein |
4 |
β-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
65.3 |
Discovered through chemical synthesis |
0.10 |
0.37 |
-1.02 |
0.00 |
503.65 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013d |
| 2,355 |
FLQP |
αs2-casein |
4 |
αs2-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.10 |
0.37 |
-1.02 |
0.00 |
503.65 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,356 |
VLGP |
κ-casein |
4 |
κ-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
580.4 |
Discovered through chemical synthesis |
0.29 |
1.50 |
-0.82 |
0.00 |
384.53 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013d |
| 2,357 |
VRGP |
κ-casein |
4 |
κ-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
>3000 |
Discovered through chemical synthesis |
-0.28 |
-0.57 |
0.38 |
1.00 |
427.55 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013d |
| 2,358 |
WIQP |
κ-casein |
4 |
κ-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
237.3 |
Discovered through chemical synthesis |
0.09 |
-0.38 |
-1.25 |
0.00 |
542.69 |
Non-Toxin |
MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2013d |
| 2,359 |
YPYY |
β-casein |
4 |
β-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
194.4 |
Discovered through chemical synthesis |
0.00 |
-1.38 |
-1.72 |
0.00 |
604.70 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory;MBPDB: Opioid |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2014b |
| 2,360 |
IPIQY |
κ-casein |
5 |
κ-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
35.2 |
Discovered through chemical synthesis |
0.14 |
0.52 |
-1.14 |
0.00 |
632.83 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2014b |
| 2,361 |
IPIQY |
κ-casein |
5 |
κ-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.14 |
0.52 |
-1.14 |
0.00 |
632.83 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,362 |
LPLPL |
Caprine αs1 -CN |
5 |
Caprine αs1 -CN |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
325 |
Discovered through chemical synthesis |
0.29 |
1.64 |
-1.08 |
0.00 |
551.80 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2014b |
| 2,363 |
LPYPY |
Caprine β-casein |
5 |
Caprine β-casein |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
108.3 |
Discovered through chemical synthesis |
0.09 |
-0.40 |
-1.28 |
0.00 |
651.82 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Nongonierma & FitzGerald, 2014b |
| 2,364 |
LPYPY |
β-lactoglobulin |
5 |
β-lactoglobulin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.09 |
-0.40 |
-1.28 |
0.00 |
651.82 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,365 |
HPINHR |
α-lactalbumin |
6 |
α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
452.2 |
Discovered through chemical synthesis |
-0.42 |
-1.92 |
0.07 |
2.00 |
772.95 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Zhang et al., 2016a |
| 2,366 |
GPFPILV |
α-lactalbumin |
7 |
α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
163.7 |
Discovered through chemical synthesis |
0.35 |
1.67 |
-1.09 |
0.00 |
742.03 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Zhang et al., 2016a |
| 2,367 |
IPAVFKIDAL |
α-lactalbumin |
10 |
α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.17 |
1.44 |
-0.44 |
0.00 |
1,086.48 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,368 |
LAHKALCSEK |
α-lactalbumin |
10 |
α-lactalbumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
-0.19 |
-0.16 |
0.32 |
1.50 |
1,099.45 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,369 |
LCSEKLDQWL |
-- |
10 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
-0.14 |
-0.22 |
-0.03 |
-1.00 |
1,234.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,370 |
LPEWVCTTFH |
-- |
10 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
0.06 |
0.27 |
-0.85 |
-0.50 |
1,232.56 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,371 |
WCKDDQNPHS |
-- |
10 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
Discovered through chemical synthesis |
-0.42 |
-2.19 |
0.48 |
-0.50 |
1,229.42 |
Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.tifs.2016.05.008, Lacroix & Li-Chan, 2015 b |
| 2,372 |
CSSV |
-- |
4 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
13.76 × 103 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.02 |
1.27 |
-0.47 |
0.00 |
394.48 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,373 |
YSFR |
-- |
4 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
10.82 × 103 µg/mL |
Identification of purified peptides by LC/MS/MS |
-0.35 |
-0.95 |
-0.38 |
1.00 |
571.67 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,374 |
SAAP |
-- |
4 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
4.46 × 103 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.04 |
0.30 |
-0.17 |
0.00 |
344.40 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,375 |
PGGP |
-- |
4 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
4.23 × 103 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.04 |
-1.00 |
0.00 |
0.00 |
326.40 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,376 |
LGGGN |
-- |
6 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
2.86 × 103 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,377 |
CSSV |
-- |
4 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
206.00 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.02 |
1.27 |
-0.47 |
0.00 |
394.48 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,378 |
YSFR |
-- |
4 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
162.00 µg/mL |
Identification of purified peptides by LC/MS/MS |
-0.35 |
-0.95 |
-0.38 |
1.00 |
571.67 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,379 |
SAAP |
-- |
4 |
Chinese giant salamander (Andrias davidianus) protein hydrolysate |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
66.90 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.04 |
0.30 |
-0.17 |
0.00 |
344.40 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,380 |
PGGP |
-- |
4 |
Cowpea |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
63.50 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.04 |
-1.00 |
0.00 |
0.00 |
326.40 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,381 |
LGGGN |
-- |
6 |
Egg yolk
protein |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
42.93 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,382 |
LGGGN |
Albumin |
6 |
Albumin |
α-amylase and α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
42.93 µg/mL |
Identification of purified peptides by LC/MS/MS |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
10.1080/10942912.2017.1354885 |
| 2,383 |
PRDA |
-- |
4 |
-- |
Enhanced insulin secretions |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.57 |
-1.95 |
1.38 |
0.00 |
457.52 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi:10.1016/j.lfs.2017.10.025 |
| 2,384 |
LAPSLPGKPKPD |
-- |
12 |
-- |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.17 |
-0.79 |
0.43 |
1.00 |
1,219.61 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi:10.1016/j.lfs.2017.10.025 |
| 2,385 |
KLPGF |
-- |
5 |
-- |
α-glucosidase and α-amylase inhibition |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.03 |
0.14 |
-0.26 |
1.00 |
560.76 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
doi:10.1016/j.lfs.2017.10.025 |
| 2,386 |
SQSPA |
-- |
5 |
-- |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
20 μM |
In silico |
-0.21 |
-0.98 |
0.06 |
0.00 |
488.55 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 28884942 |
| 2,387 |
STYV |
-- |
4 |
-- |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
0.012 μM |
In silico |
0.03 |
0.35 |
-0.97 |
0.00 |
468.55 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28884942 |
| 2,388 |
STY |
-- |
3 |
-- |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In silico |
-0.14 |
-0.93 |
-0.80 |
0.00 |
369.40 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28884942 |
| 2,389 |
LPQDIPPL |
-- |
8 |
Bovine hemoglobin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
46 µM |
-- |
0.02 |
0.04 |
-0.28 |
-1.00 |
892.18 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,390 |
IPA |
-- |
3 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.30 |
1.57 |
-0.77 |
0.00 |
299.40 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,391 |
VAPFPEV |
-- |
7 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.17 |
0.90 |
-0.43 |
-1.00 |
757.97 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,392 |
VAAA |
-- |
4 |
Macroalga hydrolyzates (Palmaria palmata) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
0.141 ± 0.014 mM |
-- |
0.32 |
2.40 |
-0.75 |
0.00 |
330.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,393 |
TTAGLLQ |
-- |
7 |
Macroalga hydrolyzates (Palmaria palmata) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
LC-MS-MS |
0.06 |
0.59 |
-0.67 |
0.00 |
702.91 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,394 |
KVSVVAL |
-- |
7 |
Macroalga hydrolyzates (Palmaria palmata) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
LC-MS-MS |
0.15 |
1.93 |
-0.50 |
1.00 |
715.00 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,395 |
ILAP |
-- |
4 |
Human serum albumin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.36 |
2.13 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,396 |
LLAP |
-- |
4 |
Endoribonuclease |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.31 |
1.95 |
-1.02 |
0.00 |
412.58 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,397 |
MAGVDHI |
-- |
7 |
Bovine hemoglobin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.12 |
0.76 |
-0.37 |
-0.50 |
741.96 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,398 |
MIM |
-- |
3 |
Bovine hemoglobin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
800.51 ± 4.90 µM |
-- |
0.42 |
2.77 |
-1.47 |
0.00 |
393.60 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,399 |
RPCF |
-- |
4 |
Bovine hemoglobin |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
1,056.78 ± 61.11 µM |
-- |
-0.30 |
-0.20 |
-0.12 |
1.00 |
521.67 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,400 |
ANVST |
-- |
5 |
-- |
GLP-1 enhancing |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.06 |
0.20 |
-0.38 |
0.00 |
490.57 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,401 |
TKAVEH |
-- |
6 |
-- |
GLP-1 enhancing |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.25 |
-0.88 |
0.52 |
0.50 |
683.84 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,402 |
KAAVT |
-- |
5 |
-- |
GLP-1 enhancing |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.05 |
0.64 |
0.02 |
1.00 |
488.64 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
PMID: 28484425 |
| 2,403 |
LRSELAAWSR |
-- |
10 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.27 |
-0.38 |
0.16 |
1.00 |
1,188.48 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.jff.2019.03.024 |
| 2,404 |
FF |
-- |
2 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.61 |
2.80 |
-2.50 |
0.00 |
312.38 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 28449998, Neves, Harnedy, O’Keeffe, and FitzGerald (2017) |
| 2,405 |
FL |
-- |
2 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.57 |
3.30 |
-2.15 |
0.00 |
278.37 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
-- |
PMID: 28449998, Nongonierma and FitzGerald (2013a) |
| 2,406 |
HL |
-- |
2 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.07 |
0.30 |
-1.15 |
0.50 |
268.34 |
Non-Toxin |
SATPdb;AHTPDB,IEDB |
Type 2 Diabetes |
-- |
PMID: 28449998, Nongonierma and FitzGerald (2013a) |
| 2,407 |
INNQFLPYPY |
k-casein |
10 |
k-casein (51-60) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.02 |
-0.52 |
-1.01 |
0.00 |
1,268.58 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Zhang et al. (2015) |
| 2,408 |
LKPTPEGDL |
b-lactoglobulin |
9 |
b-lactoglobulin (46-54) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.17 |
-0.84 |
0.56 |
-1.00 |
969.23 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Lacroix and Li-Chan (2014) |
| 2,409 |
LKPTPEGDLE |
b-lactoglobulin |
10 |
b-lactoglobulin (46-55) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.22 |
-1.11 |
0.80 |
-2.00 |
1,098.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Lacroix and Li-Chan (2014) |
| 2,410 |
LKPTPEGDLEIL |
b-lactoglobulin |
12 |
b-lactoglobulin (46-57) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.08 |
-0.23 |
0.37 |
-2.00 |
1,324.72 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Lacroix and Li-Chan (2014) |
| 2,411 |
LL |
-- |
2 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.53 |
3.80 |
-1.80 |
0.00 |
244.36 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
-- |
PMID: 28449998, Connolly, O’Keeffe, Nongonierma, Piggott and FitzGerald (2017) |
| 2,412 |
TPEVDDEALEK |
b-lactoglobulin |
11 |
b-lactoglobulin (125-135) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.30 |
-1.26 |
1.25 |
-4.00 |
1,245.45 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Silveira, Martínez-Maqueda, Recio, and Hernández-Ledesma (2013) |
| 2,413 |
VL(I) |
-- |
0 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
-- |
PMID: 28449998, Lan et al. (2015) |
| 2,414 |
VLGP |
b-casein |
4 |
b-casein (197-200) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.29 |
1.50 |
-0.82 |
0.00 |
384.53 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory,IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Nongonierma and FitzGerald (2013c) |
| 2,415 |
VLVLDTDYK |
b-lactoglobulin |
9 |
b-lactoglobulin (92-100) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.06 |
0.34 |
-0.03 |
-1.00 |
1,065.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Silveira et al. (2013) |
| 2,416 |
VPL |
as1-casein |
3 |
as1-casein (167-169) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.33 |
2.13 |
-1.10 |
0.00 |
327.46 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Umezawa et al. (1984) |
| 2,417 |
WK |
Lactoferrin |
2 |
Lactoferrin (268-269) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.37 |
-2.40 |
-0.20 |
1.00 |
332.42 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Nongonierma and FitzGerald (2013d) |
| 2,418 |
WQ |
Lactoferrin |
2 |
Lactoferrin (22-23,) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.16 |
-2.20 |
-1.60 |
0.00 |
332.38 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Nongonierma and FitzGerald (2013d) |
| 2,419 |
YPVEPF |
b-casein |
6 |
b-casein (114-119) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.07 |
-0.17 |
-0.55 |
-1.00 |
750.92 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: Opioid |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998, Nongonierma and FitzGerald (2016b) |
| 2,420 |
AMAPKHKEMPFPKYPVEP |
b-casein |
18 |
b-casein (101–118) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.17 |
-0.93 |
0.26 |
1.50 |
2,097.77 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,421 |
AMAPKHKEMPFPKYP |
b-casein |
15 |
b-casein (101–115) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.20 |
-1.06 |
0.21 |
2.50 |
1,772.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,422 |
AMAPKHKEMPFPKYP |
b-casein |
15 |
b-casein (101–115) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.20 |
-1.06 |
0.21 |
2.50 |
1,772.36 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,423 |
AMAPKHKEMPFPKYPVEP |
b-casein |
19 |
b-casein (101–118) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,424 |
AVPYPQRDMP |
b-casein |
11 |
b-casein (177–186) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,425 |
AVPYPQRDMP |
b-casein |
11 |
b-casein (177–186) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,426 |
EMPFPKYP |
b-casein |
9 |
b-casein (108–115) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,427 |
EMPFPKYPVEP |
b-casein |
11 |
b-casein (108–118) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.11 |
-0.88 |
0.13 |
-1.00 |
1,333.71 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,428 |
FAQTQ |
b-casein |
6 |
b-casein (52–56) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,429 |
FAQTQS |
b-casein |
6 |
b-casein (52–57) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.16 |
-0.65 |
-0.45 |
0.00 |
680.79 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,430 |
FL |
b-casein |
3 |
b-casein (87–88,) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,431 |
FLL |
b-casein |
4 |
b-casein (190–192) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,432 |
FQ |
b-casein |
3 |
b-casein (33–34) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,433 |
FQSEEQQQTEDELQDKIHP |
b-casein |
20 |
b-casein (33–51) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,434 |
FTESQS |
b-casein |
7 |
b-casein (119–124) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,435 |
HKEMPFPKYP |
b-casein |
10 |
b-casein (106–115) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.25 |
-1.59 |
0.24 |
1.50 |
1,273.65 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,436 |
HKEMPFPKYPVEP |
b-casein |
13 |
b-casein (106–118) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.21 |
-1.29 |
0.30 |
0.50 |
1,599.06 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,437 |
IEKFQSEEQQQTEDELQDK |
b-casein |
20 |
b-casein (30–48) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,438 |
IPPLTQTPVVVPPF |
b-casein |
14 |
b-casein (74–87) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.15 |
0.77 |
-0.80 |
0.00 |
1,505.04 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,439 |
IVESLSSSEESITR |
b-casein |
15 |
b-casein (10–25) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,440 |
KAVPYPQRDMP |
b-casein |
11 |
b-casein (176–186) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.31 |
-1.24 |
0.33 |
1.00 |
1,301.67 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,441 |
L(I)E |
b-casein |
0 |
b-casein (3–4) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,442 |
LEE |
b-casein |
3 |
b-casein (3–5) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.24 |
-1.07 |
1.40 |
-2.00 |
389.44 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,443 |
LGP |
b-casein |
3 |
b-casein (198–200) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.21 |
0.60 |
-0.60 |
0.00 |
285.38 |
Non-Toxin |
SATPdb;AHTPDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,444 |
LGPVRGPFP |
b-casein |
9 |
b-casein (198–206) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.08 |
-0.31 |
1.00 |
939.25 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,445 |
LGPVRGPFPI |
b-casein |
11 |
b-casein (198–207) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,446 |
LHLPLP |
b-casein |
7 |
b-casein (133–138) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,447 |
LHLPLPL |
b-casein |
8 |
b-casein (133–139) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,448 |
LL |
b-casein |
2 |
b-casein (139–140) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.53 |
3.80 |
-1.80 |
0.00 |
244.36 |
Non-Toxin |
SATPdb;AHTPDB;MBPDB: ACE-inhibitory |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,449 |
LLQ |
b-casein |
4 |
b-casein (139–141) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,450 |
LLQS |
b-casein |
5 |
b-casein (139–142) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,451 |
L(I)N |
b-casein |
5 |
b-casein (6–7) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,452 |
LNVPGE |
b-casein |
6 |
b-casein (6–11) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.02 |
-0.17 |
-0.02 |
-1.00 |
627.78 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,453 |
L(I)Q |
b-casein |
0 |
b-casein (45–46) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,454 |
LQPEVMG |
b-casein |
7 |
b-casein (88–94) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.02 |
0.13 |
-0.20 |
-1.00 |
773.02 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,455 |
LQPEVMG |
b-casein |
7 |
b-casein (88–94) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.02 |
0.13 |
-0.20 |
-1.00 |
773.02 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,456 |
LS |
b-casein |
3 |
b-casein (88–94,) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,457 |
LSQ/LQS |
b-casein |
8 |
b-casein (165–167) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,458 |
LSQSK |
b-casein |
5 |
b-casein (165–169) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.36 |
-1.04 |
0.40 |
1.00 |
561.70 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,459 |
LSQSKVLPVPQ |
b-casein |
12 |
b-casein (165–175) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,460 |
LSQSKVLPVPQK |
b-casein |
13 |
b-casein (165–176) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,461 |
L(I)T |
b-casein |
0 |
b-casein (77–78,) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,462 |
LTDVEN |
b-casein |
7 |
b-casein (127–132) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,463 |
LTL |
b-casein |
4 |
b-casein (125–127) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,464 |
LTQTP |
b-casein |
5 |
b-casein (77–81) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.12 |
-0.54 |
-0.48 |
0.00 |
558.70 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,465 |
LTQTPVVVPPF |
b-casein |
12 |
b-casein (77–87) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,466 |
LTQTPVVVPPF |
b-casein |
11 |
b-casein (77–87) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.14 |
0.86 |
-0.85 |
0.00 |
1,197.60 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,467 |
LV |
b-casein |
3 |
b-casein (58–59) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,468 |
LVYPFPGPIPN |
b-casein |
12 |
b-casein (58–68) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,469 |
LVYPFPGPIPNSLPQNIPP |
b-casein |
19 |
b-casein (58–76) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.06 |
-0.03 |
-0.66 |
0.00 |
2,060.71 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,470 |
LVYPFPGPIPNSLPQNIPPLTQTPVVVPPF |
b-casein |
31 |
b-casein (58–87) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,471 |
LY |
b-casein |
2 |
b-casein (192–193) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.28 |
1.25 |
-2.05 |
0.00 |
294.37 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,472 |
LYQEPVLGP |
b-casein |
10 |
b-casein (192–200) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,473 |
LYQEPVLGPVRGPFP |
b-casein |
15 |
b-casein (192–206) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.02 |
-0.08 |
-0.35 |
0.00 |
1,669.18 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,474 |
LYQEPVLGPVRGPFPIIV |
b-casein |
19 |
b-casein (192–209) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,475 |
MAPKHKEMPFPKYP |
b-casein |
15 |
b-casein (102–115) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,476 |
MAPKHKEMPFPKYPVEP |
b-casein |
18 |
b-casein (102–118) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,477 |
SLPQNIPP |
b-casein |
8 |
b-casein (69–76) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.07 |
-0.54 |
-0.36 |
0.00 |
865.11 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,478 |
SLPQNIPPLTQTP |
b-casein |
13 |
b-casein (69–81) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.09 |
-0.54 |
-0.41 |
0.00 |
1,405.81 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,479 |
VEP |
b-casein |
3 |
b-casein (116–118) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.05 |
-0.30 |
0.50 |
-1.00 |
343.41 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,480 |
VLGP |
b-casein |
5 |
b-casein (197–200) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,481 |
VLGPVRGPFP |
b-casein |
10 |
b-casein (197–206) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.06 |
0.49 |
-0.43 |
1.00 |
1,038.40 |
Non-Toxin |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,482 |
VRGPFP |
b-casein |
7 |
b-casein (201–206) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,483 |
VYPFPGP |
b-casein |
7 |
b-casein (59–65) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.16 |
0.07 |
-0.90 |
0.00 |
775.99 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,484 |
VYPFPGPIPNSLPQNIPP |
b-casein |
19 |
b-casein (59–76) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-- |
-- |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,485 |
VYPFPGPIPNSLPQNIPPLTQTP |
b-casein |
23 |
b-casein (59–81) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
0.00 |
-0.31 |
-0.57 |
0.00 |
2,488.23 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,486 |
WMHQPHQPLPPT |
b-casein |
12 |
b-casein (143–154) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.12 |
-1.31 |
-0.62 |
1.00 |
1,468.88 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
Natural Peptide |
PMID: 28449998 |
| 2,487 |
WMHQPHQPLPPT |
b-casein |
12 |
b-casein (143–154) |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-0.12 |
-1.31 |
-0.62 |
1.00 |
1,468.88 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
PMID: 28449998 |
| 2,488 |
SVPA |
-- |
4 |
-- |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.12 |
0.90 |
-0.42 |
0.00 |
372.46 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.biopha.2018.07.163 |
| 2,489 |
SEPA |
-- |
4 |
-- |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.17 |
-1.03 |
0.70 |
-1.00 |
402.44 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.biopha.2018.07.163 |
| 2,490 |
SVPA |
-- |
4 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.12 |
0.90 |
-0.42 |
0.00 |
372.46 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.biopha.2018.07.163 |
| 2,491 |
SEPA |
-- |
4 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.17 |
-1.03 |
0.70 |
-1.00 |
402.44 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.biopha.2018.07.163 |
| 2,492 |
LRSELAAWSR |
-- |
10 |
-- |
DPP-IV inhibitory |
-- |
-- |
-- |
-- |
-- |
167.3 μg/mL |
-- |
-0.27 |
-0.38 |
0.16 |
1.00 |
1,188.48 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.jff.2019.03.024 |
| 2,493 |
LRSELAAWSR |
-- |
10 |
-- |
α-glucosidase inhibitory |
-- |
-- |
-- |
-- |
-- |
134.2 μg/mL |
-- |
-0.27 |
-0.38 |
0.16 |
1.00 |
1,188.48 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.jff.2019.03.024 |
| 2,494 |
SPELTHRFFS |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.18 |
-0.57 |
-0.11 |
0.50 |
1,220.48 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,495 |
WQLNLAWGFF |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.21 |
0.58 |
-1.55 |
0.00 |
1,281.63 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,496 |
QLLPWF |
-- |
6 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.21 |
0.73 |
-1.55 |
0.00 |
803.06 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,497 |
QFDDGPF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.12 |
-0.99 |
0.17 |
-2.00 |
824.93 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,498 |
DNGYPVFF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.06 |
-0.06 |
-0.70 |
-1.00 |
958.14 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,499 |
WAAGCNHNPF |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.01 |
-0.42 |
-0.80 |
0.50 |
1,116.35 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,500 |
NPEPPVFF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.04 |
-0.25 |
-0.41 |
-1.00 |
946.17 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,501 |
FMKPSWDF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.04 |
-0.40 |
-0.42 |
0.00 |
1,057.33 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,502 |
SYYVAGFF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.24 |
0.97 |
-1.41 |
0.00 |
953.16 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,503 |
AEKFGPW |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.06 |
-0.81 |
-0.06 |
0.00 |
834.03 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,504 |
SESPWAF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.00 |
-0.43 |
-0.40 |
-1.00 |
822.95 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,505 |
NYGWRY |
-- |
6 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.30 |
-1.98 |
-0.80 |
1.00 |
858.00 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,506 |
NPEGLLPF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.05 |
-0.03 |
-0.36 |
-1.00 |
886.13 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,507 |
ALSEWKLF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.04 |
0.39 |
-0.46 |
0.00 |
993.28 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,508 |
VDMYWKM |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.05 |
-0.23 |
-0.54 |
0.00 |
972.28 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,509 |
DTRFPDPF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.29 |
-1.23 |
0.45 |
-1.00 |
994.16 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,510 |
VYMHLLF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.30 |
1.71 |
-1.67 |
0.50 |
922.26 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,511 |
PVNYDWQRWR |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.43 |
-2.00 |
-0.12 |
1.00 |
1,419.70 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,512 |
HLDMAGFM |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.12 |
0.64 |
-0.61 |
-0.50 |
921.21 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,513 |
WAAGKNEPPM |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.12 |
-0.99 |
0.05 |
0.00 |
1,100.39 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,514 |
WAAGKNEPPM |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.12 |
-0.99 |
0.05 |
0.00 |
1,100.39 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,515 |
MDSYFF |
-- |
6 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.09 |
0.32 |
-0.88 |
-1.00 |
808.97 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,516 |
FMVFMVPF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.42 |
2.38 |
-1.64 |
0.00 |
1,017.42 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,517 |
VWDPFKDF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.06 |
-0.45 |
-0.11 |
-1.00 |
1,053.28 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,518 |
QFDDGPF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.12 |
-0.99 |
0.17 |
-2.00 |
824.93 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,519 |
PVNYDWQWRR |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.43 |
-2.00 |
-0.12 |
1.00 |
1,419.70 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,520 |
TAYWYGF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.18 |
0.00 |
-1.63 |
0.00 |
907.08 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,521 |
SPNLLWANPF |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.06 |
0.03 |
-0.93 |
0.00 |
1,158.46 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,522 |
LVYMCPF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.28 |
1.76 |
-1.49 |
0.00 |
872.20 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,523 |
WSVNLLF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.24 |
1.34 |
-1.50 |
0.00 |
878.14 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,524 |
FSDEAFDGRW |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.21 |
-0.97 |
0.34 |
-2.00 |
1,229.39 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,525 |
SPLRNFL |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.15 |
0.00 |
-0.37 |
1.00 |
846.09 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,526 |
CHGSDLRF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.23 |
-0.41 |
0.06 |
0.50 |
934.14 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,527 |
ALPNFVLM |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.25 |
1.65 |
-1.15 |
0.00 |
904.25 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,528 |
SERFPDPF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.29 |
-1.24 |
0.54 |
-1.00 |
994.16 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,529 |
QMDDGPF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.17 |
-1.11 |
0.34 |
-2.00 |
808.95 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,530 |
NPEGLLPF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.05 |
-0.03 |
-0.36 |
-1.00 |
886.13 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,531 |
MWDLMDVF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.14 |
0.84 |
-0.72 |
-2.00 |
1,056.37 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,532 |
AGGGGLDLRF |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.01 |
0.26 |
-0.06 |
0.00 |
962.22 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,533 |
ALSEWKLF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.04 |
0.39 |
-0.46 |
0.00 |
993.28 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,534 |
AAHTSWPF |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.07 |
-0.10 |
-0.94 |
0.50 |
916.10 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,535 |
WWEHLPT |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.00 |
-1.00 |
-0.93 |
-0.50 |
968.18 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,536 |
LGAFSPEFDC |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.05 |
0.39 |
-0.20 |
-2.00 |
1,085.32 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,537 |
VYMHLLF |
-- |
7 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.30 |
1.71 |
-1.67 |
0.50 |
922.26 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,538 |
MPVNYDWQR |
-- |
9 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.30 |
-1.41 |
-0.23 |
0.00 |
1,208.48 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,539 |
AMPVMRLP |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.01 |
0.74 |
-0.42 |
1.00 |
914.30 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,540 |
SPELTHRFFS |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.18 |
-0.57 |
-0.11 |
0.50 |
1,220.48 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,541 |
LAAGSNCTMF |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.10 |
0.92 |
-0.75 |
0.00 |
1,014.31 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,542 |
FPVNYDKW |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.12 |
-0.96 |
-0.44 |
0.00 |
1,068.30 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,543 |
DHVWKWLY |
-- |
8 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
-0.05 |
-0.71 |
-0.86 |
0.50 |
1,146.43 |
Non-Toxin |
IEDB |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
| 2,544 |
ALADALGSLF |
-- |
10 |
-- |
α-amylase inhibitory |
-- |
-- |
-- |
-- |
-- |
-- |
In vitro |
0.21 |
1.49 |
-0.61 |
-1.00 |
977.26 |
Non-Toxin |
-- |
Type 2 Diabetes |
-- |
10.1016/j.peptides.2018.03.001 |
